data_1rkn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1rkn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HE2' ' CG ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.763 0.316 . . . . 0.0 110.952 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -121.68 136.27 25.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.771 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.02 128.45 4.37 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.597 2.198 . . . . 0.0 112.434 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.38 126.11 11.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.572 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 p -86.98 108.74 18.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.04 0.447 . . . . 0.0 111.556 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 24' ' ' LYS . 2.3 tt -69.51 114.93 8.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.914 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.597 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.6 pp -74.96 -43.8 45.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.597 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 1.4 ttmt -167.6 143.32 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.911 0.386 . . . . 0.0 111.901 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.39 148.21 25.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.518 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.3 mt -102.52 -76.07 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.21 30.67 7.1 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.622 0.231 . . . . 0.0 111.622 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.4 -45.0 2.93 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.736 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -96.64 -66.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.745 0.307 . . . . 0.0 110.419 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 m -66.75 106.84 1.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.013 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.4 ' HB ' HD21 ' A' ' 14' ' ' LEU . 34.3 m -133.17 150.53 32.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.479 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.453 ' HG2' HG12 ' A' ' 15' ' ' ILE . 1.6 tppp? -80.06 143.75 33.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.332 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -140.84 117.84 11.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.216 -179.353 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.603 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -71.83 99.05 2.1 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.012 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 8.7 t80 -94.43 109.05 20.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.13 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.9 48.81 7.14 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.767 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.63 -14.17 48.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.9 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.464 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -119.97 97.81 49.4 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 32.2 Cg_exo -60.21 145.52 98.34 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.984 2.456 . . . . 0.0 114.052 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.416 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 29.9 mtm -145.34 140.1 27.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.101 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.451 ' C ' ' CD1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -79.89 157.02 27.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.189 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.552 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 16.6 m-85 -141.14 142.9 34.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.012 0.434 . . . . 0.0 111.913 -177.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.65 99.83 8.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.859 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.563 -179.157 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.417 ' HB3' ' CB ' ' A' ' 60' ' ' ALA . 2.9 Cg_endo . . . . . 0 CA--C 1.535 0.531 0 N-CA-C 116.215 1.583 . . . . 0.0 116.215 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.538 ' HA ' ' CB ' ' A' ' 61' ' ' PHE . 4.4 tp10 -43.13 -25.56 0.12 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -91.41 -65.37 1.02 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.0 m -88.18 -30.33 19.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.417 ' CB ' ' HB3' ' A' ' 56' ' ' PRO . . . -89.45 -37.64 14.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.538 ' CB ' ' HA ' ' A' ' 57' ' ' GLU . 10.4 t80 -90.68 -43.49 10.1 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 21.3 m -40.85 -66.92 0.28 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.518 ' CB ' ' HA ' ' A' ' 16' ' ' LYS . 0.6 OUTLIER -74.19 -19.85 60.4 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 3.1 mttp -59.09 -54.59 45.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 111.125 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -58.89 -27.49 65.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.03 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 42.7 t -72.44 -30.99 36.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.106 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -86.68 -13.99 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.555 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -96.2 -28.34 14.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.684 0.278 . . . . 0.0 111.291 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.22 147.52 31.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.805 0.336 . . . . 0.0 111.168 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.5 pttt -97.73 24.48 6.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.4 98.98 3.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.819 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 93' ' ' TYR . 2.5 mp -121.84 93.76 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.733 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.419 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.8 tt0 -106.56 132.75 52.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.798 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.6 m -103.66 126.87 58.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.15 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.4 ' CG ' ' HE2' ' A' ' 9' ' ' LYS . 1.8 tt0 -79.9 52.63 1.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.322 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.757 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -97.01 149.73 21.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.649 -179.11 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.03 159.77 26.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.888 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.5 29.98 3.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.091 0.472 . . . . 0.0 110.452 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.77 35.93 0.58 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.433 ' CG ' ' CE3' ' A' ' 88' ' ' TRP . 2.0 tp60 -78.27 124.52 28.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.405 0.622 . . . . 0.0 110.707 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -67.53 88.29 0.22 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.957 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.432 HG22 ' CD1' ' A' ' 88' ' ' TRP . 92.0 m . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.552 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 78.3 m95 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.757 ' O ' ' HB2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -76.93 158.76 30.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.466 ' N ' HD21 ' A' ' 89' ' ' LEU . . . 173.02 164.61 0.13 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.263 0.554 . . . . 0.0 112.342 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -130.35 57.09 1.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.989 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -42.07 127.77 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.424 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.46 ' CB ' ' HA ' ' A' ' 98' ' ' MET . 3.1 p90 -142.89 143.88 32.23 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.075 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -112.81 124.18 52.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.789 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.66 29.07 7.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.874 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.11 -35.89 3.93 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.001 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.94 130.43 34.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.904 0.383 . . . . 0.0 111.202 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.46 ' HA ' ' CB ' ' A' ' 93' ' ' TYR . 2.7 ttt -78.97 150.1 32.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.306 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.433 ' CG1' ' HA ' ' A' ' 62' ' ' THR . 25.8 m . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.946 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HE2' ' CG ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.845 0.355 . . . . 0.0 111.127 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -104.79 127.98 27.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.518 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 83.5 Cg_endo -90.02 163.69 4.86 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.752 2.301 . . . . 0.0 112.496 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.457 ' CB ' HD11 ' A' ' 25' ' ' LEU . . . -166.34 161.42 16.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.336 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.6 p -93.55 108.34 20.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.327 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 2.2 tm? -89.15 119.57 29.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.149 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.499 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -74.76 -42.42 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.458 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.499 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 0.0 OUTLIER 179.87 173.17 0.96 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.249 0.547 . . . . 0.0 112.109 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.43 103.61 13.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.648 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' THR . 41.1 mm -53.3 -75.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.934 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -110.98 42.08 1.69 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.54 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.444 ' HA2' ' CB ' ' A' ' 58' ' ' ALA . . . 84.24 -52.15 4.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.924 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.49 -35.85 10.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.819 0.343 . . . . 0.0 110.422 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -71.39 106.79 4.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.27 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.455 ' HB ' ' CD2' ' A' ' 14' ' ' LEU . 3.2 m -122.99 129.35 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.685 0.279 . . . . 0.0 111.245 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -91.71 97.98 11.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.687 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.812 ' HG ' ' CE1' ' A' ' 34' ' ' PHE . 2.8 pp -110.51 137.72 47.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.662 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.559 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 29.0 ttm -72.51 99.96 2.62 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.533 ' CE1' ' CE1' ' A' ' 76' ' ' PHE . 86.9 t80 -88.51 109.42 20.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.174 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.457 ' O ' ' OE1' ' A' ' 30' ' ' GLN . 0.1 OUTLIER 49.18 28.27 2.12 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.821 179.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.44 -14.24 54.33 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.396 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -116.87 97.73 50.96 Favored Pre-proline 0 C--N 1.331 -0.239 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 34.1 Cg_exo -61.03 143.13 99.11 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.286 1.991 . . . . 0.0 113.129 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.438 ' O ' ' HE1' ' A' ' 34' ' ' PHE . 51.8 mtt -145.2 159.78 42.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.25 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.483 ' C ' ' CD1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -97.17 156.61 16.32 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.812 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.0 m-85 -138.05 157.98 45.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.789 0.328 . . . . 0.0 111.493 -177.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -139.13 99.06 3.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.584 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.529 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.426 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 87.3 Cg_exo . . . . . 0 CA--C 1.529 0.243 0 N-CA-C 114.087 0.764 . . . . 0.0 114.087 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -93.88 -44.75 7.94 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.444 ' CB ' ' HA2' ' A' ' 20' ' ' GLY . . . -90.51 -65.4 1.02 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.5 p -65.57 -36.96 85.3 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.426 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . . . -89.38 -57.4 2.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.507 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -61.07 -69.14 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 42.9 m -40.85 -66.57 0.31 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -25.47 43.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.21 -63.17 1.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 0.0 111.878 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.422 ' HG3' ' CD2' ' A' ' 61' ' ' PHE . 1.6 mmm -50.86 -24.84 3.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.914 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.427 HG12 HD11 ' A' ' 14' ' ' LEU . 30.0 m -76.99 -31.02 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -94.18 -11.48 30.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.295 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -98.04 -28.17 13.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.66 0.267 . . . . 0.0 111.303 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.68 143.91 31.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.884 0.374 . . . . 0.0 111.171 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -97.48 29.32 3.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.29 98.88 2.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.134 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mt -119.23 94.67 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.397 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -94.94 137.18 34.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.86 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.407 ' CG1' ' CB ' ' A' ' 90' ' ' ALA . 21.3 t -116.97 102.87 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.423 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.41 ' CG ' ' HE2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -71.59 63.48 0.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.056 179.267 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.551 ' C ' ' CD1' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -107.43 167.12 10.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.951 0.405 . . . . 0.0 111.834 -178.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -104.29 162.05 13.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.34 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -101.0 32.6 3.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.414 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.69 33.55 0.32 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.567 ' HB2' ' CE3' ' A' ' 88' ' ' TRP . 1.4 mm-40 -78.37 128.96 34.4 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.542 0.686 . . . . 0.0 110.857 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.2 mtp85 -63.55 78.18 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 48.3 m . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.84 179.975 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.567 ' CE3' ' HB2' ' A' ' 80' ' ' GLN . 63.9 m95 . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -77.36 164.43 25.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.431 ' N ' ' CD2' ' A' ' 89' ' ' LEU . . . 175.28 172.89 0.27 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.288 0.566 . . . . 0.0 112.396 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -141.78 41.7 1.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.98 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -41.96 127.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.056 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.498 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 2.2 p90 -143.98 153.93 42.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.471 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.51 135.48 53.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.685 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.85 23.91 12.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.147 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.53 -12.17 65.98 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.037 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.38 127.64 53.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.943 0.401 . . . . 0.0 110.988 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.498 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 1.5 mpt? -71.61 150.12 44.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.155 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.1 m . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.113 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.836 0.35 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -123.82 115.74 27.87 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.672 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.92 161.15 7.47 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.688 2.258 . . . . 0.0 112.437 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.471 ' CB ' HD12 ' A' ' 25' ' ' LEU . . . -166.15 172.17 11.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.448 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.1 t -103.12 108.7 19.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.071 0.462 . . . . 0.0 111.264 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 2.8 tt -76.09 125.83 29.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.778 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.541 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.7 pp -74.9 -46.01 41.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.393 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.541 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 4.1 mtmt 178.99 173.23 0.77 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.992 0.425 . . . . 0.0 111.373 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.476 ' CB ' ' HA ' ' A' ' 59' ' ' SER . . . -98.72 148.05 24.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.391 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 92.5 mt -102.71 -72.15 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.497 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -117.71 42.05 2.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.738 0.304 . . . . 0.0 111.532 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.37 -54.76 4.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.543 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.54 -35.72 11.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.018 0.437 . . . . 0.0 110.196 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.2 m -76.62 106.91 8.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.158 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.5 m -126.12 161.72 31.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.867 0.365 . . . . 0.0 111.189 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.457 ' HD2' ' HB2' ' A' ' 31' ' ' PRO . 0.5 OUTLIER -119.41 134.18 55.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.297 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.853 ' HG ' ' CE1' ' A' ' 34' ' ' PHE . 1.3 pp -141.72 132.64 25.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.61 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -72.89 99.53 2.7 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.871 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.454 ' CE2' ' CE1' ' A' ' 76' ' ' PHE . 5.8 t80 -88.88 112.37 23.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.777 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 45.06 36.73 2.13 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.711 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.05 -14.41 65.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.457 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.26 97.34 49.51 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 51.6 Cg_endo -69.63 150.06 68.51 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.537 2.158 . . . . 0.0 112.994 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.401 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 3.4 mmt -145.3 161.17 40.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.049 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.06 124.08 40.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.853 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 2.1 m-85 -111.45 149.51 31.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.911 0.386 . . . . 0.0 111.693 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.574 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 3.4 ttp85 -139.09 110.41 6.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.168 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.644 ' N ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.318 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.288 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo . . . . . 0 N--CA 1.473 0.309 0 N-CA-C 116.079 1.53 . . . . 0.0 116.079 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 5.8 mm-40 -48.82 -16.45 0.13 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.424 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -90.52 -62.31 1.49 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.671 0.272 . . . . 0.0 111.184 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.476 ' HA ' ' CB ' ' A' ' 17' ' ' ALA . 57.8 p -90.66 -48.98 6.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.975 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.06 -35.41 64.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.224 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.439 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 2.1 t80 -90.35 -19.92 23.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.479 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 1.0 OUTLIER -77.59 -67.16 0.75 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.56 0.219 . . . . 0.0 111.331 -179.453 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -23.79 64.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 111.34 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -80.93 -49.19 11.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.629 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.405 ' HG3' ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -50.03 -28.91 7.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.412 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.405 ' N ' ' HG3' ' A' ' 65' ' ' MET . 27.1 m -91.72 -26.89 4.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.273 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -76.51 -9.72 58.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.657 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -114.22 -28.1 7.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.606 0.241 . . . . 0.0 111.433 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.03 132.41 50.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 0.0 111.173 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -86.21 4.34 39.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.263 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.78 106.59 12.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.896 0.379 . . . . 0.0 110.968 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mt -127.3 95.07 2.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.654 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -95.25 150.09 20.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.663 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.409 ' CG1' ' CB ' ' A' ' 90' ' ' ALA . 2.6 t -128.98 116.38 40.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.36 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -86.89 49.76 1.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.026 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -92.97 145.24 24.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.055 -179.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -91.26 158.96 16.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.001 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -95.27 29.52 2.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.193 0.52 . . . . 0.0 110.25 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -153.49 37.68 0.73 Allowed Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -77.82 128.16 33.54 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.321 0.581 . . . . 0.0 110.198 -179.039 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -63.51 65.18 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.112 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.53 ' CG2' ' CE2' ' A' ' 88' ' ' TRP . 14.4 t . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.507 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.607 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 66.5 m95 . . . . . 0 C--O 1.225 -0.186 0 CA-C-O 120.899 0.38 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -77.86 159.23 29.07 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.515 ' H ' ' HG ' ' A' ' 36' ' ' LEU . . . -179.75 145.92 0.24 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -108.01 52.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.627 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mp -57.71 132.94 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.504 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.458 ' CZ ' ' HB3' ' A' ' 73' ' ' GLU . 2.9 p90 -150.57 153.04 35.03 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.359 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.95 131.99 54.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.828 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.7 t70 67.57 25.9 8.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.021 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.31 19.91 77.77 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.842 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -137.1 114.11 10.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.923 0.392 . . . . 0.0 110.896 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.424 ' CA ' ' HB3' ' A' ' 93' ' ' TYR . 16.0 ptp -75.39 150.19 38.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.091 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt . . . . . 0 N--CA 1.461 0.083 0 CA-C-O 120.871 0.367 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 4.5 mm-40 -136.05 145.56 52.95 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 10' ' ' GLU . 1.3 Cg_endo -83.42 105.49 1.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.735 2.29 . . . . 0.0 112.316 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.2 135.5 53.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.501 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.1 m -86.88 108.82 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.93 0.395 . . . . 0.0 111.644 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.431 ' CD2' ' CB ' ' A' ' 63' ' ' LYS . 10.2 tt -73.44 113.43 10.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.95 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.592 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.5 pp -74.7 -43.44 47.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.341 -0.391 . . . . 0.0 112.052 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.592 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 37.9 tttp -173.65 151.56 1.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.077 0.465 . . . . 0.0 111.935 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.91 148.21 23.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.671 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.0 mt -103.1 -73.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.687 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.12 26.86 9.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.633 0.254 . . . . 0.0 111.481 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.4 ' HA2' ' CB ' ' A' ' 58' ' ' ALA . . . 90.13 -44.33 2.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.744 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.7 -54.37 3.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 110.328 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.0 m -78.26 106.89 10.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.141 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.57 157.37 42.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.464 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.455 ' HB3' HG13 ' A' ' 15' ' ' ILE . 32.2 tttt -91.76 142.77 27.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.47 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.658 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -141.28 117.69 10.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.928 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.479 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -71.85 99.18 2.14 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 17.3 t80 -95.62 108.54 20.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.907 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.94 41.55 14.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.147 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.85 -14.13 61.07 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.459 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.471 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -117.75 98.19 51.43 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.999 0.428 . . . . 0.0 110.277 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.658 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 26.6 Cg_endo -62.54 144.4 94.43 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.705 2.27 . . . . 0.0 113.327 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.6 mmt -145.17 155.84 43.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.082 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 p -85.79 122.11 29.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.817 0.341 . . . . 0.0 111.214 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.616 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 16.8 m-85 -113.79 107.9 16.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.436 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 88' ' ' TRP . 7.6 ttt180 -97.41 115.0 26.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.223 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.164 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.05 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo . . . . . 0 C--O 1.232 0.191 0 N-CA-C 114.422 0.893 . . . . 0.0 114.422 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.701 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 15.8 tm-20 -91.77 -64.61 1.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -60.46 -40.71 92.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.9 m -93.63 -43.4 8.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 64' ' ' LYS . . . -89.5 -34.61 16.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.701 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 4.1 t80 -90.1 -24.34 21.14 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 1.7 m -56.82 -66.84 0.38 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.734 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -77.72 -19.73 54.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -48.03 -51.63 23.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 0.0 111.388 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.4 ttp -70.49 -17.61 62.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.305 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.1 t -88.64 -11.63 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.518 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -93.99 -6.77 44.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -114.7 -27.9 7.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.562 0.22 . . . . 0.0 111.447 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.9 142.26 32.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 111.343 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.92 28.57 4.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.556 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.2 98.92 3.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.005 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -129.18 93.24 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.641 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 8.1 mt-10 -102.65 133.5 47.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.883 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.8 m -104.26 138.26 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -89.09 48.47 1.63 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.982 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -93.7 150.96 19.98 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.518 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.612 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 3.3 t70 -87.26 162.48 17.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.996 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.38 32.44 0.95 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.421 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.69 31.29 0.17 Allowed Glycine 0 CA--C 1.507 -0.46 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.612 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 11.5 mm-40 -81.74 127.93 33.46 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.684 0.754 . . . . 0.0 111.847 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -42.05 129.57 3.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.148 -1.387 . . . . 0.0 111.807 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.457 ' CG2' ' CE2' ' A' ' 88' ' ' TRP . 43.6 p . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.033 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.616 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 54.1 m95 . . . . . 0 C--O 1.223 -0.326 0 CA-C-O 121.038 0.446 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.574 ' CD1' ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -77.96 164.89 24.7 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.925 178.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 89' ' ' LEU . . . 166.06 147.88 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.232 0.539 . . . . 0.0 111.677 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -99.47 -34.18 10.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.956 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.8 mp 59.03 115.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.508 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 6.4 p90 -141.16 136.46 31.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.986 0.422 . . . . 0.0 111.502 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 95' ' ' ASP . . . -106.0 112.5 25.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.731 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 94' ' ' ALA . 5.1 m-20 80.37 27.16 0.28 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.951 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.21 -28.63 9.34 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.957 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.77 130.85 39.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 111.165 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.44 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -76.5 145.35 39.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.922 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.213 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.449 ' HE3' ' HA ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.817 0.342 . . . . 0.0 111.159 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -151.67 113.74 2.99 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.776 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 89.7 Cg_endo -85.35 110.72 1.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.63 2.22 . . . . 0.0 112.518 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.83 156.32 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.594 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -98.1 108.09 20.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.124 0.488 . . . . 0.0 111.656 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.471 ' C ' ' CD1' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -76.28 108.93 9.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.643 178.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.483 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -74.79 -46.93 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.304 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.483 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -178.56 173.11 1.36 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.116 0.484 . . . . 0.0 111.776 179.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.86 148.26 22.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.951 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.4 mt -104.2 -70.38 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.781 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.05 42.22 2.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.726 0.298 . . . . 0.0 111.524 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.77 -57.21 5.05 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.52 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -96.74 -38.28 9.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.912 0.387 . . . . 0.0 110.116 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.7 106.75 9.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.106 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.42 143.6 40.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.333 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HG2' HG12 ' A' ' 15' ' ' ILE . 9.1 tppt? -81.88 142.78 32.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.509 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.611 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -141.79 118.44 11.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.543 -179.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.578 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -72.4 99.39 2.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.452 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 20.8 t80 -96.33 107.54 19.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.203 -177.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm 45.13 48.98 9.85 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.652 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.13 -14.1 51.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.789 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.462 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -119.86 97.84 49.56 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 121.011 0.434 . . . . 0.0 110.019 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 24.6 Cg_exo -65.26 143.34 76.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.857 2.372 . . . . 0.0 113.38 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 mmt -145.05 151.86 39.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.555 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 m -86.68 121.2 28.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.545 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.599 ' CD1' ' HB2' ' A' ' 25' ' ' LEU . 2.1 m-85 -109.79 125.54 52.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.005 0.431 . . . . 0.0 111.518 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -98.61 118.07 34.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.976 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.803 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo . . . . . 0 CA--C 1.529 0.244 0 N-CA-C 113.405 0.502 . . . . 0.0 113.405 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.461 ' HG2' ' N ' ' A' ' 58' ' ' ALA . 13.7 pm0 -94.24 -46.79 6.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.592 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -91.16 -65.67 0.99 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.8 m -60.66 -37.82 82.84 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.52 -61.83 1.61 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.448 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -55.34 -51.7 65.91 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.592 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 85.1 m -55.47 -66.26 0.45 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.619 0.247 . . . . 0.0 111.499 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -23.11 15.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -88.07 -55.86 3.57 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.51 -26.49 3.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.716 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 14' ' ' LEU . 36.0 t -91.73 -10.56 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -94.11 -5.97 46.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -111.2 -27.34 8.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.626 0.25 . . . . 0.0 111.426 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.62 141.12 37.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 0.0 111.172 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.27 29.04 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.762 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.439 ' HG3' ' HA ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -145.46 98.72 3.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.807 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 mp -127.67 92.14 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.665 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -94.87 147.58 23.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.754 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.7 t -116.31 129.15 73.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.684 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.449 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 34.2 tt0 -93.62 54.32 2.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.221 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.554 ' HA ' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -94.89 167.31 11.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.164 -178.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.428 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 2.0 t70 -104.43 162.55 13.14 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.041 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -94.18 28.78 2.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.936 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.62 26.93 0.2 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.571 ' HG3' ' CD1' ' A' ' 89' ' ' LEU . 1.8 mm-40 -78.54 127.12 31.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.63 0.729 . . . . 0.0 110.983 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -39.71 127.1 1.99 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.515 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 75.2 p . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.088 -179.748 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.545 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 96.2 m95 . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 120.88 0.371 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.571 ' CD1' ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -76.64 158.29 31.19 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.432 ' N ' HD23 ' A' ' 89' ' ' LEU . . . 179.66 160.73 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.264 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -113.1 -35.94 5.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.92 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.6 mt 59.67 119.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.809 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.423 ' OH ' ' HB3' ' A' ' 73' ' ' GLU . 4.9 p90 -141.63 123.44 15.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 95' ' ' ASP . . . -99.25 96.55 7.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.665 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 94' ' ' ALA . 2.7 t0 85.26 55.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.997 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.11 27.71 57.69 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.852 -0.613 . . . . 0.0 113.453 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -137.25 112.72 9.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 0.0 111.001 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.401 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -78.21 136.12 37.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.068 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.98 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.92 0.39 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 1.4 mp0 -141.57 113.89 6.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.632 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 5.8 Cg_exo -78.69 114.1 3.4 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.566 2.177 . . . . 0.0 112.238 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.7 146.81 42.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.524 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.1 p -92.37 109.07 20.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.899 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -76.9 119.57 20.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.758 178.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.537 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.4 pp -74.9 -41.96 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.537 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 87.6 tttt -176.89 162.48 2.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.985 0.422 . . . . 0.0 111.58 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.449 ' N ' ' HG2' ' A' ' 16' ' ' LYS . . . -97.22 148.09 23.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.89 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.1 mt -96.54 -77.0 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.476 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -118.29 34.62 5.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.434 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.56 -45.36 2.93 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.504 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.73 -57.53 2.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 110.479 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.6 p -69.71 107.52 3.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.447 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.09 141.91 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.484 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.465 ' HG2' HG12 ' A' ' 15' ' ' ILE . 4.5 tptt -79.97 139.29 37.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.2 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.583 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -141.54 119.29 11.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.6 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.59 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -72.36 99.35 2.41 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 20.0 t80 -94.84 108.34 20.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.193 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 tptp 45.68 47.5 11.63 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.594 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.48 -13.97 53.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.718 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.47 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -120.25 98.0 48.93 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 110.045 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 33.1 Cg_exo -61.67 143.92 96.92 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.849 2.366 . . . . 0.0 113.609 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.6 mmt -145.13 144.84 31.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.44 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.2 m -82.31 120.02 24.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.73 0.3 . . . . 0.0 110.495 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.606 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 5.1 m-85 -105.02 124.37 49.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.784 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 88' ' ' TRP . 12.1 ttp180 -121.83 125.38 46.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.03 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.403 ' CD2' HD21 ' A' ' 89' ' ' LEU . 11.9 tp . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.207 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.618 ' HA ' ' HB1' ' A' ' 60' ' ' ALA . 81.8 Cg_exo . . . . . 0 CA--C 1.529 0.227 0 N-CA-C 113.68 0.608 . . . . 0.0 113.68 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.614 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 9.3 mm-40 -94.63 -27.67 15.76 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.551 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -90.72 -65.36 1.02 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.58 -25.01 38.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.666 0.27 . . . . 0.0 111.472 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.618 ' HB1' ' HA ' ' A' ' 56' ' ' PRO . . . -89.27 -56.16 3.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.924 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.614 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 1.7 t80 -59.27 -39.22 82.22 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.94 0.4 . . . . 0.0 110.933 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 1.9 m -58.97 -66.39 0.51 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.675 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.466 ' HB2' ' HG3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -60.49 -38.69 85.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.781 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 11.1 mmtm -60.79 -61.48 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.73 -47.96 20.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.777 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.31 -10.56 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.862 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -89.15 -34.1 16.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.665 0.269 . . . . 0.0 111.214 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -89.97 -28.09 19.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.194 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.92 104.83 14.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.986 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.04 -26.22 64.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.065 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.85 98.95 11.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.956 0.407 . . . . 0.0 111.268 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 93' ' ' TYR . 2.3 mp -122.84 91.23 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.294 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 1.2 tt0 -97.23 139.9 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 111.04 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.436 ' CG1' ' CB ' ' A' ' 90' ' ' ALA . 29.7 t -111.29 141.36 26.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.454 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -105.28 62.03 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.304 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.79 148.45 25.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.073 0.463 . . . . 0.0 111.805 -179.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.427 ' H ' HD11 ' A' ' 89' ' ' LEU . 21.4 t0 -77.24 162.3 27.47 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.176 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.3 32.41 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.804 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.09 33.08 0.27 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -78.52 128.01 32.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.52 0.676 . . . . 0.0 110.887 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.2 ttm-85 -56.32 113.91 1.77 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.851 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.8 p . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.777 -179.409 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.606 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 98.8 m95 . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.948 0.404 . . . . 0.0 111.601 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.513 ' N ' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -77.34 156.21 31.44 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.436 ' CB ' ' CG1' ' A' ' 74' ' ' VAL . . . 176.63 160.19 0.35 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.24 0.543 . . . . 0.0 112.212 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -108.91 -35.44 6.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.719 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp 59.44 122.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.956 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.478 ' OH ' ' HB3' ' A' ' 73' ' ' GLU . 4.3 p90 -144.65 142.85 30.42 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.113 0.482 . . . . 0.0 111.635 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.35 120.67 41.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.656 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.14 27.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.109 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.46 -15.33 54.93 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.117 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -109.85 131.08 55.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.858 0.329 . . . . 0.0 110.986 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.406 ' HA ' ' HA ' ' A' ' 93' ' ' TYR . 6.2 mtt -72.01 140.69 49.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.736 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.419 ' CG1' ' HA ' ' A' ' 62' ' ' THR . 27.9 m . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.937 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.775 0.321 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -135.1 113.93 11.58 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 83.1 Cg_endo -83.37 154.15 14.08 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.721 2.281 . . . . 0.0 112.26 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.575 ' HB2' HD13 ' A' ' 25' ' ' LEU . . . -166.23 157.31 13.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.72 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 25' ' ' LEU . 5.5 m -86.85 107.55 18.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.028 0.442 . . . . 0.0 111.279 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -98.83 108.0 20.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.565 178.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.529 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 1.4 pp -125.62 -13.2 4.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -113.29 123.04 49.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.461 ' CB ' HG23 ' A' ' 62' ' ' THR . . . -112.88 103.67 11.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.241 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 22' ' ' THR . 34.7 mt -62.65 -82.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.079 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -118.17 41.94 2.81 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.28 -47.26 3.69 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.103 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -96.37 -41.09 8.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.964 0.411 . . . . 0.0 110.024 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.437 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 2.1 p -82.55 106.87 14.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.787 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.429 ' HB ' ' CD2' ' A' ' 14' ' ' LEU . 35.1 m -121.53 155.65 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 111.718 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.9 127.42 56.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.734 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.824 ' HG ' ' CE1' ' A' ' 34' ' ' PHE . 2.0 pp -133.82 143.2 48.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.32 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -72.54 99.21 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -93.41 106.37 18.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.3 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 tttm 50.35 55.33 9.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.819 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.56 13.41 60.8 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.199 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.406 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -142.14 97.94 6.23 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.699 0.285 . . . . 0.0 110.245 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.648 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 40.8 Cg_endo -67.36 146.48 75.24 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.566 2.177 . . . . 0.0 113.01 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.3 mmt -145.36 161.2 40.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.388 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.2 p -91.34 126.03 36.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.485 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.824 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.2 m-85 -111.35 124.19 51.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.041 0.448 . . . . 0.0 110.892 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -108.82 98.95 8.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.165 -179.297 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 121.015 0.436 . . . . 0.0 111.261 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.55 ' HB2' ' CB ' ' A' ' 60' ' ' ALA . 90.9 Cg_endo . . . . . 0 N--CA 1.463 -0.307 0 N-CA-C 113.763 0.64 . . . . 0.0 113.763 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -58.04 -14.08 5.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.39 -65.57 1.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.5 m -88.04 -23.59 23.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.97 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.55 ' CB ' ' HB2' ' A' ' 56' ' ' PRO . . . -88.91 -46.11 9.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.523 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -63.99 -49.97 70.36 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.207 0.527 . . . . 0.0 109.914 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 63' ' ' LYS . 2.6 t -49.81 -31.71 12.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.913 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 15' ' ' ILE . 6.9 mttm -82.71 -41.96 18.64 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.138 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -72.33 -30.43 64.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.254 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -40.62 80.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.1 p -83.14 -29.54 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.14 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.19 -9.15 59.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.519 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -111.24 -28.13 8.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.699 0.285 . . . . 0.0 111.337 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.92 141.52 39.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.177 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -102.02 25.41 8.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.81 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 98.8 3.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.69 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.13 92.35 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.94 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 7.6 mt-10 -94.98 136.77 34.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.748 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.405 ' CG2' ' CD2' ' A' ' 25' ' ' LEU . 24.6 t -116.08 123.25 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.193 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -85.57 54.51 3.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.734 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.553 ' C ' ' CD1' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -95.03 164.64 12.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.127 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.635 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -99.94 162.08 13.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.843 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -92.84 30.79 1.5 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.47 31.31 0.16 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.498 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.635 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 34.0 mm-40 -78.54 125.57 29.55 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.524 0.678 . . . . 0.0 111.081 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -44.14 120.89 2.28 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.168 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.452 ' CG2' ' CE2' ' A' ' 88' ' ' TRP . 43.5 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.04 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.52 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 70.2 m95 . . . . . 0 C--O 1.224 -0.289 0 CA-C-O 121.064 0.459 . . . . 0.0 111.916 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.562 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -77.81 158.23 29.61 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.405 ' N ' ' CD2' ' A' ' 89' ' ' LEU . . . 173.25 156.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.201 0.524 . . . . 0.0 111.895 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -112.63 -41.1 3.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.624 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.8 mp 58.55 121.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.08 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.477 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 15.0 p90 -142.54 130.59 21.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.377 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.58 124.14 48.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.603 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 t70 74.79 27.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.864 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.21 22.34 77.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.863 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 115.38 11.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 111.046 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.421 ' CG ' ' HB3' ' A' ' 93' ' ' TYR . 4.0 mtm -72.0 129.53 38.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.515 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.227 0 CA-C-O 120.863 0.364 . . . . 0.0 110.584 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.825 0.345 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -115.32 131.95 23.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.684 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -87.45 125.49 2.12 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.596 2.198 . . . . 0.0 112.398 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.19 127.74 12.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.444 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 t -86.56 108.56 18.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.039 0.447 . . . . 0.0 110.727 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 3.2 tt -77.45 121.39 23.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.418 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.503 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -74.55 -48.6 34.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.671 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.505 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 179.68 168.4 1.16 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.943 0.401 . . . . 0.0 111.259 179.21 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.416 ' CB ' HG22 ' A' ' 62' ' ' THR . . . -87.27 148.13 25.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.082 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.6 mm -91.37 -69.73 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.341 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -118.13 35.93 4.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.246 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.29 -48.5 3.4 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.65 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -96.7 -56.18 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.359 . . . . 0.0 110.616 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 m -70.69 106.81 3.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.501 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.96 154.83 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.308 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.402 ' HB3' HG13 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -92.91 140.06 29.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.762 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.688 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -141.34 118.41 11.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.052 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.485 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -72.31 99.41 2.4 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.617 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 2.7 t80 -91.23 102.29 15.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.755 -178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.9 tttp 43.16 50.15 5.63 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.658 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.33 -14.33 59.66 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.563 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.617 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -118.32 97.21 50.61 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.688 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 10.7 Cg_exo -72.06 130.19 16.24 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.319 2.013 . . . . 0.0 112.97 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 6.2 mmt -124.85 157.22 36.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.16 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 p -86.67 119.54 27.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.037 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.573 ' HA ' ' O ' ' A' ' 88' ' ' TRP . 17.9 m-85 -111.03 107.77 17.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.652 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -94.17 109.53 21.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.31 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 60' ' ' ALA . 28.1 Cg_exo . . . . . 0 N--CA 1.471 0.178 0 N-CA-C 115.136 1.168 . . . . 0.0 115.136 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.44 -19.9 0.05 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.552 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -90.63 -65.08 1.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.52 -32.25 19.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 56' ' ' PRO . . . -75.8 -35.12 60.16 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.98 -30.86 17.52 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.552 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 15.3 t -60.62 -54.56 43.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.505 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 13.3 ptmt -65.3 -43.1 92.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.373 . . . . 0.0 110.875 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -48.99 74.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.079 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -55.98 -30.38 61.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.139 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.6 m -92.5 -31.21 4.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.036 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -72.08 -5.94 38.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.657 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -95.02 -28.13 15.28 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.609 0.242 . . . . 0.0 111.598 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.98 151.01 26.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 111.404 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.8 ttmm -99.18 17.55 19.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.255 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.97 98.98 4.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.907 0.384 . . . . 0.0 110.797 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mp -118.69 94.17 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.112 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.508 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 2.4 mt-10 -104.89 131.23 52.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.607 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.4 m -106.28 145.46 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.894 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -99.78 54.41 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.488 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.44 ' CD1' ' C ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -97.63 166.23 11.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.7 -179.193 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.709 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -104.3 162.53 13.13 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.969 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.5 tmtp? -92.25 23.93 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.314 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.97 20.78 0.36 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.535 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.709 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 17.0 mm-40 -78.61 128.87 34.09 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.542 0.686 . . . . 0.0 111.116 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.451 ' C ' ' O ' ' A' ' 80' ' ' GLN . 1.4 mpp_? -23.45 118.38 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.966 -1.47 . . . . 0.0 111.784 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.434 HG22 ' CE2' ' A' ' 88' ' ' TRP . 5.8 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.688 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.573 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 68.2 m95 . . . . . 0 C--O 1.224 -0.24 0 CA-C-O 121.166 0.507 . . . . 0.0 111.458 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -81.12 154.08 26.96 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 89' ' ' LEU . . . 179.13 153.21 0.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.18 0.514 . . . . 0.0 112.14 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -111.37 -35.08 5.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.942 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp 54.38 109.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.295 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 6.4 p90 -127.74 137.13 52.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.058 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -106.38 123.88 48.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.657 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 t70 73.65 26.17 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.84 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.33 21.91 74.42 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.828 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.14 113.96 10.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.502 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 7.5 mtt -60.47 139.1 57.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.724 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.1 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.05 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.847 0.356 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -122.79 154.32 63.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 85.1 Cg_endo -86.73 156.33 8.9 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.763 2.309 . . . . 0.0 112.298 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -166.27 157.34 13.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.052 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.12 108.38 19.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.779 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 5.7 tt -77.12 121.16 23.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.519 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.6 pp -74.83 -44.6 45.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.206 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.519 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 9.1 tttm 179.51 163.32 0.94 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.878 0.37 . . . . 0.0 111.187 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.422 ' CB ' ' HA ' ' A' ' 59' ' ' SER . . . -91.75 145.91 24.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.331 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.4 mt -96.97 -75.27 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.548 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -117.5 42.14 2.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.519 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.65 -53.61 4.84 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.675 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -96.68 -37.71 10.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 110.553 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -76.99 106.84 8.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.702 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 34' ' ' PHE . 29.1 m -127.93 152.21 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.722 0.296 . . . . 0.0 111.221 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.03 131.66 55.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.211 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.816 ' HG ' ' CE1' ' A' ' 34' ' ' PHE . 0.5 OUTLIER -141.44 148.74 40.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.421 178.184 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.448 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -72.68 99.8 2.66 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.705 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 24.2 t80 -88.42 111.21 21.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.314 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 38.23 38.59 0.22 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.172 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.8 -14.47 58.87 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.295 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.705 ' NE2' ' O ' ' A' ' 27' ' ' TYR . 2.1 pm0 -120.54 96.94 48.91 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.116 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 39.4 Cg_exo -61.5 127.34 21.51 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.53 2.154 . . . . 0.0 112.552 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.562 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -133.04 161.84 33.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.709 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 88' ' ' TRP . 55.5 m -92.8 156.98 16.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.816 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 10.6 m-85 -143.14 136.04 27.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.649 0.262 . . . . 0.0 111.611 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 7.7 ttm180 -139.56 115.21 10.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.934 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 20.2 tp . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.626 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.41 ' HB3' ' CB ' ' A' ' 60' ' ' ALA . 24.6 Cg_exo . . . . . 0 CA--C 1.529 0.229 0 N-CA-C 114.983 1.109 . . . . 0.0 114.983 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.549 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 1.6 tp10 -47.41 -17.44 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.521 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -90.5 -63.16 1.31 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.422 ' HA ' ' CB ' ' A' ' 17' ' ' ALA . 37.3 m -92.79 -43.89 8.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.379 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' A' ' 56' ' ' PRO . . . -62.93 -31.96 73.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.575 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.549 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 3.3 t80 -88.83 -44.25 10.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.371 . . . . 0.0 110.997 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 3.0 m -60.15 -66.28 0.55 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.757 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -55.44 -23.48 25.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.516 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -83.6 -54.7 4.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 111.5 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 mmt -47.69 -27.62 2.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.662 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m -94.02 -19.05 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.34 -25.24 39.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.535 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -97.29 -28.3 14.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.399 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.2 108.07 18.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.143 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -15.49 52.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.877 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.423 ' HG3' ' HA ' ' A' ' 95' ' ' ASP . 2.8 ptpt -91.8 101.71 14.31 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.383 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.402 ' CG2' ' O ' ' A' ' 93' ' ' TYR . 3.3 mp -134.88 99.14 2.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.255 0.55 . . . . 0.0 110.997 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.581 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 2.2 mt-10 -93.26 179.59 5.37 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.649 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.407 HG12 ' CD2' ' A' ' 25' ' ' LEU . 31.3 m -145.22 139.67 22.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.977 0.418 . . . . 0.0 111.528 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -106.49 41.34 1.45 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.181 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.423 ' HB2' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -92.76 160.45 14.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.662 -179.154 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.401 ' O ' ' CE2' ' A' ' 76' ' ' PHE . 8.2 t0 -90.92 152.59 20.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.081 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.28 31.3 2.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.154 0.502 . . . . 0.0 110.347 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.02 38.5 0.64 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.418 ' HB2' ' CD1' ' A' ' 89' ' ' LEU . 1.3 tp60 -78.11 126.84 31.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.929 -0.636 . . . . 0.0 110.642 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.24 79.22 0.05 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.792 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.576 HG21 ' CD1' ' A' ' 88' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.009 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.755 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 20.9 m95 . . . . . 0 N--CA 1.466 0.35 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -82.82 152.09 25.79 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.451 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . . . -178.26 162.2 1.52 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.362 0.601 . . . . 0.0 112.432 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -117.15 -17.52 10.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.646 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.3 mp 64.31 158.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.843 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.581 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -151.13 134.12 15.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.752 -178.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -134.72 105.19 6.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.863 0.363 . . . . 0.0 111.496 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.423 ' HA ' ' HG3' ' A' ' 71' ' ' LYS . 14.7 t0 54.51 43.8 29.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.748 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.28 -22.41 23.45 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.13 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -116.41 127.72 54.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.89 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.53 148.9 49.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.891 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.303 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' CE ' ' HB2' ' A' ' 75' ' ' GLU . 1.2 mmpp? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.737 0.304 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.452 ' HG2' ' CE2' ' A' ' 27' ' ' TYR . 0.6 OUTLIER -132.32 125.83 20.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.065 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -84.52 146.43 10.83 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.67 2.246 . . . . 0.0 112.502 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.496 ' HB3' ' HG ' ' A' ' 25' ' ' LEU . . . -166.37 173.06 10.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.94 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.26 108.57 15.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.021 0.439 . . . . 0.0 111.246 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 3.7 tt -86.83 120.84 28.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.055 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.422 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.7 pp -75.55 -46.41 37.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.513 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.422 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 0.0 OUTLIER 179.98 173.11 0.99 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.176 0.512 . . . . 0.0 111.87 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.78 148.3 22.43 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.677 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.8 -70.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.681 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.65 42.14 1.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.318 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.68 -54.32 4.94 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.547 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -96.8 -49.37 5.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.751 0.31 . . . . 0.0 110.296 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -63.84 106.68 1.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.23 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.414 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 30.2 m -122.59 142.43 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.485 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -87.99 124.71 34.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 1.3 tt -141.52 121.89 14.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.77 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.632 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 15.0 ptp -72.48 102.46 3.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.326 0.584 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.452 ' CE2' ' HG2' ' A' ' 10' ' ' GLU . 10.5 t80 -88.72 109.65 20.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.285 -178.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.91 46.52 18.85 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.602 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.9 -6.61 65.74 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.687 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.453 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -124.59 98.47 37.45 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 17.3 Cg_exo -68.87 143.71 56.26 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.985 2.457 . . . . 0.0 114.245 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.475 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 2.3 mtt -145.36 148.54 33.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.028 -1.442 . . . . 0.0 108.255 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.425 ' C ' ' CD1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -87.48 157.29 19.23 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.554 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 5.0 m-85 -140.8 149.39 41.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.075 0.464 . . . . 0.0 111.712 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 88' ' ' TRP . 0.3 OUTLIER -117.65 97.87 6.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.886 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.314 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 60' ' ' ALA . 90.7 Cg_exo . . . . . 0 N--CA 1.476 0.474 0 N-CA-C 115.711 1.389 . . . . 0.0 115.711 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.509 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 13.9 tm-20 -60.23 -23.51 64.11 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.783 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -91.06 -57.17 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.5 m -82.73 -31.34 28.5 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . -86.63 -53.22 5.08 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.509 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -61.54 -27.87 68.92 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.001 0.429 . . . . 0.0 110.958 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 1.1 m -63.73 -57.48 9.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.033 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.462 ' HA ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -82.95 -36.14 25.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.591 -179.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 60' ' ' ALA . 28.6 ttpt -63.2 -49.44 74.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.426 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -31.49 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 0.0 111.055 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 63' ' ' LYS . 25.0 m -89.81 -29.3 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.178 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -53.28 -25.48 14.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.343 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -106.02 -28.17 10.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 111.404 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.43 130.93 37.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.08 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -96.51 28.17 3.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.62 98.93 3.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.114 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.45 HG12 ' CG1' ' A' ' 66' ' ' VAL . 3.0 mt -120.97 95.26 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.392 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.426 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 1.9 mt-10 -94.61 160.35 14.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.77 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.409 ' CG2' ' CD1' ' A' ' 25' ' ' LEU . 56.0 t -132.08 114.99 25.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.084 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.407 ' HB2' ' CE ' ' A' ' 9' ' ' LYS . 2.3 tm-20 -79.96 53.73 1.74 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.407 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.637 ' HA ' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -97.48 164.63 12.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.112 0.482 . . . . 0.0 112.026 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -104.26 162.51 13.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.087 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.58 31.76 2.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.681 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.5 32.16 0.31 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.545 ' HB2' ' CE3' ' A' ' 88' ' ' TRP . 0.7 OUTLIER -78.5 127.97 32.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.6 0.714 . . . . 0.0 111.062 -179.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -67.63 84.29 0.19 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.919 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.416 HG22 ' CE2' ' A' ' 88' ' ' TRP . 10.2 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.554 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 66.4 m95 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.637 HD11 ' HA ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -76.7 155.68 33.12 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.994 -0.683 . . . . 0.0 109.999 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 172.86 160.33 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.252 0.549 . . . . 0.0 111.794 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -112.31 -37.52 4.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.063 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.6 mp 60.12 127.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.738 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.426 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 8.9 p90 -149.07 141.46 24.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 111.321 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -111.31 119.08 37.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.491 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 76.38 20.11 1.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.071 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.93 -19.88 53.02 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.147 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.21 128.71 51.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.893 0.378 . . . . 0.0 111.426 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.0 mtt -68.41 150.21 48.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.599 -179.837 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.832 0.349 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -134.36 113.96 12.35 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.799 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 92.6 Cg_endo -85.67 147.49 9.63 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.713 2.275 . . . . 0.0 112.467 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.405 ' CB ' HD13 ' A' ' 25' ' ' LEU . . . -166.02 162.13 17.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.759 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -104.46 108.58 20.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.926 0.393 . . . . 0.0 111.258 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 2.4 pp -65.18 133.33 51.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.47 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.522 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.7 pp -74.67 -42.32 47.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.42 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.759 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER 179.47 170.66 1.02 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.597 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.92 148.17 22.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.753 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.2 mt -106.36 -74.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.391 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -118.02 42.15 2.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.824 0.345 . . . . 0.0 111.312 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.3 -56.81 5.04 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.373 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.8 -32.29 12.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.352 . . . . 0.0 110.377 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -77.21 109.86 11.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.556 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 34' ' ' PHE . 33.6 m -131.82 155.78 41.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 3.2 ttpp -119.29 135.3 54.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.803 0.335 . . . . 0.0 111.335 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.876 ' HG ' ' CE1' ' A' ' 34' ' ' PHE . 2.8 pp -141.89 146.32 35.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.303 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.498 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 6.0 ttm -72.2 101.67 2.87 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.839 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.451 ' CE1' ' CZ ' ' A' ' 76' ' ' PHE . 76.8 t80 -88.81 109.24 20.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.667 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 30' ' ' GLN . 0.1 OUTLIER 49.03 27.52 1.72 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.716 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.72 -14.55 53.28 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.608 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -116.82 98.36 51.77 Favored Pre-proline 0 C--N 1.332 -0.174 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 31.7 Cg_exo -59.44 145.9 96.59 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.377 2.052 . . . . 0.0 112.814 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.466 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 41.5 mtt -145.08 162.03 37.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.006 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -90.31 156.2 18.44 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.876 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 29.0 m-85 -142.63 121.87 13.03 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.768 0.318 . . . . 0.0 111.218 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 88' ' ' TRP . 0.6 OUTLIER -125.82 97.81 5.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.098 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.665 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.438 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 48.0 Cg_exo . . . . . 0 N--CA 1.465 -0.156 0 CA-C-O 120.81 0.254 . . . . 0.0 112.299 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 62.9 mm-40 -94.53 -33.23 13.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.617 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.15 -48.53 6.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.781 0.324 . . . . 0.0 111.72 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.2 m -87.45 -61.48 1.71 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.777 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -59.22 -37.27 77.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.614 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.432 ' CD2' ' CG ' ' A' ' 65' ' ' MET . 0.5 OUTLIER -77.37 -25.63 51.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.957 0.408 . . . . 0.0 110.644 179.647 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.425 ' CG2' ' N ' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -58.05 -66.32 0.5 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.947 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.759 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -67.45 -32.35 73.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.646 0.26 . . . . 0.0 111.589 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -64.89 -52.89 54.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.735 0.303 . . . . 0.0 111.323 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.432 ' CG ' ' CD2' ' A' ' 61' ' ' PHE . 26.0 mmt -54.85 -27.99 46.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.228 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.5 t -79.05 -39.58 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.152 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -60.79 -21.66 63.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.341 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -104.6 -28.06 11.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.288 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.06 115.52 30.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 0.0 111.172 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.59 -23.67 62.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.884 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.87 111.34 20.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 111.214 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -136.6 93.32 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.389 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 3.9 mt-10 -105.26 128.8 53.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.74 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.16 123.28 56.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.448 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.74 50.74 2.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.251 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.509 ' HB2' HD11 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -92.77 148.89 21.67 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.212 -179.289 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -73.85 156.4 37.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.225 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.48 32.52 2.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.171 0.51 . . . . 0.0 110.374 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.64 36.19 0.47 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.525 ' CG ' ' CE3' ' A' ' 88' ' ' TRP . 0.6 OUTLIER -78.17 128.24 33.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.622 0.725 . . . . 0.0 110.657 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -65.38 77.39 0.06 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.72 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.456 HG23 ' CZ2' ' A' ' 88' ' ' TRP . 12.7 t . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.154 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.696 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 19.2 m95 . . . . . 0 C--O 1.225 -0.23 0 CA-C-O 120.648 0.261 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -90.94 157.49 17.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.439 ' HB1' ' HB3' ' A' ' 34' ' ' PHE . . . 170.91 164.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.264 0.555 . . . . 0.0 112.077 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -114.24 -48.13 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.088 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp 61.85 129.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.301 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.551 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 9.4 p90 -151.19 140.62 21.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.105 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.03 122.43 47.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.524 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.9 t70 78.8 33.48 0.26 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.629 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.86 20.55 62.27 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.826 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.13 109.97 7.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.9 0.381 . . . . 0.0 111.096 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.4 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -59.64 147.26 38.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.848 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.332 -0.177 0 CA-C-O 120.974 0.416 . . . . 0.0 110.542 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.439 ' HA ' ' CE ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.794 0.33 . . . . 0.0 111.185 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -155.04 113.99 2.34 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.295 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 96.9 Cg_endo -88.44 104.77 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.718 2.279 . . . . 0.0 112.003 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.64 155.58 27.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.01 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 26' ' ' MET . 87.6 m -89.01 108.26 19.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.133 0.492 . . . . 0.0 111.151 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.496 ' C ' ' CD1' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -79.49 111.58 15.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.024 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.476 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -75.1 -46.18 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.248 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.476 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -177.29 173.14 1.79 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.006 0.432 . . . . 0.0 111.594 179.643 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.7 148.31 25.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.876 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mt -97.53 -72.91 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.639 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -118.09 41.91 2.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.713 0.292 . . . . 0.0 111.646 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.21 -52.41 4.71 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.736 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.53 -55.23 2.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 110.331 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 m -68.55 106.87 2.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.148 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.08 160.2 33.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.248 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.44 ' O ' HD12 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -95.73 142.4 28.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.662 179.644 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.678 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -141.42 118.0 10.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.958 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.475 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 3.8 mtt -72.22 99.29 2.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.554 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 5.3 t80 -96.47 104.74 16.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.192 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 38.67 52.72 1.87 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.34 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.34 -14.57 60.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.931 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.554 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -120.75 97.08 48.63 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.678 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 6.7 Cg_exo -75.52 101.87 1.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.677 2.251 . . . . 0.0 113.101 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.436 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 2.5 mtt -98.49 149.2 22.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.863 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 88' ' ' TRP . 5.8 m -77.95 158.9 29.15 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.53 ' CD1' ' HB2' ' A' ' 25' ' ' LEU . 72.4 m-85 -143.11 132.08 22.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.862 0.363 . . . . 0.0 110.833 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.68 114.47 13.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.376 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.469 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 61' ' ' PHE . 82.5 Cg_exo . . . . . 0 N--CA 1.472 0.243 0 N-CA-C 114.111 0.773 . . . . 0.0 114.111 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.786 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 2.7 tm-20 -82.62 -13.98 55.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.53 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -90.6 -65.24 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.5 t -93.18 -42.79 9.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.581 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.76 -29.53 67.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.874 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.786 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 4.9 t80 -90.05 -52.51 4.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.939 0.4 . . . . 0.0 111.295 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 16.8 m -51.79 -66.34 0.4 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.622 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -56.6 -33.31 66.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.745 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.46 -54.46 8.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.762 0.315 . . . . 0.0 111.644 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -27.0 9.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.8 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 m -99.01 -9.9 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -26.83 25.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.667 0.27 . . . . 0.0 111.305 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -103.63 -28.04 11.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.349 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -94.26 134.34 36.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.293 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -96.38 28.73 3.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.825 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.67 99.29 3.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.886 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.411 ' CG2' ' CG2' ' A' ' 92' ' ' ILE . 2.2 mp -130.16 91.29 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.071 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.406 ' HB3' ' OH ' ' A' ' 93' ' ' TYR . 0.7 OUTLIER -99.87 145.52 27.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.282 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 74' ' ' VAL . 14.8 p -119.9 128.69 75.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.257 0.551 . . . . 0.0 111.96 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.41 46.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.132 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.9 ' HB2' HD11 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -92.74 148.1 22.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.696 -178.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -76.92 159.15 30.22 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.803 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.25 35.26 2.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.974 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.23 39.77 0.31 Allowed Glycine 0 CA--C 1.496 -1.152 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.526 ' CG ' ' CD1' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -78.28 138.94 38.86 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.296 1.046 . . . . 0.0 111.896 -178.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -66.19 69.62 0.06 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.156 -1.838 . . . . 0.0 110.615 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.46 HG23 ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.919 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.507 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 12.8 m95 . . . . . 0 C--O 1.225 -0.227 0 CA-C-O 120.477 0.18 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.9 HD11 ' HB2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -76.9 161.92 28.01 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.429 ' O ' ' CD1' ' A' ' 91' ' ' TYR . . . -179.68 179.74 0.56 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 90' ' ' ALA . 54.3 m-85 -154.7 39.29 0.43 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.746 -1.116 . . . . 0.0 109.572 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.452 HG12 HD13 ' A' ' 25' ' ' LEU . 2.8 mp -37.99 143.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.05 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.485 ' HB3' ' HG3' ' A' ' 98' ' ' MET . 5.2 p90 -151.31 142.43 23.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.094 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 95' ' ' ASP . . . -108.81 108.82 19.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.363 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER 82.0 23.96 0.23 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.89 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.77 -38.84 2.98 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.423 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.14 133.56 34.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 111.416 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.485 ' HG3' ' HB3' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -68.96 139.43 55.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.535 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.829 179.826 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.81 0.338 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 42.7 p -87.21 114.68 24.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.01 117.98 27.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 m -86.64 104.03 15.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -86.99 154.9 20.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.849 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -78.87 110.38 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.51 118.15 30.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -88.18 162.45 16.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HE2' ' CG ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -93.05 121.37 34.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -121.68 136.27 25.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.771 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.02 128.45 4.37 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.597 2.198 . . . . 0.0 112.434 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.38 126.11 11.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.572 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 p -86.98 108.74 18.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.04 0.447 . . . . 0.0 111.556 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 24' ' ' LYS . 2.3 tt -69.51 114.93 8.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.914 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.597 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.6 pp -74.96 -43.8 45.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.597 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 1.4 ttmt -167.6 143.32 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.911 0.386 . . . . 0.0 111.901 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.39 148.21 25.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.518 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.3 mt -102.52 -76.07 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.21 30.67 7.1 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.622 0.231 . . . . 0.0 111.622 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.4 -45.0 2.93 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.736 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -96.64 -66.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.745 0.307 . . . . 0.0 110.419 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 m -66.75 106.84 1.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.013 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.4 ' HB ' HD21 ' A' ' 14' ' ' LEU . 34.3 m -133.17 150.53 32.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.479 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.453 ' HG2' HG12 ' A' ' 15' ' ' ILE . 1.6 tppp? -80.06 143.75 33.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.332 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -140.84 117.84 11.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.216 -179.353 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.603 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -71.83 99.05 2.1 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.012 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 8.7 t80 -94.43 109.05 20.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.13 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.9 48.81 7.14 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.767 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.63 -14.17 48.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.9 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.464 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -119.97 97.81 49.4 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 32.2 Cg_exo -60.21 145.52 98.34 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.984 2.456 . . . . 0.0 114.052 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.416 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 29.9 mtm -145.34 140.1 27.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.101 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -79.89 157.02 27.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.189 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.552 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 16.6 m-85 -141.14 142.9 34.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.012 0.434 . . . . 0.0 111.913 -177.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.65 99.83 8.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.859 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.8 mt -47.19 171.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.563 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.425 HD13 ' CE1' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -115.59 -35.88 4.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.899 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tp -56.34 91.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.986 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.43 109.91 29.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.07 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 0.4 OUTLIER -123.97 -167.53 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.626 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.47 ' HB ' ' CD ' ' A' ' 47' ' ' PRO . 10.2 m -136.79 152.51 74.43 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.599 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 14.7 Cg_exo -70.99 117.35 5.11 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.576 2.184 . . . . 0.0 113.316 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 42' ' ' PRO . 4.6 mm-40 84.09 -13.31 0.74 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.71 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -110.95 -175.69 2.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.644 0.259 . . . . 0.0 110.777 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -62.28 -135.28 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.266 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 40' ' ' ASP . 12.7 p-80 -121.15 78.49 33.77 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.892 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.47 ' CD ' ' HB ' ' A' ' 41' ' ' THR . 25.2 Cg_endo -100.6 -98.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 124.115 3.21 . . . . 0.0 112.97 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.14 96.44 4.03 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.599 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . 0.0 OUTLIER 171.67 54.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.058 0.456 . . . . 0.0 111.025 178.014 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.35 -30.06 1.89 Allowed Glycine 0 C--N 1.33 0.203 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.721 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.1 t -96.98 79.68 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.927 0.394 . . . . 0.0 110.732 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.592 ' HA ' ' HG3' ' A' ' 42' ' ' PRO . 52.8 tt0 -57.9 164.36 2.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.989 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -79.46 90.25 5.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.048 0.451 . . . . 0.0 111.024 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.64 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 8.4 p90 -135.85 -35.3 0.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.846 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.484 ' N ' ' CD1' ' A' ' 54' ' ' TYR . . . 106.27 -82.87 0.33 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.747 -0.739 . . . . 0.0 114.274 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.417 ' HB3' ' CB ' ' A' ' 60' ' ' ALA . 2.9 Cg_endo -89.38 -26.71 0.42 Allowed 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.518 2.812 . . . . 0.0 116.215 -176.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.64 ' HB3' ' CD1' ' A' ' 54' ' ' TYR . 4.4 tp10 -43.13 -25.56 0.12 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -91.41 -65.37 1.02 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.0 m -88.18 -30.33 19.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.417 ' CB ' ' HB3' ' A' ' 56' ' ' PRO . . . -89.45 -37.64 14.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.538 ' CB ' ' HA ' ' A' ' 57' ' ' GLU . 10.4 t80 -90.68 -43.49 10.1 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 21.3 m -40.85 -66.92 0.28 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.518 ' CB ' ' HA ' ' A' ' 16' ' ' LYS . 0.6 OUTLIER -74.19 -19.85 60.4 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 3.1 mttp -59.09 -54.59 45.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 111.125 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -58.89 -27.49 65.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.03 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 42.7 t -72.44 -30.99 36.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.106 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -86.68 -13.99 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.555 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -96.2 -28.34 14.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.684 0.278 . . . . 0.0 111.291 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.22 147.52 31.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.805 0.336 . . . . 0.0 111.168 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.5 pttt -97.73 24.48 6.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.4 98.98 3.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.819 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 93' ' ' TYR . 2.5 mp -121.84 93.76 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.733 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.419 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.8 tt0 -106.56 132.75 52.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.798 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.6 m -103.66 126.87 58.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.15 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.4 ' CG ' ' HE2' ' A' ' 9' ' ' LYS . 1.8 tt0 -79.9 52.63 1.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.322 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.757 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -97.01 149.73 21.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.649 -179.11 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.03 159.77 26.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.888 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.5 29.98 3.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.091 0.472 . . . . 0.0 110.452 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.77 35.93 0.58 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.433 ' CG ' ' CE3' ' A' ' 88' ' ' TRP . 2.0 tp60 -78.27 124.52 28.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.405 0.622 . . . . 0.0 110.707 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -67.53 88.29 0.22 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.957 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.432 HG22 ' CD1' ' A' ' 88' ' ' TRP . 92.0 m -97.07 161.45 13.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.26 -53.25 6.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.676 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.409 ' O ' ' CG ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -134.69 -68.69 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.719 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.409 ' CG ' ' O ' ' A' ' 84' ' ' LYS . 4.5 m-85 -169.72 24.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.234 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.558 ' O ' ' HB ' ' A' ' 33' ' ' THR . . . -137.33 -4.49 1.96 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.959 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.495 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -113.88 48.31 1.09 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.623 0.725 . . . . 0.0 111.237 -179.174 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.552 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 78.3 m95 -91.33 142.83 27.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.872 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.757 ' O ' ' HB2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -76.93 158.76 30.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.466 ' N ' HD21 ' A' ' 89' ' ' LEU . . . 173.02 164.61 0.13 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.263 0.554 . . . . 0.0 112.342 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.425 ' CE1' HD13 ' A' ' 37' ' ' LEU . 19.1 m-85 -130.35 57.09 1.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.989 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -42.07 127.77 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.424 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.46 ' CB ' ' HA ' ' A' ' 98' ' ' MET . 3.1 p90 -142.89 143.88 32.23 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.075 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -112.81 124.18 52.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.789 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.66 29.07 7.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.874 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.11 -35.89 3.93 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.001 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.94 130.43 34.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.904 0.383 . . . . 0.0 111.202 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.46 ' HA ' ' CB ' ' A' ' 93' ' ' TYR . 2.7 ttt -78.97 150.1 32.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.306 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.433 ' CG1' ' HA ' ' A' ' 62' ' ' THR . 25.8 m -51.12 -44.91 29.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.946 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.403 ' O ' ' CG2' ' A' ' 104' ' ' VAL . 3.1 m120 -68.23 -32.82 73.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.159 0.504 . . . . 0.0 110.037 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -74.22 -8.76 57.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.693 179.246 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.447 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . . . -54.53 -82.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.463 ' O ' ' NE2' ' A' ' 106' ' ' GLN . 0.2 OUTLIER -115.19 -1.19 13.03 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.716 ' HA ' ' HG ' ' A' ' 108' ' ' LEU . 5.5 t -71.29 -1.64 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.699 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.45 ' HD3' ' HA ' ' A' ' 101' ' ' GLU . 8.6 mmm180 -81.78 -37.33 27.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.635 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.474 ' NE2' ' N ' ' A' ' 108' ' ' LEU . 1.5 pm0 -100.71 -14.77 17.95 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.659 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.6 32.95 0.54 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.241 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.716 ' HG ' ' HA ' ' A' ' 104' ' ' VAL . 11.2 mt 42.24 98.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.25 0.548 . . . . 0.0 112.115 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.38 116.18 4.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.151 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.1 mttp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.923 179.967 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.822 0.344 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 t -121.36 137.96 54.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.06 116.23 31.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.46 153.08 19.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -101.15 146.07 27.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.991 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -78.02 110.72 13.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.695 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.438 ' HG ' ' HA ' ' A' ' 77' ' ' ASP . 4.2 mm? -76.56 157.03 32.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.4 25.91 10.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.731 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HE2' ' CG ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER 63.83 110.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.127 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -104.79 127.98 27.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.518 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 83.5 Cg_endo -90.02 163.69 4.86 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.752 2.301 . . . . 0.0 112.496 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.457 ' CB ' HD11 ' A' ' 25' ' ' LEU . . . -166.34 161.42 16.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.336 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.6 p -93.55 108.34 20.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.327 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 2.2 tm? -89.15 119.57 29.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.149 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.499 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -74.76 -42.42 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.458 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.499 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 0.0 OUTLIER 179.87 173.17 0.96 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.249 0.547 . . . . 0.0 112.109 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.43 103.61 13.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.648 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' THR . 41.1 mm -53.3 -75.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.934 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -110.98 42.08 1.69 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.54 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.444 ' HA2' ' CB ' ' A' ' 58' ' ' ALA . . . 84.24 -52.15 4.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.924 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.49 -35.85 10.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.819 0.343 . . . . 0.0 110.422 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -71.39 106.79 4.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.27 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.455 ' HB ' ' CD2' ' A' ' 14' ' ' LEU . 3.2 m -122.99 129.35 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.685 0.279 . . . . 0.0 111.245 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -91.71 97.98 11.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.687 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.812 ' HG ' ' CE1' ' A' ' 34' ' ' PHE . 2.8 pp -110.51 137.72 47.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.662 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.559 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 29.0 ttm -72.51 99.96 2.62 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.533 ' CE1' ' CE1' ' A' ' 76' ' ' PHE . 86.9 t80 -88.51 109.42 20.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.174 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.457 ' O ' ' OE1' ' A' ' 30' ' ' GLN . 0.1 OUTLIER 49.18 28.27 2.12 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.821 179.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.44 -14.24 54.33 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.396 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -116.87 97.73 50.96 Favored Pre-proline 0 C--N 1.331 -0.239 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 34.1 Cg_exo -61.03 143.13 99.11 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.286 1.991 . . . . 0.0 113.129 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.438 ' O ' ' HE1' ' A' ' 34' ' ' PHE . 51.8 mtt -145.2 159.78 42.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.25 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.527 ' CB ' ' HA2' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -97.17 156.61 16.32 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.812 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.0 m-85 -138.05 157.98 45.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.789 0.328 . . . . 0.0 111.493 -177.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -139.13 99.06 3.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.584 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 170.29 -82.03 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.529 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 41.01 100.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 59.4 119.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.139 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.3 112.24 25.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.508 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 50' ' ' GLY . 3.1 p30 -135.97 -165.73 1.75 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.811 0.338 . . . . 0.0 111.449 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.468 ' HB ' ' CB ' ' A' ' 48' ' ' LYS . 3.8 t -130.15 126.62 22.38 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.564 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.46 112.8 3.12 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.265 1.976 . . . . 0.0 112.467 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 69.28 -43.79 0.53 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.01 176.07 6.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.939 0.4 . . . . 0.0 111.182 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -131.66 13.66 4.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.002 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.41 ' O ' ' N ' ' A' ' 48' ' ' LYS . 2.1 m170 -95.19 170.97 7.09 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.577 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.91 83.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.611 2.207 . . . . 0.0 112.476 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.468 ' CB ' ' HB ' ' A' ' 41' ' ' THR . 0.3 OUTLIER -124.55 167.89 13.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.496 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.09 45.61 2.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.992 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . -123.25 131.92 8.35 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.623 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.3 p -94.55 109.81 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.701 0.286 . . . . 0.0 110.268 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.421 ' O ' ' CE1' ' A' ' 54' ' ' TYR . 1.1 tm-20 -57.66 166.9 1.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.854 0.359 . . . . 0.0 110.683 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.88 97.47 7.46 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.993 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -112.41 -34.88 5.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.685 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.25 -70.7 0.26 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.869 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.426 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 87.3 Cg_exo -48.79 -19.11 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.11 2.54 . . . . 0.0 114.087 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -93.88 -44.75 7.94 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.444 ' CB ' ' HA2' ' A' ' 20' ' ' GLY . . . -90.51 -65.4 1.02 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.5 p -65.57 -36.96 85.3 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.426 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . . . -89.38 -57.4 2.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.507 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -61.07 -69.14 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 42.9 m -40.85 -66.57 0.31 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -25.47 43.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.21 -63.17 1.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 0.0 111.878 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.422 ' HG3' ' CD2' ' A' ' 61' ' ' PHE . 1.6 mmm -50.86 -24.84 3.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.914 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.427 HG12 HD11 ' A' ' 14' ' ' LEU . 30.0 m -76.99 -31.02 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -94.18 -11.48 30.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.295 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -98.04 -28.17 13.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.66 0.267 . . . . 0.0 111.303 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.68 143.91 31.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.884 0.374 . . . . 0.0 111.171 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -97.48 29.32 3.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.29 98.88 2.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.134 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mt -119.23 94.67 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.397 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -94.94 137.18 34.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.86 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.407 ' CG1' ' CB ' ' A' ' 90' ' ' ALA . 21.3 t -116.97 102.87 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.423 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.41 ' CG ' ' HE2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -71.59 63.48 0.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.056 179.267 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.551 ' C ' ' CD1' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -107.43 167.12 10.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.951 0.405 . . . . 0.0 111.834 -178.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 6.9 t70 -104.29 162.05 13.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.34 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -101.0 32.6 3.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.414 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.69 33.55 0.32 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.567 ' HB2' ' CE3' ' A' ' 88' ' ' TRP . 1.4 mm-40 -78.37 128.96 34.4 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.542 0.686 . . . . 0.0 110.857 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.2 mtp85 -63.55 78.18 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 48.3 m -94.4 141.34 28.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.84 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.17 -50.55 73.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.907 0.384 . . . . 0.0 110.764 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.414 ' O ' ' CG ' ' A' ' 85' ' ' TYR . 1.8 tptm -138.44 -67.05 0.47 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.551 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.414 ' CG ' ' O ' ' A' ' 84' ' ' LYS . 7.8 m-85 -172.68 25.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.937 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.527 ' HA2' ' CB ' ' A' ' 33' ' ' THR . . . -134.4 -5.41 2.62 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.779 -1.2 . . . . 0.0 113.775 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.513 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -114.54 41.19 2.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.579 0.704 . . . . 0.0 110.924 -179.338 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.567 ' CE3' ' HB2' ' A' ' 80' ' ' GLN . 63.9 m95 -80.38 146.14 31.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.43 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -77.36 164.43 25.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.431 ' N ' ' CD2' ' A' ' 89' ' ' LEU . . . 175.28 172.89 0.27 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.288 0.566 . . . . 0.0 112.396 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -141.78 41.7 1.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.98 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp -41.96 127.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.056 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.498 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 2.2 p90 -143.98 153.93 42.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.471 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.51 135.48 53.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.685 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.85 23.91 12.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.147 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.53 -12.17 65.98 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.037 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.38 127.64 53.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.943 0.401 . . . . 0.0 110.988 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.498 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 1.5 mpt? -71.61 150.12 44.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.155 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.1 m -58.79 -37.78 68.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.113 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -75.33 -49.36 19.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.444 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.431 ' HA ' HG12 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -73.94 -8.59 56.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.229 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.453 ' CB ' ' CE2' ' A' ' 61' ' ' PHE . . . -59.06 -44.25 91.81 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.617 ' HG ' ' CD2' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -124.66 11.17 8.48 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.666 ' HA ' ' HB3' ' A' ' 108' ' ' LEU . 8.3 m -55.06 -13.26 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.706 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.423 ' CD ' ' N ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -80.73 -46.46 15.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.545 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 103' ' ' LEU . 3.5 pp0? -70.76 -13.8 62.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.644 0.259 . . . . 0.0 111.696 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.61 34.91 0.47 Allowed Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.198 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.666 ' HB3' ' HA ' ' A' ' 104' ' ' VAL . 7.7 tp -90.53 170.37 10.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.503 ' H ' ' HG ' ' A' ' 108' ' ' LEU . . . -52.13 113.01 0.89 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.814 0.34 . . . . 0.0 111.324 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.789 0.328 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.7 p -108.32 112.55 25.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.006 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 p -106.39 148.6 27.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.51 130.03 38.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.77 140.96 32.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.09 114.53 27.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.864 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pp -86.23 119.69 26.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -72.0 -177.38 2.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -114.91 128.6 56.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.059 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -123.82 115.74 27.87 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.672 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.92 161.15 7.47 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.688 2.258 . . . . 0.0 112.437 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.471 ' CB ' HD12 ' A' ' 25' ' ' LEU . . . -166.15 172.17 11.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.448 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.1 t -103.12 108.7 19.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.071 0.462 . . . . 0.0 111.264 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 2.8 tt -76.09 125.83 29.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.778 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.541 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.7 pp -74.9 -46.01 41.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.393 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.541 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 4.1 mtmt 178.99 173.23 0.77 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.992 0.425 . . . . 0.0 111.373 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.476 ' CB ' ' HA ' ' A' ' 59' ' ' SER . . . -98.72 148.05 24.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.391 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 92.5 mt -102.71 -72.15 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.497 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -117.71 42.05 2.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.738 0.304 . . . . 0.0 111.532 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.37 -54.76 4.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.543 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.54 -35.72 11.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.018 0.437 . . . . 0.0 110.196 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.4 HG21 ' HD2' ' A' ' 87' ' ' ARG . 43.2 m -76.62 106.91 8.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.158 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.5 m -126.12 161.72 31.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.867 0.365 . . . . 0.0 111.189 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.457 ' HD2' ' HB2' ' A' ' 31' ' ' PRO . 0.5 OUTLIER -119.41 134.18 55.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.297 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.853 ' HG ' ' CE1' ' A' ' 34' ' ' PHE . 1.3 pp -141.72 132.64 25.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.61 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -72.89 99.53 2.7 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.871 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.454 ' CE2' ' CE1' ' A' ' 76' ' ' PHE . 5.8 t80 -88.88 112.37 23.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.777 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 45.06 36.73 2.13 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.711 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.05 -14.41 65.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.457 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.26 97.34 49.51 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 51.6 Cg_endo -69.63 150.06 68.51 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.537 2.158 . . . . 0.0 112.994 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.401 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 3.4 mmt -145.3 161.17 40.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.049 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.411 ' HB ' ' NE ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -97.06 124.08 40.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.077 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.853 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 2.1 m-85 -111.45 149.51 31.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.911 0.386 . . . . 0.0 111.693 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.574 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 3.4 ttp85 -139.09 110.41 6.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.168 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.644 ' N ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER 163.87 -150.87 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.288 179.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.562 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 2.9 mt 72.89 -78.67 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.47 92.89 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.845 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.9 t -111.36 109.23 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 0.0 111.191 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.67 150.95 47.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.314 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 46' ' ' HIS . 4.7 t -116.19 93.58 39.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.616 0.245 . . . . 0.0 111.248 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 49' ' ' LYS . 58.3 Cg_exo -51.51 117.49 3.52 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.451 2.101 . . . . 0.0 112.336 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 77.03 -60.19 0.46 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.188 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.88 173.66 1.74 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.754 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -111.5 -26.35 9.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.848 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.499 ' O ' ' HB ' ' A' ' 41' ' ' THR . 1.1 m-70 -70.53 135.29 86.24 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 46' ' ' HIS . 25.9 Cg_exo -63.58 35.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.757 2.305 . . . . 0.0 114.25 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -129.15 95.54 4.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.675 0.274 . . . . 0.0 110.954 179.069 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.558 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER 173.3 41.12 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.454 179.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.31 -126.62 38.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.727 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.2 m -121.69 163.38 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.813 0.34 . . . . 0.0 111.37 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.495 ' HA ' ' HG3' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -75.47 161.39 29.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.57 179.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.51 92.44 9.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.156 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.55 ' CD2' ' HB2' ' A' ' 57' ' ' GLU . 9.9 p90 -135.19 -35.61 0.83 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.318 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.3 -105.98 3.33 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 114.929 0.732 . . . . 0.0 114.929 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 25.0 Cg_exo -38.56 -53.56 1.77 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.142 3.228 . . . . 0.0 116.079 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.55 ' HB2' ' CD2' ' A' ' 54' ' ' TYR . 5.8 mm-40 -48.82 -16.45 0.13 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.436 ' N ' ' HE2' ' A' ' 54' ' ' TYR . . . -90.52 -62.31 1.49 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.671 0.272 . . . . 0.0 111.184 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.476 ' HA ' ' CB ' ' A' ' 17' ' ' ALA . 57.8 p -90.66 -48.98 6.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.975 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.06 -35.41 64.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.224 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.439 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 2.1 t80 -90.35 -19.92 23.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.479 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 1.0 OUTLIER -77.59 -67.16 0.75 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.56 0.219 . . . . 0.0 111.331 -179.453 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -23.79 64.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 111.34 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -80.93 -49.19 11.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.629 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.405 ' HG3' ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -50.03 -28.91 7.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.412 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.405 ' N ' ' HG3' ' A' ' 65' ' ' MET . 27.1 m -91.72 -26.89 4.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.273 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -76.51 -9.72 58.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.657 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -114.22 -28.1 7.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.606 0.241 . . . . 0.0 111.433 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.03 132.41 50.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 0.0 111.173 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -86.21 4.34 39.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.263 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.78 106.59 12.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.896 0.379 . . . . 0.0 110.968 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mt -127.3 95.07 2.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.654 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -95.25 150.09 20.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.663 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.409 ' CG1' ' CB ' ' A' ' 90' ' ' ALA . 2.6 t -128.98 116.38 40.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.36 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -86.89 49.76 1.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.026 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -92.97 145.24 24.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.055 -179.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -91.26 158.96 16.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.001 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -95.27 29.52 2.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.193 0.52 . . . . 0.0 110.25 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -153.49 37.68 0.73 Allowed Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -77.82 128.16 33.54 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.321 0.581 . . . . 0.0 110.198 -179.039 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -63.51 65.18 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.112 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.53 ' CG2' ' CE2' ' A' ' 88' ' ' TRP . 14.4 t -109.55 171.7 7.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.507 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -108.26 78.34 1.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 1.1 mppt? 65.11 -72.02 0.07 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.106 0.479 . . . . 0.0 109.948 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -144.94 15.87 1.56 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.366 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.496 ' O ' ' CG ' ' A' ' 87' ' ' ARG . . . -59.26 -23.23 57.41 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.08 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.499 ' HG3' ' HB2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 154.87 108.39 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.069 0.548 . . . . 0.0 110.76 179.231 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.607 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 66.5 m95 -97.89 146.3 25.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.797 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -77.86 159.23 29.07 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.515 ' H ' ' HG ' ' A' ' 36' ' ' LEU . . . -179.75 145.92 0.24 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -108.01 52.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.627 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mp -57.71 132.94 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.504 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.458 ' CZ ' ' HB3' ' A' ' 73' ' ' GLU . 2.9 p90 -150.57 153.04 35.03 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.359 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.95 131.99 54.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.828 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.7 t70 67.57 25.9 8.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.021 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.31 19.91 77.77 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.842 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -137.1 114.11 10.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.923 0.392 . . . . 0.0 110.896 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.424 ' CA ' ' HB3' ' A' ' 93' ' ' TYR . 16.0 ptp -75.39 150.19 38.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.5 m -49.82 -31.58 6.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.091 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.423 ' O ' ' HB ' ' A' ' 104' ' ' VAL . 13.1 t30 -75.95 -22.57 55.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.013 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -93.24 -11.72 31.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -91.12 -56.13 3.27 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.434 ' O ' ' NE2' ' A' ' 106' ' ' GLN . 3.8 mm? -106.39 -50.78 3.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.678 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.446 ' HA ' ' HG ' ' A' ' 108' ' ' LEU . 38.6 t -56.62 -21.43 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.772 -0.194 . . . . 0.0 111.485 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -28.41 -48.12 0.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.434 ' NE2' ' O ' ' A' ' 103' ' ' LEU . 1.0 OUTLIER -121.05 -0.36 10.02 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.19 26.44 1.34 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.953 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.482 ' CD1' ' CE1' ' A' ' 54' ' ' TYR . 9.4 mt 61.44 122.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.059 0.457 . . . . 0.0 111.374 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.2 126.72 31.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.07 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.843 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.761 0.315 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.5 p -124.42 98.57 5.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.8 m -95.6 119.38 34.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.4 p -79.23 103.82 9.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.025 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.44 126.75 36.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.773 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.27 108.68 20.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.032 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.18 157.28 29.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.773 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -96.95 -40.99 8.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.0 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt 63.48 130.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.923 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 4.5 mm-40 -136.05 145.56 52.95 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 10' ' ' GLU . 1.3 Cg_endo -83.42 105.49 1.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.735 2.29 . . . . 0.0 112.316 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.2 135.5 53.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.501 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.1 m -86.88 108.82 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.93 0.395 . . . . 0.0 111.644 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.431 ' CD2' ' CB ' ' A' ' 63' ' ' LYS . 10.2 tt -73.44 113.43 10.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.95 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.592 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.5 pp -74.7 -43.44 47.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.341 -0.391 . . . . 0.0 112.052 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.592 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 37.9 tttp -173.65 151.56 1.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.077 0.465 . . . . 0.0 111.935 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.91 148.21 23.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.671 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.0 mt -103.1 -73.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.687 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.12 26.86 9.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.633 0.254 . . . . 0.0 111.481 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.4 ' HA2' ' CB ' ' A' ' 58' ' ' ALA . . . 90.13 -44.33 2.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.744 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.7 -54.37 3.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 110.328 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.403 ' CG2' ' NH1' ' A' ' 87' ' ' ARG . 91.0 m -78.26 106.89 10.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.141 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.57 157.37 42.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.464 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.455 ' HB3' HG13 ' A' ' 15' ' ' ILE . 32.2 tttt -91.76 142.77 27.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.47 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.658 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -141.28 117.69 10.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.928 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.479 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -71.85 99.18 2.14 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 17.3 t80 -95.62 108.54 20.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.907 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.94 41.55 14.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.147 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.85 -14.13 61.07 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.459 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.471 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -117.75 98.19 51.43 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.999 0.428 . . . . 0.0 110.277 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.658 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 26.6 Cg_endo -62.54 144.4 94.43 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.705 2.27 . . . . 0.0 113.327 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.6 mmt -145.17 155.84 43.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.082 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 p -85.79 122.11 29.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.817 0.341 . . . . 0.0 111.214 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.616 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 16.8 m-85 -113.79 107.9 16.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.436 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 88' ' ' TRP . 7.6 ttt180 -97.41 115.0 26.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.223 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER 179.05 -77.85 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.05 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 43.54 57.18 4.05 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.637 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.405 ' HB2' ' ND2' ' A' ' 100' ' ' ASN . 0.3 OUTLIER 53.42 94.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.343 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.9 t -67.03 109.93 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.725 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -130.18 -138.53 0.22 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.768 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 46' ' ' HIS . 11.8 t -124.16 137.52 29.17 Favored Pre-proline 0 C--N 1.334 -0.105 0 O-C-N 122.37 -0.207 . . . . 0.0 110.783 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.6 ' HB3' ' CB ' ' A' ' 52' ' ' GLU . 7.9 Cg_exo -73.09 111.92 3.4 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.123 1.882 . . . . 0.0 111.964 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.4 -40.14 0.45 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.94 -165.17 0.15 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.873 0.368 . . . . 0.0 111.466 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.401 ' C ' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -116.1 -37.7 3.78 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.715 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.537 ' O ' ' N ' ' A' ' 48' ' ' LYS . 1.1 m80 -75.89 115.71 48.88 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.468 ' HA ' ' HB ' ' A' ' 41' ' ' THR . 5.6 Cg_endo -48.09 75.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.424 2.749 . . . . 0.0 113.759 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 1.2 tppp? -129.02 95.77 4.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.685 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.572 ' CB ' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER 102.49 37.63 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.376 0.671 . . . . 0.0 112.189 178.401 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 45.43 -128.11 8.47 Favored Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.129 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.84 143.32 28.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.926 0.393 . . . . 0.0 111.526 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.6 ' CB ' ' HB3' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -75.15 -177.03 3.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.185 0.516 . . . . 0.0 110.972 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -111.09 90.87 3.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.819 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -96.52 -35.16 11.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 -179.295 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.04 -71.56 0.26 Allowed Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.615 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.404 ' CD ' ' O ' ' A' ' 54' ' ' TYR . 56.6 Cg_exo -43.54 -45.76 10.36 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.058 2.505 . . . . 0.0 114.422 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.701 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 15.8 tm-20 -91.77 -64.61 1.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -60.46 -40.71 92.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.9 m -93.63 -43.4 8.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 64' ' ' LYS . . . -89.5 -34.61 16.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.701 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 4.1 t80 -90.1 -24.34 21.14 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 1.7 m -56.82 -66.84 0.38 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.734 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -77.72 -19.73 54.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -48.03 -51.63 23.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 0.0 111.388 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.4 ttp -70.49 -17.61 62.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.305 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.1 t -88.64 -11.63 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.518 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -93.99 -6.77 44.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -114.7 -27.9 7.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.562 0.22 . . . . 0.0 111.447 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.9 142.26 32.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 111.343 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.92 28.57 4.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.556 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.2 98.92 3.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.005 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -129.18 93.24 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.641 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 8.1 mt-10 -102.65 133.5 47.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.883 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.8 m -104.26 138.26 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -89.09 48.47 1.63 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.982 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -93.7 150.96 19.98 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.518 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.612 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 3.3 t70 -87.26 162.48 17.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.996 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.38 32.44 0.95 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.421 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.69 31.29 0.17 Allowed Glycine 0 CA--C 1.507 -0.46 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.612 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 11.5 mm-40 -81.74 127.93 33.46 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.684 0.754 . . . . 0.0 111.847 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -42.05 129.57 3.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.148 -1.387 . . . . 0.0 111.807 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.457 ' CG2' ' CE2' ' A' ' 88' ' ' TRP . 43.6 p -109.44 171.41 7.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.033 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 87' ' ' ARG . 18.4 t0 -146.73 -100.52 0.09 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.474 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -98.73 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 O-C-N 122.305 -0.247 . . . . 0.0 111.065 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -87.31 48.58 1.67 Allowed 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.157 0.503 . . . . 0.0 109.749 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.454 ' O ' ' C ' ' A' ' 87' ' ' ARG . . . 97.01 -34.4 5.09 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.545 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 86' ' ' GLY . 0.3 OUTLIER 27.55 74.72 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.276 0.56 . . . . 0.0 111.219 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.616 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 54.1 m95 -105.46 158.21 16.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.175 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.574 ' CD1' ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -77.96 164.89 24.7 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.925 178.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 89' ' ' LEU . . . 166.06 147.88 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.232 0.539 . . . . 0.0 111.677 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -99.47 -34.18 10.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.956 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.8 mp 59.03 115.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.508 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 6.4 p90 -141.16 136.46 31.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.986 0.422 . . . . 0.0 111.502 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 95' ' ' ASP . . . -106.0 112.5 25.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.731 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 94' ' ' ALA . 5.1 m-20 80.37 27.16 0.28 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.951 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.21 -28.63 9.34 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.957 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.77 130.85 39.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 111.165 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.44 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -76.5 145.35 39.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.922 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 35.3 m -73.82 -37.7 49.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.213 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.405 ' ND2' ' HB2' ' A' ' 38' ' ' LEU . 0.9 OUTLIER -78.8 -37.1 41.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.977 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.91 -9.24 58.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.295 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -91.12 -28.41 17.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.787 0.327 . . . . 0.0 111.231 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.428 ' HB3' HD21 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -111.76 -60.61 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 105' ' ' ARG . 8.6 t -58.7 -20.72 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.67 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -24.85 -55.91 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.504 ' NE2' ' N ' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -121.15 8.16 10.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.548 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.07 31.56 2.43 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.144 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.504 ' N ' ' NE2' ' A' ' 106' ' ' GLN . 6.8 mt 69.3 105.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.067 0.461 . . . . 0.0 111.172 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.67 129.56 37.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.003 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.7 mttp . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.885 -179.917 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.785 0.326 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.59 119.02 20.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.9 m -110.01 127.36 54.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p -104.71 131.34 52.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.87 125.08 40.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.935 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -119.12 111.6 18.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -120.06 157.27 29.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -70.83 173.83 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.449 ' HE3' ' HA ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -99.32 157.67 16.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -151.67 113.74 2.99 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.776 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 89.7 Cg_endo -85.35 110.72 1.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.63 2.22 . . . . 0.0 112.518 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.83 156.32 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.594 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -98.1 108.09 20.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.124 0.488 . . . . 0.0 111.656 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.471 ' C ' ' CD1' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -76.28 108.93 9.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.643 178.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.483 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -74.79 -46.93 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.304 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.483 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -178.56 173.11 1.36 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.116 0.484 . . . . 0.0 111.776 179.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.86 148.26 22.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.951 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.4 mt -104.2 -70.38 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.781 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.05 42.22 2.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.726 0.298 . . . . 0.0 111.524 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.77 -57.21 5.05 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.52 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -96.74 -38.28 9.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.912 0.387 . . . . 0.0 110.116 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.7 106.75 9.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.106 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.42 143.6 40.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.333 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HG2' HG12 ' A' ' 15' ' ' ILE . 9.1 tppt? -81.88 142.78 32.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.509 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.611 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -141.79 118.44 11.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.543 -179.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.578 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -72.4 99.39 2.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.452 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 20.8 t80 -96.33 107.54 19.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.203 -177.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm 45.13 48.98 9.85 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.652 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.13 -14.1 51.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.789 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.462 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -119.86 97.84 49.56 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 121.011 0.434 . . . . 0.0 110.019 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 24.6 Cg_exo -65.26 143.34 76.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.857 2.372 . . . . 0.0 113.38 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 mmt -145.05 151.86 39.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.555 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 m -86.68 121.2 28.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.545 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.599 ' CD1' ' HB2' ' A' ' 25' ' ' LEU . 2.1 m-85 -109.79 125.54 52.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.005 0.431 . . . . 0.0 111.518 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -98.61 118.07 34.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.976 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.06 159.83 19.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.803 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.431 HD23 ' CZ ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -109.54 -171.95 1.95 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.002 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.5 tp 67.49 119.5 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.965 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.4 t -121.28 109.8 26.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.197 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.54 -163.14 0.85 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.413 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -77.19 153.77 82.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.442 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.479 ' HB3' ' N ' ' A' ' 52' ' ' GLU . 5.7 Cg_endo -83.69 112.69 1.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.611 2.208 . . . . 0.0 112.209 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 42' ' ' PRO . 6.8 pt-20 49.44 20.59 0.48 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.131 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.66 -162.76 0.81 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.683 0.278 . . . . 0.0 110.628 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -154.79 28.3 0.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.74 0.305 . . . . 0.0 111.028 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.408 ' O ' ' N ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -118.67 171.17 5.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.635 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.05 71.3 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.683 2.256 . . . . 0.0 112.188 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 46' ' ' HIS . 0.1 OUTLIER -122.86 167.32 13.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.757 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.34 -173.45 2.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.673 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 56.93 97.34 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.37 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.7 t -70.72 79.93 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.768 0.318 . . . . 0.0 110.87 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.479 ' N ' ' HB3' ' A' ' 42' ' ' PRO . 7.7 tt0 -57.68 92.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.343 0.592 . . . . 0.0 109.717 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -48.8 151.52 1.19 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.136 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -120.26 -28.43 5.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.644 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.41 -64.12 0.27 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.652 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 54' ' ' TYR . 76.9 Cg_exo -52.62 -19.52 10.55 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.07 2.513 . . . . 0.0 113.405 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' HG2' ' N ' ' A' ' 58' ' ' ALA . 13.7 pm0 -94.24 -46.79 6.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.592 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -91.16 -65.67 0.99 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.8 m -60.66 -37.82 82.84 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.52 -61.83 1.61 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.448 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -55.34 -51.7 65.91 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.592 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 85.1 m -55.47 -66.26 0.45 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.619 0.247 . . . . 0.0 111.499 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -23.11 15.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -88.07 -55.86 3.57 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.51 -26.49 3.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.716 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 14' ' ' LEU . 36.0 t -91.73 -10.56 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -94.11 -5.97 46.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -111.2 -27.34 8.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.626 0.25 . . . . 0.0 111.426 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.62 141.12 37.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 0.0 111.172 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.27 29.04 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.762 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.439 ' HG3' ' HA ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -145.46 98.72 3.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.807 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 mp -127.67 92.14 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.665 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -94.87 147.58 23.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.754 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.7 t -116.31 129.15 73.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.684 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.449 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 34.2 tt0 -93.62 54.32 2.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.221 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.554 ' HA ' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -94.89 167.31 11.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.164 -178.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.428 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 2.0 t70 -104.43 162.55 13.14 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.041 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -94.18 28.78 2.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.936 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.62 26.93 0.2 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.571 ' HG3' ' CD1' ' A' ' 89' ' ' LEU . 1.8 mm-40 -78.54 127.12 31.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.63 0.729 . . . . 0.0 110.983 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -39.71 127.1 1.99 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.515 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.493 ' HB ' ' HA2' ' A' ' 86' ' ' GLY . 75.2 p -109.18 172.04 7.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.088 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.419 ' N ' ' HB2' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -143.13 -82.19 0.18 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.471 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -81.51 -98.22 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.937 -0.119 . . . . 0.0 110.842 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -80.52 58.75 3.3 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.565 ' O ' ' CD1' ' A' ' 88' ' ' TRP . . . 58.84 37.57 90.8 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.372 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -25.86 126.3 0.05 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.295 0.569 . . . . 0.0 112.121 -179.015 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.565 ' CD1' ' O ' ' A' ' 86' ' ' GLY . 96.2 m95 -126.2 143.59 51.08 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.924 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.571 ' CD1' ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -76.64 158.29 31.19 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.432 ' N ' HD23 ' A' ' 89' ' ' LEU . . . 179.66 160.73 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.264 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.431 ' CZ ' HD23 ' A' ' 37' ' ' LEU . 3.7 m-85 -113.1 -35.94 5.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.92 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.6 mt 59.67 119.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.809 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.423 ' OH ' ' HB3' ' A' ' 73' ' ' GLU . 4.9 p90 -141.63 123.44 15.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 95' ' ' ASP . . . -99.25 96.55 7.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.665 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 94' ' ' ALA . 2.7 t0 85.26 55.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.997 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.11 27.71 57.69 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.852 -0.613 . . . . 0.0 113.453 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -137.25 112.72 9.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 0.0 111.001 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.401 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -78.21 136.12 37.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.068 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.1 m -62.84 -31.03 50.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.98 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -80.91 -45.92 16.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.772 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -20.82 62.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.104 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.39 -34.55 15.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.277 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.463 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -62.31 -33.32 74.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.851 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 m -63.78 -1.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -32.16 -48.68 0.17 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.791 0.436 . . . . 0.0 111.923 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.503 ' NE2' ' HB2' ' A' ' 108' ' ' LEU . 1.0 OUTLIER -121.35 -1.79 9.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.624 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.24 24.54 1.04 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.378 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.503 ' HB2' ' NE2' ' A' ' 106' ' ' GLN . 0.9 OUTLIER -96.57 139.23 32.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.895 0.347 . . . . 0.0 110.582 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.18 144.41 48.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.384 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.911 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.842 0.353 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.43 122.84 48.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.4 m -63.82 102.18 0.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.946 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 m -84.79 129.11 34.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.49 134.45 51.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.85 113.42 26.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.855 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 pp -119.4 157.27 28.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.855 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -70.78 166.71 20.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.757 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.79 155.39 19.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 1.4 mp0 -141.57 113.89 6.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.632 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 5.8 Cg_exo -78.69 114.1 3.4 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.566 2.177 . . . . 0.0 112.238 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.7 146.81 42.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.524 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.1 p -92.37 109.07 20.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.899 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -76.9 119.57 20.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.758 178.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.537 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.4 pp -74.9 -41.96 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.537 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 87.6 tttt -176.89 162.48 2.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.985 0.422 . . . . 0.0 111.58 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.449 ' N ' ' HG2' ' A' ' 16' ' ' LYS . . . -97.22 148.09 23.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.89 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.1 mt -96.54 -77.0 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.476 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -118.29 34.62 5.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.434 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.56 -45.36 2.93 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.504 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.73 -57.53 2.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 110.479 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.6 p -69.71 107.52 3.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.447 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.09 141.91 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.484 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.465 ' HG2' HG12 ' A' ' 15' ' ' ILE . 4.5 tptt -79.97 139.29 37.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.2 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.583 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -141.54 119.29 11.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.6 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.59 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -72.36 99.35 2.41 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 20.0 t80 -94.84 108.34 20.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.193 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 tptp 45.68 47.5 11.63 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.594 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.48 -13.97 53.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.718 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.47 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -120.25 98.0 48.93 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 110.045 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 33.1 Cg_exo -61.67 143.92 96.92 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.849 2.366 . . . . 0.0 113.609 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.6 mmt -145.13 144.84 31.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.44 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 86.2 m -82.31 120.02 24.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.73 0.3 . . . . 0.0 110.495 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.606 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 5.1 m-85 -105.02 124.37 49.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.784 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 88' ' ' TRP . 12.1 ttp180 -121.83 125.38 46.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.03 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 38' ' ' LEU . 11.9 tp -175.71 -39.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.207 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.2 mt -55.39 87.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.974 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -131.91 -44.67 0.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.235 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.24 108.84 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.08 0.467 . . . . 0.0 111.326 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.13 172.7 12.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.24 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 2.3 t -145.72 92.17 5.52 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 120.717 0.294 . . . . 0.0 111.172 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.619 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 10.1 Cg_endo -49.39 116.48 2.31 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.453 2.769 . . . . 0.0 111.972 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER 81.17 -61.21 0.22 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.613 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.98 169.09 16.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.814 0.34 . . . . 0.0 110.976 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.59 -15.33 13.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.951 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.438 ' CG ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -70.65 171.18 8.62 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.289 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.438 ' HD2' ' CG ' ' A' ' 46' ' ' HIS . 74.2 Cg_endo -75.79 51.4 3.03 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.342 2.028 . . . . 0.0 112.707 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.2 96.48 4.47 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.969 0.414 . . . . 0.0 110.932 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.542 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -67.93 80.77 0.21 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.398 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.498 ' CA ' ' HG2' ' A' ' 42' ' ' PRO . . . -58.6 -111.4 0.01 OUTLIER Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.777 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.592 ' N ' ' CG ' ' A' ' 42' ' ' PRO . 14.9 t -121.57 78.51 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 42' ' ' PRO . 0.9 OUTLIER -108.91 85.86 2.18 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 174.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.458 ' C ' ' CD1' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -144.0 89.1 2.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.047 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -135.8 -34.24 0.83 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.048 178.633 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.05 -62.29 0.29 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.607 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.618 ' HA ' ' HB1' ' A' ' 60' ' ' ALA . 81.8 Cg_exo -47.1 -20.09 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.172 2.581 . . . . 0.0 113.68 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.614 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 9.3 mm-40 -94.63 -27.67 15.76 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.551 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -90.72 -65.36 1.02 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.58 -25.01 38.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.666 0.27 . . . . 0.0 111.472 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.618 ' HB1' ' HA ' ' A' ' 56' ' ' PRO . . . -89.27 -56.16 3.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.924 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.614 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 1.7 t80 -59.27 -39.22 82.22 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.94 0.4 . . . . 0.0 110.933 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 1.9 m -58.97 -66.39 0.51 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.675 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.466 ' HB2' ' HG3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -60.49 -38.69 85.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.781 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 11.1 mmtm -60.79 -61.48 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.73 -47.96 20.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.777 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.31 -10.56 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.862 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -89.15 -34.1 16.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.665 0.269 . . . . 0.0 111.214 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -89.97 -28.09 19.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.194 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.92 104.83 14.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.986 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.04 -26.22 64.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.065 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.85 98.95 11.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.956 0.407 . . . . 0.0 111.268 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 93' ' ' TYR . 2.3 mp -122.84 91.23 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.294 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 1.2 tt0 -97.23 139.9 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 111.04 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.436 ' CG1' ' CB ' ' A' ' 90' ' ' ALA . 29.7 t -111.29 141.36 26.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.454 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -105.28 62.03 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.304 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.79 148.45 25.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.073 0.463 . . . . 0.0 111.805 -179.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.427 ' H ' HD11 ' A' ' 89' ' ' LEU . 21.4 t0 -77.24 162.3 27.47 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.176 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.3 32.41 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.804 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.09 33.08 0.27 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -78.52 128.01 32.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.52 0.676 . . . . 0.0 110.887 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.2 ttm-85 -56.32 113.91 1.77 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.851 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.469 ' HB ' ' HA2' ' A' ' 86' ' ' GLY . 29.8 p -84.43 171.49 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.777 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.77 -89.86 0.19 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.329 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -83.13 -96.31 0.05 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 110.626 -0.139 . . . . 0.0 110.626 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -77.72 59.56 2.04 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 88' ' ' TRP . . . 58.17 21.06 45.51 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.522 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 86' ' ' GLY . 54.0 mmt-85 -15.04 123.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.11 0.564 . . . . 0.0 112.239 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.606 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 98.8 m95 -126.36 145.46 50.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.601 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.513 ' N ' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -77.34 156.21 31.44 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.436 ' CB ' ' CG1' ' A' ' 74' ' ' VAL . . . 176.63 160.19 0.35 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.24 0.543 . . . . 0.0 112.212 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -108.91 -35.44 6.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.719 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp 59.44 122.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.956 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.478 ' OH ' ' HB3' ' A' ' 73' ' ' GLU . 4.3 p90 -144.65 142.85 30.42 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.113 0.482 . . . . 0.0 111.635 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.35 120.67 41.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.656 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.14 27.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.109 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.46 -15.33 54.93 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.117 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -109.85 131.08 55.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.858 0.329 . . . . 0.0 110.986 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.406 ' HA ' ' HA ' ' A' ' 93' ' ' TYR . 6.2 mtt -72.01 140.69 49.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.736 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.419 ' CG1' ' HA ' ' A' ' 62' ' ' THR . 27.9 m -47.39 -37.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.937 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' A' ' 110' ' ' LYS . 11.6 p-10 -79.21 -33.17 44.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.199 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.02 -54.75 43.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.039 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.94 -3.01 42.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.626 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.565 ' O ' ' HB2' ' A' ' 108' ' ' LEU . 5.9 tp -55.18 -28.61 54.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.808 0.337 . . . . 0.0 110.975 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.456 ' O ' ' C ' ' A' ' 105' ' ' ARG . 0.6 OUTLIER -49.65 -11.37 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.456 ' C ' ' O ' ' A' ' 104' ' ' VAL . 5.3 ptm180 -24.78 -48.44 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.415 ' N ' ' CG ' ' A' ' 105' ' ' ARG . 1.6 pp0? -121.34 -3.48 9.44 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.19 30.43 0.86 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.839 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.565 ' HB2' ' O ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -88.27 -179.94 6.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.104 0.478 . . . . 0.0 111.247 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 41' ' ' THR . . . -51.34 150.13 3.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.03 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 100' ' ' ASN . 14.8 mmtt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.908 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.836 0.35 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.21 131.99 56.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.953 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -70.34 106.08 3.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 p -105.48 115.03 29.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.33 108.02 10.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.821 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.45 110.86 18.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.903 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 pp -91.84 153.15 19.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.838 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -93.85 158.08 15.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.87 121.48 35.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.678 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -135.1 113.93 11.58 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 83.1 Cg_endo -83.37 154.15 14.08 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.721 2.281 . . . . 0.0 112.26 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.575 ' HB2' HD13 ' A' ' 25' ' ' LEU . . . -166.23 157.31 13.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.72 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 25' ' ' LEU . 5.5 m -86.85 107.55 18.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.028 0.442 . . . . 0.0 111.279 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -98.83 108.0 20.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.565 178.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.529 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 1.4 pp -125.62 -13.2 4.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -113.29 123.04 49.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.461 ' CB ' HG23 ' A' ' 62' ' ' THR . . . -112.88 103.67 11.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.241 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 22' ' ' THR . 34.7 mt -62.65 -82.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.079 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -118.17 41.94 2.81 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.28 -47.26 3.69 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.103 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.41 ' HA ' HD12 ' A' ' 37' ' ' LEU . 33.9 m-20 -96.37 -41.09 8.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.964 0.411 . . . . 0.0 110.024 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.437 ' O ' ' HB ' ' A' ' 18' ' ' ILE . 2.1 p -82.55 106.87 14.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.787 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.429 ' HB ' ' CD2' ' A' ' 14' ' ' LEU . 35.1 m -121.53 155.65 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 111.718 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.9 127.42 56.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.734 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.824 ' HG ' ' CE1' ' A' ' 34' ' ' PHE . 2.0 pp -133.82 143.2 48.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.32 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -72.54 99.21 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -93.41 106.37 18.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.3 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 tttm 50.35 55.33 9.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.819 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.56 13.41 60.8 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.199 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.406 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -142.14 97.94 6.23 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.699 0.285 . . . . 0.0 110.245 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.648 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 40.8 Cg_endo -67.36 146.48 75.24 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.566 2.177 . . . . 0.0 113.01 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.3 mmt -145.36 161.2 40.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.388 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.2 p -91.34 126.03 36.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.485 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.824 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.2 m-85 -111.35 124.19 51.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.041 0.448 . . . . 0.0 110.892 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -108.82 98.95 8.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.165 -179.297 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER 169.7 151.91 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.015 0.436 . . . . 0.0 111.261 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.412 ' CD2' ' HB3' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -179.28 39.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.609 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tp 63.64 -102.83 0.11 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.13 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.32 139.19 29.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.899 0.38 . . . . 0.0 111.162 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -137.19 62.81 1.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.961 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 59.2 p -76.77 110.79 12.79 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.738 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 12.9 Cg_exo -70.47 112.93 3.33 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.716 2.278 . . . . 0.0 112.933 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 72.04 -50.09 0.69 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.41 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.9 152.65 22.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.814 0.34 . . . . 0.0 111.343 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.09 -1.0 37.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.817 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.412 ' HB3' ' CD ' ' A' ' 47' ' ' PRO . 22.6 m170 -70.71 171.17 8.71 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.114 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.412 ' CD ' ' HB3' ' A' ' 46' ' ' HIS . 17.2 Cg_exo -67.65 47.29 0.32 Allowed 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.677 2.252 . . . . 0.0 113.077 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -128.5 96.15 4.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.684 0.278 . . . . 0.0 110.72 179.438 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 0.4 OUTLIER -83.0 -173.23 4.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.038 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 151.91 -122.28 1.31 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.403 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.36 86.59 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.854 0.359 . . . . 0.0 111.43 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 42' ' ' PRO . 0.3 OUTLIER -57.81 171.09 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.855 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -78.55 90.44 4.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.352 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.469 ' HB3' ' CB ' ' A' ' 108' ' ' LEU . 27.3 p90 -135.58 -34.57 0.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.798 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.465 ' N ' ' CD1' ' A' ' 54' ' ' TYR . . . 93.78 -110.86 4.04 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.749 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.55 ' HB2' ' CB ' ' A' ' 60' ' ' ALA . 90.9 Cg_endo -89.4 -3.49 5.89 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.077 2.518 . . . . 0.0 113.763 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -58.04 -14.08 5.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.453 ' HB1' ' CZ ' ' A' ' 54' ' ' TYR . . . -91.39 -65.57 1.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.5 m -88.04 -23.59 23.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.97 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.55 ' CB ' ' HB2' ' A' ' 56' ' ' PRO . . . -88.91 -46.11 9.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.523 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -63.99 -49.97 70.36 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.207 0.527 . . . . 0.0 109.914 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 63' ' ' LYS . 2.6 t -49.81 -31.71 12.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.913 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 15' ' ' ILE . 6.9 mttm -82.71 -41.96 18.64 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.138 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -72.33 -30.43 64.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.254 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -40.62 80.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.1 p -83.14 -29.54 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.14 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.19 -9.15 59.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.519 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -111.24 -28.13 8.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.699 0.285 . . . . 0.0 111.337 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.92 141.52 39.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.177 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -102.02 25.41 8.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.81 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 98.8 3.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.69 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.13 92.35 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.94 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 7.6 mt-10 -94.98 136.77 34.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.748 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.405 ' CG2' ' CD2' ' A' ' 25' ' ' LEU . 24.6 t -116.08 123.25 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.193 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -85.57 54.51 3.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.734 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.553 ' C ' ' CD1' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -95.03 164.64 12.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.127 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.635 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -99.94 162.08 13.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.843 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -92.84 30.79 1.5 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.47 31.31 0.16 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.498 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.635 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 34.0 mm-40 -78.54 125.57 29.55 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.524 0.678 . . . . 0.0 111.081 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -44.14 120.89 2.28 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.168 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.452 ' CG2' ' CE2' ' A' ' 88' ' ' TRP . 43.5 p -101.98 171.45 7.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.04 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 87' ' ' ARG . 32.1 m-20 -134.51 -83.37 0.43 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.478 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 -86.37 0.22 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.456 0.17 . . . . 0.0 111.132 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -93.99 36.59 1.11 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.962 0.411 . . . . 0.0 110.415 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.48 ' O ' ' C ' ' A' ' 87' ' ' ARG . . . 109.48 -33.53 6.04 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.404 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.48 ' C ' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 27.62 54.0 0.06 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.619 0.723 . . . . 0.0 110.777 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.52 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 70.2 m95 -85.41 155.44 21.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.916 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.562 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -77.81 158.23 29.61 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.405 ' N ' ' CD2' ' A' ' 89' ' ' LEU . . . 173.25 156.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.201 0.524 . . . . 0.0 111.895 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -112.63 -41.1 3.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.624 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.8 mp 58.55 121.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.08 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.477 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 15.0 p90 -142.54 130.59 21.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.377 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.58 124.14 48.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.603 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 t70 74.79 27.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.864 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.21 22.34 77.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.863 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 115.38 11.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 111.046 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.421 ' CG ' ' HB3' ' A' ' 93' ' ' TYR . 4.0 mtm -72.0 129.53 38.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.515 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -35.91 34.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.863 0.364 . . . . 0.0 110.584 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.429 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 4.3 p30 -74.36 -50.28 19.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.049 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.457 ' HA ' ' CD ' ' A' ' 105' ' ' ARG . 1.1 tm-20 -67.51 -8.93 37.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.882 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.74 -36.75 65.2 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.474 ' HG ' ' CD2' ' A' ' 108' ' ' LEU . 1.1 pt? -151.74 -47.36 0.11 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.83 ' HA ' ' HG ' ' A' ' 108' ' ' LEU . 2.9 p -39.52 -26.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.466 ' HD3' HG11 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -59.18 -44.45 92.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.114 179.604 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.52 ' NE2' ' N ' ' A' ' 108' ' ' LEU . 1.3 pm0 -92.07 -20.06 21.68 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.964 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 130.07 33.81 0.49 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.482 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.83 ' HG ' ' HA ' ' A' ' 104' ' ' VAL . 2.2 mt 43.58 98.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.096 0.474 . . . . 0.0 112.125 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.463 ' O ' ' CG ' ' A' ' 110' ' ' LYS . . . -58.44 150.43 22.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.772 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 5.4 pttp . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.214 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.832 0.349 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.97 90.45 3.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.878 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 t -74.94 117.35 16.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 t -95.21 128.76 42.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.826 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.1 118.7 6.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.43 112.54 13.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.81 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 mp -71.69 133.19 45.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.959 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.31 -49.18 6.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.627 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.37 134.95 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.997 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -115.32 131.95 23.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.684 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -87.45 125.49 2.12 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.596 2.198 . . . . 0.0 112.398 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.19 127.74 12.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.444 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 t -86.56 108.56 18.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.039 0.447 . . . . 0.0 110.727 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 3.2 tt -77.45 121.39 23.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.418 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.503 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -74.55 -48.6 34.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.671 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.505 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 179.68 168.4 1.16 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.943 0.401 . . . . 0.0 111.259 179.21 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.416 ' CB ' HG22 ' A' ' 62' ' ' THR . . . -87.27 148.13 25.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.082 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.6 mm -91.37 -69.73 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.341 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -118.13 35.93 4.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.246 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.29 -48.5 3.4 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.65 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -96.7 -56.18 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.359 . . . . 0.0 110.616 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 m -70.69 106.81 3.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.501 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.96 154.83 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.308 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.402 ' HB3' HG13 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -92.91 140.06 29.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.762 179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.688 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -141.34 118.41 11.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.052 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.485 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -72.31 99.41 2.4 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.617 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 2.7 t80 -91.23 102.29 15.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.755 -178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.9 tttp 43.16 50.15 5.63 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.658 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.33 -14.33 59.66 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.563 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.617 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -118.32 97.21 50.61 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.688 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 10.7 Cg_exo -72.06 130.19 16.24 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.319 2.013 . . . . 0.0 112.97 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 6.2 mmt -124.85 157.22 36.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.16 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 p -86.67 119.54 27.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.037 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.573 ' HA ' ' O ' ' A' ' 88' ' ' TRP . 17.9 m-85 -111.03 107.77 17.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.652 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -94.17 109.53 21.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.31 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER 171.03 -31.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.61 79.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.35 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 36' ' ' LEU . 1.4 tt 178.45 63.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.141 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.9 109.49 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 0.0 110.686 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.414 ' O ' ' CA ' ' A' ' 49' ' ' LYS . 3.2 p30 -137.71 169.72 17.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.022 0.439 . . . . 0.0 111.477 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.492 ' CB ' ' HB2' ' A' ' 48' ' ' LYS . 1.7 t -137.51 108.07 8.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.794 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 50' ' ' GLY . 11.2 Cg_exo -73.78 120.32 6.35 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.949 2.433 . . . . 0.0 113.062 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.424 ' CB ' ' O ' ' A' ' 42' ' ' PRO . 2.3 tm-20 83.72 -51.57 0.14 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.732 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.17 159.31 15.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.862 0.363 . . . . 0.0 111.095 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.32 4.65 31.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.434 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 2.3 m170 -70.79 169.12 15.57 Favored Pre-proline 0 N--CA 1.455 -0.189 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.544 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 46' ' ' HIS . 34.0 Cg_endo -65.0 64.8 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.384 2.056 . . . . 0.0 112.512 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.492 ' HB2' ' CB ' ' A' ' 41' ' ' THR . 6.1 mmpt? -101.13 168.56 9.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.329 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.414 ' CA ' ' O ' ' A' ' 40' ' ' ASP . 36.6 mtmt -123.49 9.24 9.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.386 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.479 ' O ' ' HD3' ' A' ' 42' ' ' PRO . . . -63.48 130.09 40.31 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.08 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 m -87.74 89.35 3.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.814 0.34 . . . . 0.0 111.337 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.99 -177.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.641 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.57 90.98 5.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.382 . . . . 0.0 111.355 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 55' ' ' GLY . 15.2 p90 -130.73 -34.64 1.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.696 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.52 ' N ' ' CD1' ' A' ' 54' ' ' TYR . . . 77.4 -110.88 3.13 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 114.462 0.545 . . . . 0.0 114.462 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 60' ' ' ALA . 28.1 Cg_exo -38.15 -40.99 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.947 3.098 . . . . 0.0 115.136 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.472 ' HB2' ' CD1' ' A' ' 54' ' ' TYR . 0.5 OUTLIER -45.44 -19.9 0.05 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.552 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -90.63 -65.08 1.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.52 -32.25 19.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 56' ' ' PRO . . . -75.8 -35.12 60.16 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.421 ' CG ' HD13 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -89.98 -30.86 17.52 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.158 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.552 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 15.3 t -60.62 -54.56 43.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.505 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 13.3 ptmt -65.3 -43.1 92.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.373 . . . . 0.0 110.875 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -48.99 74.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.079 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -55.98 -30.38 61.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.139 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.6 m -92.5 -31.21 4.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.036 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -72.08 -5.94 38.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.657 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -95.02 -28.13 15.28 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.609 0.242 . . . . 0.0 111.598 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.98 151.01 26.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 111.404 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.8 ttmm -99.18 17.55 19.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.255 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.97 98.98 4.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.907 0.384 . . . . 0.0 110.797 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mp -118.69 94.17 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.112 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.508 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 2.4 mt-10 -104.89 131.23 52.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.607 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.4 m -106.28 145.46 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.894 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -99.78 54.41 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.488 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.44 ' CD1' ' C ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -97.63 166.23 11.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.7 -179.193 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.709 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -104.3 162.53 13.13 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.969 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.5 tmtp? -92.25 23.93 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.314 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.97 20.78 0.36 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.535 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.709 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 17.0 mm-40 -78.61 128.87 34.09 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.542 0.686 . . . . 0.0 111.116 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.451 ' C ' ' O ' ' A' ' 80' ' ' GLN . 1.4 mpp_? -23.45 118.38 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.966 -1.47 . . . . 0.0 111.784 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 5.8 p -109.12 171.34 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.688 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -179.02 155.94 0.77 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.964 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 43.76 -101.7 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.686 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -96.94 36.33 1.43 Allowed 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 120.939 0.399 . . . . 0.0 110.762 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 82' ' ' THR . . . 104.91 -36.82 4.14 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.416 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 29.27 75.63 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.187 0.518 . . . . 0.0 111.263 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.573 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 68.2 m95 -109.96 163.23 13.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.458 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -81.12 154.08 26.96 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 89' ' ' LEU . . . 179.13 153.21 0.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.18 0.514 . . . . 0.0 112.14 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -111.37 -35.08 5.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.942 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp 54.38 109.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.295 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 6.4 p90 -127.74 137.13 52.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.058 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -106.38 123.88 48.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.657 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 t70 73.65 26.17 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.84 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.33 21.91 74.42 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.828 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.14 113.96 10.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.502 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 7.5 mtt -60.47 139.1 57.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.724 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.1 t -53.05 -53.31 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.05 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -63.71 -26.42 68.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.576 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 98' ' ' MET . 0.0 OUTLIER -58.75 -30.6 67.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.932 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 105' ' ' ARG . . . -91.1 -46.81 7.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.343 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.485 ' O ' ' NE2' ' A' ' 106' ' ' GLN . 1.4 mp -49.31 -39.2 30.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.063 0.459 . . . . 0.0 111.295 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.2 t -74.37 -1.87 3.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.962 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 102' ' ' ALA . 2.4 ptt85 -42.81 -43.91 4.21 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.694 0.283 . . . . 0.0 111.551 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -121.28 0.74 10.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.417 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 110.87 31.48 2.91 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.422 HD21 ' HG ' ' A' ' 103' ' ' LEU . 3.1 mt 73.22 111.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.466 0.651 . . . . 0.0 111.452 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.4 139.5 40.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.166 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.966 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.891 0.377 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.4 p -124.51 118.33 26.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -77.04 127.72 33.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 t -92.54 140.44 29.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.83 139.84 36.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 109.51 20.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.936 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.03 157.07 23.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.942 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.02 -167.56 0.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.88 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.96 127.52 28.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.897 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -122.79 154.32 63.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 85.1 Cg_endo -86.73 156.33 8.9 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.763 2.309 . . . . 0.0 112.298 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -166.27 157.34 13.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.052 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.12 108.38 19.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.779 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 5.7 tt -77.12 121.16 23.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.519 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.6 pp -74.83 -44.6 45.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.206 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.519 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 9.1 tttm 179.51 163.32 0.94 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.878 0.37 . . . . 0.0 111.187 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.422 ' CB ' ' HA ' ' A' ' 59' ' ' SER . . . -91.75 145.91 24.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.331 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.4 mt -96.97 -75.27 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.548 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -117.5 42.14 2.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.519 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.65 -53.61 4.84 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.675 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.455 ' HA ' ' CD1' ' A' ' 37' ' ' LEU . 13.7 m-20 -96.68 -37.71 10.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 110.553 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -76.99 106.84 8.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.702 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 34' ' ' PHE . 29.1 m -127.93 152.21 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.722 0.296 . . . . 0.0 111.221 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.03 131.66 55.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.211 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.816 ' HG ' ' CE1' ' A' ' 34' ' ' PHE . 0.5 OUTLIER -141.44 148.74 40.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.421 178.184 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.448 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -72.68 99.8 2.66 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.705 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 24.2 t80 -88.42 111.21 21.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.314 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 38.23 38.59 0.22 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.172 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.8 -14.47 58.87 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.295 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.705 ' NE2' ' O ' ' A' ' 27' ' ' TYR . 2.1 pm0 -120.54 96.94 48.91 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.116 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 39.4 Cg_exo -61.5 127.34 21.51 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.53 2.154 . . . . 0.0 112.552 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.562 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -133.04 161.84 33.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.709 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 88' ' ' TRP . 55.5 m -92.8 156.98 16.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.816 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 10.6 m-85 -143.14 136.04 27.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.649 0.262 . . . . 0.0 111.611 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.607 ' HB3' ' HD3' ' A' ' 87' ' ' ARG . 7.7 ttm180 -139.56 115.21 10.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.934 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 20.2 tp 167.21 -64.58 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.626 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 91' ' ' TYR . 2.7 mp 64.18 -83.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.119 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.424 ' HG ' ' CE2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -177.58 -76.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.717 0.294 . . . . 0.0 111.024 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.404 ' CG1' HG23 ' A' ' 41' ' ' THR . 1.4 t -141.84 123.65 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.991 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.9 34.1 5.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.281 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.404 HG23 ' CG1' ' A' ' 39' ' ' VAL . 2.6 t -76.9 123.49 87.43 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.516 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.496 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 13.2 Cg_exo -69.1 112.47 2.97 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.304 2.003 . . . . 0.0 112.257 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.59 -46.02 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.35 174.98 6.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.94 0.4 . . . . 0.0 111.417 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -128.12 15.64 6.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.882 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.45 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 1.8 m170 -95.12 168.69 10.62 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.445 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.45 ' HD2' ' CB ' ' A' ' 46' ' ' HIS . 2.0 Cg_endo -45.1 90.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.741 2.294 . . . . 0.0 112.181 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 46' ' ' HIS . 0.0 OUTLIER -44.52 167.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.44 0.638 . . . . 0.0 112.219 -179.443 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.84 -37.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.531 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.456 ' O ' ' CG ' ' A' ' 42' ' ' PRO . . . -134.17 114.97 1.39 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.023 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.1 t -69.5 147.98 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.101 0.477 . . . . 0.0 111.206 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.496 ' N ' ' HG3' ' A' ' 42' ' ' PRO . 0.6 OUTLIER -57.85 167.16 1.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.479 -179.127 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.47 90.8 5.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.495 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.525 ' CD1' ' CB ' ' A' ' 57' ' ' GLU . 12.5 p90 -124.29 -34.76 2.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.197 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.521 ' N ' ' CD1' ' A' ' 54' ' ' TYR . . . 84.41 -107.1 2.97 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.701 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 24.6 Cg_exo -38.41 -42.83 1.77 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.917 3.078 . . . . 0.0 114.983 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.549 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 1.6 tp10 -47.41 -17.44 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.521 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -90.5 -63.16 1.31 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.422 ' HA ' ' CB ' ' A' ' 17' ' ' ALA . 37.3 m -92.79 -43.89 8.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.379 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' A' ' 56' ' ' PRO . . . -62.93 -31.96 73.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.575 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.549 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 3.3 t80 -88.83 -44.25 10.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.371 . . . . 0.0 110.997 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 3.0 m -60.15 -66.28 0.55 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.757 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -55.44 -23.48 25.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.516 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -83.6 -54.7 4.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 111.5 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 mmt -47.69 -27.62 2.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.662 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m -94.02 -19.05 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.34 -25.24 39.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.535 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -97.29 -28.3 14.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.399 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.2 108.07 18.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.143 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -15.49 52.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.877 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.423 ' HG3' ' HA ' ' A' ' 95' ' ' ASP . 2.8 ptpt -91.8 101.71 14.31 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.383 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.402 ' CG2' ' O ' ' A' ' 93' ' ' TYR . 3.3 mp -134.88 99.14 2.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.255 0.55 . . . . 0.0 110.997 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.581 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 2.2 mt-10 -93.26 179.59 5.37 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.649 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.407 HG12 ' CD2' ' A' ' 25' ' ' LEU . 31.3 m -145.22 139.67 22.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.977 0.418 . . . . 0.0 111.528 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -106.49 41.34 1.45 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.181 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.423 ' HB2' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -92.76 160.45 14.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.662 -179.154 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.401 ' O ' ' CE2' ' A' ' 76' ' ' PHE . 8.2 t0 -90.92 152.59 20.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.081 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.28 31.3 2.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.154 0.502 . . . . 0.0 110.347 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.02 38.5 0.64 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.418 ' HB2' ' CD1' ' A' ' 89' ' ' LEU . 1.3 tp60 -78.11 126.84 31.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.929 -0.636 . . . . 0.0 110.642 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.24 79.22 0.05 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.792 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.576 HG21 ' CD1' ' A' ' 88' ' ' TRP . 0.1 OUTLIER -102.0 171.28 7.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.009 -178.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 84' ' ' LYS . 4.0 m-20 -92.2 -36.21 13.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.342 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.473 ' O ' ' CD2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER 177.14 -31.42 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.473 ' CD2' ' O ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER 163.38 -23.16 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 110.502 -0.185 . . . . 0.0 110.502 -179.522 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -44.46 -24.75 0.68 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.851 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.651 ' HD2' ' N ' ' A' ' 88' ' ' TRP . 0.2 OUTLIER -175.84 130.06 0.25 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.807 0.337 . . . . 0.0 110.908 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.755 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 20.9 m95 -126.95 169.81 12.92 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.53 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -82.82 152.09 25.79 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.451 ' HB3' ' CD2' ' A' ' 34' ' ' PHE . . . -178.26 162.2 1.52 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.362 0.601 . . . . 0.0 112.432 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 37' ' ' LEU . 3.5 m-85 -117.15 -17.52 10.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.646 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.3 mp 64.31 158.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.843 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.581 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -151.13 134.12 15.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.752 -178.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -134.72 105.19 6.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.863 0.363 . . . . 0.0 111.496 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.423 ' HA ' ' HG3' ' A' ' 71' ' ' LYS . 14.7 t0 54.51 43.8 29.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.748 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.28 -22.41 23.45 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.13 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -116.41 127.72 54.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.89 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.53 148.9 49.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.891 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -56.75 -35.71 46.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.303 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -78.95 -50.1 11.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.053 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -47.9 -28.3 2.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.569 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -91.02 -56.58 3.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.504 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.436 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . 2.8 mp -44.83 -51.01 9.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.89 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.7 m -67.11 -2.09 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.421 ' HG3' ' HG3' ' A' ' 106' ' ' GLN . 10.9 ptm180 -36.79 -46.04 0.58 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.81 0.338 . . . . 0.0 111.715 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.434 ' NE2' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -121.23 -0.18 9.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.254 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.6 28.68 2.05 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.436 ' CD2' ' HB3' ' A' ' 103' ' ' LEU . 1.6 mt 72.99 105.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.346 0.593 . . . . 0.0 111.371 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.94 150.08 25.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.286 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.5 mptt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.917 179.981 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.806 0.336 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.7 t -114.0 99.75 7.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.2 p -101.06 121.35 41.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.943 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.4 p -64.99 138.33 58.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.808 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -97.63 112.73 24.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.021 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.68 109.66 5.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.808 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.39 118.08 35.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -96.68 -28.38 14.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.667 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' CE ' ' HB2' ' A' ' 75' ' ' GLU . 1.2 mmpp? -131.22 121.18 24.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.786 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.452 ' HG2' ' CE2' ' A' ' 27' ' ' TYR . 0.6 OUTLIER -132.32 125.83 20.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.065 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -84.52 146.43 10.83 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.67 2.246 . . . . 0.0 112.502 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.496 ' HB3' ' HG ' ' A' ' 25' ' ' LEU . . . -166.37 173.06 10.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.94 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.26 108.57 15.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.021 0.439 . . . . 0.0 111.246 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 3.7 tt -86.83 120.84 28.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.055 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.422 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.7 pp -75.55 -46.41 37.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.513 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.422 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 0.0 OUTLIER 179.98 173.11 0.99 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.176 0.512 . . . . 0.0 111.87 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.78 148.3 22.43 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.677 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.8 -70.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.681 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.65 42.14 1.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.318 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.68 -54.32 4.94 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.547 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -96.8 -49.37 5.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.751 0.31 . . . . 0.0 110.296 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -63.84 106.68 1.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.23 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.414 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 30.2 m -122.59 142.43 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.485 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -87.99 124.71 34.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 1.3 tt -141.52 121.89 14.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.77 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.632 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 15.0 ptp -72.48 102.46 3.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.326 0.584 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.452 ' CE2' ' HG2' ' A' ' 10' ' ' GLU . 10.5 t80 -88.72 109.65 20.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.285 -178.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.91 46.52 18.85 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.602 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.9 -6.61 65.74 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.687 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.453 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -124.59 98.47 37.45 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 17.3 Cg_exo -68.87 143.71 56.26 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.985 2.457 . . . . 0.0 114.245 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.475 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 2.3 mtt -145.36 148.54 33.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.028 -1.442 . . . . 0.0 108.255 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.496 ' CA ' ' HA2' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -87.48 157.29 19.23 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.554 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 5.0 m-85 -140.8 149.39 41.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.075 0.464 . . . . 0.0 111.712 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 88' ' ' TRP . 0.3 OUTLIER -117.65 97.87 6.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.886 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.77 159.54 3.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.314 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -133.66 -178.56 5.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.797 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 63.46 38.66 9.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.2 t -104.38 160.3 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.59 179.49 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.974 0.416 . . . . 0.0 111.361 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 46' ' ' HIS . 5.9 t -105.97 143.16 26.35 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.906 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.428 ' HA ' ' CG ' ' A' ' 52' ' ' GLU . 4.6 Cg_exo -76.38 112.34 3.45 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.397 2.065 . . . . 0.0 111.808 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 76.63 -41.6 0.41 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.411 ' HB ' HG21 ' A' ' 41' ' ' THR . 0.2 OUTLIER -68.55 -178.94 1.23 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.76 0.314 . . . . 0.0 111.351 -179.489 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -108.11 -41.01 5.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.032 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.455 ' O ' ' HB ' ' A' ' 41' ' ' THR . 0.4 OUTLIER -70.54 125.62 92.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.97 45.14 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.646 2.231 . . . . 0.0 114.016 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.95 95.81 4.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.572 0.225 . . . . 0.0 110.834 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.427 ' HB3' ' CD ' ' A' ' 42' ' ' PRO . 0.0 OUTLIER 171.15 42.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.95 0.405 . . . . 0.0 110.727 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 61.75 -123.78 32.61 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.619 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.87 148.19 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 111.376 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.46 ' O ' ' CE1' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -66.86 152.29 45.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.151 179.404 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.58 90.63 6.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.719 0.295 . . . . 0.0 110.84 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.644 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 1.1 p90 -119.88 -35.75 3.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.899 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.19 -86.5 0.78 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.624 -0.798 . . . . 0.0 115.059 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 90.7 Cg_exo -49.37 -54.52 5.33 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.431 2.754 . . . . 0.0 115.711 -177.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.644 ' HB3' ' CE2' ' A' ' 54' ' ' TYR . 13.9 tm-20 -60.23 -23.51 64.11 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.783 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -91.06 -57.17 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.5 m -82.73 -31.34 28.5 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . -86.63 -53.22 5.08 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.509 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -61.54 -27.87 68.92 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.001 0.429 . . . . 0.0 110.958 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 1.1 m -63.73 -57.48 9.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.033 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.462 ' HA ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -82.95 -36.14 25.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.591 -179.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 60' ' ' ALA . 28.6 ttpt -63.2 -49.44 74.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.426 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -31.49 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 0.0 111.055 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 63' ' ' LYS . 25.0 m -89.81 -29.3 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.178 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -53.28 -25.48 14.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.343 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -106.02 -28.17 10.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 111.404 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.43 130.93 37.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.08 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -96.51 28.17 3.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.62 98.93 3.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.114 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.45 HG12 ' CG1' ' A' ' 66' ' ' VAL . 3.0 mt -120.97 95.26 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.392 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.426 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 1.9 mt-10 -94.61 160.35 14.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.77 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.409 ' CG2' ' CD1' ' A' ' 25' ' ' LEU . 56.0 t -132.08 114.99 25.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.084 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.407 ' HB2' ' CE ' ' A' ' 9' ' ' LYS . 2.3 tm-20 -79.96 53.73 1.74 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.407 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.637 ' HA ' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -97.48 164.63 12.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.112 0.482 . . . . 0.0 112.026 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -104.26 162.51 13.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.087 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.58 31.76 2.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.681 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.5 32.16 0.31 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.545 ' HB2' ' CE3' ' A' ' 88' ' ' TRP . 0.7 OUTLIER -78.5 127.97 32.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.6 0.714 . . . . 0.0 111.062 -179.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -67.63 84.29 0.19 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.919 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.416 HG22 ' CE2' ' A' ' 88' ' ' TRP . 10.2 t -106.23 163.14 13.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.87 -69.35 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -129.58 -66.41 0.8 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.807 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.407 ' CE1' ' HE1' ' A' ' 32' ' ' MET . 12.9 m-85 -162.04 24.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.806 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.515 ' C ' ' HD3' ' A' ' 87' ' ' ARG . . . -136.34 -5.22 2.09 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 119.802 -1.19 . . . . 0.0 114.143 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.515 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -114.68 42.88 2.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.487 0.661 . . . . 0.0 111.453 -178.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.554 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 66.4 m95 -80.8 150.67 29.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.089 178.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.637 HD11 ' HA ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -76.7 155.68 33.12 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.994 -0.683 . . . . 0.0 109.999 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 172.86 160.33 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.252 0.549 . . . . 0.0 111.794 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -112.31 -37.52 4.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.063 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.6 mp 60.12 127.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.738 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.426 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 8.9 p90 -149.07 141.46 24.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 111.321 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -111.31 119.08 37.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.491 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 76.38 20.11 1.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.071 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.93 -19.88 53.02 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.147 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.21 128.71 51.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.893 0.378 . . . . 0.0 111.426 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.403 ' HB2' ' CB ' ' A' ' 101' ' ' GLU . 16.0 mtt -68.41 150.21 48.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.2 m -77.78 -45.4 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.599 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.5 -33.96 36.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.238 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.403 ' CB ' ' HB2' ' A' ' 98' ' ' MET . 0.6 OUTLIER -71.47 -8.78 56.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.649 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.17 -67.88 0.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.535 ' O ' ' NE2' ' A' ' 106' ' ' GLN . 1.0 OUTLIER -55.86 -26.63 47.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.892 -179.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.1 m -66.53 -5.71 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.96 -44.05 4.44 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 103' ' ' LEU . 0.7 OUTLIER -121.09 10.89 10.83 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.89 26.78 4.28 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.653 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.6 mt 62.57 106.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.059 0.456 . . . . 0.0 111.368 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.59 113.19 2.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.088 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.7 pttt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.832 179.949 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.722 0.296 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.8 m -134.11 89.47 2.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.858 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.87 141.71 58.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.7 t -107.73 106.34 16.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -102.03 139.11 38.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.931 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -104.51 108.98 20.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.85 139.6 33.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.83 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.68 175.09 5.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.95 119.49 39.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.926 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -134.36 113.96 12.35 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.799 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 92.6 Cg_endo -85.67 147.49 9.63 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.713 2.275 . . . . 0.0 112.467 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.405 ' CB ' HD13 ' A' ' 25' ' ' LEU . . . -166.02 162.13 17.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.759 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -104.46 108.58 20.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.926 0.393 . . . . 0.0 111.258 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 25' ' ' LEU . 2.4 pp -65.18 133.33 51.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.47 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.522 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.7 pp -74.67 -42.32 47.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.42 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.759 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 0.2 OUTLIER 179.47 170.66 1.02 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.597 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.92 148.17 22.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.753 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.2 mt -106.36 -74.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.391 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -118.02 42.15 2.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.824 0.345 . . . . 0.0 111.312 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.3 -56.81 5.04 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.373 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.8 -32.29 12.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.352 . . . . 0.0 110.377 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -77.21 109.86 11.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.556 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 34' ' ' PHE . 33.6 m -131.82 155.78 41.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 3.2 ttpp -119.29 135.3 54.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.803 0.335 . . . . 0.0 111.335 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.876 ' HG ' ' CE1' ' A' ' 34' ' ' PHE . 2.8 pp -141.89 146.32 35.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.303 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.498 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 6.0 ttm -72.2 101.67 2.87 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.839 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.451 ' CE1' ' CZ ' ' A' ' 76' ' ' PHE . 76.8 t80 -88.81 109.24 20.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.667 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 30' ' ' GLN . 0.1 OUTLIER 49.03 27.52 1.72 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.716 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.72 -14.55 53.28 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.608 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -116.82 98.36 51.77 Favored Pre-proline 0 C--N 1.332 -0.174 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 31.7 Cg_exo -59.44 145.9 96.59 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.377 2.052 . . . . 0.0 112.814 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.466 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 41.5 mtt -145.08 162.03 37.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.006 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -90.31 156.2 18.44 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.876 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 29.0 m-85 -142.63 121.87 13.03 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.768 0.318 . . . . 0.0 111.218 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.721 ' HB3' ' HD3' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -125.82 97.81 5.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.098 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -178.67 161.92 1.33 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.665 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 36' ' ' LEU . 1.3 tp 164.97 -34.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.51 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mp 63.87 50.16 2.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.498 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.0 m -130.93 112.61 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.45 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -127.86 -47.3 1.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.428 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 46' ' ' HIS . 3.2 m -104.58 142.85 25.5 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.166 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HG3' ' O ' ' A' ' 51' ' ' VAL . 45.1 Cg_endo -86.62 112.46 1.03 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.562 2.174 . . . . 0.0 113.144 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 72.95 -13.88 0.64 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.37 156.25 21.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.911 0.386 . . . . 0.0 111.455 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -92.75 -29.62 15.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.524 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.527 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 4.0 m170 -70.64 171.47 8.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.813 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 46' ' ' HIS . 99.7 Cg_exo -44.64 163.34 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.282 1.988 . . . . 0.0 112.695 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -37.96 142.02 0.18 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.834 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -99.07 -50.03 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.931 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 172.15 -35.19 0.14 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.058 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.409 ' O ' ' HG3' ' A' ' 42' ' ' PRO . 2.5 m -121.57 79.14 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.873 0.368 . . . . 0.0 111.289 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.05 -178.09 3.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.522 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.75 94.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.779 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.8 -33.99 69.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.879 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 143.08 -57.47 0.55 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.036 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.438 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 48.0 Cg_exo -56.15 -21.99 37.89 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.57 2.18 . . . . 0.0 112.299 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 62.9 mm-40 -94.53 -33.23 13.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.617 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.15 -48.53 6.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.781 0.324 . . . . 0.0 111.72 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.2 m -87.45 -61.48 1.71 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.777 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -59.22 -37.27 77.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.614 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.432 ' CD2' ' CG ' ' A' ' 65' ' ' MET . 0.5 OUTLIER -77.37 -25.63 51.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.957 0.408 . . . . 0.0 110.644 179.647 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.425 ' CG2' ' N ' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -58.05 -66.32 0.5 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.947 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.759 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -67.45 -32.35 73.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.646 0.26 . . . . 0.0 111.589 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -64.89 -52.89 54.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.735 0.303 . . . . 0.0 111.323 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.432 ' CG ' ' CD2' ' A' ' 61' ' ' PHE . 26.0 mmt -54.85 -27.99 46.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.228 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.5 t -79.05 -39.58 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.152 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -60.79 -21.66 63.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.341 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -104.6 -28.06 11.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.288 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.06 115.52 30.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 0.0 111.172 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.59 -23.67 62.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.884 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.87 111.34 20.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 111.214 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -136.6 93.32 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.389 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 3.9 mt-10 -105.26 128.8 53.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.74 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.16 123.28 56.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.448 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.74 50.74 2.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.251 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.509 ' HB2' HD11 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -92.77 148.89 21.67 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.212 -179.289 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -73.85 156.4 37.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.225 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.48 32.52 2.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.171 0.51 . . . . 0.0 110.374 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.64 36.19 0.47 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.525 ' CG ' ' CE3' ' A' ' 88' ' ' TRP . 0.6 OUTLIER -78.17 128.24 33.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.622 0.725 . . . . 0.0 110.657 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -65.38 77.39 0.06 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.72 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.456 HG23 ' CZ2' ' A' ' 88' ' ' TRP . 12.7 t -83.8 160.26 21.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.154 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -91.93 49.42 1.54 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.678 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.444 ' O ' ' CB ' ' A' ' 85' ' ' TYR . 7.5 tttm 77.97 32.94 0.36 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.462 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.444 ' CB ' ' O ' ' A' ' 84' ' ' LYS . 36.5 m-85 88.73 -9.39 0.47 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.601 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.31 -16.26 41.73 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.4 -0.905 . . . . 0.0 111.654 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.721 ' HD3' ' HB3' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -177.31 131.25 0.17 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.085 0.469 . . . . 0.0 111.197 179.734 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.696 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 19.2 m95 -127.64 171.35 11.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.391 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -90.94 157.49 17.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.439 ' HB1' ' HB3' ' A' ' 34' ' ' PHE . . . 170.91 164.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.264 0.555 . . . . 0.0 112.077 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.429 ' HA ' ' CD1' ' A' ' 37' ' ' LEU . 4.2 m-85 -114.24 -48.13 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.088 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 mp 61.85 129.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.301 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.551 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 9.4 p90 -151.19 140.62 21.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.105 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.03 122.43 47.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.524 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.9 t70 78.8 33.48 0.26 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.629 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.86 20.55 62.27 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.826 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.13 109.97 7.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.9 0.381 . . . . 0.0 111.096 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.4 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -59.64 147.26 38.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.848 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -52.41 -33.2 17.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.974 0.416 . . . . 0.0 110.542 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -80.57 -36.79 32.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.873 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -24.81 62.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.711 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -91.35 -22.51 20.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.501 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.465 ' O ' ' NE2' ' A' ' 106' ' ' GLN . 0.2 OUTLIER -117.95 -66.32 1.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.806 0.336 . . . . 0.0 111.21 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 105' ' ' ARG . 40.7 t -54.85 -13.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.062 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -30.82 -44.48 0.06 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 103' ' ' LEU . 0.4 OUTLIER -121.25 -4.26 9.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.513 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.81 30.28 0.97 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.193 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.418 ' CD2' ' HB3' ' A' ' 103' ' ' LEU . 14.0 mt 63.27 107.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.183 0.516 . . . . 0.0 111.264 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.12 136.55 37.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.196 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.789 0.328 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.6 p -108.03 137.41 46.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -90.05 124.76 35.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 m -81.32 138.07 35.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.83 120.14 29.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 112.11 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.698 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pp -119.92 157.1 29.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -110.63 6.26 21.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.362 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.439 ' HA ' ' CE ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 62.52 146.2 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.794 0.33 . . . . 0.0 111.185 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -155.04 113.99 2.34 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.295 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 96.9 Cg_endo -88.44 104.77 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.718 2.279 . . . . 0.0 112.003 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.64 155.58 27.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.01 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 26' ' ' MET . 87.6 m -89.01 108.26 19.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.133 0.492 . . . . 0.0 111.151 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.496 ' C ' ' CD1' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -79.49 111.58 15.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.024 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.476 ' CD1' ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -75.1 -46.18 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.248 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.476 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -177.29 173.14 1.79 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.006 0.432 . . . . 0.0 111.594 179.643 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.7 148.31 25.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.876 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mt -97.53 -72.91 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.639 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -118.09 41.91 2.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.713 0.292 . . . . 0.0 111.646 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.21 -52.41 4.71 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.736 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.53 -55.23 2.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 110.331 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 m -68.55 106.87 2.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.148 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.08 160.2 33.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.248 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.44 ' O ' HD12 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -95.73 142.4 28.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.662 179.644 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.678 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -141.42 118.0 10.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.958 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.475 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 3.8 mtt -72.22 99.29 2.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.554 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 5.3 t80 -96.47 104.74 16.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.192 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 38.67 52.72 1.87 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.34 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.34 -14.57 60.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.931 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.554 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -120.75 97.08 48.63 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.678 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 6.7 Cg_exo -75.52 101.87 1.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.677 2.251 . . . . 0.0 113.101 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.436 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 2.5 mtt -98.49 149.2 22.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.863 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.551 ' HB ' ' CA ' ' A' ' 87' ' ' ARG . 5.8 m -77.95 158.9 29.15 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.53 ' CD1' ' HB2' ' A' ' 25' ' ' LEU . 72.4 m-85 -143.11 132.08 22.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.862 0.363 . . . . 0.0 110.833 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.44 ' HB3' ' HD3' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -133.68 114.47 13.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.376 -178.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER 170.37 -76.21 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.469 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.41 ' CD2' ' CG2' ' A' ' 99' ' ' VAL . 4.5 mt 53.32 -86.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.237 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -133.12 98.39 4.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.323 . . . . 0.0 110.672 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 p -61.77 109.93 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.867 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -136.01 -172.74 3.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 48' ' ' LYS . 1.2 t -124.53 114.88 27.08 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.153 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.535 ' HB3' ' HB3' ' A' ' 52' ' ' GLU . 22.5 Cg_exo -65.19 112.37 2.05 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.465 2.11 . . . . 0.0 112.228 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 68.71 -49.97 0.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.02 169.05 18.78 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.957 0.408 . . . . 0.0 111.384 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.405 ' HA ' HG21 ' A' ' 41' ' ' THR . 0.9 OUTLIER -119.68 -18.41 8.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.035 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.82 171.15 8.87 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.886 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -45.35 91.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.778 2.319 . . . . 0.0 112.855 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.438 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 0.8 OUTLIER -127.96 167.34 16.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.318 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.87 148.24 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.973 0.416 . . . . 0.0 111.608 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 42' ' ' PRO . . . 61.35 125.3 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.805 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.449 HG23 ' OH ' ' A' ' 54' ' ' TYR . 0.6 OUTLIER -70.66 162.16 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.965 0.412 . . . . 0.0 111.142 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -57.83 169.81 0.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.18 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.35 96.78 10.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.555 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -94.21 -35.97 12.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.527 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.06 -75.78 0.45 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.45 -0.881 . . . . 0.0 114.132 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.477 ' CD ' ' O ' ' A' ' 54' ' ' TYR . 82.5 Cg_exo -49.69 -53.31 7.26 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.992 2.462 . . . . 0.0 114.111 -178.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.786 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 2.7 tm-20 -82.62 -13.98 55.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.53 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -90.6 -65.24 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.5 t -93.18 -42.79 9.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.581 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.76 -29.53 67.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.874 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.786 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 4.9 t80 -90.05 -52.51 4.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.939 0.4 . . . . 0.0 111.295 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 16.8 m -51.79 -66.34 0.4 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.622 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -56.6 -33.31 66.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.745 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.46 -54.46 8.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.762 0.315 . . . . 0.0 111.644 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -27.0 9.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.8 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 m -99.01 -9.9 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -26.83 25.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.667 0.27 . . . . 0.0 111.305 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -103.63 -28.04 11.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.349 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -94.26 134.34 36.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.293 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -96.38 28.73 3.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.825 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.67 99.29 3.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.886 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.411 ' CG2' ' CG2' ' A' ' 92' ' ' ILE . 2.2 mp -130.16 91.29 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.071 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.406 ' HB3' ' OH ' ' A' ' 93' ' ' TYR . 0.7 OUTLIER -99.87 145.52 27.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.282 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 74' ' ' VAL . 14.8 p -119.9 128.69 75.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.257 0.551 . . . . 0.0 111.96 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.41 46.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.132 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.9 ' HB2' HD11 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -92.74 148.1 22.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.696 -178.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -76.92 159.15 30.22 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.803 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.25 35.26 2.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.974 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.23 39.77 0.31 Allowed Glycine 0 CA--C 1.496 -1.152 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.526 ' CG ' ' CD1' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -78.28 138.94 38.86 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.296 1.046 . . . . 0.0 111.896 -178.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -66.19 69.62 0.06 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.156 -1.838 . . . . 0.0 110.615 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.46 HG23 ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -91.12 164.91 13.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.919 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.36 -43.13 11.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.644 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.502 ' O ' ' CG ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -172.03 -58.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.477 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.502 ' CG ' ' O ' ' A' ' 84' ' ' LYS . 33.4 m-85 -163.14 -10.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.04 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.475 ' O ' ' HB ' ' A' ' 33' ' ' THR . . . -38.94 -34.54 0.29 Allowed Glycine 0 C--N 1.345 1.033 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.551 ' CA ' ' HB ' ' A' ' 33' ' ' THR . 0.0 OUTLIER 162.88 161.24 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.493 0.663 . . . . 0.0 111.292 177.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.507 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 12.8 m95 -126.76 172.62 10.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.162 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.9 HD11 ' HB2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -76.9 161.92 28.01 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.429 ' O ' ' CD1' ' A' ' 91' ' ' TYR . . . -179.68 179.74 0.56 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 90' ' ' ALA . 54.3 m-85 -154.7 39.29 0.43 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.746 -1.116 . . . . 0.0 109.572 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.452 HG12 HD13 ' A' ' 25' ' ' LEU . 2.8 mp -37.99 143.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.05 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.485 ' HB3' ' HG3' ' A' ' 98' ' ' MET . 5.2 p90 -151.31 142.43 23.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.094 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 95' ' ' ASP . . . -108.81 108.82 19.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.363 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER 82.0 23.96 0.23 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.89 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.77 -38.84 2.98 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.423 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.14 133.56 34.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 111.416 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.485 ' HG3' ' HB3' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -68.96 139.43 55.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.535 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.41 ' CG2' ' CD2' ' A' ' 37' ' ' LEU . 15.6 m -49.14 -28.57 2.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.829 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -87.68 -29.45 21.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.379 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 98' ' ' MET . 0.4 OUTLIER -58.22 -26.82 63.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.409 ' CB ' ' CE2' ' A' ' 61' ' ' PHE . . . -60.67 -67.7 0.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.352 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.622 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -147.75 94.71 2.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.898 0.38 . . . . 0.0 111.433 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 8.9 p -108.93 -59.08 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.256 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.401 ' H ' ' CG1' ' A' ' 104' ' ' VAL . 47.1 mmm-85 -106.61 -27.85 10.6 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.483 ' OE1' ' HA ' ' A' ' 103' ' ' LEU . 0.2 OUTLIER -71.07 15.18 0.12 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.12 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 130.72 -2.61 5.67 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.1 -1.047 . . . . 0.0 114.255 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.493 HD22 ' CD2' ' A' ' 54' ' ' TYR . 5.5 mt 48.87 179.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.287 0.543 . . . . 0.0 111.81 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.44 ' CB ' HD13 ' A' ' 103' ' ' LEU . . . -102.7 137.09 41.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.069 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.869 179.917 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HE2' ' CG ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.763 0.316 . . . . 0.0 110.952 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 74' ' ' VAL . 66.0 mm-40 -121.68 136.27 25.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.771 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.02 128.45 4.37 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.597 2.198 . . . . 0.0 112.434 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.501 ' HB3' HD22 ' A' ' 25' ' ' LEU . . . -149.38 126.11 11.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.572 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.85 HG22 HD13 ' A' ' 72' ' ' ILE . 1.7 p -86.98 108.74 18.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.04 0.447 . . . . 0.0 111.556 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.825 ' HB3' HG21 ' A' ' 66' ' ' VAL . 2.3 tt -69.51 114.93 8.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.914 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.994 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.6 pp -74.96 -43.8 45.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.994 ' N ' HD12 ' A' ' 15' ' ' ILE . 1.4 ttmt -167.6 143.32 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.911 0.386 . . . . 0.0 111.901 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.846 ' HB3' ' HA ' ' A' ' 59' ' ' SER . . . -87.39 148.21 25.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.518 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.3 mt -102.52 -76.07 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.21 30.67 7.1 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.622 0.231 . . . . 0.0 111.622 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.766 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 90.4 -45.0 2.93 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.736 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -96.64 -66.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.745 0.307 . . . . 0.0 110.419 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 m -66.75 106.84 1.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.013 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 17' ' ' ALA . 34.3 m -133.17 150.53 32.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.479 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.496 ' HG2' HG12 ' A' ' 15' ' ' ILE . 1.6 tppp? -80.06 143.75 33.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.332 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -140.84 117.84 11.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.216 -179.353 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.515 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -71.83 99.05 2.1 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.012 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 8.7 t80 -94.43 109.05 20.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.13 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.9 48.81 7.14 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.767 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.63 -14.17 48.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.9 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.465 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -119.97 97.81 49.4 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 32.2 Cg_exo -60.21 145.52 98.34 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.984 2.456 . . . . 0.0 114.052 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.416 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 29.9 mtm -145.34 140.1 27.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.101 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.451 ' C ' ' CD1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -79.89 157.02 27.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.189 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 16.6 m-85 -141.14 142.9 34.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.012 0.434 . . . . 0.0 111.913 -177.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.65 99.83 8.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.859 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.563 -179.157 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.747 ' CB ' ' HB3' ' A' ' 60' ' ' ALA . 2.9 Cg_endo . . . . . 0 CA--C 1.535 0.531 0 N-CA-C 116.215 1.583 . . . . 0.0 116.215 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.565 ' HA ' ' CB ' ' A' ' 61' ' ' PHE . 4.4 tp10 -43.13 -25.56 0.12 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.766 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -91.41 -65.37 1.02 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.846 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 4.0 m -88.18 -30.33 19.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.747 ' HB3' ' CB ' ' A' ' 56' ' ' PRO . . . -89.45 -37.64 14.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.565 ' CB ' ' HA ' ' A' ' 57' ' ' GLU . 10.4 t80 -90.68 -43.49 10.1 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.665 HG22 HD13 ' A' ' 14' ' ' LEU . 21.3 m -40.85 -66.92 0.28 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 16' ' ' LYS . 0.6 OUTLIER -74.19 -19.85 60.4 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 3.1 mttp -59.09 -54.59 45.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 111.125 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.504 ' HE2' ' HG3' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -58.89 -27.49 65.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.03 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.825 HG21 ' HB3' ' A' ' 14' ' ' LEU . 42.7 t -72.44 -30.99 36.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.106 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -86.68 -13.99 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.555 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -96.2 -28.34 14.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.684 0.278 . . . . 0.0 111.291 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.739 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -108.22 147.52 31.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.805 0.336 . . . . 0.0 111.168 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.5 pttt -97.73 24.48 6.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.401 ' HG3' ' HA ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -145.4 98.98 3.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.819 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.85 HD13 HG22 ' A' ' 13' ' ' THR . 2.5 mp -121.84 93.76 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.733 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.439 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.8 tt0 -106.56 132.75 52.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.798 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.672 ' HB ' ' HB1' ' A' ' 90' ' ' ALA . 32.6 m -103.66 126.87 58.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.15 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.407 ' CG ' ' HE2' ' A' ' 9' ' ' LYS . 1.8 tt0 -79.9 52.63 1.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.322 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.784 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -97.01 149.73 21.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.649 -179.11 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.77 ' H ' HD11 ' A' ' 89' ' ' LEU . 8.6 t70 -80.03 159.77 26.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.888 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.5 29.98 3.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.091 0.472 . . . . 0.0 110.452 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.77 35.93 0.58 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.529 ' HB2' HD12 ' A' ' 89' ' ' LEU . 2.0 tp60 -78.27 124.52 28.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.405 0.622 . . . . 0.0 110.707 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -67.53 88.29 0.22 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.957 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.0 m . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.951 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.59 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 78.3 m95 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.87 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -76.93 158.76 30.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.672 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . 173.02 164.61 0.13 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.263 0.554 . . . . 0.0 112.342 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -130.35 57.09 1.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.989 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.601 HG13 HG12 ' A' ' 74' ' ' VAL . 3.2 mp -42.07 127.77 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.424 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.485 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 3.1 p90 -142.89 143.88 32.23 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.075 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.739 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -112.81 124.18 52.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.789 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.401 ' HA ' ' HG3' ' A' ' 71' ' ' LYS . 0.1 OUTLIER 67.66 29.07 7.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.874 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.11 -35.89 3.93 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.001 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.504 ' HG3' ' HE2' ' A' ' 65' ' ' MET . 0.0 OUTLIER -86.94 130.43 34.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.904 0.383 . . . . 0.0 111.202 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.485 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 2.7 ttt -78.97 150.1 32.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.306 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.548 HG11 ' HA ' ' A' ' 62' ' ' THR . 25.8 m . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.946 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.619 ' N ' ' HZ2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.845 0.355 . . . . 0.0 111.127 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -104.79 127.98 27.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.518 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -90.02 163.69 4.86 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.752 2.301 . . . . 0.0 112.496 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.715 ' CB ' HD13 ' A' ' 25' ' ' LEU . . . -166.34 161.42 16.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.336 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 25' ' ' LEU . 35.6 p -93.55 108.34 20.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.327 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.962 HD12 HG11 ' A' ' 66' ' ' VAL . 2.2 tm? -89.15 119.57 29.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.149 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.897 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -74.76 -42.42 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.458 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.897 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER 179.87 173.17 0.96 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.249 0.547 . . . . 0.0 112.109 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.43 103.61 13.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.648 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' THR . 41.1 mm -53.3 -75.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.934 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -110.98 42.08 1.69 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.54 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.829 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 84.24 -52.15 4.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.924 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.49 -35.85 10.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.819 0.343 . . . . 0.0 110.422 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -71.39 106.79 4.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.27 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.738 HG21 HD13 ' A' ' 92' ' ' ILE . 3.2 m -122.99 129.35 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.685 0.279 . . . . 0.0 111.245 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' HD22 ' A' ' 14' ' ' LEU . 13.4 tttp -91.71 97.98 11.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.687 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.062 HD22 HG21 ' A' ' 74' ' ' VAL . 2.8 pp -110.51 137.72 47.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.662 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.567 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 29.0 ttm -72.51 99.96 2.62 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.533 ' CE1' ' CE1' ' A' ' 76' ' ' PHE . 86.9 t80 -88.51 109.42 20.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.174 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.457 ' O ' ' OE1' ' A' ' 30' ' ' GLN . 0.1 OUTLIER 49.18 28.27 2.12 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.821 179.416 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.44 -14.24 54.33 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.396 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -116.87 97.73 50.96 Favored Pre-proline 0 C--N 1.331 -0.239 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.821 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 34.1 Cg_exo -61.03 143.13 99.11 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.286 1.991 . . . . 0.0 113.129 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.444 ' O ' ' HE1' ' A' ' 34' ' ' PHE . 51.8 mtt -145.2 159.78 42.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.25 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.483 ' C ' ' CD1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -97.17 156.61 16.32 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.679 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.852 ' CZ ' HD11 ' A' ' 25' ' ' LEU . 3.0 m-85 -138.05 157.98 45.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.789 0.328 . . . . 0.0 111.493 -177.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.662 ' O ' HD12 ' A' ' 36' ' ' LEU . 2.2 ttm-85 -139.13 99.06 3.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.584 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.662 HD12 ' O ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.529 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.69 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 87.3 Cg_exo . . . . . 0 CA--C 1.529 0.243 0 N-CA-C 114.087 0.764 . . . . 0.0 114.087 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.543 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -93.88 -44.75 7.94 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.829 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -90.51 -65.4 1.02 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.5 p -65.57 -36.96 85.3 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.69 ' HB3' ' HA ' ' A' ' 56' ' ' PRO . . . -89.38 -57.4 2.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.543 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -61.07 -69.14 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.165 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.798 ' HA ' HG11 ' A' ' 99' ' ' VAL . 42.9 m -40.85 -66.57 0.31 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -55.93 -25.47 43.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.21 -63.17 1.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 0.0 111.878 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.553 ' SD ' ' HB3' ' A' ' 94' ' ' ALA . 1.6 mmm -50.86 -24.84 3.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.914 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.962 HG11 HD12 ' A' ' 14' ' ' LEU . 30.0 m -76.99 -31.02 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -94.18 -11.48 30.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.295 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -98.04 -28.17 13.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.66 0.267 . . . . 0.0 111.303 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.607 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . . . -102.68 143.91 31.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.884 0.374 . . . . 0.0 111.171 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -97.48 29.32 3.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.29 98.88 2.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.134 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.554 ' CG2' HG23 ' A' ' 92' ' ' ILE . 3.8 mt -119.23 94.67 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.397 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -94.94 137.18 34.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.86 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.062 HG21 HD22 ' A' ' 25' ' ' LEU . 21.3 t -116.97 102.87 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.423 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.435 ' CG ' ' HE2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -71.59 63.48 0.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.056 179.267 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.61 ' HB3' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -107.43 167.12 10.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.951 0.405 . . . . 0.0 111.834 -178.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.476 ' H ' HD11 ' A' ' 89' ' ' LEU . 6.9 t70 -104.29 162.05 13.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.34 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -101.0 32.6 3.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.414 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.69 33.55 0.32 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.944 ' HG3' HD12 ' A' ' 89' ' ' LEU . 1.4 mm-40 -78.37 128.96 34.4 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.542 0.686 . . . . 0.0 110.857 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.2 mtp85 -63.55 78.18 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.569 HG21 ' CD1' ' A' ' 88' ' ' TRP . 48.3 m . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.84 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.599 ' CE3' ' HB2' ' A' ' 80' ' ' GLN . 63.9 m95 . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.944 HD12 ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -77.36 164.43 25.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.885 ' HB1' HG13 ' A' ' 74' ' ' VAL . . . 175.28 172.89 0.27 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.288 0.566 . . . . 0.0 112.396 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -141.78 41.7 1.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.98 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.738 HD13 HG21 ' A' ' 23' ' ' VAL . 3.2 mp -41.96 127.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.056 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 2.2 p90 -143.98 153.93 42.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.471 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.607 ' HB1' ' CB ' ' A' ' 69' ' ' ALA . . . -113.51 135.48 53.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.685 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.85 23.91 12.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.147 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.53 -12.17 65.98 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.037 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.426 ' HG3' ' HE1' ' A' ' 65' ' ' MET . 0.0 OUTLIER -107.38 127.64 53.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.943 0.401 . . . . 0.0 110.988 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.522 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 1.5 mpt? -71.61 150.12 44.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.155 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.798 HG11 ' HA ' ' A' ' 62' ' ' THR . 11.1 m . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.113 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.836 0.35 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 20.0 mm-40 -123.82 115.74 27.87 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.672 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.92 161.15 7.47 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.688 2.258 . . . . 0.0 112.437 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.956 ' HB3' HD13 ' A' ' 25' ' ' LEU . . . -166.15 172.17 11.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.448 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.525 ' O ' HG23 ' A' ' 13' ' ' THR . 9.1 t -103.12 108.7 19.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.071 0.462 . . . . 0.0 111.264 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.682 ' HB3' HG11 ' A' ' 66' ' ' VAL . 2.8 tt -76.09 125.83 29.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.778 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.9 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.7 pp -74.9 -46.01 41.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.393 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.9 ' N ' HD12 ' A' ' 15' ' ' ILE . 4.1 mtmt 178.99 173.23 0.77 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.992 0.425 . . . . 0.0 111.373 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.964 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -98.72 148.05 24.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.391 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.771 HD12 HG22 ' A' ' 22' ' ' THR . 92.5 mt -102.71 -72.15 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.497 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -117.71 42.05 2.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.738 0.304 . . . . 0.0 111.532 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.795 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 82.37 -54.76 4.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.543 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.54 -35.72 11.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.018 0.437 . . . . 0.0 110.196 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.771 HG22 HD12 ' A' ' 18' ' ' ILE . 43.2 m -76.62 106.91 8.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.158 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.508 ' HB ' HD11 ' A' ' 14' ' ' LEU . 21.5 m -126.12 161.72 31.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.867 0.365 . . . . 0.0 111.189 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.483 ' HG2' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -119.41 134.18 55.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.297 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.956 HD13 ' HB3' ' A' ' 12' ' ' ALA . 1.3 pp -141.72 132.64 25.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.61 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.766 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -72.89 99.53 2.7 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.871 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.454 ' CE2' ' CE1' ' A' ' 76' ' ' PHE . 5.8 t80 -88.88 112.37 23.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.777 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 45.06 36.73 2.13 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.711 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.05 -14.41 65.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.457 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.26 97.34 49.51 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 51.6 Cg_endo -69.63 150.06 68.51 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.537 2.158 . . . . 0.0 112.994 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.401 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 3.4 mmt -145.3 161.17 40.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.049 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.06 124.08 40.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.861 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 2.1 m-85 -111.45 149.51 31.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.911 0.386 . . . . 0.0 111.693 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.593 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 3.4 ttp85 -139.09 110.41 6.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.168 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.717 HD21 ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.318 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.288 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 25.0 Cg_exo . . . . . 0 N--CA 1.473 0.309 0 N-CA-C 116.079 1.53 . . . . 0.0 116.079 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 5.8 mm-40 -48.82 -16.45 0.13 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.795 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -90.52 -62.31 1.49 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.671 0.272 . . . . 0.0 111.184 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.546 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 57.8 p -90.66 -48.98 6.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.975 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -55.06 -35.41 64.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.224 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.467 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 2.1 t80 -90.35 -19.92 23.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.479 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.964 HG21 ' HB2' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -77.59 -67.16 0.75 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.56 0.219 . . . . 0.0 111.331 -179.453 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.517 ' N ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -60.41 -23.79 64.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 111.34 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -80.93 -49.19 11.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.629 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.403 ' HG3' ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -50.03 -28.91 7.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.412 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.682 HG11 ' HB3' ' A' ' 14' ' ' LEU . 27.1 m -91.72 -26.89 4.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.273 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -76.51 -9.72 58.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.657 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -114.22 -28.1 7.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.606 0.241 . . . . 0.0 111.433 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.813 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -104.03 132.41 50.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 0.0 111.173 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -86.21 4.34 39.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.263 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.78 106.59 12.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.896 0.379 . . . . 0.0 110.968 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.509 HG12 HG12 ' A' ' 66' ' ' VAL . 4.1 mt -127.3 95.07 2.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.654 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -95.25 150.09 20.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.663 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.858 ' CG1' ' HB1' ' A' ' 90' ' ' ALA . 2.6 t -128.98 116.38 40.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.36 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -86.89 49.76 1.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.026 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -92.97 145.24 24.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.055 -179.204 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.513 ' H ' HD11 ' A' ' 89' ' ' LEU . 33.9 t0 -91.26 158.96 16.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.001 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -95.27 29.52 2.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.193 0.52 . . . . 0.0 110.25 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -153.49 37.68 0.73 Allowed Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.726 ' HB2' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -77.82 128.16 33.54 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.321 0.581 . . . . 0.0 110.198 -179.039 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -63.51 65.18 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.112 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.971 HG21 ' CE2' ' A' ' 88' ' ' TRP . 14.4 t . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.507 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.971 ' CE2' HG21 ' A' ' 82' ' ' THR . 66.5 m95 . . . . . 0 C--O 1.225 -0.186 0 CA-C-O 120.899 0.38 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.873 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -77.86 159.23 29.07 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.858 ' HB1' ' CG1' ' A' ' 74' ' ' VAL . . . -179.75 145.92 0.24 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -108.01 52.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.627 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.45 HG13 HG13 ' A' ' 74' ' ' VAL . 1.3 mp -57.71 132.94 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.504 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 73' ' ' GLU . 2.9 p90 -150.57 153.04 35.03 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.359 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.813 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -120.95 131.99 54.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.828 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.7 t70 67.57 25.9 8.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.021 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.31 19.91 77.77 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.842 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -137.1 114.11 10.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.923 0.392 . . . . 0.0 110.896 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.446 ' CA ' ' HB3' ' A' ' 93' ' ' TYR . 16.0 ptp -75.39 150.19 38.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.091 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt . . . . . 0 N--CA 1.461 0.083 0 CA-C-O 120.871 0.367 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.657 ' O ' HG22 ' A' ' 74' ' ' VAL . 4.5 mm-40 -136.05 145.56 52.95 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 10' ' ' GLU . 1.3 Cg_endo -83.42 105.49 1.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.735 2.29 . . . . 0.0 112.316 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.713 ' HB3' HD22 ' A' ' 25' ' ' LEU . . . -116.2 135.5 53.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.501 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.1 m -86.88 108.82 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.93 0.395 . . . . 0.0 111.644 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.579 HD22 ' HA ' ' A' ' 63' ' ' LYS . 10.2 tt -73.44 113.43 10.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.95 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.956 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.5 pp -74.7 -43.44 47.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.341 -0.391 . . . . 0.0 112.052 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.956 ' N ' HD12 ' A' ' 15' ' ' ILE . 37.9 tttp -173.65 151.56 1.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.077 0.465 . . . . 0.0 111.935 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.779 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -89.91 148.21 23.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.671 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.837 HD12 HG22 ' A' ' 22' ' ' THR . 21.0 mt -103.1 -73.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.687 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.12 26.86 9.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.633 0.254 . . . . 0.0 111.481 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.937 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 90.13 -44.33 2.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.744 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.7 -54.37 3.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 110.328 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.837 HG22 HD12 ' A' ' 18' ' ' ILE . 91.0 m -78.26 106.89 10.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.141 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.642 HG12 ' HA ' ' A' ' 17' ' ' ALA . 35.4 m -130.57 157.37 42.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.464 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.453 ' HB3' HG13 ' A' ' 15' ' ' ILE . 32.2 tttt -91.76 142.77 27.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.47 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.713 HD22 ' HB3' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -141.28 117.69 10.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.928 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.85 99.18 2.14 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.446 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 17.3 t80 -95.62 108.54 20.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.907 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.94 41.55 14.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.147 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.85 -14.13 61.07 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.459 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.471 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -117.75 98.19 51.43 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.999 0.428 . . . . 0.0 110.277 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.699 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 26.6 Cg_endo -62.54 144.4 94.43 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.705 2.27 . . . . 0.0 113.327 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.6 mmt -145.17 155.84 43.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.082 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 p -85.79 122.11 29.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.817 0.341 . . . . 0.0 111.214 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.651 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 16.8 m-85 -113.79 107.9 16.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.436 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 88' ' ' TRP . 7.6 ttt180 -97.41 115.0 26.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.223 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.48 HD23 ' HB2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.164 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.05 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.826 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 56.6 Cg_exo . . . . . 0 C--O 1.232 0.191 0 N-CA-C 114.422 0.893 . . . . 0.0 114.422 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.761 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 15.8 tm-20 -91.77 -64.61 1.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.937 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -60.46 -40.71 92.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.509 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 67.9 m -93.63 -43.4 8.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.826 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -89.5 -34.61 16.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.761 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 4.1 t80 -90.1 -24.34 21.14 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.779 HG21 ' HB2' ' A' ' 17' ' ' ALA . 1.7 m -56.82 -66.84 0.38 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.734 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -77.72 -19.73 54.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -48.03 -51.63 23.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 0.0 111.388 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.4 ttp -70.49 -17.61 62.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.305 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.847 HG13 HG12 ' A' ' 72' ' ' ILE . 48.1 t -88.64 -11.63 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.518 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -93.99 -6.77 44.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -114.7 -27.9 7.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.562 0.22 . . . . 0.0 111.447 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.642 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -100.9 142.26 32.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 111.343 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.92 28.57 4.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.556 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -142.2 98.92 3.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.005 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.847 HG12 HG13 ' A' ' 66' ' ' VAL . 3.2 mp -129.18 93.24 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.641 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.5 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 8.1 mt-10 -102.65 133.5 47.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.883 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 10' ' ' GLU . 27.8 m -104.26 138.26 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.895 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -89.09 48.47 1.63 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.982 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.588 ' HB2' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -93.7 150.96 19.98 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.518 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.635 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 3.3 t70 -87.26 162.48 17.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.996 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.38 32.44 0.95 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.421 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.69 31.29 0.17 Allowed Glycine 0 CA--C 1.507 -0.46 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.635 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 11.5 mm-40 -81.74 127.93 33.46 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.684 0.754 . . . . 0.0 111.847 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -42.05 129.57 3.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.148 -1.387 . . . . 0.0 111.807 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.623 HG22 ' CE2' ' A' ' 88' ' ' TRP . 43.6 p . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.033 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.651 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 54.1 m95 . . . . . 0 C--O 1.223 -0.326 0 CA-C-O 121.038 0.446 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.651 HD22 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -77.96 164.89 24.7 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.925 178.563 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.646 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 166.06 147.88 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.232 0.539 . . . . 0.0 111.677 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -99.47 -34.18 10.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.956 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.477 HG21 HD13 ' A' ' 14' ' ' LEU . 1.8 mp 59.03 115.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.508 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.5 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 6.4 p90 -141.16 136.46 31.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.986 0.422 . . . . 0.0 111.502 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -106.0 112.5 25.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.731 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.463 ' OD1' ' HB1' ' A' ' 69' ' ' ALA . 5.1 m-20 80.37 27.16 0.28 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.951 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.21 -28.63 9.34 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.957 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.77 130.85 39.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 111.165 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.463 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -76.5 145.35 39.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.922 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 62' ' ' THR . 35.3 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.213 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.446 ' HE3' ' HA ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.817 0.342 . . . . 0.0 111.159 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -151.67 113.74 2.99 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.776 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 89.7 Cg_endo -85.35 110.72 1.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.63 2.22 . . . . 0.0 112.518 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.516 ' HB3' HD22 ' A' ' 25' ' ' LEU . . . -120.83 156.32 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.594 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -98.1 108.09 20.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.124 0.488 . . . . 0.0 111.656 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.798 ' HB3' HG21 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -76.28 108.93 9.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.643 178.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.837 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -74.79 -46.93 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.304 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.837 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -178.56 173.11 1.36 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.116 0.484 . . . . 0.0 111.776 179.47 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.804 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -94.86 148.26 22.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.951 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.4 mt -104.2 -70.38 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.781 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.05 42.22 2.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.726 0.298 . . . . 0.0 111.524 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.77 -57.21 5.05 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.52 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -96.74 -38.28 9.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.912 0.387 . . . . 0.0 110.116 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.799 HG22 HG21 ' A' ' 33' ' ' THR . 0.2 OUTLIER -77.7 106.75 9.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.106 179.263 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 17' ' ' ALA . 27.8 m -127.42 143.6 40.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.333 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.518 ' HB3' HD11 ' A' ' 15' ' ' ILE . 9.1 tppt? -81.88 142.78 32.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.509 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.769 ' HG ' HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -141.79 118.44 11.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.543 -179.396 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -72.4 99.39 2.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.583 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 20.8 t80 -96.33 107.54 19.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.203 -177.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm 45.13 48.98 9.85 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.652 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.13 -14.1 51.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.789 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -119.86 97.84 49.56 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 121.011 0.434 . . . . 0.0 110.019 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 24.6 Cg_exo -65.26 143.34 76.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.857 2.372 . . . . 0.0 113.38 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 mmt -145.05 151.86 39.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.555 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.799 HG21 HG22 ' A' ' 22' ' ' THR . 2.8 m -86.68 121.2 28.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.545 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 25' ' ' LEU . 2.1 m-85 -109.79 125.54 52.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.005 0.431 . . . . 0.0 111.518 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -98.61 118.07 34.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.976 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 36' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.803 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.625 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 76.9 Cg_exo . . . . . 0 CA--C 1.529 0.244 0 N-CA-C 113.405 0.502 . . . . 0.0 113.405 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' HG2' ' N ' ' A' ' 58' ' ' ALA . 13.7 pm0 -94.24 -46.79 6.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.578 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -91.16 -65.67 0.99 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.792 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 73.8 m -60.66 -37.82 82.84 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.625 ' HB3' ' HA ' ' A' ' 56' ' ' PRO . . . -89.52 -61.83 1.61 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.448 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -55.34 -51.7 65.91 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.419 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 85.1 m -55.47 -66.26 0.45 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.619 0.247 . . . . 0.0 111.499 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -23.11 15.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.519 ' HZ2' ' HB1' ' A' ' 60' ' ' ALA . 1.9 mttp -88.07 -55.86 3.57 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.51 -26.49 3.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.716 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.882 HG13 HG12 ' A' ' 72' ' ' ILE . 36.0 t -91.73 -10.56 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -94.11 -5.97 46.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -111.2 -27.34 8.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.626 0.25 . . . . 0.0 111.426 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.866 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -105.62 141.12 37.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 0.0 111.172 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.27 29.04 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.762 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.45 ' HG3' ' HA ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -145.46 98.72 3.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.807 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.882 HG12 HG13 ' A' ' 66' ' ' VAL . 2.6 mp -127.67 92.14 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.665 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -94.87 147.58 23.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.754 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.588 HG13 ' HB1' ' A' ' 90' ' ' ALA . 36.7 t -116.31 129.15 73.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.684 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.446 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 34.2 tt0 -93.62 54.32 2.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.221 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.688 ' HA ' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -94.89 167.31 11.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.164 -178.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.448 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 2.0 t70 -104.43 162.55 13.14 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.041 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -94.18 28.78 2.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.936 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.62 26.93 0.2 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.776 ' HG3' HD12 ' A' ' 89' ' ' LEU . 2.2 mm100 -78.54 127.12 31.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.63 0.729 . . . . 0.0 110.983 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -39.71 127.1 1.99 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.515 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 75.2 p . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.088 -179.748 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.577 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 96.2 m95 . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 120.88 0.371 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.912 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -76.64 158.29 31.19 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.486 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.75 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 179.66 160.73 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.264 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -113.1 -35.94 5.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.92 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.6 mt 59.67 119.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.809 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.437 ' OH ' ' HB3' ' A' ' 73' ' ' GLU . 4.9 p90 -141.63 123.44 15.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.866 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -99.25 96.55 7.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.665 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 94' ' ' ALA . 2.7 t0 85.26 55.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.997 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.11 27.71 57.69 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.852 -0.613 . . . . 0.0 113.453 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -137.25 112.72 9.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 0.0 111.001 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.417 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -78.21 136.12 37.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.068 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.98 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.92 0.39 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 1.4 mp0 -141.57 113.89 6.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.632 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 5.8 Cg_exo -78.69 114.1 3.4 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.566 2.177 . . . . 0.0 112.238 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.535 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . . . -138.7 146.81 42.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.524 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.1 p -92.37 109.07 20.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.899 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.902 HD11 ' HB ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -76.9 119.57 20.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.758 178.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.921 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.4 pp -74.9 -41.96 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.921 ' N ' HD12 ' A' ' 15' ' ' ILE . 87.6 tttt -176.89 162.48 2.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.985 0.422 . . . . 0.0 111.58 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.045 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -97.22 148.09 23.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.89 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.515 HD12 ' HB ' ' A' ' 22' ' ' THR . 38.1 mt -96.54 -77.0 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.476 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -118.29 34.62 5.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.434 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.56 -45.36 2.93 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.504 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.73 -57.53 2.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 110.479 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.515 ' HB ' HD12 ' A' ' 18' ' ' ILE . 21.6 p -69.71 107.52 3.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.447 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.902 ' HB ' HD11 ' A' ' 14' ' ' LEU . 34.6 m -130.09 141.91 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.484 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.511 ' HG2' HG12 ' A' ' 15' ' ' ILE . 4.5 tptt -79.97 139.29 37.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.2 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.604 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -141.54 119.29 11.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.6 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.497 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -72.36 99.35 2.41 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.703 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 20.0 t80 -94.84 108.34 20.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.193 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 tptp 45.68 47.5 11.63 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.594 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.48 -13.97 53.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.718 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.47 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -120.25 98.0 48.93 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 110.045 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 33.1 Cg_exo -61.67 143.92 96.92 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.849 2.366 . . . . 0.0 113.609 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.6 mmt -145.13 144.84 31.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.44 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.2 m -82.31 120.02 24.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.73 0.3 . . . . 0.0 110.495 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.643 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 5.1 m-85 -105.02 124.37 49.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.784 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 88' ' ' TRP . 12.1 ttp180 -121.83 125.38 46.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.03 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.785 HD13 ' HB2' ' A' ' 89' ' ' LEU . 11.9 tp . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.207 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.905 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 81.8 Cg_exo . . . . . 0 CA--C 1.529 0.227 0 N-CA-C 113.68 0.608 . . . . 0.0 113.68 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.667 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 9.3 mm-40 -94.63 -27.67 15.76 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.501 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -90.72 -65.36 1.02 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.568 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -80.58 -25.01 38.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.666 0.27 . . . . 0.0 111.472 -179.02 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.905 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -89.27 -56.16 3.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.924 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.667 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 1.7 t80 -59.27 -39.22 82.22 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.94 0.4 . . . . 0.0 110.933 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 1.045 HG21 ' HB2' ' A' ' 17' ' ' ALA . 1.9 m -58.97 -66.39 0.51 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.675 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.485 ' HB2' ' HG3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -60.49 -38.69 85.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.781 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 11.1 mmtm -60.79 -61.48 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.654 ' CB ' HG12 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -46.73 -47.96 20.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.777 -179.12 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' ' 14' ' ' LEU . 27.5 m -70.31 -10.56 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.862 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -89.15 -34.1 16.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.665 0.269 . . . . 0.0 111.214 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -89.97 -28.09 19.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.194 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.984 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -104.92 104.83 14.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.986 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.04 -26.22 64.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.065 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.402 ' CG ' ' HA ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -85.85 98.95 11.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.956 0.407 . . . . 0.0 111.268 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 93' ' ' TYR . 2.3 mp -122.84 91.23 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.294 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 1.2 tt0 -97.23 139.9 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 111.04 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.741 HG13 ' HB1' ' A' ' 90' ' ' ALA . 29.7 t -111.29 141.36 26.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.454 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -105.28 62.03 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.304 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.716 ' HB2' HD13 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.79 148.45 25.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.073 0.463 . . . . 0.0 111.805 -179.213 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.74 ' H ' HD11 ' A' ' 89' ' ' LEU . 21.4 t0 -77.24 162.3 27.47 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.176 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.3 32.41 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.804 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.09 33.08 0.27 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.468 ' CB ' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -78.52 128.01 32.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.52 0.676 . . . . 0.0 110.887 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.2 ttm-85 -56.32 113.91 1.77 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.851 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.8 p . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.777 -179.409 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.643 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 98.8 m95 . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.948 0.404 . . . . 0.0 111.601 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.785 ' HB2' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -77.34 156.21 31.44 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.303 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.741 ' HB1' HG13 ' A' ' 74' ' ' VAL . . . 176.63 160.19 0.35 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.24 0.543 . . . . 0.0 112.212 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.431 ' C ' HD12 ' A' ' 92' ' ' ILE . 3.7 m-85 -108.91 -35.44 6.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.719 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.576 HG12 HD11 ' A' ' 25' ' ' LEU . 3.2 mp 59.44 122.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.956 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.495 ' OH ' ' HB3' ' A' ' 73' ' ' GLU . 4.3 p90 -144.65 142.85 30.42 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.113 0.482 . . . . 0.0 111.635 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.984 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -113.35 120.67 41.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.656 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.402 ' HA ' ' CG ' ' A' ' 71' ' ' LYS . 0.7 OUTLIER 76.14 27.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.109 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.46 -15.33 54.93 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.117 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -109.85 131.08 55.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.858 0.329 . . . . 0.0 110.986 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.426 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 6.2 mtt -72.01 140.69 49.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.736 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.821 HG11 ' HA ' ' A' ' 62' ' ' THR . 27.9 m . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.937 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.775 0.321 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -135.1 113.93 11.58 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 83.1 Cg_endo -83.37 154.15 14.08 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.721 2.281 . . . . 0.0 112.26 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.857 ' CB ' HD13 ' A' ' 25' ' ' LEU . . . -166.23 157.31 13.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.72 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 25' ' ' LEU . 5.5 m -86.85 107.55 18.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.028 0.442 . . . . 0.0 111.279 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 14' ' ' LEU . 0.7 OUTLIER -98.83 108.0 20.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.565 178.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.851 ' HA ' HG11 ' A' ' 66' ' ' VAL . 1.4 pp -125.62 -13.2 4.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -113.29 123.04 49.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.09 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -112.88 103.67 11.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.241 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.544 HD12 ' HB ' ' A' ' 22' ' ' THR . 34.7 mt -62.65 -82.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.079 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -118.17 41.94 2.81 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.28 -47.26 3.69 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.103 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -96.37 -41.09 8.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.964 0.411 . . . . 0.0 110.024 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.544 ' HB ' HD12 ' A' ' 18' ' ' ILE . 2.1 p -82.55 106.87 14.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.787 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.698 ' HB ' HD21 ' A' ' 14' ' ' LEU . 35.1 m -121.53 155.65 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 111.718 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.9 127.42 56.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.734 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.94 HD22 HG21 ' A' ' 74' ' ' VAL . 2.0 pp -133.82 143.2 48.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.32 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.592 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -72.54 99.21 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -93.41 106.37 18.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.3 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 tttm 50.35 55.33 9.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.819 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.56 13.41 60.8 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.199 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.406 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -142.14 97.94 6.23 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.699 0.285 . . . . 0.0 110.245 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 40.8 Cg_endo -67.36 146.48 75.24 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.566 2.177 . . . . 0.0 113.01 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.3 mmt -145.36 161.2 40.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.388 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.467 HG22 HD11 ' A' ' 18' ' ' ILE . 20.2 p -91.34 126.03 36.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.485 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.834 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.2 m-85 -111.35 124.19 51.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.041 0.448 . . . . 0.0 110.892 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.539 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -108.82 98.95 8.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.165 -179.297 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.708 HD22 ' HB2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 121.015 0.436 . . . . 0.0 111.261 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.732 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 90.9 Cg_endo . . . . . 0 N--CA 1.463 -0.307 0 N-CA-C 113.763 0.64 . . . . 0.0 113.763 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -58.04 -14.08 5.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.38 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.39 -65.57 1.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 24.5 m -88.04 -23.59 23.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.97 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -88.91 -46.11 9.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.536 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -63.99 -49.97 70.36 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.207 0.527 . . . . 0.0 109.914 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 1.09 HG21 ' HB2' ' A' ' 17' ' ' ALA . 2.6 t -49.81 -31.71 12.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.913 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' A' ' 15' ' ' ILE . 6.9 mttm -82.71 -41.96 18.64 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.138 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -72.33 -30.43 64.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.254 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -40.62 80.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.851 HG11 ' HA ' ' A' ' 15' ' ' ILE . 9.1 p -83.14 -29.54 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.14 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.19 -9.15 59.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.519 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -111.24 -28.13 8.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.699 0.285 . . . . 0.0 111.337 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.95 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -107.92 141.52 39.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.177 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -102.02 25.41 8.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.81 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 98.8 3.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.69 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.53 ' CD1' HG23 ' A' ' 66' ' ' VAL . 3.6 mp -123.13 92.35 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 7.6 mt-10 -94.98 136.77 34.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.748 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.94 HG21 HD22 ' A' ' 25' ' ' LEU . 24.6 t -116.08 123.25 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.193 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -85.57 54.51 3.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.734 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.684 ' HA ' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -95.03 164.64 12.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.127 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.681 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -99.94 162.08 13.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.843 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -92.84 30.79 1.5 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.47 31.31 0.16 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.498 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.801 ' HG3' HD12 ' A' ' 89' ' ' LEU . 34.0 mm-40 -78.54 125.57 29.55 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.524 0.678 . . . . 0.0 111.081 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -44.14 120.89 2.28 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.168 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.452 ' CG2' ' CE2' ' A' ' 88' ' ' TRP . 43.5 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.04 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.532 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 70.2 m95 . . . . . 0 C--O 1.224 -0.289 0 CA-C-O 121.064 0.459 . . . . 0.0 111.916 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.876 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -77.81 158.23 29.61 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.196 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.854 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 173.25 156.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.201 0.524 . . . . 0.0 111.895 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.706 ' C ' HD12 ' A' ' 92' ' ' ILE . 3.5 m-85 -112.63 -41.1 3.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.624 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.706 HD12 ' C ' ' A' ' 91' ' ' TYR . 2.8 mp 58.55 121.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.08 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 15.0 p90 -142.54 130.59 21.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.377 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.95 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -103.58 124.14 48.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.603 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 t70 74.79 27.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.864 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.21 22.34 77.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.863 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 115.38 11.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 111.046 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.428 ' CG ' ' HB3' ' A' ' 93' ' ' TYR . 4.0 mtm -72.0 129.53 38.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.515 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.227 0 CA-C-O 120.863 0.364 . . . . 0.0 110.584 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HE3' ' CA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.825 0.345 . . . . 0.0 110.997 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 74' ' ' VAL . 3.3 mp0 -115.32 131.95 23.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.684 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -87.45 125.49 2.12 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.596 2.198 . . . . 0.0 112.398 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.462 ' HB3' HD22 ' A' ' 25' ' ' LEU . . . -149.19 127.74 12.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.444 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.594 ' HA ' HD13 ' A' ' 72' ' ' ILE . 2.5 t -86.56 108.56 18.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.039 0.447 . . . . 0.0 110.727 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.691 HD11 ' HB ' ' A' ' 23' ' ' VAL . 3.2 tt -77.45 121.39 23.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.418 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.857 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -74.55 -48.6 34.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.671 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.857 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER 179.68 168.4 1.16 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.943 0.401 . . . . 0.0 111.259 179.21 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.714 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -87.27 148.13 25.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.082 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.6 mm -91.37 -69.73 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.341 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -118.13 35.93 4.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.246 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.29 -48.5 3.4 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.65 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -96.7 -56.18 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.359 . . . . 0.0 110.616 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 m -70.69 106.81 3.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.501 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 34' ' ' PHE . 27.8 m -114.96 154.83 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.308 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.91 140.06 29.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.762 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.698 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -141.34 118.41 11.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.052 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.31 99.41 2.4 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.636 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 2.7 t80 -91.23 102.29 15.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.755 -178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.9 tttp 43.16 50.15 5.63 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.658 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.33 -14.33 59.66 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.563 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.636 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -118.32 97.21 50.61 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.677 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.698 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 10.7 Cg_exo -72.06 130.19 16.24 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.319 2.013 . . . . 0.0 112.97 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 6.2 mmt -124.85 157.22 36.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.16 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 p -86.67 119.54 27.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.037 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.738 ' O ' HG22 ' A' ' 23' ' ' VAL . 17.9 m-85 -111.03 107.77 17.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.652 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -94.17 109.53 21.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.31 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.731 HD22 ' HB2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.447 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 28.1 Cg_exo . . . . . 0 N--CA 1.471 0.178 0 N-CA-C 115.136 1.168 . . . . 0.0 115.136 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -45.44 -19.9 0.05 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.583 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.577 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -90.63 -65.08 1.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -87.52 -32.25 19.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.605 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -75.8 -35.12 60.16 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.405 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -89.98 -30.86 17.52 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.158 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.714 HG21 ' HB2' ' A' ' 17' ' ' ALA . 15.3 t -60.62 -54.56 43.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 13.3 ptmt -65.3 -43.1 92.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.373 . . . . 0.0 110.875 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -48.99 74.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.079 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.525 ' CB ' HG13 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -55.98 -30.38 61.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.139 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.689 ' HA ' ' HB2' ' A' ' 94' ' ' ALA . 32.6 m -92.5 -31.21 4.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.036 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -72.08 -5.94 38.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.657 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -95.02 -28.13 15.28 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.609 0.242 . . . . 0.0 111.598 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.033 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -107.98 151.01 26.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 111.404 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.8 ttmm -99.18 17.55 19.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.255 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.97 98.98 4.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.907 0.384 . . . . 0.0 110.797 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.698 ' CG2' HG23 ' A' ' 92' ' ' ILE . 2.4 mp -118.69 94.17 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.112 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.515 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 2.4 mt-10 -104.89 131.23 52.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.607 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 92' ' ' ILE . 31.4 m -106.28 145.46 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.894 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.401 ' CA ' ' HE3' ' A' ' 9' ' ' LYS . 14.5 tt0 -99.78 54.41 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.488 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.533 ' HB2' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -97.63 166.23 11.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.7 -179.193 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.761 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -104.3 162.53 13.13 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.969 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.5 tmtp? -92.25 23.93 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.314 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.97 20.78 0.36 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.535 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.761 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 17.0 mm-40 -78.61 128.87 34.09 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.542 0.686 . . . . 0.0 111.116 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.451 ' C ' ' O ' ' A' ' 80' ' ' GLN . 1.4 mpp_? -23.45 118.38 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.966 -1.47 . . . . 0.0 111.784 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.51 HG22 ' CE2' ' A' ' 88' ' ' TRP . 5.8 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.688 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.589 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 68.2 m95 . . . . . 0 C--O 1.224 -0.24 0 CA-C-O 121.166 0.507 . . . . 0.0 111.458 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.731 ' HB2' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -81.12 154.08 26.96 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.375 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.442 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 179.13 153.21 0.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.18 0.514 . . . . 0.0 112.14 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.621 ' C ' HD12 ' A' ' 92' ' ' ILE . 28.9 m-85 -111.37 -35.08 5.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.942 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.698 HG23 ' CG2' ' A' ' 72' ' ' ILE . 3.3 mp 54.38 109.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.295 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.525 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 6.4 p90 -127.74 137.13 52.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.058 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.033 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -106.38 123.88 48.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.657 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 t70 73.65 26.17 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.84 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.33 21.91 74.42 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.828 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.14 113.96 10.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.525 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 7.5 mtt -60.47 139.1 57.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.724 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.661 HG11 ' HA ' ' A' ' 62' ' ' THR . 15.1 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.05 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.474 ' HZ1' ' HB2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.847 0.356 . . . . 0.0 110.897 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.883 ' O ' HG22 ' A' ' 74' ' ' VAL . 23.9 mm-40 -122.79 154.32 63.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 85.1 Cg_endo -86.73 156.33 8.9 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.763 2.309 . . . . 0.0 112.298 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.889 ' HB1' HD13 ' A' ' 25' ' ' LEU . . . -166.27 157.34 13.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.052 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.12 108.38 19.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.779 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.627 ' CD2' HG21 ' A' ' 66' ' ' VAL . 5.7 tt -77.12 121.16 23.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.859 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.6 pp -74.83 -44.6 45.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.206 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.859 ' N ' HD12 ' A' ' 15' ' ' ILE . 9.1 tttm 179.51 163.32 0.94 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.878 0.37 . . . . 0.0 111.187 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.878 ' HB3' ' HA ' ' A' ' 59' ' ' SER . . . -91.75 145.91 24.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.331 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.4 mt -96.97 -75.27 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.548 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -117.5 42.14 2.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.519 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.775 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 84.65 -53.61 4.84 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.675 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -96.68 -37.71 10.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 110.553 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -76.99 106.84 8.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.702 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 17' ' ' ALA . 29.1 m -127.93 152.21 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.722 0.296 . . . . 0.0 111.221 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.436 ' HG2' HG12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -113.03 131.66 55.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.211 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.889 HD13 ' HB1' ' A' ' 12' ' ' ALA . 0.5 OUTLIER -141.44 148.74 40.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.421 178.184 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.68 99.8 2.66 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.554 ' O ' ' OE1' ' A' ' 30' ' ' GLN . 24.2 t80 -88.42 111.21 21.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.314 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 38.23 38.59 0.22 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.172 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.8 -14.47 58.87 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.295 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.573 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -120.54 96.94 48.91 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.116 179.731 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 39.4 Cg_exo -61.5 127.34 21.51 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.53 2.154 . . . . 0.0 112.552 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.562 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -133.04 161.84 33.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.709 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.532 ' O ' ' N ' ' A' ' 88' ' ' TRP . 55.5 m -92.8 156.98 16.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.836 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 10.6 m-85 -143.14 136.04 27.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.649 0.262 . . . . 0.0 111.611 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 7.7 ttm180 -139.56 115.21 10.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.934 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 20.2 tp . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.626 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.452 ' HB3' ' HB3' ' A' ' 60' ' ' ALA . 24.6 Cg_exo . . . . . 0 CA--C 1.529 0.229 0 N-CA-C 114.983 1.109 . . . . 0.0 114.983 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.596 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 1.6 tp10 -47.41 -17.44 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.775 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -90.5 -63.16 1.31 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.878 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 37.3 m -92.79 -43.89 8.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.379 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 56' ' ' PRO . . . -62.93 -31.96 73.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.575 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.596 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 3.3 t80 -88.83 -44.25 10.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.371 . . . . 0.0 110.997 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.723 HG21 ' HB2' ' A' ' 17' ' ' ALA . 3.0 m -60.15 -66.28 0.55 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.757 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -55.44 -23.48 25.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.516 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -83.6 -54.7 4.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 111.5 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 mmt -47.69 -27.62 2.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.662 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.627 HG21 ' CD2' ' A' ' 14' ' ' LEU . 27.2 m -94.02 -19.05 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.34 -25.24 39.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.535 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -97.29 -28.3 14.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.399 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.634 ' O ' HD11 ' A' ' 72' ' ' ILE . . . -108.2 108.07 18.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.143 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -15.49 52.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.877 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.418 ' HG3' ' HA ' ' A' ' 95' ' ' ASP . 2.8 ptpt -91.8 101.71 14.31 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.383 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.891 HG23 ' O ' ' A' ' 93' ' ' TYR . 3.3 mp -134.88 99.14 2.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.255 0.55 . . . . 0.0 110.997 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 2.2 mt-10 -93.26 179.59 5.37 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.649 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.883 HG22 ' O ' ' A' ' 10' ' ' GLU . 31.3 m -145.22 139.67 22.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.977 0.418 . . . . 0.0 111.528 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.474 ' HB2' ' HZ1' ' A' ' 9' ' ' LYS . 5.1 tp10 -106.49 41.34 1.45 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.181 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -92.76 160.45 14.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.662 -179.154 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.707 ' H ' HD11 ' A' ' 89' ' ' LEU . 8.2 t0 -90.92 152.59 20.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.081 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.28 31.3 2.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.154 0.502 . . . . 0.0 110.347 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.02 38.5 0.64 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.825 ' HB2' HD12 ' A' ' 89' ' ' LEU . 1.3 tp60 -78.11 126.84 31.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.929 -0.636 . . . . 0.0 110.642 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.24 79.22 0.05 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.792 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.949 HG21 ' CG ' ' A' ' 88' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.009 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.949 ' CG ' HG21 ' A' ' 82' ' ' THR . 20.9 m95 . . . . . 0 N--CA 1.466 0.35 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.911 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -82.82 152.09 25.79 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.62 ' N ' HD22 ' A' ' 89' ' ' LEU . . . -178.26 162.2 1.52 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.362 0.601 . . . . 0.0 112.432 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.422 ' C ' HD12 ' A' ' 92' ' ' ILE . 3.5 m-85 -117.15 -17.52 10.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.646 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.477 HG22 ' N ' ' A' ' 93' ' ' TYR . 5.3 mp 64.31 158.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.843 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.891 ' O ' HG23 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -151.13 134.12 15.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.752 -178.725 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -134.72 105.19 6.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.863 0.363 . . . . 0.0 111.496 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.418 ' HA ' ' HG3' ' A' ' 71' ' ' LYS . 14.7 t0 54.51 43.8 29.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.748 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.28 -22.41 23.45 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.13 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -116.41 127.72 54.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.89 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.53 148.9 49.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.891 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.303 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 75' ' ' GLU . 1.2 mmpp? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.737 0.304 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.471 ' HG2' ' CE2' ' A' ' 27' ' ' TYR . 0.6 OUTLIER -132.32 125.83 20.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.065 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -84.52 146.43 10.83 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.67 2.246 . . . . 0.0 112.502 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.673 ' CB ' HD21 ' A' ' 25' ' ' LEU . . . -166.37 173.06 10.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.94 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.26 108.57 15.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.021 0.439 . . . . 0.0 111.246 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.651 HD11 ' HB ' ' A' ' 23' ' ' VAL . 3.7 tt -86.83 120.84 28.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.055 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.738 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.7 pp -75.55 -46.41 37.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.513 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.738 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER 179.98 173.11 0.99 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.176 0.512 . . . . 0.0 111.87 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.88 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -94.78 148.3 22.43 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.677 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.735 HD12 ' O ' ' A' ' 22' ' ' THR . 2.0 mp -101.8 -70.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.681 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.65 42.14 1.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.318 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.456 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 83.68 -54.32 4.94 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.547 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -96.8 -49.37 5.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.751 0.31 . . . . 0.0 110.296 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.735 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -63.84 106.68 1.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.23 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.651 ' HB ' HD11 ' A' ' 14' ' ' LEU . 30.2 m -122.59 142.43 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.485 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -87.99 124.71 34.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.673 HD21 ' CB ' ' A' ' 12' ' ' ALA . 1.3 tt -141.52 121.89 14.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.77 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.601 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 15.0 ptp -72.48 102.46 3.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.326 0.584 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.471 ' CE2' ' HG2' ' A' ' 10' ' ' GLU . 10.5 t80 -88.72 109.65 20.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.285 -178.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.91 46.52 18.85 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.602 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.9 -6.61 65.74 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.687 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.453 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -124.59 98.47 37.45 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.563 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 17.3 Cg_exo -68.87 143.71 56.26 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.985 2.457 . . . . 0.0 114.245 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.475 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 2.3 mtt -145.36 148.54 33.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.028 -1.442 . . . . 0.0 108.255 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.552 ' CG2' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -87.48 157.29 19.23 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.506 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.587 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 5.0 m-85 -140.8 149.39 41.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.075 0.464 . . . . 0.0 111.712 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 88' ' ' TRP . 0.3 OUTLIER -117.65 97.87 6.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.886 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.314 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.766 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 90.7 Cg_exo . . . . . 0 N--CA 1.476 0.474 0 N-CA-C 115.711 1.389 . . . . 0.0 115.711 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.541 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 13.9 tm-20 -60.23 -23.51 64.11 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.783 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.456 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -91.06 -57.17 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.609 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 28.5 m -82.73 -31.34 28.5 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -86.63 -53.22 5.08 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.541 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -61.54 -27.87 68.92 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.001 0.429 . . . . 0.0 110.958 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.88 HG21 ' HB2' ' A' ' 17' ' ' ALA . 1.1 m -63.73 -57.48 9.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.033 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.462 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -82.95 -36.14 25.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.591 -179.308 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 60' ' ' ALA . 28.6 ttpt -63.2 -49.44 74.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.426 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.505 ' CB ' HG12 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -58.25 -31.49 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 0.0 111.055 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.487 HG12 HG12 ' A' ' 72' ' ' ILE . 25.0 m -89.81 -29.3 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.178 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -53.28 -25.48 14.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.343 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -106.02 -28.17 10.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 111.404 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.918 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -92.43 130.93 37.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.08 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -96.51 28.17 3.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.62 98.93 3.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.114 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.487 HG12 HG12 ' A' ' 66' ' ' VAL . 3.0 mt -120.97 95.26 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.392 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 1.9 mt-10 -94.61 160.35 14.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.77 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.713 HG12 ' HB3' ' A' ' 76' ' ' PHE . 56.0 t -132.08 114.99 25.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.084 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.425 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 2.3 tm-20 -79.96 53.73 1.74 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.407 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.713 ' HB3' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -97.48 164.63 12.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.112 0.482 . . . . 0.0 112.026 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -104.26 162.51 13.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.087 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.58 31.76 2.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.681 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.5 32.16 0.31 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.956 ' HG3' HD12 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -78.5 127.97 32.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.6 0.714 . . . . 0.0 111.062 -179.117 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -67.63 84.29 0.19 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.919 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.574 HG21 ' NE1' ' A' ' 88' ' ' TRP . 10.2 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.587 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 66.4 m95 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.958 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -76.7 155.68 33.12 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.994 -0.683 . . . . 0.0 109.999 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.685 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 172.86 160.33 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.252 0.549 . . . . 0.0 111.794 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -112.31 -37.52 4.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.063 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.566 HG21 HD13 ' A' ' 14' ' ' LEU . 2.6 mp 60.12 127.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.738 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.45 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 8.9 p90 -149.07 141.46 24.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 111.321 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.918 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -111.31 119.08 37.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.491 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 76.38 20.11 1.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.071 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.93 -19.88 53.02 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.147 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.471 ' HG3' ' HE1' ' A' ' 65' ' ' MET . 0.0 OUTLIER -104.21 128.71 51.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.893 0.378 . . . . 0.0 111.426 -179.67 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.0 mtt -68.41 150.21 48.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.505 HG12 ' CB ' ' A' ' 65' ' ' MET . 33.2 m . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.599 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.832 0.349 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -134.36 113.96 12.35 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.799 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 92.6 Cg_endo -85.67 147.49 9.63 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.713 2.275 . . . . 0.0 112.467 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.699 ' CB ' HD13 ' A' ' 25' ' ' LEU . . . -166.02 162.13 17.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.759 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.458 HG23 HD13 ' A' ' 72' ' ' ILE . 1.4 m -104.46 108.58 20.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.926 0.393 . . . . 0.0 111.258 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.856 HD11 ' HA ' ' A' ' 63' ' ' LYS . 2.4 pp -65.18 133.33 51.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.47 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.883 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.7 pp -74.67 -42.32 47.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.42 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.883 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER 179.47 170.66 1.02 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.597 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.466 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -92.92 148.17 22.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.753 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.2 mt -106.36 -74.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.391 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -118.02 42.15 2.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.824 0.345 . . . . 0.0 111.312 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.3 -56.81 5.04 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.373 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.8 -32.29 12.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.352 . . . . 0.0 110.377 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -77.21 109.86 11.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.556 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 34' ' ' PHE . 33.6 m -131.82 155.78 41.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 3.2 ttpp -119.29 135.3 54.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.803 0.335 . . . . 0.0 111.335 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.893 ' HG ' ' CE1' ' A' ' 34' ' ' PHE . 2.8 pp -141.89 146.32 35.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.303 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.553 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 6.0 ttm -72.2 101.67 2.87 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.839 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.451 ' CE1' ' CZ ' ' A' ' 76' ' ' PHE . 76.8 t80 -88.81 109.24 20.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.667 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 30' ' ' GLN . 0.1 OUTLIER 49.03 27.52 1.72 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.716 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.72 -14.55 53.28 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.608 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -116.82 98.36 51.77 Favored Pre-proline 0 C--N 1.332 -0.174 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.685 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 31.7 Cg_exo -59.44 145.9 96.59 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.377 2.052 . . . . 0.0 112.814 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.466 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 41.5 mtt -145.08 162.03 37.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.006 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -90.31 156.2 18.44 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.904 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.893 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 29.0 m-85 -142.63 121.87 13.03 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.768 0.318 . . . . 0.0 111.218 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 88' ' ' TRP . 0.6 OUTLIER -125.82 97.81 5.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.098 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.703 HD13 ' HB2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.665 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.606 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 48.0 Cg_exo . . . . . 0 N--CA 1.465 -0.156 0 CA-C-O 120.81 0.254 . . . . 0.0 112.299 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.42 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 62.9 mm-40 -94.53 -33.23 13.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.617 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.15 -48.53 6.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.781 0.324 . . . . 0.0 111.72 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.403 ' HA ' ' CB ' ' A' ' 17' ' ' ALA . 13.2 m -87.45 -61.48 1.71 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.777 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 56' ' ' PRO . . . -59.22 -37.27 77.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.614 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.452 ' CD2' ' HG2' ' A' ' 65' ' ' MET . 0.5 OUTLIER -77.37 -25.63 51.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.957 0.408 . . . . 0.0 110.644 179.647 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.696 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.8 OUTLIER -58.05 -66.32 0.5 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.947 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.856 ' HA ' HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -67.45 -32.35 73.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.646 0.26 . . . . 0.0 111.589 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -64.89 -52.89 54.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.735 0.303 . . . . 0.0 111.323 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.586 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 26.0 mmt -54.85 -27.99 46.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.228 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.84 HG13 HG12 ' A' ' 72' ' ' ILE . 18.5 t -79.05 -39.58 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.152 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -60.79 -21.66 63.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.341 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -104.6 -28.06 11.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.288 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.027 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -108.06 115.52 30.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 0.0 111.172 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.488 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -70.59 -23.67 62.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.884 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.87 111.34 20.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 111.214 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.84 HG12 HG13 ' A' ' 66' ' ' VAL . 2.9 mp -136.6 93.32 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.389 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.563 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 3.9 mt-10 -105.26 128.8 53.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.74 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.797 HG21 ' CD2' ' A' ' 25' ' ' LEU . 22.0 t -103.16 123.28 56.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.448 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.74 50.74 2.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.251 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.575 ' HB3' HG12 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -92.77 148.89 21.67 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.212 -179.289 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.627 ' H ' HD11 ' A' ' 89' ' ' LEU . 7.3 t70 -73.85 156.4 37.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.225 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.48 32.52 2.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.171 0.51 . . . . 0.0 110.374 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.64 36.19 0.47 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.602 ' CB ' HD12 ' A' ' 89' ' ' LEU . 0.6 OUTLIER -78.17 128.24 33.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.622 0.725 . . . . 0.0 110.657 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -65.38 77.39 0.06 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.72 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.622 HG21 ' NE1' ' A' ' 88' ' ' TRP . 12.7 t . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.154 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.71 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 19.2 m95 . . . . . 0 C--O 1.225 -0.23 0 CA-C-O 120.648 0.261 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.835 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -90.94 157.49 17.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.814 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.694 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 170.91 164.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.264 0.555 . . . . 0.0 112.077 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.577 ' C ' HD12 ' A' ' 92' ' ' ILE . 4.2 m-85 -114.24 -48.13 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.088 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.577 HD12 ' C ' ' A' ' 91' ' ' TYR . 3.2 mp 61.85 129.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.301 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.563 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 9.4 p90 -151.19 140.62 21.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.105 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.027 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -113.03 122.43 47.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.524 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.9 t70 78.8 33.48 0.26 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.629 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.86 20.55 62.27 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.826 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.13 109.97 7.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.9 0.381 . . . . 0.0 111.096 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.413 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -59.64 147.26 38.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.848 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.332 -0.177 0 CA-C-O 120.974 0.416 . . . . 0.0 110.542 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.445 ' HA ' ' CE ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.794 0.33 . . . . 0.0 111.185 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.895 ' O ' HG12 ' A' ' 74' ' ' VAL . 22.5 mm-40 -155.04 113.99 2.34 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.295 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -88.44 104.77 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.718 2.279 . . . . 0.0 112.003 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.64 155.58 27.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.01 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 26' ' ' MET . 87.6 m -89.01 108.26 19.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.133 0.492 . . . . 0.0 111.151 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.817 HD22 ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -79.49 111.58 15.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.024 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.818 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -75.1 -46.18 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.248 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.818 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -177.29 173.14 1.79 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.006 0.432 . . . . 0.0 111.594 179.643 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.817 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -102.7 148.31 25.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.876 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mt -97.53 -72.91 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.639 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -118.09 41.91 2.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.713 0.292 . . . . 0.0 111.646 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.748 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 84.21 -52.41 4.71 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.736 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.53 -55.23 2.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 110.331 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.573 HG22 HG21 ' A' ' 33' ' ' THR . 4.0 m -68.55 106.87 2.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.148 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 17' ' ' ALA . 33.0 m -126.08 160.2 33.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.248 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.492 ' O ' HD13 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -95.73 142.4 28.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.662 179.644 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.817 ' HG ' HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -141.42 118.0 10.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.958 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.53 ' HB2' ' HB ' ' A' ' 13' ' ' THR . 3.8 mtt -72.22 99.29 2.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.572 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 5.3 t80 -96.47 104.74 16.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.192 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 38.67 52.72 1.87 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.34 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.34 -14.57 60.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.931 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.572 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -120.75 97.08 48.63 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.38 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 6.7 Cg_exo -75.52 101.87 1.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.677 2.251 . . . . 0.0 113.101 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.436 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 2.5 mtt -98.49 149.2 22.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.863 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.573 HG21 HG22 ' A' ' 22' ' ' THR . 5.8 m -77.95 158.9 29.15 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' A' ' 25' ' ' LEU . 72.4 m-85 -143.11 132.08 22.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.862 0.363 . . . . 0.0 110.833 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -133.68 114.47 13.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.376 -178.791 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.411 ' HB3' ' O ' ' A' ' 90' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.469 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.755 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 82.5 Cg_exo . . . . . 0 N--CA 1.472 0.243 0 N-CA-C 114.111 0.773 . . . . 0.0 114.111 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.831 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 2.7 tm-20 -82.62 -13.98 55.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.748 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -90.6 -65.24 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.517 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 32.5 t -93.18 -42.79 9.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.581 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.755 ' HB3' ' HA ' ' A' ' 56' ' ' PRO . . . -68.76 -29.53 67.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.874 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.831 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 4.9 t80 -90.05 -52.51 4.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.939 0.4 . . . . 0.0 111.295 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.817 HG21 ' HB2' ' A' ' 17' ' ' ALA . 16.8 m -51.79 -66.34 0.4 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.622 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -56.6 -33.31 66.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.745 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HD3' ' ND2' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -73.46 -54.46 8.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.762 0.315 . . . . 0.0 111.644 -179.316 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.592 ' SD ' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -51.49 -27.0 9.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.8 -179.424 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.639 HG12 HG12 ' A' ' 72' ' ' ILE . 33.6 m -99.01 -9.9 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -26.83 25.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.667 0.27 . . . . 0.0 111.305 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.4 ' ND2' ' HD3' ' A' ' 64' ' ' LYS . 25.3 p30 -103.63 -28.04 11.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.349 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -94.26 134.34 36.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.293 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -96.38 28.73 3.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.825 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.67 99.29 3.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.886 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.639 HG12 HG12 ' A' ' 66' ' ' VAL . 2.2 mp -130.16 91.29 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.071 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.427 ' HB3' ' OH ' ' A' ' 93' ' ' TYR . 0.7 OUTLIER -99.87 145.52 27.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.282 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.895 HG12 ' O ' ' A' ' 10' ' ' GLU . 14.8 p -119.9 128.69 75.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.257 0.551 . . . . 0.0 111.96 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.41 46.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.132 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.607 ' HB3' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -92.74 148.1 22.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.696 -178.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.511 ' H ' HD11 ' A' ' 89' ' ' LEU . 21.2 t0 -76.92 159.15 30.22 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.803 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.25 35.26 2.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.974 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.23 39.77 0.31 Allowed Glycine 0 CA--C 1.496 -1.152 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.773 ' CG ' HD12 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -78.28 138.94 38.86 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.296 1.046 . . . . 0.0 111.896 -178.258 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -66.19 69.62 0.06 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.156 -1.838 . . . . 0.0 110.615 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.887 HG21 ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.919 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.887 ' CD1' HG21 ' A' ' 82' ' ' THR . 12.8 m95 . . . . . 0 C--O 1.225 -0.227 0 CA-C-O 120.477 0.18 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.828 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -76.9 161.92 28.01 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.894 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.764 ' N ' HD22 ' A' ' 89' ' ' LEU . . . -179.68 179.74 0.56 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 90' ' ' ALA . 54.3 m-85 -154.7 39.29 0.43 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.746 -1.116 . . . . 0.0 109.572 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.533 HG12 HD11 ' A' ' 25' ' ' LEU . 2.8 mp -37.99 143.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.05 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.504 ' HB3' ' HG3' ' A' ' 98' ' ' MET . 5.2 p90 -151.31 142.43 23.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.094 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.592 ' HB3' ' SD ' ' A' ' 65' ' ' MET . . . -108.81 108.82 19.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.363 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER 82.0 23.96 0.23 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.89 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.77 -38.84 2.98 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.423 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.14 133.56 34.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 111.416 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.504 ' HG3' ' HB3' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -68.96 139.43 55.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.535 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.595 HG11 ' HA ' ' A' ' 62' ' ' THR . 15.6 m . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.829 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.81 0.338 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 42.7 p -87.21 114.68 24.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.01 117.98 27.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 m -86.64 104.03 15.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -86.99 154.9 20.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.849 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -78.87 110.38 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.596 HD12 ' HG3' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -91.51 118.15 30.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -88.18 162.45 16.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HE2' ' CG ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -93.05 121.37 34.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 74' ' ' VAL . 66.0 mm-40 -121.68 136.27 25.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.771 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.02 128.45 4.37 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.597 2.198 . . . . 0.0 112.434 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.501 ' HB3' HD22 ' A' ' 25' ' ' LEU . . . -149.38 126.11 11.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.572 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.85 HG22 HD13 ' A' ' 72' ' ' ILE . 1.7 p -86.98 108.74 18.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.04 0.447 . . . . 0.0 111.556 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.825 ' HB3' HG21 ' A' ' 66' ' ' VAL . 2.3 tt -69.51 114.93 8.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.914 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.994 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.6 pp -74.96 -43.8 45.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.994 ' N ' HD12 ' A' ' 15' ' ' ILE . 1.4 ttmt -167.6 143.32 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.911 0.386 . . . . 0.0 111.901 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.846 ' HB3' ' HA ' ' A' ' 59' ' ' SER . . . -87.39 148.21 25.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.518 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.3 mt -102.52 -76.07 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.21 30.67 7.1 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.622 0.231 . . . . 0.0 111.622 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.766 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 90.4 -45.0 2.93 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.736 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -96.64 -66.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.745 0.307 . . . . 0.0 110.419 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 m -66.75 106.84 1.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.013 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 17' ' ' ALA . 34.3 m -133.17 150.53 32.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.479 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.496 ' HG2' HG12 ' A' ' 15' ' ' ILE . 1.6 tppp? -80.06 143.75 33.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.332 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -140.84 117.84 11.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.216 -179.353 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.515 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -71.83 99.05 2.1 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.012 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 8.7 t80 -94.43 109.05 20.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.13 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.9 48.81 7.14 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.767 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.63 -14.17 48.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.9 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.465 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -119.97 97.81 49.4 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 32.2 Cg_exo -60.21 145.52 98.34 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.984 2.456 . . . . 0.0 114.052 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.416 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 29.9 mtm -145.34 140.1 27.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.101 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.595 ' HB ' ' O ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -79.89 157.02 27.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.189 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 16.6 m-85 -141.14 142.9 34.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.012 0.434 . . . . 0.0 111.913 -177.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.65 99.83 8.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.859 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.8 mt -47.19 171.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.563 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.794 ' O ' HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -115.59 -35.88 4.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.899 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tp -56.34 91.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.986 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 37' ' ' LEU . 21.6 t -107.43 109.91 29.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.07 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.549 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 0.4 OUTLIER -123.97 -167.53 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.626 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.665 HG23 ' HD2' ' A' ' 42' ' ' PRO . 10.2 m -136.79 152.51 74.43 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.665 ' HD2' HG23 ' A' ' 41' ' ' THR . 14.7 Cg_exo -70.99 117.35 5.11 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.576 2.184 . . . . 0.0 113.316 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 42' ' ' PRO . 4.6 mm-40 84.09 -13.31 0.74 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.71 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -110.95 -175.69 2.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.644 0.259 . . . . 0.0 110.777 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -62.28 -135.28 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.266 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 40' ' ' ASP . 16.1 p80 -121.15 78.49 33.77 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.892 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 41' ' ' THR . 25.2 Cg_endo -100.6 -98.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 124.115 3.21 . . . . 0.0 112.97 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.14 96.44 4.03 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.632 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . 0.0 OUTLIER 171.67 54.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.058 0.456 . . . . 0.0 111.025 178.014 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.35 -30.06 1.89 Allowed Glycine 0 C--N 1.33 0.203 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.721 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.1 t -96.98 79.68 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.927 0.394 . . . . 0.0 110.732 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.621 ' HA ' ' HG3' ' A' ' 42' ' ' PRO . 52.8 tt0 -57.9 164.36 2.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.989 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -79.46 90.25 5.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.048 0.451 . . . . 0.0 111.024 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.879 ' OH ' ' HB2' ' A' ' 58' ' ' ALA . 8.4 p90 -135.85 -35.3 0.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.846 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.484 ' N ' ' CD1' ' A' ' 54' ' ' TYR . . . 106.27 -82.87 0.33 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.747 -0.739 . . . . 0.0 114.274 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.747 ' CB ' ' HB3' ' A' ' 60' ' ' ALA . 2.9 Cg_endo -89.38 -26.71 0.42 Allowed 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.518 2.812 . . . . 0.0 116.215 -176.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.665 ' HB3' ' CD1' ' A' ' 54' ' ' TYR . 4.4 tp10 -43.13 -25.56 0.12 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.879 ' HB2' ' OH ' ' A' ' 54' ' ' TYR . . . -91.41 -65.37 1.02 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.846 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 4.0 m -88.18 -30.33 19.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.747 ' HB3' ' CB ' ' A' ' 56' ' ' PRO . . . -89.45 -37.64 14.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.565 ' CB ' ' HA ' ' A' ' 57' ' ' GLU . 10.4 t80 -90.68 -43.49 10.1 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.665 HG22 HD13 ' A' ' 14' ' ' LEU . 21.3 m -40.85 -66.92 0.28 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 16' ' ' LYS . 0.6 OUTLIER -74.19 -19.85 60.4 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 3.1 mttp -59.09 -54.59 45.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 111.125 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.504 ' HE2' ' HG3' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -58.89 -27.49 65.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.03 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.825 HG21 ' HB3' ' A' ' 14' ' ' LEU . 42.7 t -72.44 -30.99 36.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.106 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -86.68 -13.99 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.555 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -96.2 -28.34 14.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.684 0.278 . . . . 0.0 111.291 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.739 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -108.22 147.52 31.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.805 0.336 . . . . 0.0 111.168 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.5 pttt -97.73 24.48 6.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.401 ' HG3' ' HA ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -145.4 98.98 3.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.819 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.85 HD13 HG22 ' A' ' 13' ' ' THR . 2.5 mp -121.84 93.76 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.733 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.439 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.8 tt0 -106.56 132.75 52.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.798 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.672 ' HB ' ' HB1' ' A' ' 90' ' ' ALA . 32.6 m -103.66 126.87 58.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.15 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.596 ' HG3' HD12 ' A' ' 7' ' ' LEU . 1.8 tt0 -79.9 52.63 1.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.322 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.784 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -97.01 149.73 21.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.649 -179.11 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.77 ' H ' HD11 ' A' ' 89' ' ' LEU . 8.6 t70 -80.03 159.77 26.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.888 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.5 29.98 3.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.091 0.472 . . . . 0.0 110.452 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.77 35.93 0.58 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.529 ' HB2' HD12 ' A' ' 89' ' ' LEU . 2.0 tp60 -78.27 124.52 28.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.405 0.622 . . . . 0.0 110.707 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -67.53 88.29 0.22 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.957 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.446 HG22 ' N ' ' A' ' 83' ' ' ASP . 92.0 m -97.07 161.45 13.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.446 ' N ' HG22 ' A' ' 82' ' ' THR . 0.9 OUTLIER -80.26 -53.25 6.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.676 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.409 ' O ' ' CG ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -134.69 -68.69 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.719 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.409 ' CG ' ' O ' ' A' ' 84' ' ' LYS . 4.5 m-85 -169.72 24.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.234 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.595 ' O ' ' HB ' ' A' ' 33' ' ' THR . . . -137.33 -4.49 1.96 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.959 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.524 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -113.88 48.31 1.09 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.623 0.725 . . . . 0.0 111.237 -179.174 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.59 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 78.3 m95 -91.33 142.83 27.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.872 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.87 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -76.93 158.76 30.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.672 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . 173.02 164.61 0.13 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.263 0.554 . . . . 0.0 112.342 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.787 ' CE1' HD13 ' A' ' 37' ' ' LEU . 19.1 m-85 -130.35 57.09 1.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.989 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.601 HG13 HG12 ' A' ' 74' ' ' VAL . 3.2 mp -42.07 127.77 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.424 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.485 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 3.1 p90 -142.89 143.88 32.23 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.075 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.739 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -112.81 124.18 52.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.789 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.401 ' HA ' ' HG3' ' A' ' 71' ' ' LYS . 0.1 OUTLIER 67.66 29.07 7.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.874 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.11 -35.89 3.93 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.001 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.504 ' HG3' ' HE2' ' A' ' 65' ' ' MET . 0.0 OUTLIER -86.94 130.43 34.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.904 0.383 . . . . 0.0 111.202 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.485 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 2.7 ttt -78.97 150.1 32.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.306 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.548 HG11 ' HA ' ' A' ' 62' ' ' THR . 25.8 m -51.12 -44.91 29.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.946 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.493 ' N ' HG23 ' A' ' 99' ' ' VAL . 3.1 m120 -68.23 -32.82 73.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.159 0.504 . . . . 0.0 110.037 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.49 ' HA ' ' HD3' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -74.22 -8.76 57.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.693 179.246 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.519 ' CB ' HD23 ' A' ' 103' ' ' LEU . . . -54.53 -82.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.744 ' HG ' HD23 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -115.19 -1.19 13.03 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.984 HG22 HD21 ' A' ' 108' ' ' LEU . 5.5 t -71.29 -1.64 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.699 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.49 ' HD3' ' HA ' ' A' ' 101' ' ' GLU . 8.6 mmm180 -81.78 -37.33 27.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.635 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.474 ' NE2' ' N ' ' A' ' 108' ' ' LEU . 1.5 pm0 -100.71 -14.77 17.95 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.659 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.6 32.95 0.54 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.241 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.984 HD21 HG22 ' A' ' 104' ' ' VAL . 11.2 mt 42.24 98.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.25 0.548 . . . . 0.0 112.115 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.496 ' N ' HD12 ' A' ' 103' ' ' LEU . . . -61.38 116.18 4.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.151 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.1 mttp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.923 179.967 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.822 0.344 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 t -121.36 137.96 54.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.06 116.23 31.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.46 153.08 19.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -101.15 146.07 27.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.991 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -78.02 110.72 13.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.695 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.447 ' HG ' ' HA ' ' A' ' 77' ' ' ASP . 4.2 mm? -76.56 157.03 32.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.4 25.91 10.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.731 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.435 ' HE2' ' CG ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER 63.83 110.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.127 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -104.79 127.98 27.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.518 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -90.02 163.69 4.86 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.752 2.301 . . . . 0.0 112.496 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.715 ' CB ' HD13 ' A' ' 25' ' ' LEU . . . -166.34 161.42 16.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.336 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 25' ' ' LEU . 35.6 p -93.55 108.34 20.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.327 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.962 HD12 HG11 ' A' ' 66' ' ' VAL . 2.2 tm? -89.15 119.57 29.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.149 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.897 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -74.76 -42.42 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.458 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.897 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER 179.87 173.17 0.96 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.249 0.547 . . . . 0.0 112.109 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.43 103.61 13.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.648 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' THR . 41.1 mm -53.3 -75.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.934 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -110.98 42.08 1.69 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.54 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.829 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 84.24 -52.15 4.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.924 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.49 -35.85 10.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.819 0.343 . . . . 0.0 110.422 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -71.39 106.79 4.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.27 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.738 HG21 HD13 ' A' ' 92' ' ' ILE . 3.2 m -122.99 129.35 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.685 0.279 . . . . 0.0 111.245 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' HD22 ' A' ' 14' ' ' LEU . 13.4 tttp -91.71 97.98 11.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.687 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.062 HD22 HG21 ' A' ' 74' ' ' VAL . 2.8 pp -110.51 137.72 47.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.662 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.567 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 29.0 ttm -72.51 99.96 2.62 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.533 ' CE1' ' CE1' ' A' ' 76' ' ' PHE . 86.9 t80 -88.51 109.42 20.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.174 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.457 ' O ' ' OE1' ' A' ' 30' ' ' GLN . 0.1 OUTLIER 49.18 28.27 2.12 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.821 179.416 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.44 -14.24 54.33 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.396 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -116.87 97.73 50.96 Favored Pre-proline 0 C--N 1.331 -0.239 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.821 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 34.1 Cg_exo -61.03 143.13 99.11 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.286 1.991 . . . . 0.0 113.129 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.444 ' O ' ' HE1' ' A' ' 34' ' ' PHE . 51.8 mtt -145.2 159.78 42.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.25 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.556 ' CB ' ' HA2' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -97.17 156.61 16.32 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.852 ' CZ ' HD11 ' A' ' 25' ' ' LEU . 3.0 m-85 -138.05 157.98 45.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.789 0.328 . . . . 0.0 111.493 -177.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.662 ' O ' HD12 ' A' ' 36' ' ' LEU . 2.2 ttm-85 -139.13 99.06 3.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.584 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.662 HD12 ' O ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER 170.29 -82.03 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.529 179.394 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 41.01 100.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.769 HD21 ' HG3' ' A' ' 101' ' ' GLU . 0.2 OUTLIER 59.4 119.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.139 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.545 HG23 ' OH ' ' A' ' 91' ' ' TYR . 41.9 t -91.3 112.24 25.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.508 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 50' ' ' GLY . 3.1 p30 -135.97 -165.73 1.75 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.811 0.338 . . . . 0.0 111.449 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.617 HG23 ' O ' ' A' ' 44' ' ' THR . 3.8 t -130.15 126.62 22.38 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.564 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 41' ' ' THR . 14.0 Cg_exo -69.46 112.8 3.12 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.265 1.976 . . . . 0.0 112.467 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 69.28 -43.79 0.53 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 41' ' ' THR . 0.2 OUTLIER -73.01 176.07 6.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.939 0.4 . . . . 0.0 111.182 -179.297 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -131.66 13.66 4.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.002 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.41 ' O ' ' N ' ' A' ' 48' ' ' LYS . 2.1 m170 -95.19 170.97 7.09 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.577 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.91 83.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.611 2.207 . . . . 0.0 112.476 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.463 ' CB ' ' HB ' ' A' ' 41' ' ' THR . 0.3 OUTLIER -124.55 167.89 13.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.496 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.521 ' CB ' HG13 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -138.09 45.61 2.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.992 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . -123.25 131.92 8.35 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.623 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 51' ' ' VAL . 9.3 p -94.55 109.81 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.701 0.286 . . . . 0.0 110.268 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.421 ' O ' ' CE1' ' A' ' 54' ' ' TYR . 1.1 tm-20 -57.66 166.9 1.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.854 0.359 . . . . 0.0 110.683 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.88 97.47 7.46 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.993 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.637 ' OH ' ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -112.41 -34.88 5.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.685 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.25 -70.7 0.26 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.869 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.69 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 87.3 Cg_exo -48.79 -19.11 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.11 2.54 . . . . 0.0 114.087 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.811 ' HG3' HD21 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -93.88 -44.75 7.94 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.829 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -90.51 -65.4 1.02 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.5 p -65.57 -36.96 85.3 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.69 ' HB3' ' HA ' ' A' ' 56' ' ' PRO . . . -89.38 -57.4 2.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.543 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -61.07 -69.14 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.165 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.798 ' HA ' HG11 ' A' ' 99' ' ' VAL . 42.9 m -40.85 -66.57 0.31 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -55.93 -25.47 43.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.21 -63.17 1.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 0.0 111.878 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.553 ' SD ' ' HB3' ' A' ' 94' ' ' ALA . 1.6 mmm -50.86 -24.84 3.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.914 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.962 HG11 HD12 ' A' ' 14' ' ' LEU . 30.0 m -76.99 -31.02 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -94.18 -11.48 30.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.295 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -98.04 -28.17 13.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.66 0.267 . . . . 0.0 111.303 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.607 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . . . -102.68 143.91 31.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.884 0.374 . . . . 0.0 111.171 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -97.48 29.32 3.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.29 98.88 2.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.134 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.554 ' CG2' HG23 ' A' ' 92' ' ' ILE . 3.8 mt -119.23 94.67 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.397 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -94.94 137.18 34.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.86 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.062 HG21 HD22 ' A' ' 25' ' ' LEU . 21.3 t -116.97 102.87 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.423 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.435 ' CG ' ' HE2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -71.59 63.48 0.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.056 179.267 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.61 ' HB3' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -107.43 167.12 10.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.951 0.405 . . . . 0.0 111.834 -178.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.476 ' H ' HD11 ' A' ' 89' ' ' LEU . 6.9 t70 -104.29 162.05 13.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.34 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -101.0 32.6 3.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.414 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.69 33.55 0.32 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.944 ' HG3' HD12 ' A' ' 89' ' ' LEU . 1.4 mm-40 -78.37 128.96 34.4 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.542 0.686 . . . . 0.0 110.857 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.2 mtp85 -63.55 78.18 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.569 HG21 ' CD1' ' A' ' 88' ' ' TRP . 48.3 m -94.4 141.34 28.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.84 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.17 -50.55 73.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.907 0.384 . . . . 0.0 110.764 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.414 ' O ' ' CG ' ' A' ' 85' ' ' TYR . 1.8 tptm -138.44 -67.05 0.47 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.551 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.414 ' CG ' ' O ' ' A' ' 84' ' ' LYS . 7.8 m-85 -172.68 25.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.937 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.556 ' HA2' ' CB ' ' A' ' 33' ' ' THR . . . -134.4 -5.41 2.62 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.779 -1.2 . . . . 0.0 113.775 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.545 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -114.54 41.19 2.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.579 0.704 . . . . 0.0 110.924 -179.338 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.599 ' CE3' ' HB2' ' A' ' 80' ' ' GLN . 63.9 m95 -80.38 146.14 31.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.43 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.944 HD12 ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -77.36 164.43 25.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.885 ' HB1' HG13 ' A' ' 74' ' ' VAL . . . 175.28 172.89 0.27 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.288 0.566 . . . . 0.0 112.396 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.545 ' OH ' HG23 ' A' ' 39' ' ' VAL . 28.7 m-85 -141.78 41.7 1.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.98 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.738 HD13 HG21 ' A' ' 23' ' ' VAL . 3.2 mp -41.96 127.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.056 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 2.2 p90 -143.98 153.93 42.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.471 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.607 ' HB1' ' CB ' ' A' ' 69' ' ' ALA . . . -113.51 135.48 53.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.685 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.85 23.91 12.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.147 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.53 -12.17 65.98 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.037 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.426 ' HG3' ' HE1' ' A' ' 65' ' ' MET . 0.0 OUTLIER -107.38 127.64 53.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.943 0.401 . . . . 0.0 110.988 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.522 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 1.5 mpt? -71.61 150.12 44.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.155 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.798 HG11 ' HA ' ' A' ' 62' ' ' THR . 11.1 m -58.79 -37.78 68.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.113 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.893 ' O ' HG13 ' A' ' 104' ' ' VAL . 3.6 m-80 -75.33 -49.36 19.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.444 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.769 ' HG3' HD21 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -73.94 -8.59 56.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.229 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.484 ' HB3' HD23 ' A' ' 103' ' ' LEU . . . -59.06 -44.25 91.81 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.901 ' HG ' HD22 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -124.66 11.17 8.48 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.893 HG13 ' O ' ' A' ' 100' ' ' ASN . 8.3 m -55.06 -13.26 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.706 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.638 ' HD3' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -80.73 -46.46 15.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.545 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -70.76 -13.8 62.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.644 0.259 . . . . 0.0 111.696 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.61 34.91 0.47 Allowed Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.198 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.901 HD22 ' HG ' ' A' ' 103' ' ' LEU . 7.7 tp -90.53 170.37 10.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.637 ' HB3' ' OH ' ' A' ' 54' ' ' TYR . . . -52.13 113.01 0.89 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.814 0.34 . . . . 0.0 111.324 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.789 0.328 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.7 p -108.32 112.55 25.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.006 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 p -106.39 148.6 27.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.51 130.03 38.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.77 140.96 32.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.09 114.53 27.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.864 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pp -86.23 119.69 26.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -72.0 -177.38 2.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -114.91 128.6 56.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.059 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 20.0 mm-40 -123.82 115.74 27.87 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.672 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.92 161.15 7.47 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.688 2.258 . . . . 0.0 112.437 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.956 ' HB3' HD13 ' A' ' 25' ' ' LEU . . . -166.15 172.17 11.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.448 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.525 ' O ' HG23 ' A' ' 13' ' ' THR . 9.1 t -103.12 108.7 19.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.071 0.462 . . . . 0.0 111.264 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.682 ' HB3' HG11 ' A' ' 66' ' ' VAL . 2.8 tt -76.09 125.83 29.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.778 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.9 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.7 pp -74.9 -46.01 41.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.393 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.9 ' N ' HD12 ' A' ' 15' ' ' ILE . 4.1 mtmt 178.99 173.23 0.77 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.992 0.425 . . . . 0.0 111.373 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.964 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -98.72 148.05 24.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.391 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.771 HD12 HG22 ' A' ' 22' ' ' THR . 92.5 mt -102.71 -72.15 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.497 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -117.71 42.05 2.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.738 0.304 . . . . 0.0 111.532 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.795 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 82.37 -54.76 4.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.543 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.54 -35.72 11.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.018 0.437 . . . . 0.0 110.196 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.771 HG22 HD12 ' A' ' 18' ' ' ILE . 43.2 m -76.62 106.91 8.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.158 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.508 ' HB ' HD11 ' A' ' 14' ' ' LEU . 21.5 m -126.12 161.72 31.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.867 0.365 . . . . 0.0 111.189 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.483 ' HG2' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -119.41 134.18 55.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.297 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.956 HD13 ' HB3' ' A' ' 12' ' ' ALA . 1.3 pp -141.72 132.64 25.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.61 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.766 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -72.89 99.53 2.7 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.871 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.454 ' CE2' ' CE1' ' A' ' 76' ' ' PHE . 5.8 t80 -88.88 112.37 23.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.777 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 45.06 36.73 2.13 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.711 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.05 -14.41 65.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.457 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.26 97.34 49.51 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 51.6 Cg_endo -69.63 150.06 68.51 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.537 2.158 . . . . 0.0 112.994 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.401 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 3.4 mmt -145.3 161.17 40.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.049 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.06 124.08 40.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.861 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 2.1 m-85 -111.45 149.51 31.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.911 0.386 . . . . 0.0 111.693 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.593 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 3.4 ttp85 -139.09 110.41 6.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.168 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.717 HD21 ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER 163.87 -150.87 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.288 179.042 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.817 HD11 HD12 ' A' ' 92' ' ' ILE . 2.9 mt 72.89 -78.67 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.798 HD21 HG21 ' A' ' 99' ' ' VAL . 3.0 mm? -67.47 92.89 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.845 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.9 t -111.36 109.23 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 0.0 111.191 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.412 ' OD1' HG13 ' A' ' 104' ' ' VAL . 0.8 OUTLIER -137.67 150.95 47.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.314 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 44' ' ' THR . 4.7 t -116.19 93.58 39.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.616 0.245 . . . . 0.0 111.248 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 49' ' ' LYS . 58.3 Cg_exo -51.51 117.49 3.52 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.451 2.101 . . . . 0.0 112.336 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 77.03 -60.19 0.46 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.188 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.545 ' O ' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -63.88 173.66 1.74 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.754 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.524 ' C ' HG21 ' A' ' 41' ' ' THR . 2.2 mmmp? -111.5 -26.35 9.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.848 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.443 ' O ' ' HB ' ' A' ' 41' ' ' THR . 1.1 m-70 -70.53 135.29 86.24 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 46' ' ' HIS . 25.9 Cg_exo -63.58 35.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.757 2.305 . . . . 0.0 114.25 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -129.15 95.54 4.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.675 0.274 . . . . 0.0 110.954 179.069 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.575 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER 173.3 41.12 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.454 179.547 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.31 -126.62 38.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.727 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.2 m -121.69 163.38 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.813 0.34 . . . . 0.0 111.37 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -75.47 161.39 29.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.57 179.433 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.51 92.44 9.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.156 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.808 ' CE1' HD13 ' A' ' 108' ' ' LEU . 9.9 p90 -135.19 -35.61 0.83 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.318 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.3 -105.98 3.33 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 114.929 0.732 . . . . 0.0 114.929 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 25.0 Cg_exo -38.56 -53.56 1.77 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.142 3.228 . . . . 0.0 116.079 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.554 ' HB2' ' CD2' ' A' ' 54' ' ' TYR . 5.8 mm-40 -48.82 -16.45 0.13 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.795 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -90.52 -62.31 1.49 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.671 0.272 . . . . 0.0 111.184 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.546 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 57.8 p -90.66 -48.98 6.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.975 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -55.06 -35.41 64.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.224 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.467 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 2.1 t80 -90.35 -19.92 23.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.479 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.964 HG21 ' HB2' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -77.59 -67.16 0.75 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.56 0.219 . . . . 0.0 111.331 -179.453 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.517 ' N ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -60.41 -23.79 64.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 111.34 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -80.93 -49.19 11.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.629 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.403 ' HG3' ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -50.03 -28.91 7.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.412 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.682 HG11 ' HB3' ' A' ' 14' ' ' LEU . 27.1 m -91.72 -26.89 4.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.273 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -76.51 -9.72 58.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.657 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -114.22 -28.1 7.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.606 0.241 . . . . 0.0 111.433 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.813 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -104.03 132.41 50.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 0.0 111.173 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -86.21 4.34 39.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.263 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.78 106.59 12.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.896 0.379 . . . . 0.0 110.968 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.509 HG12 HG12 ' A' ' 66' ' ' VAL . 4.1 mt -127.3 95.07 2.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.654 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -95.25 150.09 20.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.663 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.858 ' CG1' ' HB1' ' A' ' 90' ' ' ALA . 2.6 t -128.98 116.38 40.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.36 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -86.89 49.76 1.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.026 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -92.97 145.24 24.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.055 -179.204 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.513 ' H ' HD11 ' A' ' 89' ' ' LEU . 33.9 t0 -91.26 158.96 16.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.001 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -95.27 29.52 2.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.193 0.52 . . . . 0.0 110.25 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -153.49 37.68 0.73 Allowed Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.726 ' HB2' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -77.82 128.16 33.54 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.321 0.581 . . . . 0.0 110.198 -179.039 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -63.51 65.18 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.112 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.971 HG21 ' CE2' ' A' ' 88' ' ' TRP . 14.4 t -109.55 171.7 7.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.507 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -108.26 78.34 1.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 1.1 mppt? 65.11 -72.02 0.07 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.106 0.479 . . . . 0.0 109.948 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -144.94 15.87 1.56 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.366 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.496 ' O ' ' CG ' ' A' ' 87' ' ' ARG . . . -59.26 -23.23 57.41 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.08 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.515 ' HG3' ' HB2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 154.87 108.39 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.069 0.548 . . . . 0.0 110.76 179.231 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.971 ' CE2' HG21 ' A' ' 82' ' ' THR . 66.5 m95 -97.89 146.3 25.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.797 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.873 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -77.86 159.23 29.07 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.858 ' HB1' ' CG1' ' A' ' 74' ' ' VAL . . . -179.75 145.92 0.24 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -108.01 52.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.627 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.817 HD12 HD11 ' A' ' 37' ' ' LEU . 1.3 mp -57.71 132.94 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.504 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 73' ' ' GLU . 2.9 p90 -150.57 153.04 35.03 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.359 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.813 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -120.95 131.99 54.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.828 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.7 t70 67.57 25.9 8.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.021 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.31 19.91 77.77 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.842 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -137.1 114.11 10.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.923 0.392 . . . . 0.0 110.896 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.446 ' CA ' ' HB3' ' A' ' 93' ' ' TYR . 16.0 ptp -75.39 150.19 38.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.798 HG21 HD21 ' A' ' 38' ' ' LEU . 15.5 m -49.82 -31.58 6.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.091 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.654 ' OD1' HG11 ' A' ' 104' ' ' VAL . 13.1 t30 -75.95 -22.57 55.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.013 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -93.24 -11.72 31.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -91.12 -56.13 3.27 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.681 ' HB3' HD23 ' A' ' 108' ' ' LEU . 3.8 mm? -106.39 -50.78 3.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.678 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.654 HG11 ' OD1' ' A' ' 100' ' ' ASN . 38.6 t -56.62 -21.43 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.772 -0.194 . . . . 0.0 111.485 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -28.41 -48.12 0.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.417 ' HG3' ' CD ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -121.05 -0.36 10.02 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.19 26.44 1.34 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.953 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.808 HD13 ' CE1' ' A' ' 54' ' ' TYR . 9.4 mt 61.44 122.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.059 0.457 . . . . 0.0 111.374 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.2 126.72 31.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.07 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.843 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.761 0.315 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.5 p -124.42 98.57 5.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.8 m -95.6 119.38 34.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.4 p -79.23 103.82 9.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.025 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.44 126.75 36.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.773 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.27 108.68 20.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.032 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.727 HD12 ' HG3' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -120.18 157.28 29.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.773 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -96.95 -40.99 8.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.0 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.727 ' HG3' HD12 ' A' ' 7' ' ' LEU . 11.7 mtpt 63.48 130.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.923 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.657 ' O ' HG22 ' A' ' 74' ' ' VAL . 4.5 mm-40 -136.05 145.56 52.95 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 10' ' ' GLU . 1.3 Cg_endo -83.42 105.49 1.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.735 2.29 . . . . 0.0 112.316 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.713 ' HB3' HD22 ' A' ' 25' ' ' LEU . . . -116.2 135.5 53.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.501 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.1 m -86.88 108.82 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.93 0.395 . . . . 0.0 111.644 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.579 HD22 ' HA ' ' A' ' 63' ' ' LYS . 10.2 tt -73.44 113.43 10.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.95 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.956 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.5 pp -74.7 -43.44 47.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.341 -0.391 . . . . 0.0 112.052 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.956 ' N ' HD12 ' A' ' 15' ' ' ILE . 37.9 tttp -173.65 151.56 1.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.077 0.465 . . . . 0.0 111.935 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.779 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -89.91 148.21 23.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.671 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.837 HD12 HG22 ' A' ' 22' ' ' THR . 21.0 mt -103.1 -73.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.687 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.12 26.86 9.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.633 0.254 . . . . 0.0 111.481 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.937 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 90.13 -44.33 2.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.744 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.7 -54.37 3.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 110.328 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.837 HG22 HD12 ' A' ' 18' ' ' ILE . 91.0 m -78.26 106.89 10.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.141 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.642 HG12 ' HA ' ' A' ' 17' ' ' ALA . 35.4 m -130.57 157.37 42.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.464 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.453 ' HB3' HG13 ' A' ' 15' ' ' ILE . 32.2 tttt -91.76 142.77 27.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.47 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.713 HD22 ' HB3' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -141.28 117.69 10.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.928 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.85 99.18 2.14 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.446 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 17.3 t80 -95.62 108.54 20.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.907 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.94 41.55 14.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.147 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.85 -14.13 61.07 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.459 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.471 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -117.75 98.19 51.43 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.999 0.428 . . . . 0.0 110.277 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.699 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 26.6 Cg_endo -62.54 144.4 94.43 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.705 2.27 . . . . 0.0 113.327 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.6 mmt -145.17 155.84 43.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.082 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.422 ' H ' ' HG1' ' A' ' 33' ' ' THR . 11.4 p -85.79 122.11 29.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.817 0.341 . . . . 0.0 111.214 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.651 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 16.8 m-85 -113.79 107.9 16.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.436 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 88' ' ' TRP . 7.6 ttt180 -97.41 115.0 26.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.223 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.63 ' CD1' HG23 ' A' ' 39' ' ' VAL . 0.1 OUTLIER 179.05 -77.85 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.05 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.819 HD13 ' O ' ' A' ' 20' ' ' GLY . 0.4 OUTLIER 43.54 57.18 4.05 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.637 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 53.42 94.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.343 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.63 HG23 ' CD1' ' A' ' 36' ' ' LEU . 38.9 t -67.03 109.93 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.725 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -130.18 -138.53 0.22 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.768 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.603 ' HB ' ' HA ' ' A' ' 47' ' ' PRO . 11.8 t -124.16 137.52 29.17 Favored Pre-proline 0 C--N 1.334 -0.105 0 O-C-N 122.37 -0.207 . . . . 0.0 110.783 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.616 ' HB3' ' CB ' ' A' ' 52' ' ' GLU . 7.9 Cg_exo -73.09 111.92 3.4 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.123 1.882 . . . . 0.0 111.964 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.4 -40.14 0.45 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -71.94 -165.17 0.15 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.873 0.368 . . . . 0.0 111.466 -179.04 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.448 ' C ' HG21 ' A' ' 41' ' ' THR . 0.0 OUTLIER -116.1 -37.7 3.78 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.715 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.537 ' O ' ' N ' ' A' ' 48' ' ' LYS . 1.1 m80 -75.89 115.71 48.88 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.603 ' HA ' ' HB ' ' A' ' 41' ' ' THR . 5.6 Cg_endo -48.09 75.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.424 2.749 . . . . 0.0 113.759 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 1.2 tppp? -129.02 95.77 4.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.685 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.572 ' CB ' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER 102.49 37.63 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.376 0.671 . . . . 0.0 112.189 178.401 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 45.43 -128.11 8.47 Favored Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.129 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.84 143.32 28.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.926 0.393 . . . . 0.0 111.526 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.616 ' CB ' ' HB3' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -75.15 -177.03 3.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.185 0.516 . . . . 0.0 110.972 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -111.09 90.87 3.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.819 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.737 ' CZ ' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -96.52 -35.16 11.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 -179.295 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.04 -71.56 0.26 Allowed Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.615 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.826 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 56.6 Cg_exo -43.54 -45.76 10.36 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.058 2.505 . . . . 0.0 114.422 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.761 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 15.8 tm-20 -91.77 -64.61 1.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.937 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -60.46 -40.71 92.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.509 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 67.9 m -93.63 -43.4 8.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.826 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -89.5 -34.61 16.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.761 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 4.1 t80 -90.1 -24.34 21.14 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.779 HG21 ' HB2' ' A' ' 17' ' ' ALA . 1.7 m -56.82 -66.84 0.38 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.734 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -77.72 -19.73 54.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -48.03 -51.63 23.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 0.0 111.388 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.4 ttp -70.49 -17.61 62.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.305 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.847 HG13 HG12 ' A' ' 72' ' ' ILE . 48.1 t -88.64 -11.63 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.518 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -93.99 -6.77 44.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -114.7 -27.9 7.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.562 0.22 . . . . 0.0 111.447 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.642 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -100.9 142.26 32.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 111.343 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.92 28.57 4.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.556 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -142.2 98.92 3.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.005 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.847 HG12 HG13 ' A' ' 66' ' ' VAL . 3.2 mp -129.18 93.24 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.641 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.5 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 8.1 mt-10 -102.65 133.5 47.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.883 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 10' ' ' GLU . 27.8 m -104.26 138.26 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.895 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.464 ' HG3' HD13 ' A' ' 7' ' ' LEU . 64.8 tt0 -89.09 48.47 1.63 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.982 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.588 ' HB2' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -93.7 150.96 19.98 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.518 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.635 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 3.3 t70 -87.26 162.48 17.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.996 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.38 32.44 0.95 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.421 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.69 31.29 0.17 Allowed Glycine 0 CA--C 1.507 -0.46 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.635 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 11.5 mm-40 -81.74 127.93 33.46 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.684 0.754 . . . . 0.0 111.847 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -42.05 129.57 3.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.148 -1.387 . . . . 0.0 111.807 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.623 HG22 ' CE2' ' A' ' 88' ' ' TRP . 43.6 p -109.44 171.41 7.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.033 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 87' ' ' ARG . 18.4 t0 -146.73 -100.52 0.09 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.474 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -98.73 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 O-C-N 122.305 -0.247 . . . . 0.0 111.065 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.4 ' HB2' ' CG2' ' A' ' 33' ' ' THR . 42.6 m-85 -87.31 48.58 1.67 Allowed 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.157 0.503 . . . . 0.0 109.749 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.454 ' O ' ' C ' ' A' ' 87' ' ' ARG . . . 97.01 -34.4 5.09 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.545 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 86' ' ' GLY . 0.3 OUTLIER 27.55 74.72 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.276 0.56 . . . . 0.0 111.219 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.651 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 54.1 m95 -105.46 158.21 16.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.175 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.651 HD22 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -77.96 164.89 24.7 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.925 178.563 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.646 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 166.06 147.88 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.232 0.539 . . . . 0.0 111.677 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.446 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 3.1 m-85 -99.47 -34.18 10.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.956 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.477 HG21 HD13 ' A' ' 14' ' ' LEU . 1.8 mp 59.03 115.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.508 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.5 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 6.4 p90 -141.16 136.46 31.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.986 0.422 . . . . 0.0 111.502 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -106.0 112.5 25.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.731 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.463 ' OD1' ' HB1' ' A' ' 69' ' ' ALA . 5.1 m-20 80.37 27.16 0.28 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.951 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.21 -28.63 9.34 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.957 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.77 130.85 39.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 111.165 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.463 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -76.5 145.35 39.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.922 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 62' ' ' THR . 35.3 m -73.82 -37.7 49.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.213 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 91' ' ' TYR . 6.2 p30 -78.8 -37.1 41.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.977 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 98' ' ' MET . 0.2 OUTLIER -72.91 -9.24 58.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.295 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -91.12 -28.41 17.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.787 0.327 . . . . 0.0 111.231 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.623 ' HB3' HD23 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -111.76 -60.61 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 105' ' ' ARG . 8.6 t -58.7 -20.72 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.67 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.694 ' HD2' HE22 ' A' ' 106' ' ' GLN . 0.0 OUTLIER -24.85 -55.91 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.694 HE22 ' HD2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -121.15 8.16 10.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.548 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.07 31.56 2.43 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.144 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.737 HD11 ' CZ ' ' A' ' 54' ' ' TYR . 6.8 mt 69.3 105.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.067 0.461 . . . . 0.0 111.172 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.67 129.56 37.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.003 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.7 mttp . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.885 -179.917 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.785 0.326 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.59 119.02 20.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.9 m -110.01 127.36 54.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p -104.71 131.34 52.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.87 125.08 40.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.935 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -119.12 111.6 18.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.681 ' N ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -120.06 157.27 29.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -70.83 173.83 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.446 ' HE3' ' HA ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -99.32 157.67 16.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -151.67 113.74 2.99 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.776 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 89.7 Cg_endo -85.35 110.72 1.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.63 2.22 . . . . 0.0 112.518 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.516 ' HB3' HD22 ' A' ' 25' ' ' LEU . . . -120.83 156.32 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.594 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -98.1 108.09 20.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.124 0.488 . . . . 0.0 111.656 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.798 ' HB3' HG21 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -76.28 108.93 9.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.643 178.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.837 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -74.79 -46.93 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.304 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.837 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -178.56 173.11 1.36 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.116 0.484 . . . . 0.0 111.776 179.47 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.804 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -94.86 148.26 22.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.951 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.4 mt -104.2 -70.38 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.781 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.05 42.22 2.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.726 0.298 . . . . 0.0 111.524 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.77 -57.21 5.05 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.52 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -96.74 -38.28 9.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.912 0.387 . . . . 0.0 110.116 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.799 HG22 HG21 ' A' ' 33' ' ' THR . 0.2 OUTLIER -77.7 106.75 9.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.106 179.263 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 17' ' ' ALA . 27.8 m -127.42 143.6 40.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.333 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.518 ' HB3' HD11 ' A' ' 15' ' ' ILE . 9.1 tppt? -81.88 142.78 32.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.509 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.769 ' HG ' HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -141.79 118.44 11.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.543 -179.396 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -72.4 99.39 2.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.583 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 20.8 t80 -96.33 107.54 19.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.203 -177.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm 45.13 48.98 9.85 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.652 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.13 -14.1 51.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.789 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -119.86 97.84 49.56 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 121.011 0.434 . . . . 0.0 110.019 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 24.6 Cg_exo -65.26 143.34 76.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.857 2.372 . . . . 0.0 113.38 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 mmt -145.05 151.86 39.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.555 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.799 HG21 HG22 ' A' ' 22' ' ' THR . 2.8 m -86.68 121.2 28.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.545 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 25' ' ' LEU . 2.1 m-85 -109.79 125.54 52.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.005 0.431 . . . . 0.0 111.518 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -98.61 118.07 34.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.976 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -64.06 159.83 19.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.803 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.627 ' CD1' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -109.54 -171.95 1.95 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.002 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.5 tp 67.49 119.5 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.965 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.542 HG13 HG23 ' A' ' 51' ' ' VAL . 24.4 t -121.28 109.8 26.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.197 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.54 -163.14 0.85 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.413 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.456 HG21 ' HB ' ' A' ' 44' ' ' THR . 9.7 t -77.19 153.77 82.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.442 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.483 ' HB3' ' N ' ' A' ' 52' ' ' GLU . 5.7 Cg_endo -83.69 112.69 1.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.611 2.208 . . . . 0.0 112.209 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 42' ' ' PRO . 6.8 pt-20 49.44 20.59 0.48 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.131 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.456 ' HB ' HG21 ' A' ' 41' ' ' THR . 0.2 OUTLIER -111.66 -162.76 0.81 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.683 0.278 . . . . 0.0 110.628 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -154.79 28.3 0.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.74 0.305 . . . . 0.0 111.028 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.408 ' O ' ' N ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -118.67 171.17 5.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.635 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.05 71.3 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.683 2.256 . . . . 0.0 112.188 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 46' ' ' HIS . 0.1 OUTLIER -122.86 167.32 13.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.757 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.34 -173.45 2.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.673 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 56.93 97.34 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.37 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.542 HG23 HG13 ' A' ' 39' ' ' VAL . 16.7 t -70.72 79.93 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.768 0.318 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.483 ' N ' ' HB3' ' A' ' 42' ' ' PRO . 7.7 tt0 -57.68 92.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.343 0.592 . . . . 0.0 109.717 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -48.8 151.52 1.19 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.136 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.535 ' HE2' HD21 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -120.26 -28.43 5.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.644 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.41 -64.12 0.27 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.652 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.625 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 76.9 Cg_exo -52.62 -19.52 10.55 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.07 2.513 . . . . 0.0 113.405 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' HG2' ' N ' ' A' ' 58' ' ' ALA . 13.7 pm0 -94.24 -46.79 6.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.578 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -91.16 -65.67 0.99 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.792 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 73.8 m -60.66 -37.82 82.84 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.625 ' HB3' ' HA ' ' A' ' 56' ' ' PRO . . . -89.52 -61.83 1.61 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.448 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -55.34 -51.7 65.91 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.419 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 85.1 m -55.47 -66.26 0.45 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.619 0.247 . . . . 0.0 111.499 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -23.11 15.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.519 ' HZ2' ' HB1' ' A' ' 60' ' ' ALA . 1.9 mttp -88.07 -55.86 3.57 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.51 -26.49 3.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.716 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.882 HG13 HG12 ' A' ' 72' ' ' ILE . 36.0 t -91.73 -10.56 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -94.11 -5.97 46.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -111.2 -27.34 8.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.626 0.25 . . . . 0.0 111.426 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.866 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -105.62 141.12 37.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 0.0 111.172 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.27 29.04 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.762 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.45 ' HG3' ' HA ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -145.46 98.72 3.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.807 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.882 HG12 HG13 ' A' ' 66' ' ' VAL . 2.6 mp -127.67 92.14 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.665 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -94.87 147.58 23.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.754 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.588 HG13 ' HB1' ' A' ' 90' ' ' ALA . 36.7 t -116.31 129.15 73.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.684 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.446 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 34.2 tt0 -93.62 54.32 2.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.221 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.688 ' HA ' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -94.89 167.31 11.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.164 -178.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.448 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 2.0 t70 -104.43 162.55 13.14 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.041 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -94.18 28.78 2.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.936 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.62 26.93 0.2 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.776 ' HG3' HD12 ' A' ' 89' ' ' LEU . 2.2 mm100 -78.54 127.12 31.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.63 0.729 . . . . 0.0 110.983 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -39.71 127.1 1.99 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.515 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 87' ' ' ARG . 75.2 p -109.18 172.04 7.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.088 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.423 ' N ' ' HB2' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -143.13 -82.19 0.18 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.471 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -81.51 -98.22 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.937 -0.119 . . . . 0.0 110.842 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -80.52 58.75 3.3 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.565 ' O ' ' CD1' ' A' ' 88' ' ' TRP . . . 58.84 37.57 90.8 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.372 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.591 ' O ' HG22 ' A' ' 82' ' ' THR . 0.0 OUTLIER -25.86 126.3 0.05 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.295 0.569 . . . . 0.0 112.121 -179.015 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.577 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 96.2 m95 -126.2 143.59 51.08 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.924 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.912 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -76.64 158.29 31.19 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.486 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.75 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 179.66 160.73 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.264 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.493 ' CE1' HD11 ' A' ' 37' ' ' LEU . 3.7 m-85 -113.1 -35.94 5.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.92 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.6 mt 59.67 119.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.809 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.437 ' OH ' ' HB3' ' A' ' 73' ' ' GLU . 4.9 p90 -141.63 123.44 15.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.866 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -99.25 96.55 7.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.665 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 94' ' ' ALA . 2.7 t0 85.26 55.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.997 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.11 27.71 57.69 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.852 -0.613 . . . . 0.0 113.453 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -137.25 112.72 9.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 0.0 111.001 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.417 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -78.21 136.12 37.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.068 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.615 ' O ' HD23 ' A' ' 103' ' ' LEU . 4.1 m -62.84 -31.03 50.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.98 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -80.91 -45.92 16.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.772 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -20.82 62.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.104 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.39 -34.55 15.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.277 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.888 ' CG ' HD22 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -62.31 -33.32 74.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.851 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 m -63.78 -1.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.504 ' HG3' ' NE2' ' A' ' 106' ' ' GLN . 13.9 ptp180 -32.16 -48.68 0.17 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.791 0.436 . . . . 0.0 111.923 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.504 ' NE2' ' HG3' ' A' ' 105' ' ' ARG . 0.1 OUTLIER -121.35 -1.79 9.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.624 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.24 24.54 1.04 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.378 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.888 HD22 ' CG ' ' A' ' 103' ' ' LEU . 0.9 OUTLIER -96.57 139.23 32.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.895 0.347 . . . . 0.0 110.582 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.18 144.41 48.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.384 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.911 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.842 0.353 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.43 122.84 48.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.4 m -63.82 102.18 0.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.946 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 m -84.79 129.11 34.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.49 134.45 51.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.85 113.42 26.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.855 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.792 HD11 ' HG2' ' A' ' 75' ' ' GLU . 2.0 pp -119.4 157.27 28.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.855 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.764 ' O ' HD12 ' A' ' 7' ' ' LEU . 7.7 m-70 -70.78 166.71 20.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.757 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.79 155.39 19.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 1.4 mp0 -141.57 113.89 6.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.632 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 5.8 Cg_exo -78.69 114.1 3.4 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.566 2.177 . . . . 0.0 112.238 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.535 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . . . -138.7 146.81 42.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.524 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.1 p -92.37 109.07 20.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.899 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.902 HD11 ' HB ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -76.9 119.57 20.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.758 178.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.921 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.4 pp -74.9 -41.96 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.921 ' N ' HD12 ' A' ' 15' ' ' ILE . 87.6 tttt -176.89 162.48 2.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.985 0.422 . . . . 0.0 111.58 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.045 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -97.22 148.09 23.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.89 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.515 HD12 ' HB ' ' A' ' 22' ' ' THR . 38.1 mt -96.54 -77.0 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.476 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -118.29 34.62 5.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.434 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.56 -45.36 2.93 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.504 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.73 -57.53 2.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 110.479 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.554 HG22 ' HE ' ' A' ' 87' ' ' ARG . 21.6 p -69.71 107.52 3.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.447 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.902 ' HB ' HD11 ' A' ' 14' ' ' LEU . 34.6 m -130.09 141.91 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.484 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.511 ' HG2' HG12 ' A' ' 15' ' ' ILE . 4.5 tptt -79.97 139.29 37.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.2 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.604 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -141.54 119.29 11.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.6 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.497 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -72.36 99.35 2.41 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.703 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 20.0 t80 -94.84 108.34 20.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.193 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 tptp 45.68 47.5 11.63 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.594 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.48 -13.97 53.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.718 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.47 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -120.25 98.0 48.93 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 110.045 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 33.1 Cg_exo -61.67 143.92 96.92 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.849 2.366 . . . . 0.0 113.609 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.6 mmt -145.13 144.84 31.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.44 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.49 HG21 ' CZ ' ' A' ' 87' ' ' ARG . 86.2 m -82.31 120.02 24.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.73 0.3 . . . . 0.0 110.495 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.643 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 5.1 m-85 -105.02 124.37 49.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.784 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 88' ' ' TRP . 12.1 ttp180 -121.83 125.38 46.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.03 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.785 HD13 ' HB2' ' A' ' 89' ' ' LEU . 11.9 tp -175.71 -39.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.207 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.471 HD11 HD13 ' A' ' 92' ' ' ILE . 9.2 mt -55.39 87.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.974 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -131.91 -44.67 0.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.235 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.24 108.84 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.08 0.467 . . . . 0.0 111.326 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.13 172.7 12.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.24 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.673 HG23 ' O ' ' A' ' 44' ' ' THR . 2.3 t -145.72 92.17 5.52 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 120.717 0.294 . . . . 0.0 111.172 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.629 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 10.1 Cg_endo -49.39 116.48 2.31 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.453 2.769 . . . . 0.0 111.972 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER 81.17 -61.21 0.22 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.613 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.673 ' O ' HG23 ' A' ' 41' ' ' THR . 0.2 OUTLIER -71.98 169.09 16.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.814 0.34 . . . . 0.0 110.976 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' C ' HG21 ' A' ' 41' ' ' THR . 0.0 OUTLIER -111.59 -15.33 13.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.951 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.466 ' CG ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -70.65 171.18 8.62 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.289 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.466 ' HD2' ' CG ' ' A' ' 46' ' ' HIS . 74.2 Cg_endo -75.79 51.4 3.03 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.342 2.028 . . . . 0.0 112.707 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.2 96.48 4.47 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.969 0.414 . . . . 0.0 110.932 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.582 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -67.93 80.77 0.21 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.398 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.532 ' CA ' ' HG2' ' A' ' 42' ' ' PRO . . . -58.6 -111.4 0.01 OUTLIER Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.777 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.592 ' N ' ' CG ' ' A' ' 42' ' ' PRO . 14.9 t -121.57 78.51 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.629 ' HB2' ' HB3' ' A' ' 42' ' ' PRO . 0.9 OUTLIER -108.91 85.86 2.18 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 174.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.458 ' C ' ' CD1' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -144.0 89.1 2.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.047 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.466 ' CE2' HD21 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -135.8 -34.24 0.83 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.048 178.633 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.05 -62.29 0.29 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.607 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.905 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 81.8 Cg_exo -47.1 -20.09 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.172 2.581 . . . . 0.0 113.68 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.741 ' HB3' HD11 ' A' ' 103' ' ' LEU . 9.3 mm-40 -94.63 -27.67 15.76 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.501 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -90.72 -65.36 1.02 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.568 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -80.58 -25.01 38.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.666 0.27 . . . . 0.0 111.472 -179.02 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.905 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -89.27 -56.16 3.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.924 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.667 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 1.7 t80 -59.27 -39.22 82.22 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.94 0.4 . . . . 0.0 110.933 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 1.045 HG21 ' HB2' ' A' ' 17' ' ' ALA . 1.9 m -58.97 -66.39 0.51 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.675 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.485 ' HB2' ' HG3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -60.49 -38.69 85.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.781 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 11.1 mmtm -60.79 -61.48 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.654 ' CB ' HG12 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -46.73 -47.96 20.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.777 -179.12 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' ' 14' ' ' LEU . 27.5 m -70.31 -10.56 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.862 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -89.15 -34.1 16.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.665 0.269 . . . . 0.0 111.214 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -89.97 -28.09 19.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.194 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.984 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -104.92 104.83 14.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.986 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.04 -26.22 64.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.065 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.402 ' CG ' ' HA ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -85.85 98.95 11.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.956 0.407 . . . . 0.0 111.268 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 93' ' ' TYR . 2.3 mp -122.84 91.23 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.294 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 1.2 tt0 -97.23 139.9 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 111.04 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.741 HG13 ' HB1' ' A' ' 90' ' ' ALA . 29.7 t -111.29 141.36 26.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.454 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.792 ' HG2' HD11 ' A' ' 7' ' ' LEU . 2.8 tt0 -105.28 62.03 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.304 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.716 ' HB2' HD13 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.79 148.45 25.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.073 0.463 . . . . 0.0 111.805 -179.213 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.74 ' H ' HD11 ' A' ' 89' ' ' LEU . 21.4 t0 -77.24 162.3 27.47 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.176 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.3 32.41 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.804 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.09 33.08 0.27 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.468 ' CB ' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -78.52 128.01 32.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.52 0.676 . . . . 0.0 110.887 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.2 ttm-85 -56.32 113.91 1.77 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.851 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 87' ' ' ARG . 29.8 p -84.43 171.49 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.777 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.77 -89.86 0.19 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.329 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -83.13 -96.31 0.05 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 110.626 -0.139 . . . . 0.0 110.626 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -77.72 59.56 2.04 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 88' ' ' TRP . . . 58.17 21.06 45.51 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.522 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.554 ' HE ' HG22 ' A' ' 22' ' ' THR . 54.0 mmt-85 -15.04 123.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.11 0.564 . . . . 0.0 112.239 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.643 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 98.8 m95 -126.36 145.46 50.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.601 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.785 ' HB2' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -77.34 156.21 31.44 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.303 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.741 ' HB1' HG13 ' A' ' 74' ' ' VAL . . . 176.63 160.19 0.35 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.24 0.543 . . . . 0.0 112.212 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.431 ' C ' HD12 ' A' ' 92' ' ' ILE . 3.7 m-85 -108.91 -35.44 6.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.719 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.576 HG12 HD11 ' A' ' 25' ' ' LEU . 3.2 mp 59.44 122.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.956 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.495 ' OH ' ' HB3' ' A' ' 73' ' ' GLU . 4.3 p90 -144.65 142.85 30.42 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.113 0.482 . . . . 0.0 111.635 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.984 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -113.35 120.67 41.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.656 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.402 ' HA ' ' CG ' ' A' ' 71' ' ' LYS . 0.7 OUTLIER 76.14 27.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.109 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.46 -15.33 54.93 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.117 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.543 ' HD2' ' HB2' ' A' ' 102' ' ' ALA . 35.8 pttt -109.85 131.08 55.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.858 0.329 . . . . 0.0 110.986 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.426 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 6.2 mtt -72.01 140.69 49.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.736 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.821 HG11 ' HA ' ' A' ' 62' ' ' THR . 27.9 m -47.39 -37.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.937 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 110' ' ' LYS . 11.6 p-10 -79.21 -33.17 44.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.199 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 110' ' ' LYS . 0.8 OUTLIER -58.02 -54.75 43.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.039 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.543 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . . . -78.94 -3.01 42.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.626 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.747 ' HG ' HD13 ' A' ' 108' ' ' LEU . 5.9 tp -55.18 -28.61 54.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.808 0.337 . . . . 0.0 110.975 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.69 HG13 ' O ' ' A' ' 110' ' ' LYS . 0.6 OUTLIER -49.65 -11.37 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.456 ' C ' ' O ' ' A' ' 104' ' ' VAL . 5.3 ptm180 -24.78 -48.44 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.512 ' OE1' HD12 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -121.34 -3.48 9.44 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.19 30.43 0.86 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.839 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.747 HD13 ' HG ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -88.27 -179.94 6.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.104 0.478 . . . . 0.0 111.247 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 41' ' ' THR . . . -51.34 150.13 3.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.03 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.69 ' O ' HG13 ' A' ' 104' ' ' VAL . 14.8 mmtt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.908 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.836 0.35 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.21 131.99 56.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.953 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -70.34 106.08 3.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 p -105.48 115.03 29.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.33 108.02 10.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.821 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.45 110.86 18.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.903 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.761 HD11 ' HG2' ' A' ' 75' ' ' GLU . 3.3 pp -91.84 153.15 19.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.838 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -93.85 158.08 15.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.87 121.48 35.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.678 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -135.1 113.93 11.58 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 83.1 Cg_endo -83.37 154.15 14.08 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.721 2.281 . . . . 0.0 112.26 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.857 ' CB ' HD13 ' A' ' 25' ' ' LEU . . . -166.23 157.31 13.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.72 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 25' ' ' LEU . 5.5 m -86.85 107.55 18.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.028 0.442 . . . . 0.0 111.279 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 14' ' ' LEU . 0.7 OUTLIER -98.83 108.0 20.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.565 178.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.851 ' HA ' HG11 ' A' ' 66' ' ' VAL . 1.4 pp -125.62 -13.2 4.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -113.29 123.04 49.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.09 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -112.88 103.67 11.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.241 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.544 HD12 ' HB ' ' A' ' 22' ' ' THR . 34.7 mt -62.65 -82.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.079 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -118.17 41.94 2.81 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.28 -47.26 3.69 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.103 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.568 ' HA ' HD13 ' A' ' 37' ' ' LEU . 33.9 m-20 -96.37 -41.09 8.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.964 0.411 . . . . 0.0 110.024 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.544 ' HB ' HD12 ' A' ' 18' ' ' ILE . 2.1 p -82.55 106.87 14.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.787 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.698 ' HB ' HD21 ' A' ' 14' ' ' LEU . 35.1 m -121.53 155.65 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 111.718 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.9 127.42 56.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.734 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.94 HD22 HG21 ' A' ' 74' ' ' VAL . 2.0 pp -133.82 143.2 48.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.32 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.592 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -72.54 99.21 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -93.41 106.37 18.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.3 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 tttm 50.35 55.33 9.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.819 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.56 13.41 60.8 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.199 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.406 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -142.14 97.94 6.23 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.699 0.285 . . . . 0.0 110.245 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 40.8 Cg_endo -67.36 146.48 75.24 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.566 2.177 . . . . 0.0 113.01 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.3 mmt -145.36 161.2 40.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.388 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.467 HG22 HD11 ' A' ' 18' ' ' ILE . 20.2 p -91.34 126.03 36.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.485 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.834 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.2 m-85 -111.35 124.19 51.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.041 0.448 . . . . 0.0 110.892 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.539 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -108.82 98.95 8.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.165 -179.297 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.708 HD22 ' HB2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER 169.7 151.91 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.015 0.436 . . . . 0.0 111.261 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.697 HD23 ' HB3' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -179.28 39.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.609 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tp 63.64 -102.83 0.11 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.13 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.49 ' CG2' HG23 ' A' ' 41' ' ' THR . 11.3 p -142.32 139.19 29.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.899 0.38 . . . . 0.0 111.162 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.499 ' OD1' HG21 ' A' ' 104' ' ' VAL . 75.6 m-20 -137.19 62.81 1.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.961 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.661 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 59.2 p -76.77 110.79 12.79 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.738 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 12.9 Cg_exo -70.47 112.93 3.33 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.716 2.278 . . . . 0.0 112.933 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 72.04 -50.09 0.69 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.41 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.9 152.65 22.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.814 0.34 . . . . 0.0 111.343 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.09 -1.0 37.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.817 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.634 ' O ' HG21 ' A' ' 41' ' ' THR . 22.6 m170 -70.71 171.17 8.71 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.114 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.412 ' CD ' ' HB3' ' A' ' 46' ' ' HIS . 17.2 Cg_exo -67.65 47.29 0.32 Allowed 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.677 2.252 . . . . 0.0 113.077 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -128.5 96.15 4.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.684 0.278 . . . . 0.0 110.72 179.438 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.661 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 0.4 OUTLIER -83.0 -173.23 4.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.038 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 151.91 -122.28 1.31 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.403 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.6 p -121.36 86.59 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.854 0.359 . . . . 0.0 111.43 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.449 ' HB3' HD12 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -57.81 171.09 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.855 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -78.55 90.44 4.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.352 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.721 ' CZ ' ' HB2' ' A' ' 58' ' ' ALA . 27.3 p90 -135.58 -34.57 0.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.798 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.465 ' N ' ' CD1' ' A' ' 54' ' ' TYR . . . 93.78 -110.86 4.04 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.749 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.732 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 90.9 Cg_endo -89.4 -3.49 5.89 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.077 2.518 . . . . 0.0 113.763 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.908 ' HG2' HD11 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -58.04 -14.08 5.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.38 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.721 ' HB2' ' CZ ' ' A' ' 54' ' ' TYR . . . -91.39 -65.57 1.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 24.5 m -88.04 -23.59 23.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.97 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -88.91 -46.11 9.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.536 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -63.99 -49.97 70.36 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.207 0.527 . . . . 0.0 109.914 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 1.09 HG21 ' HB2' ' A' ' 17' ' ' ALA . 2.6 t -49.81 -31.71 12.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.913 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' A' ' 15' ' ' ILE . 6.9 mttm -82.71 -41.96 18.64 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.138 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -72.33 -30.43 64.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.254 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -40.62 80.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.851 HG11 ' HA ' ' A' ' 15' ' ' ILE . 9.1 p -83.14 -29.54 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.14 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.19 -9.15 59.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.519 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -111.24 -28.13 8.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.699 0.285 . . . . 0.0 111.337 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.95 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -107.92 141.52 39.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.177 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -102.02 25.41 8.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.81 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 98.8 3.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.69 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.53 ' CD1' HG23 ' A' ' 66' ' ' VAL . 3.6 mp -123.13 92.35 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 7.6 mt-10 -94.98 136.77 34.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.748 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.94 HG21 HD22 ' A' ' 25' ' ' LEU . 24.6 t -116.08 123.25 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.193 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.761 ' HG2' HD11 ' A' ' 7' ' ' LEU . 4.9 tt0 -85.57 54.51 3.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.734 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.684 ' HA ' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -95.03 164.64 12.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.127 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.681 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -99.94 162.08 13.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.843 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -92.84 30.79 1.5 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.47 31.31 0.16 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.498 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.801 ' HG3' HD12 ' A' ' 89' ' ' LEU . 34.0 mm-40 -78.54 125.57 29.55 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.524 0.678 . . . . 0.0 111.081 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -44.14 120.89 2.28 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.168 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 86' ' ' GLY . 43.5 p -101.98 171.45 7.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.04 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -134.51 -83.37 0.43 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.478 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 -86.37 0.22 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.456 0.17 . . . . 0.0 111.132 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -93.99 36.59 1.11 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.962 0.411 . . . . 0.0 110.415 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.482 ' O ' HG22 ' A' ' 82' ' ' THR . . . 109.48 -33.53 6.04 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.404 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.48 ' C ' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 27.62 54.0 0.06 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.619 0.723 . . . . 0.0 110.777 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.532 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 70.2 m95 -85.41 155.44 21.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.916 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.876 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -77.81 158.23 29.61 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.196 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.854 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 173.25 156.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.201 0.524 . . . . 0.0 111.895 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.706 ' C ' HD12 ' A' ' 92' ' ' ILE . 3.5 m-85 -112.63 -41.1 3.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.624 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.706 HD12 ' C ' ' A' ' 91' ' ' TYR . 2.8 mp 58.55 121.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.08 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 15.0 p90 -142.54 130.59 21.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.377 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.95 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -103.58 124.14 48.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.603 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 t70 74.79 27.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.864 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.21 22.34 77.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.863 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 115.38 11.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 111.046 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.428 ' CG ' ' HB3' ' A' ' 93' ' ' TYR . 4.0 mtm -72.0 129.53 38.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.515 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -35.91 34.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.863 0.364 . . . . 0.0 110.584 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.985 ' O ' HG12 ' A' ' 104' ' ' VAL . 4.3 p30 -74.36 -50.28 19.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.049 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.468 ' HA ' ' CD ' ' A' ' 105' ' ' ARG . 1.1 tm-20 -67.51 -8.93 37.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.882 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.74 -36.75 65.2 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.929 ' HG ' HD23 ' A' ' 108' ' ' LEU . 1.1 pt? -151.74 -47.36 0.11 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.985 HG12 ' O ' ' A' ' 100' ' ' ASN . 2.9 p -39.52 -26.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.468 ' CD ' ' HA ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -59.18 -44.45 92.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.114 179.604 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.52 ' NE2' ' N ' ' A' ' 108' ' ' LEU . 1.3 pm0 -92.07 -20.06 21.68 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.964 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 130.07 33.81 0.49 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.482 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.929 HD23 ' HG ' ' A' ' 103' ' ' LEU . 2.2 mt 43.58 98.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.096 0.474 . . . . 0.0 112.125 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.463 ' O ' ' CG ' ' A' ' 110' ' ' LYS . . . -58.44 150.43 22.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.772 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 5.4 pttp . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.214 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.832 0.349 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.97 90.45 3.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.878 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 t -74.94 117.35 16.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 t -95.21 128.76 42.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.826 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.1 118.7 6.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.43 112.54 13.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.81 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.652 HD21 ' HB2' ' A' ' 78' ' ' LYS . 3.1 mp -71.69 133.19 45.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.959 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.31 -49.18 6.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.627 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HE3' ' CA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER 179.37 134.95 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.997 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 74' ' ' VAL . 3.3 mp0 -115.32 131.95 23.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.684 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -87.45 125.49 2.12 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.596 2.198 . . . . 0.0 112.398 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.462 ' HB3' HD22 ' A' ' 25' ' ' LEU . . . -149.19 127.74 12.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.444 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.594 ' HA ' HD13 ' A' ' 72' ' ' ILE . 2.5 t -86.56 108.56 18.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.039 0.447 . . . . 0.0 110.727 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.691 HD11 ' HB ' ' A' ' 23' ' ' VAL . 3.2 tt -77.45 121.39 23.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.418 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.857 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -74.55 -48.6 34.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.671 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.857 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER 179.68 168.4 1.16 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.943 0.401 . . . . 0.0 111.259 179.21 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.714 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -87.27 148.13 25.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.082 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.6 mm -91.37 -69.73 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.341 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -118.13 35.93 4.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.246 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.84 ' C ' HD12 ' A' ' 38' ' ' LEU . . . 89.29 -48.5 3.4 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.65 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -96.7 -56.18 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.359 . . . . 0.0 110.616 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.516 HG23 ' HD2' ' A' ' 87' ' ' ARG . 11.4 m -70.69 106.81 3.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.501 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 34' ' ' PHE . 27.8 m -114.96 154.83 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.308 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.91 140.06 29.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.762 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.698 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -141.34 118.41 11.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.052 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.31 99.41 2.4 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.636 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 2.7 t80 -91.23 102.29 15.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.755 -178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.9 tttp 43.16 50.15 5.63 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.658 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.33 -14.33 59.66 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.563 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.636 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -118.32 97.21 50.61 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.677 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.698 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 10.7 Cg_exo -72.06 130.19 16.24 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.319 2.013 . . . . 0.0 112.97 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 6.2 mmt -124.85 157.22 36.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.16 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 p -86.67 119.54 27.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.037 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.738 ' O ' HG22 ' A' ' 23' ' ' VAL . 17.9 m-85 -111.03 107.77 17.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.652 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -94.17 109.53 21.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.31 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.731 HD22 ' HB2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER 171.03 -31.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.671 HD12 HD13 ' A' ' 92' ' ' ILE . 1.3 tt -60.61 79.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.35 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.84 HD12 ' C ' ' A' ' 20' ' ' GLY . 1.4 tt 178.45 63.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.141 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.9 109.49 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 0.0 110.686 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.428 ' HB3' HD11 ' A' ' 108' ' ' LEU . 3.2 p30 -137.71 169.72 17.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.022 0.439 . . . . 0.0 111.477 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.494 ' CB ' ' HB2' ' A' ' 48' ' ' LYS . 1.7 t -137.51 108.07 8.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.794 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.471 ' CD ' ' HA3' ' A' ' 50' ' ' GLY . 11.2 Cg_exo -73.78 120.32 6.35 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.949 2.433 . . . . 0.0 113.062 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.424 ' CB ' ' O ' ' A' ' 42' ' ' PRO . 2.3 tm-20 83.72 -51.57 0.14 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.732 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 41' ' ' THR . 0.6 OUTLIER -93.17 159.31 15.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.862 0.363 . . . . 0.0 111.095 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.32 4.65 31.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 2.3 m170 -70.79 169.12 15.57 Favored Pre-proline 0 N--CA 1.455 -0.189 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.544 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 46' ' ' HIS . 34.0 Cg_endo -65.0 64.8 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.384 2.056 . . . . 0.0 112.512 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.494 ' HB2' ' CB ' ' A' ' 41' ' ' THR . 6.1 mmpt? -101.13 168.56 9.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.329 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.414 ' CA ' ' O ' ' A' ' 40' ' ' ASP . 36.6 mtmt -123.49 9.24 9.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.386 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.471 ' HA3' ' CD ' ' A' ' 42' ' ' PRO . . . -63.48 130.09 40.31 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.08 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.493 ' O ' HG23 ' A' ' 51' ' ' VAL . 11.4 m -87.74 89.35 3.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.814 0.34 . . . . 0.0 111.337 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.99 -177.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.641 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.57 90.98 5.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.382 . . . . 0.0 111.355 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 55' ' ' GLY . 15.2 p90 -130.73 -34.64 1.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.696 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.52 ' N ' ' CD1' ' A' ' 54' ' ' TYR . . . 77.4 -110.88 3.13 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 114.462 0.545 . . . . 0.0 114.462 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.447 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 28.1 Cg_exo -38.15 -40.99 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.947 3.098 . . . . 0.0 115.136 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.622 ' O ' HD21 ' A' ' 103' ' ' LEU . 0.5 OUTLIER -45.44 -19.9 0.05 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.583 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.577 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -90.63 -65.08 1.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -87.52 -32.25 19.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.605 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -75.8 -35.12 60.16 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.534 ' CD2' HD11 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -89.98 -30.86 17.52 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.158 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.714 HG21 ' HB2' ' A' ' 17' ' ' ALA . 15.3 t -60.62 -54.56 43.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 13.3 ptmt -65.3 -43.1 92.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.373 . . . . 0.0 110.875 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -48.99 74.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.079 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.525 ' CB ' HG13 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -55.98 -30.38 61.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.139 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.689 ' HA ' ' HB2' ' A' ' 94' ' ' ALA . 32.6 m -92.5 -31.21 4.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.036 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -72.08 -5.94 38.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.657 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -95.02 -28.13 15.28 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.609 0.242 . . . . 0.0 111.598 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.033 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -107.98 151.01 26.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 111.404 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.8 ttmm -99.18 17.55 19.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.255 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.97 98.98 4.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.907 0.384 . . . . 0.0 110.797 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.698 ' CG2' HG23 ' A' ' 92' ' ' ILE . 2.4 mp -118.69 94.17 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.112 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.515 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 2.4 mt-10 -104.89 131.23 52.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.607 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 92' ' ' ILE . 31.4 m -106.28 145.46 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.894 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.401 ' CA ' ' HE3' ' A' ' 9' ' ' LYS . 14.5 tt0 -99.78 54.41 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.488 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.533 ' HB2' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -97.63 166.23 11.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.7 -179.193 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.761 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -104.3 162.53 13.13 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.969 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.652 ' HB2' HD21 ' A' ' 7' ' ' LEU . 4.5 tmtp? -92.25 23.93 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.314 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.97 20.78 0.36 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.535 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.761 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 17.0 mm-40 -78.61 128.87 34.09 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.542 0.686 . . . . 0.0 111.116 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.451 ' C ' ' O ' ' A' ' 80' ' ' GLN . 1.4 mpp_? -23.45 118.38 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.966 -1.47 . . . . 0.0 111.784 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.51 HG22 ' CE2' ' A' ' 88' ' ' TRP . 5.8 p -109.12 171.34 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.688 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 3.8 t0 -179.02 155.94 0.77 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.964 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 43.76 -101.7 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.686 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -96.94 36.33 1.43 Allowed 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 120.939 0.399 . . . . 0.0 110.762 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 82' ' ' THR . . . 104.91 -36.82 4.14 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.416 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.516 ' HD2' HG23 ' A' ' 22' ' ' THR . 0.0 OUTLIER 29.27 75.63 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.187 0.518 . . . . 0.0 111.263 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.589 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 68.2 m95 -109.96 163.23 13.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.458 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.731 ' HB2' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -81.12 154.08 26.96 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.375 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.442 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 179.13 153.21 0.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.18 0.514 . . . . 0.0 112.14 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.621 ' C ' HD12 ' A' ' 92' ' ' ILE . 28.9 m-85 -111.37 -35.08 5.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.942 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.698 HG23 ' CG2' ' A' ' 72' ' ' ILE . 3.3 mp 54.38 109.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.295 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.525 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 6.4 p90 -127.74 137.13 52.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.058 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.033 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -106.38 123.88 48.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.657 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 t70 73.65 26.17 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.84 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.33 21.91 74.42 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.828 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.14 113.96 10.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.525 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 7.5 mtt -60.47 139.1 57.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.724 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.661 HG11 ' HA ' ' A' ' 62' ' ' THR . 15.1 t -53.05 -53.31 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.05 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.68 ' O ' HG23 ' A' ' 104' ' ' VAL . 12.4 p30 -63.71 -26.42 68.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.576 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 98' ' ' MET . 0.0 OUTLIER -58.75 -30.6 67.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.932 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -91.1 -46.81 7.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.343 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.799 HD23 HD21 ' A' ' 108' ' ' LEU . 1.4 mp -49.31 -39.2 30.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.063 0.459 . . . . 0.0 111.295 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 100' ' ' ASN . 24.2 t -74.37 -1.87 3.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.962 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.4 ptt85 -42.81 -43.91 4.21 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.694 0.283 . . . . 0.0 111.551 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -121.28 0.74 10.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.417 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 110.87 31.48 2.91 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.799 HD21 HD23 ' A' ' 103' ' ' LEU . 3.1 mt 73.22 111.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.466 0.651 . . . . 0.0 111.452 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.4 139.5 40.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.166 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.966 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.891 0.377 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.4 p -124.51 118.33 26.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -77.04 127.72 33.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 t -92.54 140.44 29.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.83 139.84 36.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.564 ' C ' HD22 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -90.26 109.51 20.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.936 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.564 HD22 ' C ' ' A' ' 6' ' ' LYS . 3.4 mm? -115.03 157.07 23.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.942 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.02 -167.56 0.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.88 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.474 ' HZ1' ' HB2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -135.96 127.52 28.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.897 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.883 ' O ' HG22 ' A' ' 74' ' ' VAL . 23.9 mm-40 -122.79 154.32 63.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 85.1 Cg_endo -86.73 156.33 8.9 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.763 2.309 . . . . 0.0 112.298 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.889 ' HB1' HD13 ' A' ' 25' ' ' LEU . . . -166.27 157.34 13.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.052 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.12 108.38 19.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.779 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.627 ' CD2' HG21 ' A' ' 66' ' ' VAL . 5.7 tt -77.12 121.16 23.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.859 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.6 pp -74.83 -44.6 45.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.206 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.859 ' N ' HD12 ' A' ' 15' ' ' ILE . 9.1 tttm 179.51 163.32 0.94 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.878 0.37 . . . . 0.0 111.187 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.878 ' HB3' ' HA ' ' A' ' 59' ' ' SER . . . -91.75 145.91 24.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.331 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.4 mt -96.97 -75.27 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.548 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -117.5 42.14 2.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.519 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.775 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 84.65 -53.61 4.84 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.675 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.47 ' HA ' ' CD1' ' A' ' 37' ' ' LEU . 13.7 m-20 -96.68 -37.71 10.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 110.553 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -76.99 106.84 8.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.702 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 17' ' ' ALA . 29.1 m -127.93 152.21 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.722 0.296 . . . . 0.0 111.221 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.436 ' HG2' HG12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -113.03 131.66 55.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.211 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.889 HD13 ' HB1' ' A' ' 12' ' ' ALA . 0.5 OUTLIER -141.44 148.74 40.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.421 178.184 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.68 99.8 2.66 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.554 ' O ' ' OE1' ' A' ' 30' ' ' GLN . 24.2 t80 -88.42 111.21 21.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.314 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 38.23 38.59 0.22 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.172 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.8 -14.47 58.87 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.295 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.573 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -120.54 96.94 48.91 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.116 179.731 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 39.4 Cg_exo -61.5 127.34 21.51 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.53 2.154 . . . . 0.0 112.552 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.562 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -133.04 161.84 33.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.709 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 88' ' ' TRP . 55.5 m -92.8 156.98 16.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.836 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 10.6 m-85 -143.14 136.04 27.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.649 0.262 . . . . 0.0 111.611 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 87' ' ' ARG . 7.7 ttm180 -139.56 115.21 10.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.934 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 20.2 tp 167.21 -64.58 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.626 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.795 HD23 ' HB2' ' A' ' 100' ' ' ASN . 2.7 mp 64.18 -83.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.119 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.426 ' HG ' ' CE2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -177.58 -76.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.717 0.294 . . . . 0.0 111.024 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.553 HG12 HG22 ' A' ' 41' ' ' THR . 1.4 t -141.84 123.65 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.991 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.728 ' HB3' HG22 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -115.9 34.1 5.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.281 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 44' ' ' THR . 2.6 t -76.9 123.49 87.43 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.516 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.507 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 13.2 Cg_exo -69.1 112.47 2.97 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.304 2.003 . . . . 0.0 112.257 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.59 -46.02 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.568 ' O ' HG23 ' A' ' 41' ' ' THR . 0.2 OUTLIER -72.35 174.98 6.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.94 0.4 . . . . 0.0 111.417 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -128.12 15.64 6.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.882 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.452 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 1.8 m170 -95.12 168.69 10.62 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.445 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HD2' ' CB ' ' A' ' 46' ' ' HIS . 2.0 Cg_endo -45.1 90.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.741 2.294 . . . . 0.0 112.181 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.414 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -44.52 167.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.44 0.638 . . . . 0.0 112.219 -179.443 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.84 -37.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.531 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.456 ' O ' ' CG ' ' A' ' 42' ' ' PRO . . . -134.17 114.97 1.39 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.023 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.728 HG22 ' HB3' ' A' ' 40' ' ' ASP . 9.1 t -69.5 147.98 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.101 0.477 . . . . 0.0 111.206 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.507 ' N ' ' HG3' ' A' ' 42' ' ' PRO . 0.6 OUTLIER -57.85 167.16 1.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.479 -179.127 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.47 90.8 5.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.495 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.764 ' CE2' HD13 ' A' ' 108' ' ' LEU . 12.5 p90 -124.29 -34.76 2.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.197 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.521 ' N ' ' CD1' ' A' ' 54' ' ' TYR . . . 84.41 -107.1 2.97 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.701 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.524 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 24.6 Cg_exo -38.41 -42.83 1.77 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.917 3.078 . . . . 0.0 114.983 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.596 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 1.6 tp10 -47.41 -17.44 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.775 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -90.5 -63.16 1.31 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.878 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 37.3 m -92.79 -43.89 8.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.379 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 56' ' ' PRO . . . -62.93 -31.96 73.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.575 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.596 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 3.3 t80 -88.83 -44.25 10.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.371 . . . . 0.0 110.997 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.723 HG21 ' HB2' ' A' ' 17' ' ' ALA . 3.0 m -60.15 -66.28 0.55 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.757 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -55.44 -23.48 25.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.516 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -83.6 -54.7 4.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 111.5 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 mmt -47.69 -27.62 2.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.662 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.627 HG21 ' CD2' ' A' ' 14' ' ' LEU . 27.2 m -94.02 -19.05 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.34 -25.24 39.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.535 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -97.29 -28.3 14.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.399 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.634 ' O ' HD11 ' A' ' 72' ' ' ILE . . . -108.2 108.07 18.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.143 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -15.49 52.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.877 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.418 ' HG3' ' HA ' ' A' ' 95' ' ' ASP . 2.8 ptpt -91.8 101.71 14.31 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.383 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.891 HG23 ' O ' ' A' ' 93' ' ' TYR . 3.3 mp -134.88 99.14 2.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.255 0.55 . . . . 0.0 110.997 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 2.2 mt-10 -93.26 179.59 5.37 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.649 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.883 HG22 ' O ' ' A' ' 10' ' ' GLU . 31.3 m -145.22 139.67 22.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.977 0.418 . . . . 0.0 111.528 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.474 ' HB2' ' HZ1' ' A' ' 9' ' ' LYS . 5.1 tp10 -106.49 41.34 1.45 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.181 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -92.76 160.45 14.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.662 -179.154 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.707 ' H ' HD11 ' A' ' 89' ' ' LEU . 8.2 t0 -90.92 152.59 20.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.081 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.28 31.3 2.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.154 0.502 . . . . 0.0 110.347 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.02 38.5 0.64 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.825 ' HB2' HD12 ' A' ' 89' ' ' LEU . 1.3 tp60 -78.11 126.84 31.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.929 -0.636 . . . . 0.0 110.642 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.24 79.22 0.05 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.792 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.949 HG21 ' CG ' ' A' ' 88' ' ' TRP . 0.1 OUTLIER -102.0 171.28 7.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.009 -178.69 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.2 -36.21 13.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.342 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.473 ' O ' ' CD2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER 177.14 -31.42 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.473 ' CD2' ' O ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER 163.38 -23.16 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 110.502 -0.185 . . . . 0.0 110.502 -179.522 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -44.46 -24.75 0.68 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.851 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.849 ' O ' HG22 ' A' ' 82' ' ' THR . 0.2 OUTLIER -175.84 130.06 0.25 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.807 0.337 . . . . 0.0 110.908 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.949 ' CG ' HG21 ' A' ' 82' ' ' THR . 20.9 m95 -126.95 169.81 12.92 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.53 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.911 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -82.82 152.09 25.79 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.62 ' N ' HD22 ' A' ' 89' ' ' LEU . . . -178.26 162.2 1.52 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.362 0.601 . . . . 0.0 112.432 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 37' ' ' LEU . 3.5 m-85 -117.15 -17.52 10.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.646 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.737 HD13 ' HG ' ' A' ' 37' ' ' LEU . 5.3 mp 64.31 158.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.843 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.891 ' O ' HG23 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -151.13 134.12 15.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.752 -178.725 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -134.72 105.19 6.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.863 0.363 . . . . 0.0 111.496 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.418 ' HA ' ' HG3' ' A' ' 71' ' ' LYS . 14.7 t0 54.51 43.8 29.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.748 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.28 -22.41 23.45 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.13 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -116.41 127.72 54.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.89 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.53 148.9 49.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.891 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -56.75 -35.71 46.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.303 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.919 ' O ' HG22 ' A' ' 104' ' ' VAL . 11.6 t30 -78.95 -50.1 11.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.053 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -47.9 -28.3 2.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.569 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -91.02 -56.58 3.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.504 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.86 HD23 HD21 ' A' ' 108' ' ' LEU . 2.8 mp -44.83 -51.01 9.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.89 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 100' ' ' ASN . 14.7 m -67.11 -2.09 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.437 ' HG3' ' HG3' ' A' ' 106' ' ' GLN . 10.9 ptm180 -36.79 -46.04 0.58 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.81 0.338 . . . . 0.0 111.715 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.437 ' HG3' ' HG3' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -121.23 -0.18 9.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.254 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.6 28.68 2.05 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.86 HD21 HD23 ' A' ' 103' ' ' LEU . 1.6 mt 72.99 105.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.346 0.593 . . . . 0.0 111.371 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.94 150.08 25.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.286 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.5 mptt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.917 179.981 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.806 0.336 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.7 t -114.0 99.75 7.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.2 p -101.06 121.35 41.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.943 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.4 p -64.99 138.33 58.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.808 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -97.63 112.73 24.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.021 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.68 109.66 5.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.808 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -105.39 118.08 35.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -96.68 -28.38 14.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.667 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 75' ' ' GLU . 1.2 mmpp? -131.22 121.18 24.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.786 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.471 ' HG2' ' CE2' ' A' ' 27' ' ' TYR . 0.6 OUTLIER -132.32 125.83 20.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.065 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -84.52 146.43 10.83 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.67 2.246 . . . . 0.0 112.502 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.673 ' CB ' HD21 ' A' ' 25' ' ' LEU . . . -166.37 173.06 10.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.94 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.26 108.57 15.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.021 0.439 . . . . 0.0 111.246 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.651 HD11 ' HB ' ' A' ' 23' ' ' VAL . 3.7 tt -86.83 120.84 28.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.055 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.738 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.7 pp -75.55 -46.41 37.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.513 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.738 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER 179.98 173.11 0.99 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.176 0.512 . . . . 0.0 111.87 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.88 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -94.78 148.3 22.43 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.677 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.735 HD12 ' O ' ' A' ' 22' ' ' THR . 2.0 mp -101.8 -70.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.681 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.65 42.14 1.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.318 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.456 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 83.68 -54.32 4.94 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.547 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -96.8 -49.37 5.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.751 0.31 . . . . 0.0 110.296 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.735 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -63.84 106.68 1.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.23 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.651 ' HB ' HD11 ' A' ' 14' ' ' LEU . 30.2 m -122.59 142.43 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.485 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -87.99 124.71 34.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.673 HD21 ' CB ' ' A' ' 12' ' ' ALA . 1.3 tt -141.52 121.89 14.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.77 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.601 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 15.0 ptp -72.48 102.46 3.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.326 0.584 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.471 ' CE2' ' HG2' ' A' ' 10' ' ' GLU . 10.5 t80 -88.72 109.65 20.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.285 -178.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.91 46.52 18.85 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.602 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.9 -6.61 65.74 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.687 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.453 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -124.59 98.47 37.45 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.563 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 17.3 Cg_exo -68.87 143.71 56.26 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.985 2.457 . . . . 0.0 114.245 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.475 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 2.3 mtt -145.36 148.54 33.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.028 -1.442 . . . . 0.0 108.255 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.552 ' CG2' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -87.48 157.29 19.23 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.506 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.587 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 5.0 m-85 -140.8 149.39 41.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.075 0.464 . . . . 0.0 111.712 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 88' ' ' TRP . 0.3 OUTLIER -117.65 97.87 6.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.886 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.759 ' C ' HD13 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -56.77 159.54 3.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.314 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.847 HD11 ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -133.66 -178.56 5.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.797 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 63.46 38.66 9.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.038 HG11 HG12 ' A' ' 51' ' ' VAL . 13.2 t -104.38 160.3 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.478 ' N ' HG12 ' A' ' 39' ' ' VAL . 0.6 OUTLIER -66.59 179.49 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.974 0.416 . . . . 0.0 111.361 -179.534 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 5.9 t -105.97 143.16 26.35 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.906 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.45 ' CD ' ' HB3' ' A' ' 49' ' ' LYS . 4.6 Cg_exo -76.38 112.34 3.45 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.397 2.065 . . . . 0.0 111.808 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 76.63 -41.6 0.41 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.437 ' HB ' HG21 ' A' ' 41' ' ' THR . 0.2 OUTLIER -68.55 -178.94 1.23 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.76 0.314 . . . . 0.0 111.351 -179.489 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.405 ' H ' HG22 ' A' ' 44' ' ' THR . 3.0 mmmt -108.11 -41.01 5.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.032 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.425 ' O ' ' HB ' ' A' ' 41' ' ' THR . 0.4 OUTLIER -70.54 125.62 92.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.417 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.97 45.14 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.646 2.231 . . . . 0.0 114.016 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.95 95.81 4.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.572 0.225 . . . . 0.0 110.834 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.45 ' HB3' ' CD ' ' A' ' 42' ' ' PRO . 0.0 OUTLIER 171.15 42.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.95 0.405 . . . . 0.0 110.727 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 61.75 -123.78 32.61 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.619 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.038 HG12 HG11 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -117.87 148.19 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 111.376 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.46 ' O ' ' CE1' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -66.86 152.29 45.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.151 179.404 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.58 90.63 6.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.719 0.295 . . . . 0.0 110.84 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.661 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 1.1 p90 -119.88 -35.75 3.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.899 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.19 -86.5 0.78 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.624 -0.798 . . . . 0.0 115.059 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.766 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 90.7 Cg_exo -49.37 -54.52 5.33 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.431 2.754 . . . . 0.0 115.711 -177.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.661 ' HB3' ' CE2' ' A' ' 54' ' ' TYR . 13.9 tm-20 -60.23 -23.51 64.11 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.783 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.456 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -91.06 -57.17 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.609 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 28.5 m -82.73 -31.34 28.5 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -86.63 -53.22 5.08 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.541 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -61.54 -27.87 68.92 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.001 0.429 . . . . 0.0 110.958 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.88 HG21 ' HB2' ' A' ' 17' ' ' ALA . 1.1 m -63.73 -57.48 9.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.033 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.462 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -82.95 -36.14 25.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.591 -179.308 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 60' ' ' ALA . 28.6 ttpt -63.2 -49.44 74.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.426 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.505 ' CB ' HG12 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -58.25 -31.49 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 0.0 111.055 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.487 HG12 HG12 ' A' ' 72' ' ' ILE . 25.0 m -89.81 -29.3 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.178 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -53.28 -25.48 14.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.343 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -106.02 -28.17 10.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 111.404 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.918 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -92.43 130.93 37.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.08 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -96.51 28.17 3.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.62 98.93 3.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.114 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.487 HG12 HG12 ' A' ' 66' ' ' VAL . 3.0 mt -120.97 95.26 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.392 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 1.9 mt-10 -94.61 160.35 14.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.77 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.713 HG12 ' HB3' ' A' ' 76' ' ' PHE . 56.0 t -132.08 114.99 25.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.084 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.425 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 2.3 tm-20 -79.96 53.73 1.74 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.407 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.713 ' HB3' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -97.48 164.63 12.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.112 0.482 . . . . 0.0 112.026 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -104.26 162.51 13.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.087 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.636 ' HB2' HD11 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -96.58 31.76 2.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.681 179.656 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.5 32.16 0.31 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.956 ' HG3' HD12 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -78.5 127.97 32.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.6 0.714 . . . . 0.0 111.062 -179.117 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -67.63 84.29 0.19 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.919 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.574 HG21 ' NE1' ' A' ' 88' ' ' TRP . 10.2 t -106.23 163.14 13.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.87 -69.35 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -129.58 -66.41 0.8 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.807 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -162.04 24.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.806 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.547 ' C ' ' HD3' ' A' ' 87' ' ' ARG . . . -136.34 -5.22 2.09 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 119.802 -1.19 . . . . 0.0 114.143 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.547 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -114.68 42.88 2.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.487 0.661 . . . . 0.0 111.453 -178.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.587 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 66.4 m95 -80.8 150.67 29.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.089 178.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.958 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -76.7 155.68 33.12 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.994 -0.683 . . . . 0.0 109.999 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.685 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 172.86 160.33 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.252 0.549 . . . . 0.0 111.794 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -112.31 -37.52 4.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.063 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.566 HG21 HD13 ' A' ' 14' ' ' LEU . 2.6 mp 60.12 127.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.738 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.45 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 8.9 p90 -149.07 141.46 24.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 111.321 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.918 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -111.31 119.08 37.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.491 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 76.38 20.11 1.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.071 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.93 -19.88 53.02 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.147 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.471 ' HG3' ' HE1' ' A' ' 65' ' ' MET . 0.0 OUTLIER -104.21 128.71 51.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.893 0.378 . . . . 0.0 111.426 -179.67 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.423 ' HB2' ' CB ' ' A' ' 101' ' ' GLU . 16.0 mtt -68.41 150.21 48.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.505 HG12 ' CB ' ' A' ' 65' ' ' MET . 33.2 m -77.78 -45.4 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.599 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.619 ' O ' HG13 ' A' ' 104' ' ' VAL . 9.9 t-20 -80.5 -33.96 36.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.238 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.423 ' CB ' ' HB2' ' A' ' 98' ' ' MET . 0.6 OUTLIER -71.47 -8.78 56.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.649 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.17 -67.88 0.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.77 ' HB3' HD23 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -55.86 -26.63 47.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.892 -179.016 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 100' ' ' ASN . 17.1 m -66.53 -5.71 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.96 -44.05 4.44 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.09 10.89 10.83 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.89 26.78 4.28 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.653 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.77 HD23 ' HB3' ' A' ' 103' ' ' LEU . 11.6 mt 62.57 106.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.059 0.456 . . . . 0.0 111.368 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.437 ' H ' HD12 ' A' ' 103' ' ' LEU . . . -62.59 113.19 2.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.088 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.7 pttt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.832 179.949 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.722 0.296 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.8 m -134.11 89.47 2.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.858 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.87 141.71 58.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 4' ' ' THR . 4.7 t -107.73 106.34 16.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -102.03 139.11 38.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.931 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -104.51 108.98 20.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.85 139.6 33.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.83 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.68 175.09 5.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.95 119.49 39.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.926 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -134.36 113.96 12.35 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.799 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 92.6 Cg_endo -85.67 147.49 9.63 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.713 2.275 . . . . 0.0 112.467 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.699 ' CB ' HD13 ' A' ' 25' ' ' LEU . . . -166.02 162.13 17.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.759 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.458 HG23 HD13 ' A' ' 72' ' ' ILE . 1.4 m -104.46 108.58 20.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.926 0.393 . . . . 0.0 111.258 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.856 HD11 ' HA ' ' A' ' 63' ' ' LYS . 2.4 pp -65.18 133.33 51.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.47 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.883 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.7 pp -74.67 -42.32 47.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.42 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.883 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER 179.47 170.66 1.02 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.597 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.466 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -92.92 148.17 22.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.753 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.2 mt -106.36 -74.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.391 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -118.02 42.15 2.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.824 0.345 . . . . 0.0 111.312 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.3 -56.81 5.04 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.373 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.8 -32.29 12.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.352 . . . . 0.0 110.377 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -77.21 109.86 11.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.556 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 34' ' ' PHE . 33.6 m -131.82 155.78 41.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 3.2 ttpp -119.29 135.3 54.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.803 0.335 . . . . 0.0 111.335 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.893 ' HG ' ' CE1' ' A' ' 34' ' ' PHE . 2.8 pp -141.89 146.32 35.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.303 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.553 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 6.0 ttm -72.2 101.67 2.87 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.839 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.451 ' CE1' ' CZ ' ' A' ' 76' ' ' PHE . 76.8 t80 -88.81 109.24 20.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.667 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 30' ' ' GLN . 0.1 OUTLIER 49.03 27.52 1.72 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.716 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.72 -14.55 53.28 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.608 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -116.82 98.36 51.77 Favored Pre-proline 0 C--N 1.332 -0.174 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 31.7 Cg_exo -59.44 145.9 96.59 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.377 2.052 . . . . 0.0 112.814 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.466 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 41.5 mtt -145.08 162.03 37.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.006 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -90.31 156.2 18.44 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.893 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 29.0 m-85 -142.63 121.87 13.03 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.768 0.318 . . . . 0.0 111.218 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.729 ' HB3' ' HD3' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -125.82 97.81 5.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.098 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.703 HD13 ' HB2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -178.67 161.92 1.33 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.665 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 36' ' ' LEU . 1.3 tp 164.97 -34.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.51 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mp 63.87 50.16 2.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.498 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 39' ' ' VAL . 28.0 m -130.93 112.61 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.45 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -127.86 -47.3 1.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.428 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.439 HG22 ' HD2' ' A' ' 42' ' ' PRO . 3.2 m -104.58 142.85 25.5 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.166 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.439 ' HD2' HG22 ' A' ' 41' ' ' THR . 45.1 Cg_endo -86.62 112.46 1.03 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.562 2.174 . . . . 0.0 113.144 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 72.95 -13.88 0.64 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.37 156.25 21.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.911 0.386 . . . . 0.0 111.455 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -92.75 -29.62 15.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.524 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.582 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 4.0 m170 -70.64 171.47 8.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.813 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 46' ' ' HIS . 99.7 Cg_exo -44.64 163.34 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.282 1.988 . . . . 0.0 112.695 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.438 ' HA ' HG23 ' A' ' 41' ' ' THR . 0.1 OUTLIER -37.96 142.02 0.18 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.834 -179.39 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -99.07 -50.03 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.931 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 172.15 -35.19 0.14 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.058 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.402 ' O ' ' HG3' ' A' ' 42' ' ' PRO . 2.5 m -121.57 79.14 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.873 0.368 . . . . 0.0 111.289 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.05 -178.09 3.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.522 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.75 94.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.779 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.41 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 0.3 OUTLIER -71.8 -33.99 69.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.879 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 143.08 -57.47 0.55 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.036 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.606 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 48.0 Cg_exo -56.15 -21.99 37.89 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.57 2.18 . . . . 0.0 112.299 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.523 ' HG3' HD22 ' A' ' 108' ' ' LEU . 62.9 mm-40 -94.53 -33.23 13.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.617 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.15 -48.53 6.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.781 0.324 . . . . 0.0 111.72 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.403 ' HA ' ' CB ' ' A' ' 17' ' ' ALA . 13.2 m -87.45 -61.48 1.71 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.777 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 56' ' ' PRO . . . -59.22 -37.27 77.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.614 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.452 ' CD2' ' HG2' ' A' ' 65' ' ' MET . 0.5 OUTLIER -77.37 -25.63 51.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.957 0.408 . . . . 0.0 110.644 179.647 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.696 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.8 OUTLIER -58.05 -66.32 0.5 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.947 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.856 ' HA ' HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -67.45 -32.35 73.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.646 0.26 . . . . 0.0 111.589 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -64.89 -52.89 54.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.735 0.303 . . . . 0.0 111.323 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.586 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 26.0 mmt -54.85 -27.99 46.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.228 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.84 HG13 HG12 ' A' ' 72' ' ' ILE . 18.5 t -79.05 -39.58 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.152 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -60.79 -21.66 63.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.341 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -104.6 -28.06 11.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.288 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.027 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -108.06 115.52 30.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 0.0 111.172 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.488 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -70.59 -23.67 62.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.884 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.87 111.34 20.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 111.214 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.84 HG12 HG13 ' A' ' 66' ' ' VAL . 2.9 mp -136.6 93.32 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.389 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.563 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 3.9 mt-10 -105.26 128.8 53.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.74 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.797 HG21 ' CD2' ' A' ' 25' ' ' LEU . 22.0 t -103.16 123.28 56.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.448 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.74 50.74 2.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.251 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.575 ' HB3' HG12 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -92.77 148.89 21.67 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.212 -179.289 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.627 ' H ' HD11 ' A' ' 89' ' ' LEU . 7.3 t70 -73.85 156.4 37.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.225 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.48 32.52 2.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.171 0.51 . . . . 0.0 110.374 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.64 36.19 0.47 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.602 ' CB ' HD12 ' A' ' 89' ' ' LEU . 0.6 OUTLIER -78.17 128.24 33.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.622 0.725 . . . . 0.0 110.657 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -65.38 77.39 0.06 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.72 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.622 HG21 ' NE1' ' A' ' 88' ' ' TRP . 12.7 t -83.8 160.26 21.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.154 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -91.93 49.42 1.54 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.678 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.444 ' O ' ' CB ' ' A' ' 85' ' ' TYR . 7.5 tttm 77.97 32.94 0.36 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.462 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.444 ' CB ' ' O ' ' A' ' 84' ' ' LYS . 36.5 m-85 88.73 -9.39 0.47 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.601 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.31 -16.26 41.73 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.4 -0.905 . . . . 0.0 111.654 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.729 ' HD3' ' HB3' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -177.31 131.25 0.17 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.085 0.469 . . . . 0.0 111.197 179.734 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.71 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 19.2 m95 -127.64 171.35 11.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.391 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.835 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -90.94 157.49 17.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.814 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.694 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 170.91 164.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.264 0.555 . . . . 0.0 112.077 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.577 ' C ' HD12 ' A' ' 92' ' ' ILE . 4.2 m-85 -114.24 -48.13 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.088 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.577 HD12 ' C ' ' A' ' 91' ' ' TYR . 3.2 mp 61.85 129.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.301 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.563 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 9.4 p90 -151.19 140.62 21.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.105 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.027 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -113.03 122.43 47.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.524 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.9 t70 78.8 33.48 0.26 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.629 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.86 20.55 62.27 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.826 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.458 ' HD3' ' HB2' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -137.13 109.97 7.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.9 0.381 . . . . 0.0 111.096 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.413 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -59.64 147.26 38.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.848 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -52.41 -33.2 17.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.974 0.416 . . . . 0.0 110.542 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.48 ' HA ' HG23 ' A' ' 104' ' ' VAL . 3.0 m-80 -80.57 -36.79 32.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.873 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -24.81 62.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.711 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.458 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . . . -91.35 -22.51 20.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.501 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.62 ' HB3' HD23 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -117.95 -66.32 1.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.806 0.336 . . . . 0.0 111.21 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.48 HG23 ' HA ' ' A' ' 100' ' ' ASN . 40.7 t -54.85 -13.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.062 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -30.82 -44.48 0.06 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.25 -4.26 9.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.513 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.81 30.28 0.97 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.193 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.62 HD23 ' HB3' ' A' ' 103' ' ' LEU . 14.0 mt 63.27 107.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.183 0.516 . . . . 0.0 111.264 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.12 136.55 37.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.196 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.789 0.328 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.6 p -108.03 137.41 46.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -90.05 124.76 35.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 m -81.32 138.07 35.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.83 120.14 29.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 112.11 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.698 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.477 HD22 ' HG3' ' A' ' 75' ' ' GLU . 1.3 pp -119.92 157.1 29.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -110.63 6.26 21.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.362 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.445 ' HA ' ' CE ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 62.52 146.2 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.794 0.33 . . . . 0.0 111.185 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.895 ' O ' HG12 ' A' ' 74' ' ' VAL . 22.5 mm-40 -155.04 113.99 2.34 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.295 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -88.44 104.77 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.718 2.279 . . . . 0.0 112.003 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.64 155.58 27.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.01 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 26' ' ' MET . 87.6 m -89.01 108.26 19.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.133 0.492 . . . . 0.0 111.151 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.817 HD22 ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -79.49 111.58 15.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.024 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.818 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -75.1 -46.18 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.248 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.818 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -177.29 173.14 1.79 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.006 0.432 . . . . 0.0 111.594 179.643 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.817 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -102.7 148.31 25.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.876 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mt -97.53 -72.91 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.639 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -118.09 41.91 2.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.713 0.292 . . . . 0.0 111.646 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.748 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 84.21 -52.41 4.71 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.736 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.53 -55.23 2.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 110.331 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.573 HG22 HG21 ' A' ' 33' ' ' THR . 4.0 m -68.55 106.87 2.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.148 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 17' ' ' ALA . 33.0 m -126.08 160.2 33.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.248 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.492 ' O ' HD13 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -95.73 142.4 28.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.662 179.644 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.817 ' HG ' HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -141.42 118.0 10.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.958 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.53 ' HB2' ' HB ' ' A' ' 13' ' ' THR . 3.8 mtt -72.22 99.29 2.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.572 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 5.3 t80 -96.47 104.74 16.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.192 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 38.67 52.72 1.87 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.34 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.34 -14.57 60.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.931 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.572 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -120.75 97.08 48.63 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.38 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 6.7 Cg_exo -75.52 101.87 1.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.677 2.251 . . . . 0.0 113.101 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.436 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 2.5 mtt -98.49 149.2 22.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.863 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.632 ' HB ' ' HA ' ' A' ' 87' ' ' ARG . 5.8 m -77.95 158.9 29.15 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.551 ' HA ' ' H ' ' A' ' 88' ' ' TRP . 72.4 m-85 -143.11 132.08 22.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.862 0.363 . . . . 0.0 110.833 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.467 ' HB3' ' HD3' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -133.68 114.47 13.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.376 -178.791 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER 170.37 -76.21 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.469 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.53 HD22 ' CG2' ' A' ' 99' ' ' VAL . 4.5 mt 53.32 -86.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.237 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -133.12 98.39 4.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.323 . . . . 0.0 110.672 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 39' ' ' VAL . 9.6 p -61.77 109.93 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.867 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.77 ' HB2' HG13 ' A' ' 51' ' ' VAL . 2.6 m-20 -136.01 -172.74 3.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 48' ' ' LYS . 1.2 t -124.53 114.88 27.08 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.153 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.546 ' HB3' ' HB3' ' A' ' 52' ' ' GLU . 22.5 Cg_exo -65.19 112.37 2.05 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.465 2.11 . . . . 0.0 112.228 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 68.71 -49.97 0.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.02 169.05 18.78 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.957 0.408 . . . . 0.0 111.384 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.404 ' HA ' HG21 ' A' ' 41' ' ' THR . 0.9 OUTLIER -119.68 -18.41 8.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.035 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.82 171.15 8.87 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.886 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -45.35 91.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.778 2.319 . . . . 0.0 112.855 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.429 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 0.8 OUTLIER -127.96 167.34 16.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.318 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.546 ' HG3' HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -133.87 148.24 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.973 0.416 . . . . 0.0 111.608 -179.394 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 42' ' ' PRO . . . 61.35 125.3 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.805 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.77 HG13 ' HB2' ' A' ' 40' ' ' ASP . 0.6 OUTLIER -70.66 162.16 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.965 0.412 . . . . 0.0 111.142 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -57.83 169.81 0.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.18 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.35 96.78 10.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.555 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.582 ' CD2' HD22 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -94.21 -35.97 12.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.527 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.06 -75.78 0.45 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.45 -0.881 . . . . 0.0 114.132 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.755 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 82.5 Cg_exo -49.69 -53.31 7.26 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.992 2.462 . . . . 0.0 114.111 -178.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.831 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 2.7 tm-20 -82.62 -13.98 55.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.748 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -90.6 -65.24 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.517 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 32.5 t -93.18 -42.79 9.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.581 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.755 ' HB3' ' HA ' ' A' ' 56' ' ' PRO . . . -68.76 -29.53 67.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.874 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.831 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 4.9 t80 -90.05 -52.51 4.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.939 0.4 . . . . 0.0 111.295 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.817 HG21 ' HB2' ' A' ' 17' ' ' ALA . 16.8 m -51.79 -66.34 0.4 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.622 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -56.6 -33.31 66.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.745 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HD3' ' ND2' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -73.46 -54.46 8.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.762 0.315 . . . . 0.0 111.644 -179.316 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.592 ' SD ' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -51.49 -27.0 9.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.8 -179.424 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.639 HG12 HG12 ' A' ' 72' ' ' ILE . 33.6 m -99.01 -9.9 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -26.83 25.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.667 0.27 . . . . 0.0 111.305 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.4 ' ND2' ' HD3' ' A' ' 64' ' ' LYS . 25.3 p30 -103.63 -28.04 11.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.349 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -94.26 134.34 36.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.293 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -96.38 28.73 3.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.825 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.67 99.29 3.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.886 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.639 HG12 HG12 ' A' ' 66' ' ' VAL . 2.2 mp -130.16 91.29 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.071 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.427 ' HB3' ' OH ' ' A' ' 93' ' ' TYR . 0.7 OUTLIER -99.87 145.52 27.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.282 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.895 HG12 ' O ' ' A' ' 10' ' ' GLU . 14.8 p -119.9 128.69 75.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.257 0.551 . . . . 0.0 111.96 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.477 ' HG3' HD22 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -90.41 46.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.132 179.115 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.607 ' HB3' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -92.74 148.1 22.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.696 -178.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.511 ' H ' HD11 ' A' ' 89' ' ' LEU . 21.2 t0 -76.92 159.15 30.22 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.803 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.25 35.26 2.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.974 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.23 39.77 0.31 Allowed Glycine 0 CA--C 1.496 -1.152 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.773 ' CG ' HD12 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -78.28 138.94 38.86 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.296 1.046 . . . . 0.0 111.896 -178.258 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -66.19 69.62 0.06 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.156 -1.838 . . . . 0.0 110.615 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.887 HG21 ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -91.12 164.91 13.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.919 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.36 -43.13 11.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.644 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.502 ' O ' ' CG ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -172.03 -58.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.477 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.502 ' CG ' ' O ' ' A' ' 84' ' ' LYS . 33.4 m-85 -163.14 -10.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.04 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' A' ' 33' ' ' THR . . . -38.94 -34.54 0.29 Allowed Glycine 0 C--N 1.345 1.033 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.682 ' O ' HG22 ' A' ' 82' ' ' THR . 0.0 OUTLIER 162.88 161.24 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.493 0.663 . . . . 0.0 111.292 177.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.887 ' CD1' HG21 ' A' ' 82' ' ' THR . 12.8 m95 -126.76 172.62 10.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.162 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.828 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -76.9 161.92 28.01 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.894 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.764 ' N ' HD22 ' A' ' 89' ' ' LEU . . . -179.68 179.74 0.56 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 90' ' ' ALA . 54.3 m-85 -154.7 39.29 0.43 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.746 -1.116 . . . . 0.0 109.572 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.533 HG12 HD11 ' A' ' 25' ' ' LEU . 2.8 mp -37.99 143.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.05 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.504 ' HB3' ' HG3' ' A' ' 98' ' ' MET . 5.2 p90 -151.31 142.43 23.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.094 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.592 ' HB3' ' SD ' ' A' ' 65' ' ' MET . . . -108.81 108.82 19.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.363 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER 82.0 23.96 0.23 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.89 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.77 -38.84 2.98 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.423 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.14 133.56 34.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 111.416 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.504 ' HG3' ' HB3' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -68.96 139.43 55.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.535 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.595 HG11 ' HA ' ' A' ' 62' ' ' THR . 15.6 m -49.14 -28.57 2.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.829 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.462 ' ND2' ' OE2' ' A' ' 57' ' ' GLU . 2.0 m120 -87.68 -29.45 21.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.379 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 98' ' ' MET . 0.4 OUTLIER -58.22 -26.82 63.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.409 ' CB ' ' CE2' ' A' ' 61' ' ' PHE . . . -60.67 -67.7 0.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.352 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.842 HD11 ' HB2' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -147.75 94.71 2.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.898 0.38 . . . . 0.0 111.433 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.59 HG13 ' N ' ' A' ' 105' ' ' ARG . 8.9 p -108.93 -59.08 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.256 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.59 ' N ' HG13 ' A' ' 104' ' ' VAL . 47.1 mmm-85 -106.61 -27.85 10.6 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.488 ' OE1' ' HA ' ' A' ' 103' ' ' LEU . 0.2 OUTLIER -71.07 15.18 0.12 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.12 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 130.72 -2.61 5.67 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.1 -1.047 . . . . 0.0 114.255 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.582 HD22 ' CD2' ' A' ' 54' ' ' TYR . 5.5 mt 48.87 179.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.287 0.543 . . . . 0.0 111.81 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.842 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -102.7 137.09 41.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.069 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.869 179.917 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HE2' ' CG ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.763 0.316 . . . . 0.0 110.952 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 74' ' ' VAL . 66.0 mm-40 -121.68 136.27 25.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.771 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.02 128.45 4.37 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.597 2.198 . . . . 0.0 112.434 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.501 ' HB3' HD22 ' A' ' 25' ' ' LEU . . . -149.38 126.11 11.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.572 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.85 HG22 HD13 ' A' ' 72' ' ' ILE . 1.7 p -86.98 108.74 18.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.04 0.447 . . . . 0.0 111.556 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.825 ' HB3' HG21 ' A' ' 66' ' ' VAL . 2.3 tt -69.51 114.93 8.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.914 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.994 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.6 pp -74.96 -43.8 45.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.994 ' N ' HD12 ' A' ' 15' ' ' ILE . 1.4 ttmt -167.6 143.32 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.911 0.386 . . . . 0.0 111.901 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.846 ' HB3' ' HA ' ' A' ' 59' ' ' SER . . . -87.39 148.21 25.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.518 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.3 mt -102.52 -76.07 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.21 30.67 7.1 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.622 0.231 . . . . 0.0 111.622 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.766 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 90.4 -45.0 2.93 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.736 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -96.64 -66.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.745 0.307 . . . . 0.0 110.419 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 m -66.75 106.84 1.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.013 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 17' ' ' ALA . 34.3 m -133.17 150.53 32.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.479 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.496 ' HG2' HG12 ' A' ' 15' ' ' ILE . 1.6 tppp? -80.06 143.75 33.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.332 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -140.84 117.84 11.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.216 -179.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.515 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -71.83 99.05 2.1 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.012 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 8.7 t80 -94.43 109.05 20.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.13 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.9 48.81 7.14 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.767 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.63 -14.17 48.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.9 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.465 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -119.97 97.81 49.4 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 32.2 Cg_exo -60.21 145.52 98.34 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.984 2.456 . . . . 0.0 114.052 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.416 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 29.9 mtm -145.34 140.1 27.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.101 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.451 ' C ' ' CD1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -79.89 157.02 27.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 16.6 m-85 -141.14 142.9 34.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.012 0.434 . . . . 0.0 111.913 -177.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.65 99.83 8.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.859 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.563 -179.157 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.747 ' CB ' ' HB3' ' A' ' 60' ' ' ALA . 2.9 Cg_endo . . . . . 0 CA--C 1.535 0.531 0 N-CA-C 116.215 1.583 . . . . 0.0 116.215 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.565 ' HA ' ' CB ' ' A' ' 61' ' ' PHE . 4.4 tp10 -43.13 -25.56 0.12 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.766 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -91.41 -65.37 1.02 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.846 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 4.0 m -88.18 -30.33 19.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.747 ' HB3' ' CB ' ' A' ' 56' ' ' PRO . . . -89.45 -37.64 14.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.565 ' CB ' ' HA ' ' A' ' 57' ' ' GLU . 10.4 t80 -90.68 -43.49 10.1 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.665 HG22 HD13 ' A' ' 14' ' ' LEU . 21.3 m -40.85 -66.92 0.28 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 16' ' ' LYS . 0.6 OUTLIER -74.19 -19.85 60.4 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 3.1 mttp -59.09 -54.59 45.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 111.125 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.504 ' HE2' ' HG3' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -58.89 -27.49 65.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.03 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.825 HG21 ' HB3' ' A' ' 14' ' ' LEU . 42.7 t -72.44 -30.99 36.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.106 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -86.68 -13.99 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.555 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -96.2 -28.34 14.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.684 0.278 . . . . 0.0 111.291 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.739 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -108.22 147.52 31.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.805 0.336 . . . . 0.0 111.168 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.5 pttt -97.73 24.48 6.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.401 ' HG3' ' HA ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -145.4 98.98 3.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.819 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.85 HD13 HG22 ' A' ' 13' ' ' THR . 2.5 mp -121.84 93.76 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.733 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.439 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.8 tt0 -106.56 132.75 52.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.798 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.672 ' HB ' ' HB1' ' A' ' 90' ' ' ALA . 32.6 m -103.66 126.87 58.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.15 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.407 ' CG ' ' HE2' ' A' ' 9' ' ' LYS . 1.8 tt0 -79.9 52.63 1.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.322 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.784 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -97.01 149.73 21.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.649 -179.11 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.77 ' H ' HD11 ' A' ' 89' ' ' LEU . 8.6 t70 -80.03 159.77 26.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.888 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.5 29.98 3.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.091 0.472 . . . . 0.0 110.452 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.77 35.93 0.58 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.529 ' HB2' HD12 ' A' ' 89' ' ' LEU . 2.0 tp60 -78.27 124.52 28.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.405 0.622 . . . . 0.0 110.707 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -67.53 88.29 0.22 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.957 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.0 m . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.951 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.59 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 78.3 m95 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.87 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -76.93 158.76 30.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.672 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . 173.02 164.61 0.13 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.263 0.554 . . . . 0.0 112.342 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -130.35 57.09 1.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.989 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.601 HG13 HG12 ' A' ' 74' ' ' VAL . 3.2 mp -42.07 127.77 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.424 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.485 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 3.1 p90 -142.89 143.88 32.23 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.075 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.739 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -112.81 124.18 52.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.789 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.401 ' HA ' ' HG3' ' A' ' 71' ' ' LYS . 0.1 OUTLIER 67.66 29.07 7.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.874 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.11 -35.89 3.93 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.001 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.504 ' HG3' ' HE2' ' A' ' 65' ' ' MET . 0.0 OUTLIER -86.94 130.43 34.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.904 0.383 . . . . 0.0 111.202 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.485 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 2.7 ttt -78.97 150.1 32.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.306 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.548 HG11 ' HA ' ' A' ' 62' ' ' THR . 25.8 m . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.946 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.619 ' N ' ' HZ2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.845 0.355 . . . . 0.0 111.127 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -104.79 127.98 27.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.518 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -90.02 163.69 4.86 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.752 2.301 . . . . 0.0 112.496 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.715 ' CB ' HD13 ' A' ' 25' ' ' LEU . . . -166.34 161.42 16.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.336 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 25' ' ' LEU . 35.6 p -93.55 108.34 20.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.327 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.962 HD12 HG11 ' A' ' 66' ' ' VAL . 2.2 tm? -89.15 119.57 29.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.149 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.897 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -74.76 -42.42 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.458 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.897 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER 179.87 173.17 0.96 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.249 0.547 . . . . 0.0 112.109 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.43 103.61 13.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.648 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' THR . 41.1 mm -53.3 -75.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.934 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -110.98 42.08 1.69 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.54 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.829 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 84.24 -52.15 4.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.924 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.49 -35.85 10.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.819 0.343 . . . . 0.0 110.422 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -71.39 106.79 4.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.27 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.738 HG21 HD13 ' A' ' 92' ' ' ILE . 3.2 m -122.99 129.35 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.685 0.279 . . . . 0.0 111.245 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' HD22 ' A' ' 14' ' ' LEU . 13.4 tttp -91.71 97.98 11.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.687 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.062 HD22 HG21 ' A' ' 74' ' ' VAL . 2.8 pp -110.51 137.72 47.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.662 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.567 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 29.0 ttm -72.51 99.96 2.62 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.533 ' CE1' ' CE1' ' A' ' 76' ' ' PHE . 86.9 t80 -88.51 109.42 20.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.174 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.457 ' O ' ' OE1' ' A' ' 30' ' ' GLN . 0.1 OUTLIER 49.18 28.27 2.12 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.821 179.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.44 -14.24 54.33 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.396 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -116.87 97.73 50.96 Favored Pre-proline 0 C--N 1.331 -0.239 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 34.1 Cg_exo -61.03 143.13 99.11 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.286 1.991 . . . . 0.0 113.129 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.444 ' O ' ' HE1' ' A' ' 34' ' ' PHE . 51.8 mtt -145.2 159.78 42.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.25 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.483 ' C ' ' CD1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -97.17 156.61 16.32 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.852 ' CZ ' HD11 ' A' ' 25' ' ' LEU . 3.0 m-85 -138.05 157.98 45.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.789 0.328 . . . . 0.0 111.493 -177.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.662 ' O ' HD12 ' A' ' 36' ' ' LEU . 2.2 ttm-85 -139.13 99.06 3.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.584 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.662 HD12 ' O ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.529 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.69 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 87.3 Cg_exo . . . . . 0 CA--C 1.529 0.243 0 N-CA-C 114.087 0.764 . . . . 0.0 114.087 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.543 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -93.88 -44.75 7.94 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.829 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -90.51 -65.4 1.02 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.5 p -65.57 -36.96 85.3 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.69 ' HB3' ' HA ' ' A' ' 56' ' ' PRO . . . -89.38 -57.4 2.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.543 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -61.07 -69.14 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.798 ' HA ' HG11 ' A' ' 99' ' ' VAL . 42.9 m -40.85 -66.57 0.31 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -55.93 -25.47 43.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.21 -63.17 1.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 0.0 111.878 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.553 ' SD ' ' HB3' ' A' ' 94' ' ' ALA . 1.6 mmm -50.86 -24.84 3.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.914 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.962 HG11 HD12 ' A' ' 14' ' ' LEU . 30.0 m -76.99 -31.02 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -94.18 -11.48 30.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.295 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -98.04 -28.17 13.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.66 0.267 . . . . 0.0 111.303 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.607 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . . . -102.68 143.91 31.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.884 0.374 . . . . 0.0 111.171 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -97.48 29.32 3.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.29 98.88 2.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.134 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.554 ' CG2' HG23 ' A' ' 92' ' ' ILE . 3.8 mt -119.23 94.67 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.397 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -94.94 137.18 34.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.86 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.062 HG21 HD22 ' A' ' 25' ' ' LEU . 21.3 t -116.97 102.87 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.423 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.435 ' CG ' ' HE2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -71.59 63.48 0.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.056 179.267 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.61 ' HB3' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -107.43 167.12 10.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.951 0.405 . . . . 0.0 111.834 -178.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.476 ' H ' HD11 ' A' ' 89' ' ' LEU . 6.9 t70 -104.29 162.05 13.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.34 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -101.0 32.6 3.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.414 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.69 33.55 0.32 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.944 ' HG3' HD12 ' A' ' 89' ' ' LEU . 1.4 mm-40 -78.37 128.96 34.4 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.542 0.686 . . . . 0.0 110.857 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.2 mtp85 -63.55 78.18 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.569 HG21 ' CD1' ' A' ' 88' ' ' TRP . 48.3 m . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.84 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.599 ' CE3' ' HB2' ' A' ' 80' ' ' GLN . 63.9 m95 . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.944 HD12 ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -77.36 164.43 25.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.885 ' HB1' HG13 ' A' ' 74' ' ' VAL . . . 175.28 172.89 0.27 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.288 0.566 . . . . 0.0 112.396 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -141.78 41.7 1.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.98 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.738 HD13 HG21 ' A' ' 23' ' ' VAL . 3.2 mp -41.96 127.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.056 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 2.2 p90 -143.98 153.93 42.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.471 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.607 ' HB1' ' CB ' ' A' ' 69' ' ' ALA . . . -113.51 135.48 53.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.685 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.85 23.91 12.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.147 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.53 -12.17 65.98 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.037 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.426 ' HG3' ' HE1' ' A' ' 65' ' ' MET . 0.0 OUTLIER -107.38 127.64 53.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.943 0.401 . . . . 0.0 110.988 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.522 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 1.5 mpt? -71.61 150.12 44.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.155 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.798 HG11 ' HA ' ' A' ' 62' ' ' THR . 11.1 m . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.113 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.836 0.35 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 20.0 mm-40 -123.82 115.74 27.87 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.672 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.92 161.15 7.47 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.688 2.258 . . . . 0.0 112.437 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.956 ' HB3' HD13 ' A' ' 25' ' ' LEU . . . -166.15 172.17 11.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.448 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 13' ' ' THR . 9.1 t -103.12 108.7 19.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.071 0.462 . . . . 0.0 111.264 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.682 ' HB3' HG11 ' A' ' 66' ' ' VAL . 2.8 tt -76.09 125.83 29.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.778 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.9 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.7 pp -74.9 -46.01 41.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.393 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.9 ' N ' HD12 ' A' ' 15' ' ' ILE . 4.1 mtmt 178.99 173.23 0.77 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.992 0.425 . . . . 0.0 111.373 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.964 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -98.72 148.05 24.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.391 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.771 HD12 HG22 ' A' ' 22' ' ' THR . 92.5 mt -102.71 -72.15 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.497 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -117.71 42.05 2.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.738 0.304 . . . . 0.0 111.532 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.795 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 82.37 -54.76 4.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.543 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.54 -35.72 11.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.018 0.437 . . . . 0.0 110.196 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.771 HG22 HD12 ' A' ' 18' ' ' ILE . 43.2 m -76.62 106.91 8.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.158 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.508 ' HB ' HD11 ' A' ' 14' ' ' LEU . 21.5 m -126.12 161.72 31.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.867 0.365 . . . . 0.0 111.189 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.483 ' HG2' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -119.41 134.18 55.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.297 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.956 HD13 ' HB3' ' A' ' 12' ' ' ALA . 1.3 pp -141.72 132.64 25.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.61 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.766 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -72.89 99.53 2.7 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.871 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.454 ' CE2' ' CE1' ' A' ' 76' ' ' PHE . 5.8 t80 -88.88 112.37 23.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.777 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 45.06 36.73 2.13 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.711 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.05 -14.41 65.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.457 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.26 97.34 49.51 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 51.6 Cg_endo -69.63 150.06 68.51 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.537 2.158 . . . . 0.0 112.994 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.401 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 3.4 mmt -145.3 161.17 40.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.049 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.06 124.08 40.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.861 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 2.1 m-85 -111.45 149.51 31.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.911 0.386 . . . . 0.0 111.693 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.593 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 3.4 ttp85 -139.09 110.41 6.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.168 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.717 HD21 ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.318 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.288 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 25.0 Cg_exo . . . . . 0 N--CA 1.473 0.309 0 N-CA-C 116.079 1.53 . . . . 0.0 116.079 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 5.8 mm-40 -48.82 -16.45 0.13 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.795 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -90.52 -62.31 1.49 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.671 0.272 . . . . 0.0 111.184 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.546 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 57.8 p -90.66 -48.98 6.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.975 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -55.06 -35.41 64.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.224 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.467 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 2.1 t80 -90.35 -19.92 23.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.479 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.964 HG21 ' HB2' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -77.59 -67.16 0.75 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.56 0.219 . . . . 0.0 111.331 -179.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.517 ' N ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -60.41 -23.79 64.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 111.34 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -80.93 -49.19 11.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.629 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.403 ' HG3' ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -50.03 -28.91 7.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.412 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.682 HG11 ' HB3' ' A' ' 14' ' ' LEU . 27.1 m -91.72 -26.89 4.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.273 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -76.51 -9.72 58.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.657 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -114.22 -28.1 7.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.606 0.241 . . . . 0.0 111.433 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.813 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -104.03 132.41 50.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 0.0 111.173 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -86.21 4.34 39.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.263 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.78 106.59 12.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.896 0.379 . . . . 0.0 110.968 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.509 HG12 HG12 ' A' ' 66' ' ' VAL . 4.1 mt -127.3 95.07 2.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.654 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -95.25 150.09 20.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.663 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.858 ' CG1' ' HB1' ' A' ' 90' ' ' ALA . 2.6 t -128.98 116.38 40.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.36 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -86.89 49.76 1.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.026 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -92.97 145.24 24.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.055 -179.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.513 ' H ' HD11 ' A' ' 89' ' ' LEU . 33.9 t0 -91.26 158.96 16.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.001 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -95.27 29.52 2.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.193 0.52 . . . . 0.0 110.25 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -153.49 37.68 0.73 Allowed Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.726 ' HB2' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -77.82 128.16 33.54 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.321 0.581 . . . . 0.0 110.198 -179.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -63.51 65.18 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.112 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.971 HG21 ' CE2' ' A' ' 88' ' ' TRP . 14.4 t . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.507 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.971 ' CE2' HG21 ' A' ' 82' ' ' THR . 66.5 m95 . . . . . 0 C--O 1.225 -0.186 0 CA-C-O 120.899 0.38 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.873 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -77.86 159.23 29.07 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.858 ' HB1' ' CG1' ' A' ' 74' ' ' VAL . . . -179.75 145.92 0.24 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -108.01 52.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.627 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.45 HG13 HG13 ' A' ' 74' ' ' VAL . 1.3 mp -57.71 132.94 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.504 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 73' ' ' GLU . 2.9 p90 -150.57 153.04 35.03 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.359 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.813 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -120.95 131.99 54.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.828 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.7 t70 67.57 25.9 8.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.021 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.31 19.91 77.77 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.842 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -137.1 114.11 10.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.923 0.392 . . . . 0.0 110.896 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.446 ' CA ' ' HB3' ' A' ' 93' ' ' TYR . 16.0 ptp -75.39 150.19 38.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.091 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt . . . . . 0 N--CA 1.461 0.083 0 CA-C-O 120.871 0.367 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.657 ' O ' HG22 ' A' ' 74' ' ' VAL . 4.5 mm-40 -136.05 145.56 52.95 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 10' ' ' GLU . 1.3 Cg_endo -83.42 105.49 1.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.735 2.29 . . . . 0.0 112.316 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.713 ' HB3' HD22 ' A' ' 25' ' ' LEU . . . -116.2 135.5 53.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.501 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.1 m -86.88 108.82 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.93 0.395 . . . . 0.0 111.644 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.579 HD22 ' HA ' ' A' ' 63' ' ' LYS . 10.2 tt -73.44 113.43 10.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.95 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.956 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.5 pp -74.7 -43.44 47.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.341 -0.391 . . . . 0.0 112.052 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.956 ' N ' HD12 ' A' ' 15' ' ' ILE . 37.9 tttp -173.65 151.56 1.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.077 0.465 . . . . 0.0 111.935 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.779 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -89.91 148.21 23.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.671 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.837 HD12 HG22 ' A' ' 22' ' ' THR . 21.0 mt -103.1 -73.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.687 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.12 26.86 9.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.633 0.254 . . . . 0.0 111.481 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.937 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 90.13 -44.33 2.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.744 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.7 -54.37 3.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 110.328 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.837 HG22 HD12 ' A' ' 18' ' ' ILE . 91.0 m -78.26 106.89 10.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.141 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.642 HG12 ' HA ' ' A' ' 17' ' ' ALA . 35.4 m -130.57 157.37 42.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.464 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.453 ' HB3' HG13 ' A' ' 15' ' ' ILE . 32.2 tttt -91.76 142.77 27.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.47 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.713 HD22 ' HB3' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -141.28 117.69 10.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.928 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.85 99.18 2.14 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.446 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 17.3 t80 -95.62 108.54 20.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.907 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.94 41.55 14.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.147 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.85 -14.13 61.07 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.459 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.471 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -117.75 98.19 51.43 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.999 0.428 . . . . 0.0 110.277 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.699 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 26.6 Cg_endo -62.54 144.4 94.43 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.705 2.27 . . . . 0.0 113.327 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.6 mmt -145.17 155.84 43.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.082 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 p -85.79 122.11 29.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.817 0.341 . . . . 0.0 111.214 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.651 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 16.8 m-85 -113.79 107.9 16.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.436 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 88' ' ' TRP . 7.6 ttt180 -97.41 115.0 26.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.223 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.48 HD23 ' HB2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.164 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.05 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.826 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 56.6 Cg_exo . . . . . 0 C--O 1.232 0.191 0 N-CA-C 114.422 0.893 . . . . 0.0 114.422 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.761 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 15.8 tm-20 -91.77 -64.61 1.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.937 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -60.46 -40.71 92.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.509 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 67.9 m -93.63 -43.4 8.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.826 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -89.5 -34.61 16.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.761 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 4.1 t80 -90.1 -24.34 21.14 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.779 HG21 ' HB2' ' A' ' 17' ' ' ALA . 1.7 m -56.82 -66.84 0.38 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.734 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -77.72 -19.73 54.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -48.03 -51.63 23.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 0.0 111.388 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.4 ttp -70.49 -17.61 62.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.305 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.847 HG13 HG12 ' A' ' 72' ' ' ILE . 48.1 t -88.64 -11.63 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.518 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -93.99 -6.77 44.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -114.7 -27.9 7.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.562 0.22 . . . . 0.0 111.447 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.642 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -100.9 142.26 32.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 111.343 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.92 28.57 4.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.556 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -142.2 98.92 3.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.005 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.847 HG12 HG13 ' A' ' 66' ' ' VAL . 3.2 mp -129.18 93.24 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.641 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.5 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 8.1 mt-10 -102.65 133.5 47.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.883 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 10' ' ' GLU . 27.8 m -104.26 138.26 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.895 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -89.09 48.47 1.63 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.982 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.588 ' HB2' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -93.7 150.96 19.98 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.518 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.635 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 3.3 t70 -87.26 162.48 17.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.996 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.38 32.44 0.95 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.421 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.69 31.29 0.17 Allowed Glycine 0 CA--C 1.507 -0.46 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.635 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 11.5 mm-40 -81.74 127.93 33.46 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.684 0.754 . . . . 0.0 111.847 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -42.05 129.57 3.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.148 -1.387 . . . . 0.0 111.807 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.623 HG22 ' CE2' ' A' ' 88' ' ' TRP . 43.6 p . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.033 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.651 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 54.1 m95 . . . . . 0 C--O 1.223 -0.326 0 CA-C-O 121.038 0.446 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.651 HD22 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -77.96 164.89 24.7 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.925 178.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.646 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 166.06 147.88 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.232 0.539 . . . . 0.0 111.677 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -99.47 -34.18 10.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.956 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.477 HG21 HD13 ' A' ' 14' ' ' LEU . 1.8 mp 59.03 115.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.508 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.5 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 6.4 p90 -141.16 136.46 31.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.986 0.422 . . . . 0.0 111.502 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -106.0 112.5 25.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.731 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.463 ' OD1' ' HB1' ' A' ' 69' ' ' ALA . 5.1 m-20 80.37 27.16 0.28 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.951 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.21 -28.63 9.34 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.957 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.77 130.85 39.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 111.165 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.463 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -76.5 145.35 39.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.922 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 62' ' ' THR . 35.3 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.213 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.446 ' HE3' ' HA ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.817 0.342 . . . . 0.0 111.159 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -151.67 113.74 2.99 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.776 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 89.7 Cg_endo -85.35 110.72 1.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.63 2.22 . . . . 0.0 112.518 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.516 ' HB3' HD22 ' A' ' 25' ' ' LEU . . . -120.83 156.32 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.594 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -98.1 108.09 20.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.124 0.488 . . . . 0.0 111.656 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.798 ' HB3' HG21 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -76.28 108.93 9.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.643 178.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.837 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -74.79 -46.93 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.304 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.837 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -178.56 173.11 1.36 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.116 0.484 . . . . 0.0 111.776 179.47 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.804 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -94.86 148.26 22.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.951 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.4 mt -104.2 -70.38 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.781 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.05 42.22 2.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.726 0.298 . . . . 0.0 111.524 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.77 -57.21 5.05 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.52 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -96.74 -38.28 9.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.912 0.387 . . . . 0.0 110.116 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.799 HG22 HG21 ' A' ' 33' ' ' THR . 0.2 OUTLIER -77.7 106.75 9.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.106 179.263 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 17' ' ' ALA . 27.8 m -127.42 143.6 40.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.333 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.518 ' HB3' HD11 ' A' ' 15' ' ' ILE . 9.1 tppt? -81.88 142.78 32.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.509 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.769 ' HG ' HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -141.79 118.44 11.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.543 -179.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -72.4 99.39 2.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 20.8 t80 -96.33 107.54 19.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.203 -177.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm 45.13 48.98 9.85 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.652 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.13 -14.1 51.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.789 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -119.86 97.84 49.56 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 121.011 0.434 . . . . 0.0 110.019 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 24.6 Cg_exo -65.26 143.34 76.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.857 2.372 . . . . 0.0 113.38 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 mmt -145.05 151.86 39.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.555 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.799 HG21 HG22 ' A' ' 22' ' ' THR . 2.8 m -86.68 121.2 28.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.545 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 25' ' ' LEU . 2.1 m-85 -109.79 125.54 52.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.005 0.431 . . . . 0.0 111.518 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -98.61 118.07 34.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.976 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.496 ' N ' HD23 ' A' ' 36' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.803 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.625 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 76.9 Cg_exo . . . . . 0 CA--C 1.529 0.244 0 N-CA-C 113.405 0.502 . . . . 0.0 113.405 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' HG2' ' N ' ' A' ' 58' ' ' ALA . 13.7 pm0 -94.24 -46.79 6.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.578 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -91.16 -65.67 0.99 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.792 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 73.8 m -60.66 -37.82 82.84 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.625 ' HB3' ' HA ' ' A' ' 56' ' ' PRO . . . -89.52 -61.83 1.61 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.448 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -55.34 -51.7 65.91 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 85.1 m -55.47 -66.26 0.45 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.619 0.247 . . . . 0.0 111.499 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -23.11 15.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.519 ' HZ2' ' HB1' ' A' ' 60' ' ' ALA . 1.9 mttp -88.07 -55.86 3.57 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.51 -26.49 3.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.716 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.882 HG13 HG12 ' A' ' 72' ' ' ILE . 36.0 t -91.73 -10.56 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -94.11 -5.97 46.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -111.2 -27.34 8.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.626 0.25 . . . . 0.0 111.426 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.866 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -105.62 141.12 37.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 0.0 111.172 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.27 29.04 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.762 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.45 ' HG3' ' HA ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -145.46 98.72 3.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.807 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.882 HG12 HG13 ' A' ' 66' ' ' VAL . 2.6 mp -127.67 92.14 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.665 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -94.87 147.58 23.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.754 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.588 HG13 ' HB1' ' A' ' 90' ' ' ALA . 36.7 t -116.31 129.15 73.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.684 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.446 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 34.2 tt0 -93.62 54.32 2.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.221 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.688 ' HA ' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -94.89 167.31 11.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.164 -178.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.448 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 2.0 t70 -104.43 162.55 13.14 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.041 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -94.18 28.78 2.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.936 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.62 26.93 0.2 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.776 ' HG3' HD12 ' A' ' 89' ' ' LEU . 1.8 mm-40 -78.54 127.12 31.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.63 0.729 . . . . 0.0 110.983 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -39.71 127.1 1.99 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.515 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 75.2 p . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.088 -179.748 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.577 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 96.2 m95 . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 120.88 0.371 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.912 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -76.64 158.29 31.19 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.75 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 179.66 160.73 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.264 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -113.1 -35.94 5.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.92 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.6 mt 59.67 119.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.809 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.437 ' OH ' ' HB3' ' A' ' 73' ' ' GLU . 4.9 p90 -141.63 123.44 15.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.866 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -99.25 96.55 7.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.665 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 94' ' ' ALA . 2.7 t0 85.26 55.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.997 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.11 27.71 57.69 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.852 -0.613 . . . . 0.0 113.453 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -137.25 112.72 9.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 0.0 111.001 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.417 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -78.21 136.12 37.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.068 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.98 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.92 0.39 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 1.4 mp0 -141.57 113.89 6.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.632 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 5.8 Cg_exo -78.69 114.1 3.4 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.566 2.177 . . . . 0.0 112.238 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.535 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . . . -138.7 146.81 42.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.524 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.1 p -92.37 109.07 20.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.899 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.902 HD11 ' HB ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -76.9 119.57 20.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.758 178.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.921 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.4 pp -74.9 -41.96 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.921 ' N ' HD12 ' A' ' 15' ' ' ILE . 87.6 tttt -176.89 162.48 2.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.985 0.422 . . . . 0.0 111.58 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.045 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -97.22 148.09 23.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.89 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.515 HD12 ' HB ' ' A' ' 22' ' ' THR . 38.1 mt -96.54 -77.0 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.476 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -118.29 34.62 5.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.434 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.56 -45.36 2.93 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.504 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.73 -57.53 2.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 110.479 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.515 ' HB ' HD12 ' A' ' 18' ' ' ILE . 21.6 p -69.71 107.52 3.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.447 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.902 ' HB ' HD11 ' A' ' 14' ' ' LEU . 34.6 m -130.09 141.91 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.484 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.511 ' HG2' HG12 ' A' ' 15' ' ' ILE . 4.5 tptt -79.97 139.29 37.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.2 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.604 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -141.54 119.29 11.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.6 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.497 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -72.36 99.35 2.41 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 20.0 t80 -94.84 108.34 20.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.193 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 tptp 45.68 47.5 11.63 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.594 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.48 -13.97 53.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.718 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.47 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -120.25 98.0 48.93 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 110.045 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 33.1 Cg_exo -61.67 143.92 96.92 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.849 2.366 . . . . 0.0 113.609 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.6 mmt -145.13 144.84 31.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.44 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.2 m -82.31 120.02 24.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.73 0.3 . . . . 0.0 110.495 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.643 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 5.1 m-85 -105.02 124.37 49.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.784 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 88' ' ' TRP . 12.1 ttp180 -121.83 125.38 46.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.03 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.785 HD13 ' HB2' ' A' ' 89' ' ' LEU . 11.9 tp . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.207 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.905 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 81.8 Cg_exo . . . . . 0 CA--C 1.529 0.227 0 N-CA-C 113.68 0.608 . . . . 0.0 113.68 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.667 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 9.3 mm-40 -94.63 -27.67 15.76 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.501 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -90.72 -65.36 1.02 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.568 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -80.58 -25.01 38.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.666 0.27 . . . . 0.0 111.472 -179.02 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.905 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -89.27 -56.16 3.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.924 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.667 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 1.7 t80 -59.27 -39.22 82.22 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.94 0.4 . . . . 0.0 110.933 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 1.045 HG21 ' HB2' ' A' ' 17' ' ' ALA . 1.9 m -58.97 -66.39 0.51 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.675 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.485 ' HB2' ' HG3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -60.49 -38.69 85.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.781 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 11.1 mmtm -60.79 -61.48 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.654 ' CB ' HG12 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -46.73 -47.96 20.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.777 -179.12 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' ' 14' ' ' LEU . 27.5 m -70.31 -10.56 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.862 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -89.15 -34.1 16.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.665 0.269 . . . . 0.0 111.214 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -89.97 -28.09 19.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.194 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.984 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -104.92 104.83 14.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.986 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.04 -26.22 64.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.065 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.402 ' CG ' ' HA ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -85.85 98.95 11.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.956 0.407 . . . . 0.0 111.268 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 93' ' ' TYR . 2.3 mp -122.84 91.23 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.294 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 1.2 tt0 -97.23 139.9 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 111.04 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.741 HG13 ' HB1' ' A' ' 90' ' ' ALA . 29.7 t -111.29 141.36 26.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.454 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -105.28 62.03 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.304 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.716 ' HB2' HD13 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.79 148.45 25.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.073 0.463 . . . . 0.0 111.805 -179.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.74 ' H ' HD11 ' A' ' 89' ' ' LEU . 21.4 t0 -77.24 162.3 27.47 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.176 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.3 32.41 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.804 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.09 33.08 0.27 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.468 ' CB ' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -78.52 128.01 32.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.52 0.676 . . . . 0.0 110.887 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.2 ttm-85 -56.32 113.91 1.77 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.851 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.8 p . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.777 -179.409 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.643 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 98.8 m95 . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.948 0.404 . . . . 0.0 111.601 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.785 ' HB2' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -77.34 156.21 31.44 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.741 ' HB1' HG13 ' A' ' 74' ' ' VAL . . . 176.63 160.19 0.35 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.24 0.543 . . . . 0.0 112.212 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.431 ' C ' HD12 ' A' ' 92' ' ' ILE . 3.7 m-85 -108.91 -35.44 6.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.719 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.576 HG12 HD11 ' A' ' 25' ' ' LEU . 3.2 mp 59.44 122.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.956 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.495 ' OH ' ' HB3' ' A' ' 73' ' ' GLU . 4.3 p90 -144.65 142.85 30.42 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.113 0.482 . . . . 0.0 111.635 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.984 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -113.35 120.67 41.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.656 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.402 ' HA ' ' CG ' ' A' ' 71' ' ' LYS . 0.7 OUTLIER 76.14 27.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.109 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.46 -15.33 54.93 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.117 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -109.85 131.08 55.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.858 0.329 . . . . 0.0 110.986 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.426 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 6.2 mtt -72.01 140.69 49.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.736 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.821 HG11 ' HA ' ' A' ' 62' ' ' THR . 27.9 m . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.937 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.775 0.321 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -135.1 113.93 11.58 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 83.1 Cg_endo -83.37 154.15 14.08 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.721 2.281 . . . . 0.0 112.26 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.857 ' CB ' HD13 ' A' ' 25' ' ' LEU . . . -166.23 157.31 13.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.72 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 25' ' ' LEU . 5.5 m -86.85 107.55 18.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.028 0.442 . . . . 0.0 111.279 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 14' ' ' LEU . 0.7 OUTLIER -98.83 108.0 20.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.565 178.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.851 ' HA ' HG11 ' A' ' 66' ' ' VAL . 1.4 pp -125.62 -13.2 4.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -113.29 123.04 49.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.09 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -112.88 103.67 11.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.241 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.544 HD12 ' HB ' ' A' ' 22' ' ' THR . 34.7 mt -62.65 -82.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.079 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -118.17 41.94 2.81 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.28 -47.26 3.69 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.103 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -96.37 -41.09 8.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.964 0.411 . . . . 0.0 110.024 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.544 ' HB ' HD12 ' A' ' 18' ' ' ILE . 2.1 p -82.55 106.87 14.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.787 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.698 ' HB ' HD21 ' A' ' 14' ' ' LEU . 35.1 m -121.53 155.65 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 111.718 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.9 127.42 56.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.734 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.94 HD22 HG21 ' A' ' 74' ' ' VAL . 2.0 pp -133.82 143.2 48.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.32 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.592 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -72.54 99.21 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -93.41 106.37 18.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.3 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 tttm 50.35 55.33 9.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.819 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.56 13.41 60.8 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.199 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.406 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -142.14 97.94 6.23 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.699 0.285 . . . . 0.0 110.245 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 40.8 Cg_endo -67.36 146.48 75.24 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.566 2.177 . . . . 0.0 113.01 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.3 mmt -145.36 161.2 40.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.388 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.467 HG22 HD11 ' A' ' 18' ' ' ILE . 20.2 p -91.34 126.03 36.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.485 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.834 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.2 m-85 -111.35 124.19 51.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.041 0.448 . . . . 0.0 110.892 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.539 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -108.82 98.95 8.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.165 -179.297 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.708 HD22 ' HB2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 121.015 0.436 . . . . 0.0 111.261 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.732 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 90.9 Cg_endo . . . . . 0 N--CA 1.463 -0.307 0 N-CA-C 113.763 0.64 . . . . 0.0 113.763 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -58.04 -14.08 5.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.39 -65.57 1.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 24.5 m -88.04 -23.59 23.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.97 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -88.91 -46.11 9.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.536 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -63.99 -49.97 70.36 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.207 0.527 . . . . 0.0 109.914 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 1.09 HG21 ' HB2' ' A' ' 17' ' ' ALA . 2.6 t -49.81 -31.71 12.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.913 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' A' ' 15' ' ' ILE . 6.9 mttm -82.71 -41.96 18.64 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.138 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -72.33 -30.43 64.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.254 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -40.62 80.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.851 HG11 ' HA ' ' A' ' 15' ' ' ILE . 9.1 p -83.14 -29.54 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.14 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.19 -9.15 59.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.519 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -111.24 -28.13 8.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.699 0.285 . . . . 0.0 111.337 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.95 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -107.92 141.52 39.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.177 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -102.02 25.41 8.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.81 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 98.8 3.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.69 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.53 ' CD1' HG23 ' A' ' 66' ' ' VAL . 3.6 mp -123.13 92.35 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 7.6 mt-10 -94.98 136.77 34.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.748 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.94 HG21 HD22 ' A' ' 25' ' ' LEU . 24.6 t -116.08 123.25 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.193 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -85.57 54.51 3.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.734 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.684 ' HA ' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -95.03 164.64 12.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.127 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.681 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -99.94 162.08 13.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.843 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -92.84 30.79 1.5 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.47 31.31 0.16 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.498 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.801 ' HG3' HD12 ' A' ' 89' ' ' LEU . 34.0 mm-40 -78.54 125.57 29.55 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.524 0.678 . . . . 0.0 111.081 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -44.14 120.89 2.28 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.168 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.452 ' CG2' ' CE2' ' A' ' 88' ' ' TRP . 43.5 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.04 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.532 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 70.2 m95 . . . . . 0 C--O 1.224 -0.289 0 CA-C-O 121.064 0.459 . . . . 0.0 111.916 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.876 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -77.81 158.23 29.61 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.854 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 173.25 156.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.201 0.524 . . . . 0.0 111.895 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.706 ' C ' HD12 ' A' ' 92' ' ' ILE . 3.5 m-85 -112.63 -41.1 3.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.624 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.706 HD12 ' C ' ' A' ' 91' ' ' TYR . 2.8 mp 58.55 121.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.08 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 15.0 p90 -142.54 130.59 21.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.377 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.95 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -103.58 124.14 48.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.603 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 t70 74.79 27.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.864 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.21 22.34 77.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.863 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 115.38 11.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 111.046 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.428 ' CG ' ' HB3' ' A' ' 93' ' ' TYR . 4.0 mtm -72.0 129.53 38.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.515 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.227 0 CA-C-O 120.863 0.364 . . . . 0.0 110.584 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HE3' ' CA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.825 0.345 . . . . 0.0 110.997 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 74' ' ' VAL . 3.3 mp0 -115.32 131.95 23.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.684 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -87.45 125.49 2.12 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.596 2.198 . . . . 0.0 112.398 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.462 ' HB3' HD22 ' A' ' 25' ' ' LEU . . . -149.19 127.74 12.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.444 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.594 ' HA ' HD13 ' A' ' 72' ' ' ILE . 2.5 t -86.56 108.56 18.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.039 0.447 . . . . 0.0 110.727 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.691 HD11 ' HB ' ' A' ' 23' ' ' VAL . 3.2 tt -77.45 121.39 23.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.418 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.857 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -74.55 -48.6 34.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.671 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.857 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER 179.68 168.4 1.16 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.943 0.401 . . . . 0.0 111.259 179.21 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.714 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -87.27 148.13 25.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.082 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.6 mm -91.37 -69.73 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.341 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -118.13 35.93 4.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.246 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.29 -48.5 3.4 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.65 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -96.7 -56.18 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.359 . . . . 0.0 110.616 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.4 m -70.69 106.81 3.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.501 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 34' ' ' PHE . 27.8 m -114.96 154.83 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.308 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.91 140.06 29.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.762 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.698 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -141.34 118.41 11.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.052 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.31 99.41 2.4 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.636 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 2.7 t80 -91.23 102.29 15.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.755 -178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.9 tttp 43.16 50.15 5.63 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.658 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.33 -14.33 59.66 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.563 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.636 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -118.32 97.21 50.61 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.698 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 10.7 Cg_exo -72.06 130.19 16.24 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.319 2.013 . . . . 0.0 112.97 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 6.2 mmt -124.85 157.22 36.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.16 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 p -86.67 119.54 27.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.037 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.738 ' O ' HG22 ' A' ' 23' ' ' VAL . 17.9 m-85 -111.03 107.77 17.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.652 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -94.17 109.53 21.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.31 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.731 HD22 ' HB2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.447 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 28.1 Cg_exo . . . . . 0 N--CA 1.471 0.178 0 N-CA-C 115.136 1.168 . . . . 0.0 115.136 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -45.44 -19.9 0.05 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.577 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -90.63 -65.08 1.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -87.52 -32.25 19.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -75.8 -35.12 60.16 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.405 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -89.98 -30.86 17.52 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.714 HG21 ' HB2' ' A' ' 17' ' ' ALA . 15.3 t -60.62 -54.56 43.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 13.3 ptmt -65.3 -43.1 92.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.373 . . . . 0.0 110.875 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -48.99 74.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.079 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.525 ' CB ' HG13 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -55.98 -30.38 61.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.139 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.689 ' HA ' ' HB2' ' A' ' 94' ' ' ALA . 32.6 m -92.5 -31.21 4.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.036 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -72.08 -5.94 38.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.657 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -95.02 -28.13 15.28 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.609 0.242 . . . . 0.0 111.598 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.033 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -107.98 151.01 26.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 111.404 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.8 ttmm -99.18 17.55 19.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.255 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.97 98.98 4.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.907 0.384 . . . . 0.0 110.797 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.698 ' CG2' HG23 ' A' ' 92' ' ' ILE . 2.4 mp -118.69 94.17 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.112 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.515 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 2.4 mt-10 -104.89 131.23 52.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.607 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 92' ' ' ILE . 31.4 m -106.28 145.46 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.894 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.401 ' CA ' ' HE3' ' A' ' 9' ' ' LYS . 14.5 tt0 -99.78 54.41 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.488 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.533 ' HB2' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -97.63 166.23 11.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.7 -179.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.761 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -104.3 162.53 13.13 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.969 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.5 tmtp? -92.25 23.93 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.314 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.97 20.78 0.36 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.535 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.761 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 17.0 mm-40 -78.61 128.87 34.09 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.542 0.686 . . . . 0.0 111.116 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.451 ' C ' ' O ' ' A' ' 80' ' ' GLN . 1.4 mpp_? -23.45 118.38 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.966 -1.47 . . . . 0.0 111.784 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.51 HG22 ' CE2' ' A' ' 88' ' ' TRP . 5.8 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.688 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.589 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 68.2 m95 . . . . . 0 C--O 1.224 -0.24 0 CA-C-O 121.166 0.507 . . . . 0.0 111.458 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.731 ' HB2' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -81.12 154.08 26.96 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.442 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 179.13 153.21 0.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.18 0.514 . . . . 0.0 112.14 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.621 ' C ' HD12 ' A' ' 92' ' ' ILE . 28.9 m-85 -111.37 -35.08 5.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.942 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.698 HG23 ' CG2' ' A' ' 72' ' ' ILE . 3.3 mp 54.38 109.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.295 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.525 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 6.4 p90 -127.74 137.13 52.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.058 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.033 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -106.38 123.88 48.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.657 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 t70 73.65 26.17 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.84 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.33 21.91 74.42 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.828 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.14 113.96 10.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.525 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 7.5 mtt -60.47 139.1 57.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.724 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.661 HG11 ' HA ' ' A' ' 62' ' ' THR . 15.1 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.05 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.474 ' HZ1' ' HB2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.847 0.356 . . . . 0.0 110.897 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.883 ' O ' HG22 ' A' ' 74' ' ' VAL . 23.9 mm-40 -122.79 154.32 63.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 85.1 Cg_endo -86.73 156.33 8.9 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.763 2.309 . . . . 0.0 112.298 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.889 ' HB1' HD13 ' A' ' 25' ' ' LEU . . . -166.27 157.34 13.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.052 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.12 108.38 19.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.779 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.627 ' CD2' HG21 ' A' ' 66' ' ' VAL . 5.7 tt -77.12 121.16 23.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.859 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.6 pp -74.83 -44.6 45.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.206 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.859 ' N ' HD12 ' A' ' 15' ' ' ILE . 9.1 tttm 179.51 163.32 0.94 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.878 0.37 . . . . 0.0 111.187 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.878 ' HB3' ' HA ' ' A' ' 59' ' ' SER . . . -91.75 145.91 24.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.331 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.4 mt -96.97 -75.27 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.548 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -117.5 42.14 2.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.519 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.775 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 84.65 -53.61 4.84 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.675 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -96.68 -37.71 10.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 110.553 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -76.99 106.84 8.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.702 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 17' ' ' ALA . 29.1 m -127.93 152.21 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.722 0.296 . . . . 0.0 111.221 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.436 ' HG2' HG12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -113.03 131.66 55.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.211 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.889 HD13 ' HB1' ' A' ' 12' ' ' ALA . 0.5 OUTLIER -141.44 148.74 40.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.421 178.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.68 99.8 2.66 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.705 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 24.2 t80 -88.42 111.21 21.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.314 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 38.23 38.59 0.22 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.172 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.8 -14.47 58.87 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.295 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.705 ' NE2' ' O ' ' A' ' 27' ' ' TYR . 2.1 pm0 -120.54 96.94 48.91 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.116 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 39.4 Cg_exo -61.5 127.34 21.51 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.53 2.154 . . . . 0.0 112.552 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.562 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -133.04 161.84 33.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.709 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.532 ' O ' ' N ' ' A' ' 88' ' ' TRP . 55.5 m -92.8 156.98 16.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.836 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 10.6 m-85 -143.14 136.04 27.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.649 0.262 . . . . 0.0 111.611 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 7.7 ttm180 -139.56 115.21 10.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.934 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 20.2 tp . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.626 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.452 ' HB3' ' HB3' ' A' ' 60' ' ' ALA . 24.6 Cg_exo . . . . . 0 CA--C 1.529 0.229 0 N-CA-C 114.983 1.109 . . . . 0.0 114.983 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.596 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 1.6 tp10 -47.41 -17.44 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.775 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -90.5 -63.16 1.31 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.878 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 37.3 m -92.79 -43.89 8.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.379 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 56' ' ' PRO . . . -62.93 -31.96 73.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.575 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.596 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 3.3 t80 -88.83 -44.25 10.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.371 . . . . 0.0 110.997 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.723 HG21 ' HB2' ' A' ' 17' ' ' ALA . 3.0 m -60.15 -66.28 0.55 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.757 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -55.44 -23.48 25.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.516 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -83.6 -54.7 4.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 111.5 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 mmt -47.69 -27.62 2.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.662 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.627 HG21 ' CD2' ' A' ' 14' ' ' LEU . 27.2 m -94.02 -19.05 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.34 -25.24 39.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.535 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -97.29 -28.3 14.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.399 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.634 ' O ' HD11 ' A' ' 72' ' ' ILE . . . -108.2 108.07 18.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.143 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -15.49 52.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.877 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.418 ' HG3' ' HA ' ' A' ' 95' ' ' ASP . 2.8 ptpt -91.8 101.71 14.31 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.383 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.891 HG23 ' O ' ' A' ' 93' ' ' TYR . 3.3 mp -134.88 99.14 2.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.255 0.55 . . . . 0.0 110.997 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 2.2 mt-10 -93.26 179.59 5.37 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.649 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.883 HG22 ' O ' ' A' ' 10' ' ' GLU . 31.3 m -145.22 139.67 22.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.977 0.418 . . . . 0.0 111.528 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.474 ' HB2' ' HZ1' ' A' ' 9' ' ' LYS . 5.1 tp10 -106.49 41.34 1.45 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.181 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -92.76 160.45 14.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.662 -179.154 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.707 ' H ' HD11 ' A' ' 89' ' ' LEU . 8.2 t0 -90.92 152.59 20.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.081 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.28 31.3 2.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.154 0.502 . . . . 0.0 110.347 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.02 38.5 0.64 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.825 ' HB2' HD12 ' A' ' 89' ' ' LEU . 1.3 tp60 -78.11 126.84 31.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.929 -0.636 . . . . 0.0 110.642 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.24 79.22 0.05 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.792 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.949 HG21 ' CG ' ' A' ' 88' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.009 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.949 ' CG ' HG21 ' A' ' 82' ' ' THR . 20.9 m95 . . . . . 0 N--CA 1.466 0.35 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.911 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -82.82 152.09 25.79 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.62 ' N ' HD22 ' A' ' 89' ' ' LEU . . . -178.26 162.2 1.52 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.362 0.601 . . . . 0.0 112.432 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.422 ' C ' HD12 ' A' ' 92' ' ' ILE . 3.5 m-85 -117.15 -17.52 10.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.646 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.477 HG22 ' N ' ' A' ' 93' ' ' TYR . 5.3 mp 64.31 158.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.843 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.891 ' O ' HG23 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -151.13 134.12 15.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.752 -178.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -134.72 105.19 6.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.863 0.363 . . . . 0.0 111.496 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.418 ' HA ' ' HG3' ' A' ' 71' ' ' LYS . 14.7 t0 54.51 43.8 29.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.748 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.28 -22.41 23.45 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.13 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -116.41 127.72 54.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.89 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.53 148.9 49.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.891 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.303 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 75' ' ' GLU . 1.2 mmpp? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.737 0.304 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.471 ' HG2' ' CE2' ' A' ' 27' ' ' TYR . 0.6 OUTLIER -132.32 125.83 20.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.065 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -84.52 146.43 10.83 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.67 2.246 . . . . 0.0 112.502 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.673 ' CB ' HD21 ' A' ' 25' ' ' LEU . . . -166.37 173.06 10.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.94 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.26 108.57 15.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.021 0.439 . . . . 0.0 111.246 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.651 HD11 ' HB ' ' A' ' 23' ' ' VAL . 3.7 tt -86.83 120.84 28.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.055 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.738 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.7 pp -75.55 -46.41 37.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.513 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.738 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER 179.98 173.11 0.99 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.176 0.512 . . . . 0.0 111.87 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.88 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -94.78 148.3 22.43 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.677 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.735 HD12 ' O ' ' A' ' 22' ' ' THR . 2.0 mp -101.8 -70.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.681 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.65 42.14 1.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.318 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.456 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 83.68 -54.32 4.94 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.547 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -96.8 -49.37 5.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.751 0.31 . . . . 0.0 110.296 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.735 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -63.84 106.68 1.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.23 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.651 ' HB ' HD11 ' A' ' 14' ' ' LEU . 30.2 m -122.59 142.43 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.485 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -87.99 124.71 34.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.673 HD21 ' CB ' ' A' ' 12' ' ' ALA . 1.3 tt -141.52 121.89 14.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.77 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.601 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 15.0 ptp -72.48 102.46 3.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.326 0.584 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.471 ' CE2' ' HG2' ' A' ' 10' ' ' GLU . 10.5 t80 -88.72 109.65 20.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.285 -178.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.91 46.52 18.85 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.602 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.9 -6.61 65.74 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.687 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.453 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -124.59 98.47 37.45 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 17.3 Cg_exo -68.87 143.71 56.26 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.985 2.457 . . . . 0.0 114.245 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.475 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 2.3 mtt -145.36 148.54 33.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.028 -1.442 . . . . 0.0 108.255 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.552 ' CG2' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -87.48 157.29 19.23 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.587 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 5.0 m-85 -140.8 149.39 41.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.075 0.464 . . . . 0.0 111.712 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 88' ' ' TRP . 0.3 OUTLIER -117.65 97.87 6.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.886 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.314 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.766 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 90.7 Cg_exo . . . . . 0 N--CA 1.476 0.474 0 N-CA-C 115.711 1.389 . . . . 0.0 115.711 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.541 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 13.9 tm-20 -60.23 -23.51 64.11 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.783 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.456 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -91.06 -57.17 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.609 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 28.5 m -82.73 -31.34 28.5 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -86.63 -53.22 5.08 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.541 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -61.54 -27.87 68.92 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.001 0.429 . . . . 0.0 110.958 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.88 HG21 ' HB2' ' A' ' 17' ' ' ALA . 1.1 m -63.73 -57.48 9.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.033 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.462 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -82.95 -36.14 25.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.591 -179.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 60' ' ' ALA . 28.6 ttpt -63.2 -49.44 74.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.426 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.505 ' CB ' HG12 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -58.25 -31.49 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 0.0 111.055 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.487 HG12 HG12 ' A' ' 72' ' ' ILE . 25.0 m -89.81 -29.3 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.178 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -53.28 -25.48 14.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.343 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -106.02 -28.17 10.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 111.404 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.918 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -92.43 130.93 37.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.08 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -96.51 28.17 3.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.62 98.93 3.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.114 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.487 HG12 HG12 ' A' ' 66' ' ' VAL . 3.0 mt -120.97 95.26 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.392 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 1.9 mt-10 -94.61 160.35 14.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.77 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.713 HG12 ' HB3' ' A' ' 76' ' ' PHE . 56.0 t -132.08 114.99 25.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.084 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.425 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 2.3 tm-20 -79.96 53.73 1.74 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.407 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.713 ' HB3' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -97.48 164.63 12.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.112 0.482 . . . . 0.0 112.026 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -104.26 162.51 13.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.087 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.58 31.76 2.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.681 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.5 32.16 0.31 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.956 ' HG3' HD12 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -78.5 127.97 32.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.6 0.714 . . . . 0.0 111.062 -179.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -67.63 84.29 0.19 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.919 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.574 HG21 ' NE1' ' A' ' 88' ' ' TRP . 10.2 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.587 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 66.4 m95 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.958 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -76.7 155.68 33.12 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.994 -0.683 . . . . 0.0 109.999 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.685 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 172.86 160.33 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.252 0.549 . . . . 0.0 111.794 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -112.31 -37.52 4.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.063 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.566 HG21 HD13 ' A' ' 14' ' ' LEU . 2.6 mp 60.12 127.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.738 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.45 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 8.9 p90 -149.07 141.46 24.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 111.321 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.918 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -111.31 119.08 37.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.491 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 76.38 20.11 1.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.071 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.93 -19.88 53.02 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.147 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.471 ' HG3' ' HE1' ' A' ' 65' ' ' MET . 0.0 OUTLIER -104.21 128.71 51.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.893 0.378 . . . . 0.0 111.426 -179.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.0 mtt -68.41 150.21 48.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.505 HG12 ' CB ' ' A' ' 65' ' ' MET . 33.2 m . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.599 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.832 0.349 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -134.36 113.96 12.35 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.799 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 92.6 Cg_endo -85.67 147.49 9.63 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.713 2.275 . . . . 0.0 112.467 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.699 ' CB ' HD13 ' A' ' 25' ' ' LEU . . . -166.02 162.13 17.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.759 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.458 HG23 HD13 ' A' ' 72' ' ' ILE . 1.4 m -104.46 108.58 20.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.926 0.393 . . . . 0.0 111.258 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.856 HD11 ' HA ' ' A' ' 63' ' ' LYS . 2.4 pp -65.18 133.33 51.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.47 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.883 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.7 pp -74.67 -42.32 47.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.42 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.883 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER 179.47 170.66 1.02 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.597 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.466 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -92.92 148.17 22.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.753 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.2 mt -106.36 -74.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.391 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -118.02 42.15 2.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.824 0.345 . . . . 0.0 111.312 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.3 -56.81 5.04 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.373 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.8 -32.29 12.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.352 . . . . 0.0 110.377 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -77.21 109.86 11.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.556 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 34' ' ' PHE . 33.6 m -131.82 155.78 41.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 3.2 ttpp -119.29 135.3 54.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.803 0.335 . . . . 0.0 111.335 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.893 ' HG ' ' CE1' ' A' ' 34' ' ' PHE . 2.8 pp -141.89 146.32 35.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.303 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.553 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 6.0 ttm -72.2 101.67 2.87 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.839 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.451 ' CE1' ' CZ ' ' A' ' 76' ' ' PHE . 76.8 t80 -88.81 109.24 20.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.667 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 30' ' ' GLN . 0.1 OUTLIER 49.03 27.52 1.72 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.716 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.72 -14.55 53.28 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.608 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -116.82 98.36 51.77 Favored Pre-proline 0 C--N 1.332 -0.174 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 31.7 Cg_exo -59.44 145.9 96.59 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.377 2.052 . . . . 0.0 112.814 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.466 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 41.5 mtt -145.08 162.03 37.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.006 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -90.31 156.2 18.44 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.893 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 29.0 m-85 -142.63 121.87 13.03 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.768 0.318 . . . . 0.0 111.218 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 88' ' ' TRP . 0.6 OUTLIER -125.82 97.81 5.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.098 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.703 HD13 ' HB2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.665 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.606 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 48.0 Cg_exo . . . . . 0 N--CA 1.465 -0.156 0 CA-C-O 120.81 0.254 . . . . 0.0 112.299 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.42 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 62.9 mm-40 -94.53 -33.23 13.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.617 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.15 -48.53 6.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.781 0.324 . . . . 0.0 111.72 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.403 ' HA ' ' CB ' ' A' ' 17' ' ' ALA . 13.2 m -87.45 -61.48 1.71 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.777 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 56' ' ' PRO . . . -59.22 -37.27 77.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.614 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.452 ' CD2' ' HG2' ' A' ' 65' ' ' MET . 0.5 OUTLIER -77.37 -25.63 51.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.957 0.408 . . . . 0.0 110.644 179.647 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.696 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.8 OUTLIER -58.05 -66.32 0.5 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.947 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.856 ' HA ' HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -67.45 -32.35 73.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.646 0.26 . . . . 0.0 111.589 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -64.89 -52.89 54.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.735 0.303 . . . . 0.0 111.323 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.586 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 26.0 mmt -54.85 -27.99 46.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.228 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.84 HG13 HG12 ' A' ' 72' ' ' ILE . 18.5 t -79.05 -39.58 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.152 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -60.79 -21.66 63.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.341 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -104.6 -28.06 11.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.288 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.027 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -108.06 115.52 30.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 0.0 111.172 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.488 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -70.59 -23.67 62.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.884 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.87 111.34 20.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 111.214 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.84 HG12 HG13 ' A' ' 66' ' ' VAL . 2.9 mp -136.6 93.32 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.389 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.563 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 3.9 mt-10 -105.26 128.8 53.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.74 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.797 HG21 ' CD2' ' A' ' 25' ' ' LEU . 22.0 t -103.16 123.28 56.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.448 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.74 50.74 2.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.251 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.575 ' HB3' HG12 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -92.77 148.89 21.67 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.212 -179.289 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.627 ' H ' HD11 ' A' ' 89' ' ' LEU . 7.3 t70 -73.85 156.4 37.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.225 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.48 32.52 2.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.171 0.51 . . . . 0.0 110.374 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.64 36.19 0.47 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.602 ' CB ' HD12 ' A' ' 89' ' ' LEU . 0.6 OUTLIER -78.17 128.24 33.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.622 0.725 . . . . 0.0 110.657 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -65.38 77.39 0.06 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.72 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.622 HG21 ' NE1' ' A' ' 88' ' ' TRP . 12.7 t . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.154 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.71 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 19.2 m95 . . . . . 0 C--O 1.225 -0.23 0 CA-C-O 120.648 0.261 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.835 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -90.94 157.49 17.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.694 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 170.91 164.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.264 0.555 . . . . 0.0 112.077 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.577 ' C ' HD12 ' A' ' 92' ' ' ILE . 4.2 m-85 -114.24 -48.13 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.088 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.577 HD12 ' C ' ' A' ' 91' ' ' TYR . 3.2 mp 61.85 129.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.301 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.563 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 9.4 p90 -151.19 140.62 21.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.105 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.027 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -113.03 122.43 47.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.524 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.9 t70 78.8 33.48 0.26 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.629 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.86 20.55 62.27 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.826 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.13 109.97 7.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.9 0.381 . . . . 0.0 111.096 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.413 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -59.64 147.26 38.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.848 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.332 -0.177 0 CA-C-O 120.974 0.416 . . . . 0.0 110.542 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.445 ' HA ' ' CE ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.794 0.33 . . . . 0.0 111.185 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.895 ' O ' HG12 ' A' ' 74' ' ' VAL . 22.5 mm-40 -155.04 113.99 2.34 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.295 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -88.44 104.77 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.718 2.279 . . . . 0.0 112.003 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.64 155.58 27.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.01 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 26' ' ' MET . 87.6 m -89.01 108.26 19.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.133 0.492 . . . . 0.0 111.151 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.817 HD22 ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -79.49 111.58 15.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.024 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.818 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -75.1 -46.18 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.248 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.818 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -177.29 173.14 1.79 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.006 0.432 . . . . 0.0 111.594 179.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.817 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -102.7 148.31 25.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.876 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mt -97.53 -72.91 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.639 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -118.09 41.91 2.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.713 0.292 . . . . 0.0 111.646 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.748 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 84.21 -52.41 4.71 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.736 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.53 -55.23 2.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 110.331 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.573 HG22 HG21 ' A' ' 33' ' ' THR . 4.0 m -68.55 106.87 2.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.148 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 17' ' ' ALA . 33.0 m -126.08 160.2 33.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.248 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.492 ' O ' HD13 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -95.73 142.4 28.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.662 179.644 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.817 ' HG ' HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -141.42 118.0 10.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.958 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.53 ' HB2' ' HB ' ' A' ' 13' ' ' THR . 3.8 mtt -72.22 99.29 2.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.572 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 5.3 t80 -96.47 104.74 16.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.192 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 38.67 52.72 1.87 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.34 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.34 -14.57 60.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.931 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.572 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -120.75 97.08 48.63 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 6.7 Cg_exo -75.52 101.87 1.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.677 2.251 . . . . 0.0 113.101 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.436 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 2.5 mtt -98.49 149.2 22.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.863 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.573 HG21 HG22 ' A' ' 22' ' ' THR . 5.8 m -77.95 158.9 29.15 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' A' ' 25' ' ' LEU . 72.4 m-85 -143.11 132.08 22.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.862 0.363 . . . . 0.0 110.833 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -133.68 114.47 13.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.376 -178.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.411 ' HB3' ' O ' ' A' ' 90' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.469 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.755 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 82.5 Cg_exo . . . . . 0 N--CA 1.472 0.243 0 N-CA-C 114.111 0.773 . . . . 0.0 114.111 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.831 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 2.7 tm-20 -82.62 -13.98 55.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.748 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -90.6 -65.24 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.517 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 32.5 t -93.18 -42.79 9.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.581 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.755 ' HB3' ' HA ' ' A' ' 56' ' ' PRO . . . -68.76 -29.53 67.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.874 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.831 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 4.9 t80 -90.05 -52.51 4.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.939 0.4 . . . . 0.0 111.295 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.817 HG21 ' HB2' ' A' ' 17' ' ' ALA . 16.8 m -51.79 -66.34 0.4 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.622 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -56.6 -33.31 66.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.745 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HD3' ' ND2' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -73.46 -54.46 8.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.762 0.315 . . . . 0.0 111.644 -179.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.592 ' SD ' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -51.49 -27.0 9.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.8 -179.424 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.639 HG12 HG12 ' A' ' 72' ' ' ILE . 33.6 m -99.01 -9.9 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -26.83 25.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.667 0.27 . . . . 0.0 111.305 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.4 ' ND2' ' HD3' ' A' ' 64' ' ' LYS . 25.3 p30 -103.63 -28.04 11.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.349 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -94.26 134.34 36.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.293 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -96.38 28.73 3.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.825 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.67 99.29 3.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.886 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.639 HG12 HG12 ' A' ' 66' ' ' VAL . 2.2 mp -130.16 91.29 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.071 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.427 ' HB3' ' OH ' ' A' ' 93' ' ' TYR . 0.7 OUTLIER -99.87 145.52 27.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.282 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.895 HG12 ' O ' ' A' ' 10' ' ' GLU . 14.8 p -119.9 128.69 75.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.257 0.551 . . . . 0.0 111.96 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.41 46.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.132 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.607 ' HB3' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -92.74 148.1 22.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.696 -178.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.511 ' H ' HD11 ' A' ' 89' ' ' LEU . 21.2 t0 -76.92 159.15 30.22 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.803 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.25 35.26 2.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.974 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.23 39.77 0.31 Allowed Glycine 0 CA--C 1.496 -1.152 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.773 ' CG ' HD12 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -78.28 138.94 38.86 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.296 1.046 . . . . 0.0 111.896 -178.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -66.19 69.62 0.06 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.156 -1.838 . . . . 0.0 110.615 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.887 HG21 ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.919 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.887 ' CD1' HG21 ' A' ' 82' ' ' THR . 12.8 m95 . . . . . 0 C--O 1.225 -0.227 0 CA-C-O 120.477 0.18 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.828 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -76.9 161.92 28.01 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.764 ' N ' HD22 ' A' ' 89' ' ' LEU . . . -179.68 179.74 0.56 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 90' ' ' ALA . 54.3 m-85 -154.7 39.29 0.43 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.746 -1.116 . . . . 0.0 109.572 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.533 HG12 HD11 ' A' ' 25' ' ' LEU . 2.8 mp -37.99 143.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.05 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.504 ' HB3' ' HG3' ' A' ' 98' ' ' MET . 5.2 p90 -151.31 142.43 23.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.094 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.592 ' HB3' ' SD ' ' A' ' 65' ' ' MET . . . -108.81 108.82 19.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.363 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER 82.0 23.96 0.23 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.89 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.77 -38.84 2.98 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.423 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.14 133.56 34.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 111.416 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.504 ' HG3' ' HB3' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -68.96 139.43 55.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.535 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.595 HG11 ' HA ' ' A' ' 62' ' ' THR . 15.6 m . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.829 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.81 0.338 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 42.7 p -87.21 114.68 24.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.909 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.01 117.98 27.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 m -86.64 104.03 15.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -86.99 154.9 20.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.849 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -78.87 110.38 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.596 HD12 ' HG3' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -91.51 118.15 30.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -88.18 162.45 16.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HE2' ' CG ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -93.05 121.37 34.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 74' ' ' VAL . 66.0 mm-40 -121.68 136.27 25.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.771 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.02 128.45 4.37 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.597 2.198 . . . . 0.0 112.434 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.501 ' HB3' HD22 ' A' ' 25' ' ' LEU . . . -149.38 126.11 11.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.572 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.85 HG22 HD13 ' A' ' 72' ' ' ILE . 1.7 p -86.98 108.74 18.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.04 0.447 . . . . 0.0 111.556 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.825 ' HB3' HG21 ' A' ' 66' ' ' VAL . 2.3 tt -69.51 114.93 8.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.914 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.994 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.6 pp -74.96 -43.8 45.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.994 ' N ' HD12 ' A' ' 15' ' ' ILE . 1.4 ttmt -167.6 143.32 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.911 0.386 . . . . 0.0 111.901 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.846 ' HB3' ' HA ' ' A' ' 59' ' ' SER . . . -87.39 148.21 25.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.518 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.3 mt -102.52 -76.07 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.21 30.67 7.1 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.622 0.231 . . . . 0.0 111.622 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.766 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 90.4 -45.0 2.93 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.736 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -96.64 -66.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.745 0.307 . . . . 0.0 110.419 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 m -66.75 106.84 1.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.013 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 17' ' ' ALA . 34.3 m -133.17 150.53 32.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.479 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.496 ' HG2' HG12 ' A' ' 15' ' ' ILE . 1.6 tppp? -80.06 143.75 33.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.332 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -140.84 117.84 11.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.216 -179.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.515 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -71.83 99.05 2.1 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.012 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 8.7 t80 -94.43 109.05 20.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.13 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.9 48.81 7.14 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.767 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.63 -14.17 48.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.9 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.465 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -119.97 97.81 49.4 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 32.2 Cg_exo -60.21 145.52 98.34 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.984 2.456 . . . . 0.0 114.052 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.416 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 29.9 mtm -145.34 140.1 27.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.101 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.595 ' HB ' ' O ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -79.89 157.02 27.04 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 16.6 m-85 -141.14 142.9 34.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.012 0.434 . . . . 0.0 111.913 -177.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.65 99.83 8.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.859 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.8 mt -47.19 171.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.563 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.794 ' O ' HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -115.59 -35.88 4.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.899 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tp -56.34 91.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.986 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 37' ' ' LEU . 21.6 t -107.43 109.91 29.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.07 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.549 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 0.4 OUTLIER -123.97 -167.53 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.626 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.665 HG23 ' HD2' ' A' ' 42' ' ' PRO . 10.2 m -136.79 152.51 74.43 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.665 ' HD2' HG23 ' A' ' 41' ' ' THR . 14.7 Cg_exo -70.99 117.35 5.11 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.576 2.184 . . . . 0.0 113.316 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 42' ' ' PRO . 4.6 mm-40 84.09 -13.31 0.74 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.71 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -110.95 -175.69 2.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.644 0.259 . . . . 0.0 110.777 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -62.28 -135.28 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 40' ' ' ASP . 12.7 p-80 -121.15 78.49 33.77 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.892 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 41' ' ' THR . 25.2 Cg_endo -100.6 -98.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 124.115 3.21 . . . . 0.0 112.97 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.14 96.44 4.03 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.632 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . 0.0 OUTLIER 171.67 54.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.058 0.456 . . . . 0.0 111.025 178.014 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.35 -30.06 1.89 Allowed Glycine 0 C--N 1.33 0.203 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.721 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.1 t -96.98 79.68 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.927 0.394 . . . . 0.0 110.732 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.621 ' HA ' ' HG3' ' A' ' 42' ' ' PRO . 52.8 tt0 -57.9 164.36 2.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.989 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -79.46 90.25 5.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.048 0.451 . . . . 0.0 111.024 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.879 ' OH ' ' HB2' ' A' ' 58' ' ' ALA . 8.4 p90 -135.85 -35.3 0.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.846 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.484 ' N ' ' CD1' ' A' ' 54' ' ' TYR . . . 106.27 -82.87 0.33 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.747 -0.739 . . . . 0.0 114.274 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.747 ' CB ' ' HB3' ' A' ' 60' ' ' ALA . 2.9 Cg_endo -89.38 -26.71 0.42 Allowed 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.518 2.812 . . . . 0.0 116.215 -176.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.665 ' HB3' ' CD1' ' A' ' 54' ' ' TYR . 4.4 tp10 -43.13 -25.56 0.12 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.879 ' HB2' ' OH ' ' A' ' 54' ' ' TYR . . . -91.41 -65.37 1.02 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.846 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 4.0 m -88.18 -30.33 19.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.747 ' HB3' ' CB ' ' A' ' 56' ' ' PRO . . . -89.45 -37.64 14.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.565 ' CB ' ' HA ' ' A' ' 57' ' ' GLU . 10.4 t80 -90.68 -43.49 10.1 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.665 HG22 HD13 ' A' ' 14' ' ' LEU . 21.3 m -40.85 -66.92 0.28 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 16' ' ' LYS . 0.6 OUTLIER -74.19 -19.85 60.4 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 3.1 mttp -59.09 -54.59 45.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 111.125 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.504 ' HE2' ' HG3' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -58.89 -27.49 65.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.03 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.825 HG21 ' HB3' ' A' ' 14' ' ' LEU . 42.7 t -72.44 -30.99 36.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.106 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -86.68 -13.99 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.555 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -96.2 -28.34 14.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.684 0.278 . . . . 0.0 111.291 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.739 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -108.22 147.52 31.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.805 0.336 . . . . 0.0 111.168 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.5 pttt -97.73 24.48 6.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.401 ' HG3' ' HA ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -145.4 98.98 3.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.819 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.85 HD13 HG22 ' A' ' 13' ' ' THR . 2.5 mp -121.84 93.76 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.733 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.439 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.8 tt0 -106.56 132.75 52.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.798 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.672 ' HB ' ' HB1' ' A' ' 90' ' ' ALA . 32.6 m -103.66 126.87 58.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.15 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.596 ' HG3' HD12 ' A' ' 7' ' ' LEU . 1.8 tt0 -79.9 52.63 1.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.322 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.784 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -97.01 149.73 21.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.649 -179.11 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.77 ' H ' HD11 ' A' ' 89' ' ' LEU . 8.6 t70 -80.03 159.77 26.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.888 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.5 29.98 3.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.091 0.472 . . . . 0.0 110.452 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.77 35.93 0.58 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.529 ' HB2' HD12 ' A' ' 89' ' ' LEU . 2.0 tp60 -78.27 124.52 28.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.405 0.622 . . . . 0.0 110.707 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -67.53 88.29 0.22 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.957 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.446 HG22 ' N ' ' A' ' 83' ' ' ASP . 92.0 m -97.07 161.45 13.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.446 ' N ' HG22 ' A' ' 82' ' ' THR . 0.9 OUTLIER -80.26 -53.25 6.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.676 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.409 ' O ' ' CG ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -134.69 -68.69 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.719 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.409 ' CG ' ' O ' ' A' ' 84' ' ' LYS . 4.5 m-85 -169.72 24.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.234 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.595 ' O ' ' HB ' ' A' ' 33' ' ' THR . . . -137.33 -4.49 1.96 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.959 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.524 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -113.88 48.31 1.09 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.623 0.725 . . . . 0.0 111.237 -179.174 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.59 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 78.3 m95 -91.33 142.83 27.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.872 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.87 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -76.93 158.76 30.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.672 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . 173.02 164.61 0.13 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.263 0.554 . . . . 0.0 112.342 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.787 ' CE1' HD13 ' A' ' 37' ' ' LEU . 19.1 m-85 -130.35 57.09 1.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.989 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.601 HG13 HG12 ' A' ' 74' ' ' VAL . 3.2 mp -42.07 127.77 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.424 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.485 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 3.1 p90 -142.89 143.88 32.23 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.075 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.739 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -112.81 124.18 52.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.789 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.401 ' HA ' ' HG3' ' A' ' 71' ' ' LYS . 0.1 OUTLIER 67.66 29.07 7.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.874 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.11 -35.89 3.93 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.001 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.504 ' HG3' ' HE2' ' A' ' 65' ' ' MET . 0.0 OUTLIER -86.94 130.43 34.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.904 0.383 . . . . 0.0 111.202 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.485 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 2.7 ttt -78.97 150.1 32.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.306 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.548 HG11 ' HA ' ' A' ' 62' ' ' THR . 25.8 m -51.12 -44.91 29.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.946 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.493 ' N ' HG23 ' A' ' 99' ' ' VAL . 3.1 m120 -68.23 -32.82 73.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.159 0.504 . . . . 0.0 110.037 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.49 ' HA ' ' HD3' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -74.22 -8.76 57.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.693 179.246 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.519 ' CB ' HD23 ' A' ' 103' ' ' LEU . . . -54.53 -82.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.744 ' HG ' HD23 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -115.19 -1.19 13.03 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.984 HG22 HD21 ' A' ' 108' ' ' LEU . 5.5 t -71.29 -1.64 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.699 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.49 ' HD3' ' HA ' ' A' ' 101' ' ' GLU . 8.6 mmm180 -81.78 -37.33 27.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.635 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.474 ' NE2' ' N ' ' A' ' 108' ' ' LEU . 1.5 pm0 -100.71 -14.77 17.95 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.659 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.6 32.95 0.54 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.241 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.984 HD21 HG22 ' A' ' 104' ' ' VAL . 11.2 mt 42.24 98.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.25 0.548 . . . . 0.0 112.115 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.496 ' N ' HD12 ' A' ' 103' ' ' LEU . . . -61.38 116.18 4.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.151 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.1 mttp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.923 179.967 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.822 0.344 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 t -121.36 137.96 54.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.06 116.23 31.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.46 153.08 19.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -101.15 146.07 27.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.991 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -78.02 110.72 13.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.695 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.447 ' HG ' ' HA ' ' A' ' 77' ' ' ASP . 4.2 mm? -76.56 157.03 32.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.4 25.91 10.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.731 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.435 ' HE2' ' CG ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER 63.83 110.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.127 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -104.79 127.98 27.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.518 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -90.02 163.69 4.86 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.752 2.301 . . . . 0.0 112.496 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.715 ' CB ' HD13 ' A' ' 25' ' ' LEU . . . -166.34 161.42 16.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.336 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 25' ' ' LEU . 35.6 p -93.55 108.34 20.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.327 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.962 HD12 HG11 ' A' ' 66' ' ' VAL . 2.2 tm? -89.15 119.57 29.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.149 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.897 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -74.76 -42.42 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.458 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.897 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER 179.87 173.17 0.96 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.249 0.547 . . . . 0.0 112.109 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.43 103.61 13.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.648 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' THR . 41.1 mm -53.3 -75.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.934 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -110.98 42.08 1.69 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.54 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.829 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 84.24 -52.15 4.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.924 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.49 -35.85 10.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.819 0.343 . . . . 0.0 110.422 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -71.39 106.79 4.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.27 179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.738 HG21 HD13 ' A' ' 92' ' ' ILE . 3.2 m -122.99 129.35 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.685 0.279 . . . . 0.0 111.245 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' HD22 ' A' ' 14' ' ' LEU . 13.4 tttp -91.71 97.98 11.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.687 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.062 HD22 HG21 ' A' ' 74' ' ' VAL . 2.8 pp -110.51 137.72 47.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.662 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.567 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 29.0 ttm -72.51 99.96 2.62 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.533 ' CE1' ' CE1' ' A' ' 76' ' ' PHE . 86.9 t80 -88.51 109.42 20.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.174 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.457 ' O ' ' OE1' ' A' ' 30' ' ' GLN . 0.1 OUTLIER 49.18 28.27 2.12 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.821 179.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.44 -14.24 54.33 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.396 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -116.87 97.73 50.96 Favored Pre-proline 0 C--N 1.331 -0.239 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 34.1 Cg_exo -61.03 143.13 99.11 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.286 1.991 . . . . 0.0 113.129 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.444 ' O ' ' HE1' ' A' ' 34' ' ' PHE . 51.8 mtt -145.2 159.78 42.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.25 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.556 ' CB ' ' HA2' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -97.17 156.61 16.32 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.852 ' CZ ' HD11 ' A' ' 25' ' ' LEU . 3.0 m-85 -138.05 157.98 45.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.789 0.328 . . . . 0.0 111.493 -177.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.662 ' O ' HD12 ' A' ' 36' ' ' LEU . 2.2 ttm-85 -139.13 99.06 3.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.584 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.662 HD12 ' O ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER 170.29 -82.03 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.529 179.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 41.01 100.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.769 HD21 ' HG3' ' A' ' 101' ' ' GLU . 0.2 OUTLIER 59.4 119.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.139 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.545 HG23 ' OH ' ' A' ' 91' ' ' TYR . 41.9 t -91.3 112.24 25.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.508 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 50' ' ' GLY . 3.1 p30 -135.97 -165.73 1.75 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.811 0.338 . . . . 0.0 111.449 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.617 HG23 ' O ' ' A' ' 44' ' ' THR . 3.8 t -130.15 126.62 22.38 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.564 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 41' ' ' THR . 14.0 Cg_exo -69.46 112.8 3.12 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.265 1.976 . . . . 0.0 112.467 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 69.28 -43.79 0.53 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 41' ' ' THR . 0.2 OUTLIER -73.01 176.07 6.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.939 0.4 . . . . 0.0 111.182 -179.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -131.66 13.66 4.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.002 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.41 ' O ' ' N ' ' A' ' 48' ' ' LYS . 2.1 m170 -95.19 170.97 7.09 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.577 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.91 83.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.611 2.207 . . . . 0.0 112.476 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.463 ' CB ' ' HB ' ' A' ' 41' ' ' THR . 0.3 OUTLIER -124.55 167.89 13.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.496 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.521 ' CB ' HG13 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -138.09 45.61 2.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.992 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 40' ' ' ASP . . . -123.25 131.92 8.35 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.623 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 51' ' ' VAL . 9.3 p -94.55 109.81 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.701 0.286 . . . . 0.0 110.268 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.421 ' O ' ' CE1' ' A' ' 54' ' ' TYR . 1.1 tm-20 -57.66 166.9 1.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.854 0.359 . . . . 0.0 110.683 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.88 97.47 7.46 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.993 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.637 ' OH ' ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -112.41 -34.88 5.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.685 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.25 -70.7 0.26 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.869 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.69 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 87.3 Cg_exo -48.79 -19.11 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.11 2.54 . . . . 0.0 114.087 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.811 ' HG3' HD21 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -93.88 -44.75 7.94 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.829 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -90.51 -65.4 1.02 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.5 p -65.57 -36.96 85.3 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.69 ' HB3' ' HA ' ' A' ' 56' ' ' PRO . . . -89.38 -57.4 2.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.543 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -61.07 -69.14 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.798 ' HA ' HG11 ' A' ' 99' ' ' VAL . 42.9 m -40.85 -66.57 0.31 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -55.93 -25.47 43.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.21 -63.17 1.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 0.0 111.878 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.553 ' SD ' ' HB3' ' A' ' 94' ' ' ALA . 1.6 mmm -50.86 -24.84 3.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.914 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.962 HG11 HD12 ' A' ' 14' ' ' LEU . 30.0 m -76.99 -31.02 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -94.18 -11.48 30.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.295 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -98.04 -28.17 13.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.66 0.267 . . . . 0.0 111.303 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.607 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . . . -102.68 143.91 31.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.884 0.374 . . . . 0.0 111.171 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -97.48 29.32 3.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.29 98.88 2.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.134 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.554 ' CG2' HG23 ' A' ' 92' ' ' ILE . 3.8 mt -119.23 94.67 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.397 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -94.94 137.18 34.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.86 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.062 HG21 HD22 ' A' ' 25' ' ' LEU . 21.3 t -116.97 102.87 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.423 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.435 ' CG ' ' HE2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -71.59 63.48 0.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.056 179.267 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.61 ' HB3' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -107.43 167.12 10.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.951 0.405 . . . . 0.0 111.834 -178.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.476 ' H ' HD11 ' A' ' 89' ' ' LEU . 6.9 t70 -104.29 162.05 13.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.34 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -101.0 32.6 3.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.414 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.69 33.55 0.32 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.944 ' HG3' HD12 ' A' ' 89' ' ' LEU . 1.4 mm-40 -78.37 128.96 34.4 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.542 0.686 . . . . 0.0 110.857 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.2 mtp85 -63.55 78.18 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.569 HG21 ' CD1' ' A' ' 88' ' ' TRP . 48.3 m -94.4 141.34 28.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.84 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.17 -50.55 73.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.907 0.384 . . . . 0.0 110.764 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.414 ' O ' ' CG ' ' A' ' 85' ' ' TYR . 1.8 tptm -138.44 -67.05 0.47 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.551 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.414 ' CG ' ' O ' ' A' ' 84' ' ' LYS . 7.8 m-85 -172.68 25.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.937 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.556 ' HA2' ' CB ' ' A' ' 33' ' ' THR . . . -134.4 -5.41 2.62 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.779 -1.2 . . . . 0.0 113.775 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.545 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -114.54 41.19 2.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.579 0.704 . . . . 0.0 110.924 -179.338 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.599 ' CE3' ' HB2' ' A' ' 80' ' ' GLN . 63.9 m95 -80.38 146.14 31.66 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.43 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.944 HD12 ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -77.36 164.43 25.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.885 ' HB1' HG13 ' A' ' 74' ' ' VAL . . . 175.28 172.89 0.27 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.288 0.566 . . . . 0.0 112.396 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.545 ' OH ' HG23 ' A' ' 39' ' ' VAL . 28.7 m-85 -141.78 41.7 1.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.98 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.738 HD13 HG21 ' A' ' 23' ' ' VAL . 3.2 mp -41.96 127.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.056 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 2.2 p90 -143.98 153.93 42.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.471 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.607 ' HB1' ' CB ' ' A' ' 69' ' ' ALA . . . -113.51 135.48 53.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.685 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.85 23.91 12.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.147 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.53 -12.17 65.98 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.037 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.426 ' HG3' ' HE1' ' A' ' 65' ' ' MET . 0.0 OUTLIER -107.38 127.64 53.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.943 0.401 . . . . 0.0 110.988 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.522 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 1.5 mpt? -71.61 150.12 44.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.155 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.798 HG11 ' HA ' ' A' ' 62' ' ' THR . 11.1 m -58.79 -37.78 68.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.113 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.893 ' O ' HG13 ' A' ' 104' ' ' VAL . 3.6 m-80 -75.33 -49.36 19.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.444 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.769 ' HG3' HD21 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -73.94 -8.59 56.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.229 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.484 ' HB3' HD23 ' A' ' 103' ' ' LEU . . . -59.06 -44.25 91.81 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.901 ' HG ' HD22 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -124.66 11.17 8.48 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.893 HG13 ' O ' ' A' ' 100' ' ' ASN . 8.3 m -55.06 -13.26 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.706 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.638 ' HD3' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -80.73 -46.46 15.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.545 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 103' ' ' LEU . 3.5 pp0? -70.76 -13.8 62.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.644 0.259 . . . . 0.0 111.696 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.61 34.91 0.47 Allowed Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.198 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.901 HD22 ' HG ' ' A' ' 103' ' ' LEU . 7.7 tp -90.53 170.37 10.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.637 ' HB3' ' OH ' ' A' ' 54' ' ' TYR . . . -52.13 113.01 0.89 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.814 0.34 . . . . 0.0 111.324 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.789 0.328 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.7 p -108.32 112.55 25.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.006 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 p -106.39 148.6 27.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.51 130.03 38.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.77 140.96 32.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.09 114.53 27.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.864 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pp -86.23 119.69 26.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -72.0 -177.38 2.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -114.91 128.6 56.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.059 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 20.0 mm-40 -123.82 115.74 27.87 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.672 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.92 161.15 7.47 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.688 2.258 . . . . 0.0 112.437 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.956 ' HB3' HD13 ' A' ' 25' ' ' LEU . . . -166.15 172.17 11.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.448 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 13' ' ' THR . 9.1 t -103.12 108.7 19.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.071 0.462 . . . . 0.0 111.264 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.682 ' HB3' HG11 ' A' ' 66' ' ' VAL . 2.8 tt -76.09 125.83 29.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.778 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.9 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.7 pp -74.9 -46.01 41.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.393 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.9 ' N ' HD12 ' A' ' 15' ' ' ILE . 4.1 mtmt 178.99 173.23 0.77 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.992 0.425 . . . . 0.0 111.373 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.964 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -98.72 148.05 24.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.391 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.771 HD12 HG22 ' A' ' 22' ' ' THR . 92.5 mt -102.71 -72.15 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.497 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -117.71 42.05 2.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.738 0.304 . . . . 0.0 111.532 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.795 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 82.37 -54.76 4.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.543 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.54 -35.72 11.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.018 0.437 . . . . 0.0 110.196 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.771 HG22 HD12 ' A' ' 18' ' ' ILE . 43.2 m -76.62 106.91 8.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.158 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.508 ' HB ' HD11 ' A' ' 14' ' ' LEU . 21.5 m -126.12 161.72 31.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.867 0.365 . . . . 0.0 111.189 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.483 ' HG2' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -119.41 134.18 55.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.297 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.956 HD13 ' HB3' ' A' ' 12' ' ' ALA . 1.3 pp -141.72 132.64 25.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.61 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.766 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -72.89 99.53 2.7 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.871 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.454 ' CE2' ' CE1' ' A' ' 76' ' ' PHE . 5.8 t80 -88.88 112.37 23.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.777 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 45.06 36.73 2.13 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.711 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.05 -14.41 65.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.457 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.26 97.34 49.51 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 51.6 Cg_endo -69.63 150.06 68.51 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.537 2.158 . . . . 0.0 112.994 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.401 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 3.4 mmt -145.3 161.17 40.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.049 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.06 124.08 40.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.861 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 2.1 m-85 -111.45 149.51 31.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.911 0.386 . . . . 0.0 111.693 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.593 ' O ' ' HB3' ' A' ' 36' ' ' LEU . 3.4 ttp85 -139.09 110.41 6.95 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.168 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.717 HD21 ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER 163.87 -150.87 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.288 179.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.817 HD11 HD12 ' A' ' 92' ' ' ILE . 2.9 mt 72.89 -78.67 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.798 HD21 HG21 ' A' ' 99' ' ' VAL . 3.0 mm? -67.47 92.89 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.845 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.9 t -111.36 109.23 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 0.0 111.191 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.412 ' OD1' HG13 ' A' ' 104' ' ' VAL . 0.8 OUTLIER -137.67 150.95 47.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.314 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 44' ' ' THR . 4.7 t -116.19 93.58 39.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.616 0.245 . . . . 0.0 111.248 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 49' ' ' LYS . 58.3 Cg_exo -51.51 117.49 3.52 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.451 2.101 . . . . 0.0 112.336 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 77.03 -60.19 0.46 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.188 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.545 ' O ' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -63.88 173.66 1.74 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.754 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.524 ' C ' HG21 ' A' ' 41' ' ' THR . 2.2 mmmp? -111.5 -26.35 9.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.848 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.443 ' O ' ' HB ' ' A' ' 41' ' ' THR . 1.1 m-70 -70.53 135.29 86.24 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 46' ' ' HIS . 25.9 Cg_exo -63.58 35.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.757 2.305 . . . . 0.0 114.25 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -129.15 95.54 4.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.675 0.274 . . . . 0.0 110.954 179.069 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.575 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER 173.3 41.12 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.454 179.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.31 -126.62 38.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.727 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.2 m -121.69 163.38 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.813 0.34 . . . . 0.0 111.37 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -75.47 161.39 29.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.57 179.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.51 92.44 9.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.156 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.808 ' CE1' HD13 ' A' ' 108' ' ' LEU . 9.9 p90 -135.19 -35.61 0.83 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.318 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.3 -105.98 3.33 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 114.929 0.732 . . . . 0.0 114.929 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 25.0 Cg_exo -38.56 -53.56 1.77 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.142 3.228 . . . . 0.0 116.079 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.554 ' HB2' ' CD2' ' A' ' 54' ' ' TYR . 5.8 mm-40 -48.82 -16.45 0.13 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.795 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -90.52 -62.31 1.49 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.671 0.272 . . . . 0.0 111.184 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.546 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 57.8 p -90.66 -48.98 6.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.975 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -55.06 -35.41 64.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.224 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.467 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 2.1 t80 -90.35 -19.92 23.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.479 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.964 HG21 ' HB2' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -77.59 -67.16 0.75 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.56 0.219 . . . . 0.0 111.331 -179.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.517 ' N ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -60.41 -23.79 64.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 111.34 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -80.93 -49.19 11.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.629 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.403 ' HG3' ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -50.03 -28.91 7.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.412 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.682 HG11 ' HB3' ' A' ' 14' ' ' LEU . 27.1 m -91.72 -26.89 4.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.273 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -76.51 -9.72 58.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.657 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -114.22 -28.1 7.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.606 0.241 . . . . 0.0 111.433 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.813 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -104.03 132.41 50.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 0.0 111.173 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -86.21 4.34 39.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.263 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.78 106.59 12.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.896 0.379 . . . . 0.0 110.968 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.509 HG12 HG12 ' A' ' 66' ' ' VAL . 4.1 mt -127.3 95.07 2.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.654 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -95.25 150.09 20.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.663 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.858 ' CG1' ' HB1' ' A' ' 90' ' ' ALA . 2.6 t -128.98 116.38 40.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.36 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -86.89 49.76 1.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.026 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -92.97 145.24 24.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.055 -179.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.513 ' H ' HD11 ' A' ' 89' ' ' LEU . 33.9 t0 -91.26 158.96 16.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.001 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -95.27 29.52 2.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.193 0.52 . . . . 0.0 110.25 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -153.49 37.68 0.73 Allowed Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.726 ' HB2' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -77.82 128.16 33.54 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.321 0.581 . . . . 0.0 110.198 -179.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -63.51 65.18 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.112 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.971 HG21 ' CE2' ' A' ' 88' ' ' TRP . 14.4 t -109.55 171.7 7.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.507 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -108.26 78.34 1.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 1.1 mppt? 65.11 -72.02 0.07 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.106 0.479 . . . . 0.0 109.948 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -144.94 15.87 1.56 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.366 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.496 ' O ' ' CG ' ' A' ' 87' ' ' ARG . . . -59.26 -23.23 57.41 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.08 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.515 ' HG3' ' HB2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 154.87 108.39 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.069 0.548 . . . . 0.0 110.76 179.231 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.971 ' CE2' HG21 ' A' ' 82' ' ' THR . 66.5 m95 -97.89 146.3 25.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.797 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.873 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -77.86 159.23 29.07 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.858 ' HB1' ' CG1' ' A' ' 74' ' ' VAL . . . -179.75 145.92 0.24 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -108.01 52.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.627 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.817 HD12 HD11 ' A' ' 37' ' ' LEU . 1.3 mp -57.71 132.94 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.504 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 73' ' ' GLU . 2.9 p90 -150.57 153.04 35.03 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.359 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.813 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -120.95 131.99 54.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.828 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.7 t70 67.57 25.9 8.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.021 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.31 19.91 77.77 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.842 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -137.1 114.11 10.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.923 0.392 . . . . 0.0 110.896 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.446 ' CA ' ' HB3' ' A' ' 93' ' ' TYR . 16.0 ptp -75.39 150.19 38.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.798 HG21 HD21 ' A' ' 38' ' ' LEU . 15.5 m -49.82 -31.58 6.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.091 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.654 ' OD1' HG11 ' A' ' 104' ' ' VAL . 13.1 t30 -75.95 -22.57 55.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.013 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -93.24 -11.72 31.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -91.12 -56.13 3.27 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.681 ' HB3' HD23 ' A' ' 108' ' ' LEU . 3.8 mm? -106.39 -50.78 3.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.678 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.654 HG11 ' OD1' ' A' ' 100' ' ' ASN . 38.6 t -56.62 -21.43 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.772 -0.194 . . . . 0.0 111.485 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -28.41 -48.12 0.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.432 HE22 ' N ' ' A' ' 108' ' ' LEU . 1.0 OUTLIER -121.05 -0.36 10.02 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.19 26.44 1.34 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.953 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.808 HD13 ' CE1' ' A' ' 54' ' ' TYR . 9.4 mt 61.44 122.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.059 0.457 . . . . 0.0 111.374 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.2 126.72 31.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.07 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.843 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.761 0.315 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.5 p -124.42 98.57 5.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.8 m -95.6 119.38 34.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.4 p -79.23 103.82 9.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.025 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.44 126.75 36.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.773 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.27 108.68 20.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.032 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.727 HD12 ' HG3' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -120.18 157.28 29.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.773 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -96.95 -40.99 8.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.0 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.727 ' HG3' HD12 ' A' ' 7' ' ' LEU . 11.7 mtpt 63.48 130.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.923 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.657 ' O ' HG22 ' A' ' 74' ' ' VAL . 4.5 mm-40 -136.05 145.56 52.95 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 10' ' ' GLU . 1.3 Cg_endo -83.42 105.49 1.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.735 2.29 . . . . 0.0 112.316 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.713 ' HB3' HD22 ' A' ' 25' ' ' LEU . . . -116.2 135.5 53.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.501 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.1 m -86.88 108.82 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.93 0.395 . . . . 0.0 111.644 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.579 HD22 ' HA ' ' A' ' 63' ' ' LYS . 10.2 tt -73.44 113.43 10.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.95 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.956 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.5 pp -74.7 -43.44 47.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.341 -0.391 . . . . 0.0 112.052 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.956 ' N ' HD12 ' A' ' 15' ' ' ILE . 37.9 tttp -173.65 151.56 1.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.077 0.465 . . . . 0.0 111.935 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.779 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -89.91 148.21 23.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.671 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.837 HD12 HG22 ' A' ' 22' ' ' THR . 21.0 mt -103.1 -73.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.687 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.12 26.86 9.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.633 0.254 . . . . 0.0 111.481 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.937 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 90.13 -44.33 2.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.744 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.7 -54.37 3.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 110.328 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.837 HG22 HD12 ' A' ' 18' ' ' ILE . 91.0 m -78.26 106.89 10.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.141 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.642 HG12 ' HA ' ' A' ' 17' ' ' ALA . 35.4 m -130.57 157.37 42.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.464 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.453 ' HB3' HG13 ' A' ' 15' ' ' ILE . 32.2 tttt -91.76 142.77 27.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.47 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.713 HD22 ' HB3' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -141.28 117.69 10.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.928 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.85 99.18 2.14 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.446 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 17.3 t80 -95.62 108.54 20.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.907 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.94 41.55 14.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.147 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.85 -14.13 61.07 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.459 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.471 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -117.75 98.19 51.43 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.999 0.428 . . . . 0.0 110.277 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.699 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 26.6 Cg_endo -62.54 144.4 94.43 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.705 2.27 . . . . 0.0 113.327 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.6 mmt -145.17 155.84 43.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.082 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.422 ' H ' ' HG1' ' A' ' 33' ' ' THR . 11.4 p -85.79 122.11 29.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.817 0.341 . . . . 0.0 111.214 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.651 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 16.8 m-85 -113.79 107.9 16.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.436 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.468 ' N ' ' O ' ' A' ' 88' ' ' TRP . 7.6 ttt180 -97.41 115.0 26.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.223 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.63 ' CD1' HG23 ' A' ' 39' ' ' VAL . 0.1 OUTLIER 179.05 -77.85 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.05 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.819 HD13 ' O ' ' A' ' 20' ' ' GLY . 0.4 OUTLIER 43.54 57.18 4.05 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.637 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.422 ' HB2' ' ND2' ' A' ' 100' ' ' ASN . 0.3 OUTLIER 53.42 94.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.343 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.63 HG23 ' CD1' ' A' ' 36' ' ' LEU . 38.9 t -67.03 109.93 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.725 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -130.18 -138.53 0.22 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.768 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.603 ' HB ' ' HA ' ' A' ' 47' ' ' PRO . 11.8 t -124.16 137.52 29.17 Favored Pre-proline 0 C--N 1.334 -0.105 0 O-C-N 122.37 -0.207 . . . . 0.0 110.783 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.616 ' HB3' ' CB ' ' A' ' 52' ' ' GLU . 7.9 Cg_exo -73.09 111.92 3.4 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.123 1.882 . . . . 0.0 111.964 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.4 -40.14 0.45 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -71.94 -165.17 0.15 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.873 0.368 . . . . 0.0 111.466 -179.04 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.448 ' C ' HG21 ' A' ' 41' ' ' THR . 0.0 OUTLIER -116.1 -37.7 3.78 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.715 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.537 ' O ' ' N ' ' A' ' 48' ' ' LYS . 1.1 m80 -75.89 115.71 48.88 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.603 ' HA ' ' HB ' ' A' ' 41' ' ' THR . 5.6 Cg_endo -48.09 75.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.424 2.749 . . . . 0.0 113.759 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 49' ' ' LYS . 1.2 tppp? -129.02 95.77 4.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.685 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.572 ' CB ' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER 102.49 37.63 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.376 0.671 . . . . 0.0 112.189 178.401 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 45.43 -128.11 8.47 Favored Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.129 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.84 143.32 28.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.926 0.393 . . . . 0.0 111.526 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.616 ' CB ' ' HB3' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -75.15 -177.03 3.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.185 0.516 . . . . 0.0 110.972 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -111.09 90.87 3.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.819 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.737 ' CZ ' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -96.52 -35.16 11.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 -179.295 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.04 -71.56 0.26 Allowed Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.615 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.826 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 56.6 Cg_exo -43.54 -45.76 10.36 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.058 2.505 . . . . 0.0 114.422 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.761 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 15.8 tm-20 -91.77 -64.61 1.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.937 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -60.46 -40.71 92.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.509 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 67.9 m -93.63 -43.4 8.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.826 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -89.5 -34.61 16.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.761 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 4.1 t80 -90.1 -24.34 21.14 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.779 HG21 ' HB2' ' A' ' 17' ' ' ALA . 1.7 m -56.82 -66.84 0.38 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.734 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -77.72 -19.73 54.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -48.03 -51.63 23.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 0.0 111.388 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.4 ttp -70.49 -17.61 62.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.305 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.847 HG13 HG12 ' A' ' 72' ' ' ILE . 48.1 t -88.64 -11.63 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.518 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -93.99 -6.77 44.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -114.7 -27.9 7.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.562 0.22 . . . . 0.0 111.447 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.642 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -100.9 142.26 32.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 111.343 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.92 28.57 4.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.556 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -142.2 98.92 3.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.005 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.847 HG12 HG13 ' A' ' 66' ' ' VAL . 3.2 mp -129.18 93.24 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.641 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.5 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 8.1 mt-10 -102.65 133.5 47.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.883 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 10' ' ' GLU . 27.8 m -104.26 138.26 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.895 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.464 ' HG3' HD13 ' A' ' 7' ' ' LEU . 64.8 tt0 -89.09 48.47 1.63 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.982 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.588 ' HB2' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -93.7 150.96 19.98 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.518 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.635 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 3.3 t70 -87.26 162.48 17.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.996 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.38 32.44 0.95 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.421 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.69 31.29 0.17 Allowed Glycine 0 CA--C 1.507 -0.46 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.635 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 11.5 mm-40 -81.74 127.93 33.46 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.684 0.754 . . . . 0.0 111.847 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -42.05 129.57 3.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.148 -1.387 . . . . 0.0 111.807 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.623 HG22 ' CE2' ' A' ' 88' ' ' TRP . 43.6 p -109.44 171.41 7.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.033 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 87' ' ' ARG . 18.4 t0 -146.73 -100.52 0.09 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.474 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -98.73 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 O-C-N 122.305 -0.247 . . . . 0.0 111.065 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.4 ' HB2' ' CG2' ' A' ' 33' ' ' THR . 42.6 m-85 -87.31 48.58 1.67 Allowed 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.157 0.503 . . . . 0.0 109.749 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.454 ' O ' ' C ' ' A' ' 87' ' ' ARG . . . 97.01 -34.4 5.09 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.545 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 86' ' ' GLY . 0.3 OUTLIER 27.55 74.72 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.276 0.56 . . . . 0.0 111.219 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.651 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 54.1 m95 -105.46 158.21 16.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.175 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.651 HD22 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -77.96 164.89 24.7 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.925 178.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.646 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 166.06 147.88 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.232 0.539 . . . . 0.0 111.677 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -99.47 -34.18 10.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.956 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.477 HG21 HD13 ' A' ' 14' ' ' LEU . 1.8 mp 59.03 115.19 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.508 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.5 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 6.4 p90 -141.16 136.46 31.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.986 0.422 . . . . 0.0 111.502 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -106.0 112.5 25.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.731 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.463 ' OD1' ' HB1' ' A' ' 69' ' ' ALA . 5.1 m-20 80.37 27.16 0.28 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.951 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.21 -28.63 9.34 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.957 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.77 130.85 39.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 111.165 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.463 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -76.5 145.35 39.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.922 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 62' ' ' THR . 35.3 m -73.82 -37.7 49.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.213 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 38' ' ' LEU . 0.9 OUTLIER -78.8 -37.1 41.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.977 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 98' ' ' MET . 0.2 OUTLIER -72.91 -9.24 58.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.295 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -91.12 -28.41 17.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.787 0.327 . . . . 0.0 111.231 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.623 ' HB3' HD23 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -111.76 -60.61 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 105' ' ' ARG . 8.6 t -58.7 -20.72 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.67 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -24.85 -55.91 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.504 ' NE2' ' N ' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -121.15 8.16 10.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.548 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.07 31.56 2.43 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.144 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.737 HD11 ' CZ ' ' A' ' 54' ' ' TYR . 6.8 mt 69.3 105.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.067 0.461 . . . . 0.0 111.172 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.67 129.56 37.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.003 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.7 mttp . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.885 -179.917 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.785 0.326 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.59 119.02 20.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.9 m -110.01 127.36 54.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p -104.71 131.34 52.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.87 125.08 40.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.935 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -119.12 111.6 18.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.936 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.681 ' N ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -120.06 157.27 29.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -70.83 173.83 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.446 ' HE3' ' HA ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -99.32 157.67 16.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -151.67 113.74 2.99 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.776 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 89.7 Cg_endo -85.35 110.72 1.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.63 2.22 . . . . 0.0 112.518 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.516 ' HB3' HD22 ' A' ' 25' ' ' LEU . . . -120.83 156.32 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.594 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -98.1 108.09 20.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.124 0.488 . . . . 0.0 111.656 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.798 ' HB3' HG21 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -76.28 108.93 9.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.643 178.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.837 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -74.79 -46.93 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.304 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.837 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -178.56 173.11 1.36 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.116 0.484 . . . . 0.0 111.776 179.47 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.804 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -94.86 148.26 22.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.951 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.4 mt -104.2 -70.38 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.781 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.05 42.22 2.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.726 0.298 . . . . 0.0 111.524 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.77 -57.21 5.05 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.52 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -96.74 -38.28 9.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.912 0.387 . . . . 0.0 110.116 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.799 HG22 HG21 ' A' ' 33' ' ' THR . 0.2 OUTLIER -77.7 106.75 9.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.106 179.263 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 17' ' ' ALA . 27.8 m -127.42 143.6 40.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.333 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.518 ' HB3' HD11 ' A' ' 15' ' ' ILE . 9.1 tppt? -81.88 142.78 32.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.509 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.769 ' HG ' HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -141.79 118.44 11.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.543 -179.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -72.4 99.39 2.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 20.8 t80 -96.33 107.54 19.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.203 -177.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm 45.13 48.98 9.85 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.652 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.13 -14.1 51.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.789 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -119.86 97.84 49.56 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 121.011 0.434 . . . . 0.0 110.019 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 24.6 Cg_exo -65.26 143.34 76.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.857 2.372 . . . . 0.0 113.38 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 mmt -145.05 151.86 39.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.555 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.799 HG21 HG22 ' A' ' 22' ' ' THR . 2.8 m -86.68 121.2 28.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.545 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 25' ' ' LEU . 2.1 m-85 -109.79 125.54 52.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.005 0.431 . . . . 0.0 111.518 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -98.61 118.07 34.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.976 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.496 ' N ' HD23 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -64.06 159.83 19.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.803 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.627 ' CD1' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -109.54 -171.95 1.95 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.002 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.5 tp 67.49 119.5 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.965 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.542 HG13 HG23 ' A' ' 51' ' ' VAL . 24.4 t -121.28 109.8 26.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.197 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.54 -163.14 0.85 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.413 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.456 HG21 ' HB ' ' A' ' 44' ' ' THR . 9.7 t -77.19 153.77 82.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.442 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.483 ' HB3' ' N ' ' A' ' 52' ' ' GLU . 5.7 Cg_endo -83.69 112.69 1.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.611 2.208 . . . . 0.0 112.209 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 42' ' ' PRO . 6.8 pt-20 49.44 20.59 0.48 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.131 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.456 ' HB ' HG21 ' A' ' 41' ' ' THR . 0.2 OUTLIER -111.66 -162.76 0.81 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.683 0.278 . . . . 0.0 110.628 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -154.79 28.3 0.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.74 0.305 . . . . 0.0 111.028 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.408 ' O ' ' N ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -118.67 171.17 5.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.635 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.05 71.3 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.683 2.256 . . . . 0.0 112.188 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 46' ' ' HIS . 0.1 OUTLIER -122.86 167.32 13.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.757 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.34 -173.45 2.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.673 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 56.93 97.34 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.37 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.542 HG23 HG13 ' A' ' 39' ' ' VAL . 16.7 t -70.72 79.93 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.768 0.318 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.483 ' N ' ' HB3' ' A' ' 42' ' ' PRO . 7.7 tt0 -57.68 92.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.343 0.592 . . . . 0.0 109.717 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -48.8 151.52 1.19 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.136 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.535 ' HE2' HD21 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -120.26 -28.43 5.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.644 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.41 -64.12 0.27 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.652 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.625 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 76.9 Cg_exo -52.62 -19.52 10.55 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.07 2.513 . . . . 0.0 113.405 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' HG2' ' N ' ' A' ' 58' ' ' ALA . 13.7 pm0 -94.24 -46.79 6.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.578 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -91.16 -65.67 0.99 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.792 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 73.8 m -60.66 -37.82 82.84 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.625 ' HB3' ' HA ' ' A' ' 56' ' ' PRO . . . -89.52 -61.83 1.61 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.448 ' CB ' ' O ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -55.34 -51.7 65.91 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' A' ' 58' ' ' ALA . 85.1 m -55.47 -66.26 0.45 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.619 0.247 . . . . 0.0 111.499 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -23.11 15.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.519 ' HZ2' ' HB1' ' A' ' 60' ' ' ALA . 1.9 mttp -88.07 -55.86 3.57 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.51 -26.49 3.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.716 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.882 HG13 HG12 ' A' ' 72' ' ' ILE . 36.0 t -91.73 -10.56 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -94.11 -5.97 46.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -111.2 -27.34 8.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.626 0.25 . . . . 0.0 111.426 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.866 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -105.62 141.12 37.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 0.0 111.172 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.27 29.04 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.762 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.45 ' HG3' ' HA ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -145.46 98.72 3.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.807 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.882 HG12 HG13 ' A' ' 66' ' ' VAL . 2.6 mp -127.67 92.14 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.665 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -94.87 147.58 23.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.754 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.588 HG13 ' HB1' ' A' ' 90' ' ' ALA . 36.7 t -116.31 129.15 73.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.684 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.446 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 34.2 tt0 -93.62 54.32 2.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.221 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.688 ' HA ' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -94.89 167.31 11.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.164 -178.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.448 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 2.0 t70 -104.43 162.55 13.14 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.041 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -94.18 28.78 2.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.936 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.62 26.93 0.2 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.776 ' HG3' HD12 ' A' ' 89' ' ' LEU . 1.8 mm-40 -78.54 127.12 31.7 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.63 0.729 . . . . 0.0 110.983 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -39.71 127.1 1.99 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.515 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 87' ' ' ARG . 75.2 p -109.18 172.04 7.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.088 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.423 ' N ' ' HB2' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -143.13 -82.19 0.18 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.471 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -81.51 -98.22 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.937 -0.119 . . . . 0.0 110.842 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -80.52 58.75 3.3 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.565 ' O ' ' CD1' ' A' ' 88' ' ' TRP . . . 58.84 37.57 90.8 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.372 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.591 ' O ' HG22 ' A' ' 82' ' ' THR . 0.0 OUTLIER -25.86 126.3 0.05 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.295 0.569 . . . . 0.0 112.121 -179.015 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.577 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 96.2 m95 -126.2 143.59 51.08 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.924 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.912 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -76.64 158.29 31.19 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.75 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 179.66 160.73 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.277 -0.569 . . . . 0.0 112.264 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.493 ' CE1' HD11 ' A' ' 37' ' ' LEU . 3.7 m-85 -113.1 -35.94 5.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.92 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.6 mt 59.67 119.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.809 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.437 ' OH ' ' HB3' ' A' ' 73' ' ' GLU . 4.9 p90 -141.63 123.44 15.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.866 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -99.25 96.55 7.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.665 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 94' ' ' ALA . 2.7 t0 85.26 55.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.997 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.11 27.71 57.69 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.852 -0.613 . . . . 0.0 113.453 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -137.25 112.72 9.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 0.0 111.001 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.417 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -78.21 136.12 37.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.068 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.615 ' O ' HD23 ' A' ' 103' ' ' LEU . 4.1 m -62.84 -31.03 50.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.98 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -80.91 -45.92 16.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.772 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -20.82 62.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.104 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.39 -34.55 15.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.277 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.888 ' CG ' HD22 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -62.31 -33.32 74.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.851 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 m -63.78 -1.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -32.16 -48.68 0.17 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.791 0.436 . . . . 0.0 111.923 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.522 ' NE2' ' HB2' ' A' ' 108' ' ' LEU . 1.0 OUTLIER -121.35 -1.79 9.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.624 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.24 24.54 1.04 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.378 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.888 HD22 ' CG ' ' A' ' 103' ' ' LEU . 0.9 OUTLIER -96.57 139.23 32.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.895 0.347 . . . . 0.0 110.582 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.18 144.41 48.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.384 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.911 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.842 0.353 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.43 122.84 48.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.4 m -63.82 102.18 0.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.946 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 m -84.79 129.11 34.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.49 134.45 51.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.85 113.42 26.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.855 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.792 HD11 ' HG2' ' A' ' 75' ' ' GLU . 2.0 pp -119.4 157.27 28.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.855 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.764 ' O ' HD12 ' A' ' 7' ' ' LEU . 7.7 m-70 -70.78 166.71 20.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.757 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.79 155.39 19.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 1.4 mp0 -141.57 113.89 6.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.632 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 5.8 Cg_exo -78.69 114.1 3.4 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.566 2.177 . . . . 0.0 112.238 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.535 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . . . -138.7 146.81 42.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.524 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.1 p -92.37 109.07 20.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.899 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.902 HD11 ' HB ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -76.9 119.57 20.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.758 178.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.921 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.4 pp -74.9 -41.96 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.921 ' N ' HD12 ' A' ' 15' ' ' ILE . 87.6 tttt -176.89 162.48 2.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.985 0.422 . . . . 0.0 111.58 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.045 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -97.22 148.09 23.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.89 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.515 HD12 ' HB ' ' A' ' 22' ' ' THR . 38.1 mt -96.54 -77.0 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.476 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -118.29 34.62 5.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.434 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.56 -45.36 2.93 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.504 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.73 -57.53 2.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 110.479 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.554 HG22 ' HE ' ' A' ' 87' ' ' ARG . 21.6 p -69.71 107.52 3.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.447 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.902 ' HB ' HD11 ' A' ' 14' ' ' LEU . 34.6 m -130.09 141.91 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.484 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.511 ' HG2' HG12 ' A' ' 15' ' ' ILE . 4.5 tptt -79.97 139.29 37.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.2 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.604 ' HB2' ' CD1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -141.54 119.29 11.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.6 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.497 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -72.36 99.35 2.41 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 20.0 t80 -94.84 108.34 20.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.193 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 tptp 45.68 47.5 11.63 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.594 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.48 -13.97 53.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.718 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.47 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -120.25 98.0 48.93 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 110.045 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 33.1 Cg_exo -61.67 143.92 96.92 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.849 2.366 . . . . 0.0 113.609 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.6 mmt -145.13 144.84 31.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.44 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.49 HG21 ' CZ ' ' A' ' 87' ' ' ARG . 86.2 m -82.31 120.02 24.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.73 0.3 . . . . 0.0 110.495 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.643 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 5.1 m-85 -105.02 124.37 49.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.784 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 88' ' ' TRP . 12.1 ttp180 -121.83 125.38 46.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.03 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.785 HD13 ' HB2' ' A' ' 89' ' ' LEU . 11.9 tp -175.71 -39.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.207 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.471 HD11 HD13 ' A' ' 92' ' ' ILE . 9.2 mt -55.39 87.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.974 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -131.91 -44.67 0.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.235 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.24 108.84 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.08 0.467 . . . . 0.0 111.326 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.13 172.7 12.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.24 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.673 HG23 ' O ' ' A' ' 44' ' ' THR . 2.3 t -145.72 92.17 5.52 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 120.717 0.294 . . . . 0.0 111.172 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.629 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 10.1 Cg_endo -49.39 116.48 2.31 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.453 2.769 . . . . 0.0 111.972 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER 81.17 -61.21 0.22 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.613 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.673 ' O ' HG23 ' A' ' 41' ' ' THR . 0.2 OUTLIER -71.98 169.09 16.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.814 0.34 . . . . 0.0 110.976 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' C ' HG21 ' A' ' 41' ' ' THR . 0.0 OUTLIER -111.59 -15.33 13.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.951 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.466 ' CG ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -70.65 171.18 8.62 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.289 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.466 ' HD2' ' CG ' ' A' ' 46' ' ' HIS . 74.2 Cg_endo -75.79 51.4 3.03 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.342 2.028 . . . . 0.0 112.707 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.2 96.48 4.47 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.969 0.414 . . . . 0.0 110.932 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.582 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -67.93 80.77 0.21 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.398 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.532 ' CA ' ' HG2' ' A' ' 42' ' ' PRO . . . -58.6 -111.4 0.01 OUTLIER Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.777 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.592 ' N ' ' CG ' ' A' ' 42' ' ' PRO . 14.9 t -121.57 78.51 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.629 ' HB2' ' HB3' ' A' ' 42' ' ' PRO . 0.9 OUTLIER -108.91 85.86 2.18 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 174.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.458 ' C ' ' CD1' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -144.0 89.1 2.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.047 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.466 ' CE2' HD21 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -135.8 -34.24 0.83 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.048 178.633 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.05 -62.29 0.29 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.607 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.905 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 81.8 Cg_exo -47.1 -20.09 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.172 2.581 . . . . 0.0 113.68 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.741 ' HB3' HD11 ' A' ' 103' ' ' LEU . 9.3 mm-40 -94.63 -27.67 15.76 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.501 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -90.72 -65.36 1.02 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.568 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -80.58 -25.01 38.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.666 0.27 . . . . 0.0 111.472 -179.02 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.905 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -89.27 -56.16 3.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.924 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.667 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 1.7 t80 -59.27 -39.22 82.22 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.94 0.4 . . . . 0.0 110.933 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 1.045 HG21 ' HB2' ' A' ' 17' ' ' ALA . 1.9 m -58.97 -66.39 0.51 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.675 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.485 ' HB2' ' HG3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -60.49 -38.69 85.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.781 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 11.1 mmtm -60.79 -61.48 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.654 ' CB ' HG12 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -46.73 -47.96 20.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.777 -179.12 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' ' 14' ' ' LEU . 27.5 m -70.31 -10.56 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.862 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -89.15 -34.1 16.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.665 0.269 . . . . 0.0 111.214 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -89.97 -28.09 19.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.194 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.984 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -104.92 104.83 14.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.986 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.04 -26.22 64.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.065 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.402 ' CG ' ' HA ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -85.85 98.95 11.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.956 0.407 . . . . 0.0 111.268 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 93' ' ' TYR . 2.3 mp -122.84 91.23 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.294 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 1.2 tt0 -97.23 139.9 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 111.04 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.741 HG13 ' HB1' ' A' ' 90' ' ' ALA . 29.7 t -111.29 141.36 26.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.454 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.792 ' HG2' HD11 ' A' ' 7' ' ' LEU . 2.8 tt0 -105.28 62.03 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.304 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.716 ' HB2' HD13 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.79 148.45 25.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.073 0.463 . . . . 0.0 111.805 -179.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.74 ' H ' HD11 ' A' ' 89' ' ' LEU . 21.4 t0 -77.24 162.3 27.47 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.176 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.3 32.41 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.804 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.09 33.08 0.27 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.468 ' CB ' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -78.52 128.01 32.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.52 0.676 . . . . 0.0 110.887 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.2 ttm-85 -56.32 113.91 1.77 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.851 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 87' ' ' ARG . 29.8 p -84.43 171.49 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.777 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.77 -89.86 0.19 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.329 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -83.13 -96.31 0.05 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 110.626 -0.139 . . . . 0.0 110.626 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -77.72 59.56 2.04 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 88' ' ' TRP . . . 58.17 21.06 45.51 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.522 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.554 ' HE ' HG22 ' A' ' 22' ' ' THR . 54.0 mmt-85 -15.04 123.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.11 0.564 . . . . 0.0 112.239 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.643 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 98.8 m95 -126.36 145.46 50.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.601 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.785 ' HB2' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -77.34 156.21 31.44 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.741 ' HB1' HG13 ' A' ' 74' ' ' VAL . . . 176.63 160.19 0.35 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.24 0.543 . . . . 0.0 112.212 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.431 ' C ' HD12 ' A' ' 92' ' ' ILE . 3.7 m-85 -108.91 -35.44 6.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.719 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.576 HG12 HD11 ' A' ' 25' ' ' LEU . 3.2 mp 59.44 122.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.956 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.495 ' OH ' ' HB3' ' A' ' 73' ' ' GLU . 4.3 p90 -144.65 142.85 30.42 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.113 0.482 . . . . 0.0 111.635 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.984 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -113.35 120.67 41.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.656 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.402 ' HA ' ' CG ' ' A' ' 71' ' ' LYS . 0.7 OUTLIER 76.14 27.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.109 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.46 -15.33 54.93 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.117 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.543 ' HD2' ' HB2' ' A' ' 102' ' ' ALA . 35.8 pttt -109.85 131.08 55.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.858 0.329 . . . . 0.0 110.986 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.426 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 6.2 mtt -72.01 140.69 49.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.736 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.821 HG11 ' HA ' ' A' ' 62' ' ' THR . 27.9 m -47.39 -37.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.937 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 110' ' ' LYS . 11.6 p-10 -79.21 -33.17 44.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.199 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 110' ' ' LYS . 0.8 OUTLIER -58.02 -54.75 43.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.039 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.543 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . . . -78.94 -3.01 42.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.626 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.747 ' HG ' HD13 ' A' ' 108' ' ' LEU . 5.9 tp -55.18 -28.61 54.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.808 0.337 . . . . 0.0 110.975 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.69 HG13 ' O ' ' A' ' 110' ' ' LYS . 0.6 OUTLIER -49.65 -11.37 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.456 ' C ' ' O ' ' A' ' 104' ' ' VAL . 5.3 ptm180 -24.78 -48.44 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.662 ' NE2' HD12 ' A' ' 108' ' ' LEU . 1.6 pp0? -121.34 -3.48 9.44 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.19 30.43 0.86 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.839 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.747 HD13 ' HG ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -88.27 -179.94 6.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.104 0.478 . . . . 0.0 111.247 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 41' ' ' THR . . . -51.34 150.13 3.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.03 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.69 ' O ' HG13 ' A' ' 104' ' ' VAL . 14.8 mmtt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.908 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.836 0.35 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.21 131.99 56.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.953 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -70.34 106.08 3.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 p -105.48 115.03 29.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.33 108.02 10.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.821 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.45 110.86 18.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.903 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.761 HD11 ' HG2' ' A' ' 75' ' ' GLU . 3.3 pp -91.84 153.15 19.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.838 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -93.85 158.08 15.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.87 121.48 35.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.678 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -135.1 113.93 11.58 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 83.1 Cg_endo -83.37 154.15 14.08 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.721 2.281 . . . . 0.0 112.26 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.857 ' CB ' HD13 ' A' ' 25' ' ' LEU . . . -166.23 157.31 13.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.72 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 25' ' ' LEU . 5.5 m -86.85 107.55 18.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.028 0.442 . . . . 0.0 111.279 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 14' ' ' LEU . 0.7 OUTLIER -98.83 108.0 20.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.565 178.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.851 ' HA ' HG11 ' A' ' 66' ' ' VAL . 1.4 pp -125.62 -13.2 4.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -113.29 123.04 49.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.09 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -112.88 103.67 11.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.241 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.544 HD12 ' HB ' ' A' ' 22' ' ' THR . 34.7 mt -62.65 -82.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.079 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -118.17 41.94 2.81 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.28 -47.26 3.69 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.103 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.568 ' HA ' HD13 ' A' ' 37' ' ' LEU . 33.9 m-20 -96.37 -41.09 8.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.964 0.411 . . . . 0.0 110.024 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.544 ' HB ' HD12 ' A' ' 18' ' ' ILE . 2.1 p -82.55 106.87 14.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.787 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.698 ' HB ' HD21 ' A' ' 14' ' ' LEU . 35.1 m -121.53 155.65 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 111.718 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.9 127.42 56.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.734 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.94 HD22 HG21 ' A' ' 74' ' ' VAL . 2.0 pp -133.82 143.2 48.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.32 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.592 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -72.54 99.21 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -93.41 106.37 18.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.3 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 tttm 50.35 55.33 9.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.819 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.56 13.41 60.8 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.199 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.406 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -142.14 97.94 6.23 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.699 0.285 . . . . 0.0 110.245 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 40.8 Cg_endo -67.36 146.48 75.24 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.566 2.177 . . . . 0.0 113.01 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.3 mmt -145.36 161.2 40.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.388 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.467 HG22 HD11 ' A' ' 18' ' ' ILE . 20.2 p -91.34 126.03 36.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.485 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.834 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 3.2 m-85 -111.35 124.19 51.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.041 0.448 . . . . 0.0 110.892 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.539 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -108.82 98.95 8.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.165 -179.297 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.708 HD22 ' HB2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER 169.7 151.91 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.015 0.436 . . . . 0.0 111.261 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.697 HD23 ' HB3' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -179.28 39.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.609 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tp 63.64 -102.83 0.11 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.13 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.49 ' CG2' HG23 ' A' ' 41' ' ' THR . 11.3 p -142.32 139.19 29.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.899 0.38 . . . . 0.0 111.162 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.499 ' OD1' HG21 ' A' ' 104' ' ' VAL . 75.6 m-20 -137.19 62.81 1.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.961 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.661 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 59.2 p -76.77 110.79 12.79 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.738 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 12.9 Cg_exo -70.47 112.93 3.33 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.716 2.278 . . . . 0.0 112.933 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 72.04 -50.09 0.69 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.41 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.9 152.65 22.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.814 0.34 . . . . 0.0 111.343 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.09 -1.0 37.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.817 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.634 ' O ' HG21 ' A' ' 41' ' ' THR . 22.6 m170 -70.71 171.17 8.71 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.114 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.412 ' CD ' ' HB3' ' A' ' 46' ' ' HIS . 17.2 Cg_exo -67.65 47.29 0.32 Allowed 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.677 2.252 . . . . 0.0 113.077 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -128.5 96.15 4.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.684 0.278 . . . . 0.0 110.72 179.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.661 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 0.4 OUTLIER -83.0 -173.23 4.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.038 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 151.91 -122.28 1.31 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.403 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.6 p -121.36 86.59 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.854 0.359 . . . . 0.0 111.43 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.449 ' HB3' HD12 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -57.81 171.09 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.855 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -78.55 90.44 4.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.352 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.721 ' CZ ' ' HB2' ' A' ' 58' ' ' ALA . 27.3 p90 -135.58 -34.57 0.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.798 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.465 ' N ' ' CD1' ' A' ' 54' ' ' TYR . . . 93.78 -110.86 4.04 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.749 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.732 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 90.9 Cg_endo -89.4 -3.49 5.89 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.077 2.518 . . . . 0.0 113.763 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.908 ' HG2' HD11 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -58.04 -14.08 5.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.721 ' HB2' ' CZ ' ' A' ' 54' ' ' TYR . . . -91.39 -65.57 1.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 24.5 m -88.04 -23.59 23.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.97 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -88.91 -46.11 9.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.536 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -63.99 -49.97 70.36 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.207 0.527 . . . . 0.0 109.914 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 1.09 HG21 ' HB2' ' A' ' 17' ' ' ALA . 2.6 t -49.81 -31.71 12.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.913 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' A' ' 15' ' ' ILE . 6.9 mttm -82.71 -41.96 18.64 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.138 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -72.33 -30.43 64.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.254 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -40.62 80.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.851 HG11 ' HA ' ' A' ' 15' ' ' ILE . 9.1 p -83.14 -29.54 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.14 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.19 -9.15 59.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.519 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -111.24 -28.13 8.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.699 0.285 . . . . 0.0 111.337 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.95 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -107.92 141.52 39.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.177 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -102.02 25.41 8.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.81 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 98.8 3.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.69 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.53 ' CD1' HG23 ' A' ' 66' ' ' VAL . 3.6 mp -123.13 92.35 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . 7.6 mt-10 -94.98 136.77 34.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.748 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.94 HG21 HD22 ' A' ' 25' ' ' LEU . 24.6 t -116.08 123.25 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.193 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.761 ' HG2' HD11 ' A' ' 7' ' ' LEU . 4.9 tt0 -85.57 54.51 3.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.734 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.684 ' HA ' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -95.03 164.64 12.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.127 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.681 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -99.94 162.08 13.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.843 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -92.84 30.79 1.5 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.47 31.31 0.16 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.498 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.801 ' HG3' HD12 ' A' ' 89' ' ' LEU . 34.0 mm-40 -78.54 125.57 29.55 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.524 0.678 . . . . 0.0 111.081 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -44.14 120.89 2.28 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.168 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 86' ' ' GLY . 43.5 p -101.98 171.45 7.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.04 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -134.51 -83.37 0.43 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.478 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 -86.37 0.22 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.456 0.17 . . . . 0.0 111.132 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -93.99 36.59 1.11 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.962 0.411 . . . . 0.0 110.415 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.482 ' O ' HG22 ' A' ' 82' ' ' THR . . . 109.48 -33.53 6.04 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.404 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.48 ' C ' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 27.62 54.0 0.06 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.619 0.723 . . . . 0.0 110.777 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.532 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 70.2 m95 -85.41 155.44 21.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.916 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.876 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -77.81 158.23 29.61 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.854 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 173.25 156.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.201 0.524 . . . . 0.0 111.895 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.706 ' C ' HD12 ' A' ' 92' ' ' ILE . 3.5 m-85 -112.63 -41.1 3.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.624 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.706 HD12 ' C ' ' A' ' 91' ' ' TYR . 2.8 mp 58.55 121.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.08 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 15.0 p90 -142.54 130.59 21.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.377 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.95 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -103.58 124.14 48.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.603 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.3 t70 74.79 27.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.864 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.21 22.34 77.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.863 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 115.38 11.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 111.046 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.428 ' CG ' ' HB3' ' A' ' 93' ' ' TYR . 4.0 mtm -72.0 129.53 38.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.515 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -35.91 34.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.863 0.364 . . . . 0.0 110.584 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.985 ' O ' HG12 ' A' ' 104' ' ' VAL . 4.3 p30 -74.36 -50.28 19.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.049 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.468 ' HA ' ' CD ' ' A' ' 105' ' ' ARG . 1.1 tm-20 -67.51 -8.93 37.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.882 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.74 -36.75 65.2 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.929 ' HG ' HD23 ' A' ' 108' ' ' LEU . 1.1 pt? -151.74 -47.36 0.11 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.985 HG12 ' O ' ' A' ' 100' ' ' ASN . 2.9 p -39.52 -26.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.468 ' CD ' ' HA ' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -59.18 -44.45 92.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.114 179.604 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.52 ' NE2' ' N ' ' A' ' 108' ' ' LEU . 1.3 pm0 -92.07 -20.06 21.68 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.964 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 130.07 33.81 0.49 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.482 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.929 HD23 ' HG ' ' A' ' 103' ' ' LEU . 2.2 mt 43.58 98.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.096 0.474 . . . . 0.0 112.125 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.463 ' O ' ' CG ' ' A' ' 110' ' ' LYS . . . -58.44 150.43 22.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.772 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 109' ' ' ALA . 5.4 pttp . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.214 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.832 0.349 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.97 90.45 3.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.878 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 t -74.94 117.35 16.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 t -95.21 128.76 42.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.826 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.1 118.7 6.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.43 112.54 13.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.81 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.652 HD21 ' HB2' ' A' ' 78' ' ' LYS . 3.1 mp -71.69 133.19 45.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.959 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.31 -49.18 6.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.627 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HE3' ' CA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER 179.37 134.95 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.997 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 74' ' ' VAL . 3.3 mp0 -115.32 131.95 23.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.684 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -87.45 125.49 2.12 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.596 2.198 . . . . 0.0 112.398 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.462 ' HB3' HD22 ' A' ' 25' ' ' LEU . . . -149.19 127.74 12.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.444 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.594 ' HA ' HD13 ' A' ' 72' ' ' ILE . 2.5 t -86.56 108.56 18.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.039 0.447 . . . . 0.0 110.727 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.691 HD11 ' HB ' ' A' ' 23' ' ' VAL . 3.2 tt -77.45 121.39 23.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.418 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.857 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -74.55 -48.6 34.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.671 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.857 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER 179.68 168.4 1.16 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.943 0.401 . . . . 0.0 111.259 179.21 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.714 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -87.27 148.13 25.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.082 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.6 mm -91.37 -69.73 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.341 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -118.13 35.93 4.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.246 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.84 ' C ' HD12 ' A' ' 38' ' ' LEU . . . 89.29 -48.5 3.4 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.65 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -96.7 -56.18 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.359 . . . . 0.0 110.616 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.516 HG23 ' HD2' ' A' ' 87' ' ' ARG . 11.4 m -70.69 106.81 3.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.501 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 34' ' ' PHE . 27.8 m -114.96 154.83 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.308 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.91 140.06 29.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.762 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.698 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -141.34 118.41 11.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.052 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.31 99.41 2.4 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.636 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 2.7 t80 -91.23 102.29 15.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.755 -178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.9 tttp 43.16 50.15 5.63 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.658 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.33 -14.33 59.66 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.563 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.636 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -118.32 97.21 50.61 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.698 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 10.7 Cg_exo -72.06 130.19 16.24 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.319 2.013 . . . . 0.0 112.97 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 6.2 mmt -124.85 157.22 36.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.16 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 p -86.67 119.54 27.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.037 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.738 ' O ' HG22 ' A' ' 23' ' ' VAL . 17.9 m-85 -111.03 107.77 17.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.652 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -94.17 109.53 21.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.31 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.731 HD22 ' HB2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER 171.03 -31.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 179.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.671 HD12 HD13 ' A' ' 92' ' ' ILE . 1.3 tt -60.61 79.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.35 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.84 HD12 ' C ' ' A' ' 20' ' ' GLY . 1.4 tt 178.45 63.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.141 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.9 109.49 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 0.0 110.686 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.428 ' HB3' HD11 ' A' ' 108' ' ' LEU . 3.2 p30 -137.71 169.72 17.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.022 0.439 . . . . 0.0 111.477 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.494 ' CB ' ' HB2' ' A' ' 48' ' ' LYS . 1.7 t -137.51 108.07 8.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.794 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.471 ' CD ' ' HA3' ' A' ' 50' ' ' GLY . 11.2 Cg_exo -73.78 120.32 6.35 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.949 2.433 . . . . 0.0 113.062 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.424 ' CB ' ' O ' ' A' ' 42' ' ' PRO . 2.3 tm-20 83.72 -51.57 0.14 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.732 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 41' ' ' THR . 0.6 OUTLIER -93.17 159.31 15.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.862 0.363 . . . . 0.0 111.095 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.32 4.65 31.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 2.3 m170 -70.79 169.12 15.57 Favored Pre-proline 0 N--CA 1.455 -0.189 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.544 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 46' ' ' HIS . 34.0 Cg_endo -65.0 64.8 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.384 2.056 . . . . 0.0 112.512 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.494 ' HB2' ' CB ' ' A' ' 41' ' ' THR . 6.1 mmpt? -101.13 168.56 9.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.329 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.414 ' CA ' ' O ' ' A' ' 40' ' ' ASP . 36.6 mtmt -123.49 9.24 9.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.386 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.471 ' HA3' ' CD ' ' A' ' 42' ' ' PRO . . . -63.48 130.09 40.31 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.08 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 51' ' ' VAL . 11.4 m -87.74 89.35 3.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.814 0.34 . . . . 0.0 111.337 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.99 -177.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.641 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.57 90.98 5.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.382 . . . . 0.0 111.355 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 55' ' ' GLY . 15.2 p90 -130.73 -34.64 1.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.696 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.52 ' N ' ' CD1' ' A' ' 54' ' ' TYR . . . 77.4 -110.88 3.13 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 114.462 0.545 . . . . 0.0 114.462 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.447 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 28.1 Cg_exo -38.15 -40.99 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.947 3.098 . . . . 0.0 115.136 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.622 ' O ' HD21 ' A' ' 103' ' ' LEU . 0.5 OUTLIER -45.44 -19.9 0.05 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.577 ' O ' ' HB ' ' A' ' 62' ' ' THR . . . -90.63 -65.08 1.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -87.52 -32.25 19.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -75.8 -35.12 60.16 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.534 ' CD2' HD11 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -89.98 -30.86 17.52 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.714 HG21 ' HB2' ' A' ' 17' ' ' ALA . 15.3 t -60.62 -54.56 43.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . 13.3 ptmt -65.3 -43.1 92.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.373 . . . . 0.0 110.875 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -48.99 74.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.079 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.525 ' CB ' HG13 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -55.98 -30.38 61.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.139 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.689 ' HA ' ' HB2' ' A' ' 94' ' ' ALA . 32.6 m -92.5 -31.21 4.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.036 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -72.08 -5.94 38.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.657 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -95.02 -28.13 15.28 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.609 0.242 . . . . 0.0 111.598 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.033 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -107.98 151.01 26.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 111.404 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.8 ttmm -99.18 17.55 19.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.255 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.97 98.98 4.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.907 0.384 . . . . 0.0 110.797 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.698 ' CG2' HG23 ' A' ' 92' ' ' ILE . 2.4 mp -118.69 94.17 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.112 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.515 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 2.4 mt-10 -104.89 131.23 52.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.607 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 92' ' ' ILE . 31.4 m -106.28 145.46 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.894 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.401 ' CA ' ' HE3' ' A' ' 9' ' ' LYS . 14.5 tt0 -99.78 54.41 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.488 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.533 ' HB2' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -97.63 166.23 11.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.7 -179.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.761 ' HB3' ' HG2' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -104.3 162.53 13.13 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.969 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.652 ' HB2' HD21 ' A' ' 7' ' ' LEU . 4.5 tmtp? -92.25 23.93 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.314 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.97 20.78 0.36 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.535 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.761 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 17.0 mm-40 -78.61 128.87 34.09 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.542 0.686 . . . . 0.0 111.116 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.451 ' C ' ' O ' ' A' ' 80' ' ' GLN . 1.4 mpp_? -23.45 118.38 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.966 -1.47 . . . . 0.0 111.784 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.51 HG22 ' CE2' ' A' ' 88' ' ' TRP . 5.8 p -109.12 171.34 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.688 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 3.8 t0 -179.02 155.94 0.77 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.964 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 43.76 -101.7 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.686 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -96.94 36.33 1.43 Allowed 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 120.939 0.399 . . . . 0.0 110.762 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 82' ' ' THR . . . 104.91 -36.82 4.14 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.416 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.516 ' HD2' HG23 ' A' ' 22' ' ' THR . 0.0 OUTLIER 29.27 75.63 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.187 0.518 . . . . 0.0 111.263 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.589 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 68.2 m95 -109.96 163.23 13.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.458 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.731 ' HB2' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -81.12 154.08 26.96 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.442 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 179.13 153.21 0.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.18 0.514 . . . . 0.0 112.14 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.621 ' C ' HD12 ' A' ' 92' ' ' ILE . 28.9 m-85 -111.37 -35.08 5.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.942 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.698 HG23 ' CG2' ' A' ' 72' ' ' ILE . 3.3 mp 54.38 109.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.295 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.525 ' HB3' ' HA ' ' A' ' 98' ' ' MET . 6.4 p90 -127.74 137.13 52.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.058 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.033 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -106.38 123.88 48.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.657 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 t70 73.65 26.17 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.84 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.33 21.91 74.42 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.828 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.14 113.96 10.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.525 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 7.5 mtt -60.47 139.1 57.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.724 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.661 HG11 ' HA ' ' A' ' 62' ' ' THR . 15.1 t -53.05 -53.31 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.05 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.68 ' O ' HG23 ' A' ' 104' ' ' VAL . 12.4 p30 -63.71 -26.42 68.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.576 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 98' ' ' MET . 0.0 OUTLIER -58.75 -30.6 67.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.932 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -91.1 -46.81 7.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.343 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.799 HD23 HD21 ' A' ' 108' ' ' LEU . 1.4 mp -49.31 -39.2 30.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.063 0.459 . . . . 0.0 111.295 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 100' ' ' ASN . 24.2 t -74.37 -1.87 3.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.962 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.4 ptt85 -42.81 -43.91 4.21 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.694 0.283 . . . . 0.0 111.551 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -121.28 0.74 10.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.417 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 110.87 31.48 2.91 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.799 HD21 HD23 ' A' ' 103' ' ' LEU . 3.1 mt 73.22 111.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.466 0.651 . . . . 0.0 111.452 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.4 139.5 40.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.166 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.966 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.891 0.377 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.4 p -124.51 118.33 26.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -77.04 127.72 33.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 t -92.54 140.44 29.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.83 139.84 36.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.564 ' C ' HD22 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -90.26 109.51 20.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.936 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.564 HD22 ' C ' ' A' ' 6' ' ' LYS . 3.4 mm? -115.03 157.07 23.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.942 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.02 -167.56 0.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.88 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.474 ' HZ1' ' HB2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -135.96 127.52 28.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.897 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.883 ' O ' HG22 ' A' ' 74' ' ' VAL . 23.9 mm-40 -122.79 154.32 63.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 85.1 Cg_endo -86.73 156.33 8.9 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.763 2.309 . . . . 0.0 112.298 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.889 ' HB1' HD13 ' A' ' 25' ' ' LEU . . . -166.27 157.34 13.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.052 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.12 108.38 19.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.779 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.627 ' CD2' HG21 ' A' ' 66' ' ' VAL . 5.7 tt -77.12 121.16 23.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.859 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.6 pp -74.83 -44.6 45.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.206 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.859 ' N ' HD12 ' A' ' 15' ' ' ILE . 9.1 tttm 179.51 163.32 0.94 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.878 0.37 . . . . 0.0 111.187 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.878 ' HB3' ' HA ' ' A' ' 59' ' ' SER . . . -91.75 145.91 24.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.331 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.4 mt -96.97 -75.27 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.548 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -117.5 42.14 2.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.519 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.775 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 84.65 -53.61 4.84 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.675 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.47 ' HA ' ' CD1' ' A' ' 37' ' ' LEU . 13.7 m-20 -96.68 -37.71 10.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 110.553 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -76.99 106.84 8.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.702 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 17' ' ' ALA . 29.1 m -127.93 152.21 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.722 0.296 . . . . 0.0 111.221 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.436 ' HG2' HG12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -113.03 131.66 55.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.211 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.889 HD13 ' HB1' ' A' ' 12' ' ' ALA . 0.5 OUTLIER -141.44 148.74 40.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.421 178.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.68 99.8 2.66 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.705 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 24.2 t80 -88.42 111.21 21.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.314 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 38.23 38.59 0.22 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.172 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.8 -14.47 58.87 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.295 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.705 ' NE2' ' O ' ' A' ' 27' ' ' TYR . 2.1 pm0 -120.54 96.94 48.91 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.116 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 39.4 Cg_exo -61.5 127.34 21.51 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.53 2.154 . . . . 0.0 112.552 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.562 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -133.04 161.84 33.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.709 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 88' ' ' TRP . 55.5 m -92.8 156.98 16.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.836 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 10.6 m-85 -143.14 136.04 27.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.649 0.262 . . . . 0.0 111.611 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.615 ' HB3' ' HD3' ' A' ' 87' ' ' ARG . 7.7 ttm180 -139.56 115.21 10.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.934 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 20.2 tp 167.21 -64.58 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.626 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.795 HD23 ' HB2' ' A' ' 100' ' ' ASN . 2.7 mp 64.18 -83.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.119 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.426 ' HG ' ' CE2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -177.58 -76.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.717 0.294 . . . . 0.0 111.024 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.553 HG12 HG22 ' A' ' 41' ' ' THR . 1.4 t -141.84 123.65 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.991 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.728 ' HB3' HG22 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -115.9 34.1 5.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.281 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 44' ' ' THR . 2.6 t -76.9 123.49 87.43 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.516 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.507 ' HG3' ' N ' ' A' ' 52' ' ' GLU . 13.2 Cg_exo -69.1 112.47 2.97 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.304 2.003 . . . . 0.0 112.257 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.59 -46.02 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.568 ' O ' HG23 ' A' ' 41' ' ' THR . 0.2 OUTLIER -72.35 174.98 6.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.94 0.4 . . . . 0.0 111.417 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -128.12 15.64 6.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.882 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.452 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 1.8 m170 -95.12 168.69 10.62 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.445 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HD2' ' CB ' ' A' ' 46' ' ' HIS . 2.0 Cg_endo -45.1 90.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.741 2.294 . . . . 0.0 112.181 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.414 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -44.52 167.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.44 0.638 . . . . 0.0 112.219 -179.443 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.84 -37.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.531 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.456 ' O ' ' CG ' ' A' ' 42' ' ' PRO . . . -134.17 114.97 1.39 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.023 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.728 HG22 ' HB3' ' A' ' 40' ' ' ASP . 9.1 t -69.5 147.98 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.101 0.477 . . . . 0.0 111.206 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.507 ' N ' ' HG3' ' A' ' 42' ' ' PRO . 0.6 OUTLIER -57.85 167.16 1.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.479 -179.127 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.47 90.8 5.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.495 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.764 ' CE2' HD13 ' A' ' 108' ' ' LEU . 12.5 p90 -124.29 -34.76 2.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.197 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.521 ' N ' ' CD1' ' A' ' 54' ' ' TYR . . . 84.41 -107.1 2.97 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.701 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.524 ' HD2' ' O ' ' A' ' 54' ' ' TYR . 24.6 Cg_exo -38.41 -42.83 1.77 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.917 3.078 . . . . 0.0 114.983 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.596 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 1.6 tp10 -47.41 -17.44 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.775 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -90.5 -63.16 1.31 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.878 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 37.3 m -92.79 -43.89 8.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.379 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 56' ' ' PRO . . . -62.93 -31.96 73.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.575 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.596 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 3.3 t80 -88.83 -44.25 10.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.371 . . . . 0.0 110.997 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.723 HG21 ' HB2' ' A' ' 17' ' ' ALA . 3.0 m -60.15 -66.28 0.55 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.757 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -55.44 -23.48 25.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.516 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -83.6 -54.7 4.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 111.5 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 mmt -47.69 -27.62 2.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.662 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.627 HG21 ' CD2' ' A' ' 14' ' ' LEU . 27.2 m -94.02 -19.05 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.34 -25.24 39.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.535 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -97.29 -28.3 14.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.399 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.634 ' O ' HD11 ' A' ' 72' ' ' ILE . . . -108.2 108.07 18.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.143 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -15.49 52.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.877 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.418 ' HG3' ' HA ' ' A' ' 95' ' ' ASP . 2.8 ptpt -91.8 101.71 14.31 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.383 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.891 HG23 ' O ' ' A' ' 93' ' ' TYR . 3.3 mp -134.88 99.14 2.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.255 0.55 . . . . 0.0 110.997 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 2.2 mt-10 -93.26 179.59 5.37 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.649 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.883 HG22 ' O ' ' A' ' 10' ' ' GLU . 31.3 m -145.22 139.67 22.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.977 0.418 . . . . 0.0 111.528 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.474 ' HB2' ' HZ1' ' A' ' 9' ' ' LYS . 5.1 tp10 -106.49 41.34 1.45 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.181 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -92.76 160.45 14.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.662 -179.154 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.707 ' H ' HD11 ' A' ' 89' ' ' LEU . 8.2 t0 -90.92 152.59 20.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.081 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.28 31.3 2.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.154 0.502 . . . . 0.0 110.347 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.02 38.5 0.64 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.825 ' HB2' HD12 ' A' ' 89' ' ' LEU . 1.3 tp60 -78.11 126.84 31.41 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.929 -0.636 . . . . 0.0 110.642 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.24 79.22 0.05 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.792 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.949 HG21 ' CG ' ' A' ' 88' ' ' TRP . 0.1 OUTLIER -102.0 171.28 7.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.009 -178.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.2 -36.21 13.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.342 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.473 ' O ' ' CD2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER 177.14 -31.42 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.473 ' CD2' ' O ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER 163.38 -23.16 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 110.502 -0.185 . . . . 0.0 110.502 -179.522 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -44.46 -24.75 0.68 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.851 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.849 ' O ' HG22 ' A' ' 82' ' ' THR . 0.2 OUTLIER -175.84 130.06 0.25 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.807 0.337 . . . . 0.0 110.908 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.949 ' CG ' HG21 ' A' ' 82' ' ' THR . 20.9 m95 -126.95 169.81 12.92 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.53 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.911 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -82.82 152.09 25.79 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.62 ' N ' HD22 ' A' ' 89' ' ' LEU . . . -178.26 162.2 1.52 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.362 0.601 . . . . 0.0 112.432 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 37' ' ' LEU . 3.5 m-85 -117.15 -17.52 10.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.646 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.737 HD13 ' HG ' ' A' ' 37' ' ' LEU . 5.3 mp 64.31 158.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.843 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.891 ' O ' HG23 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -151.13 134.12 15.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.752 -178.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -134.72 105.19 6.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.863 0.363 . . . . 0.0 111.496 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.418 ' HA ' ' HG3' ' A' ' 71' ' ' LYS . 14.7 t0 54.51 43.8 29.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.748 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.28 -22.41 23.45 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.13 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -116.41 127.72 54.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.942 0.401 . . . . 0.0 110.89 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.53 148.9 49.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.891 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -56.75 -35.71 46.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.303 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.919 ' O ' HG22 ' A' ' 104' ' ' VAL . 11.6 t30 -78.95 -50.1 11.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.053 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -47.9 -28.3 2.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.569 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -91.02 -56.58 3.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.504 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.86 HD23 HD21 ' A' ' 108' ' ' LEU . 2.8 mp -44.83 -51.01 9.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.89 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 100' ' ' ASN . 14.7 m -67.11 -2.09 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.437 ' HG3' ' HG3' ' A' ' 106' ' ' GLN . 10.9 ptm180 -36.79 -46.04 0.58 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.81 0.338 . . . . 0.0 111.715 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.437 ' HG3' ' HG3' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -121.23 -0.18 9.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.254 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.6 28.68 2.05 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.86 HD21 HD23 ' A' ' 103' ' ' LEU . 1.6 mt 72.99 105.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.346 0.593 . . . . 0.0 111.371 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.94 150.08 25.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.286 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.5 mptt . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.917 179.981 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.806 0.336 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.7 t -114.0 99.75 7.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.2 p -101.06 121.35 41.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.943 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.4 p -64.99 138.33 58.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.808 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -97.63 112.73 24.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.021 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.68 109.66 5.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.808 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -105.39 118.08 35.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -96.68 -28.38 14.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.667 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 75' ' ' GLU . 1.2 mmpp? -131.22 121.18 24.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.786 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.471 ' HG2' ' CE2' ' A' ' 27' ' ' TYR . 0.6 OUTLIER -132.32 125.83 20.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.065 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -84.52 146.43 10.83 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.67 2.246 . . . . 0.0 112.502 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.673 ' CB ' HD21 ' A' ' 25' ' ' LEU . . . -166.37 173.06 10.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.94 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.26 108.57 15.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.021 0.439 . . . . 0.0 111.246 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.651 HD11 ' HB ' ' A' ' 23' ' ' VAL . 3.7 tt -86.83 120.84 28.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.055 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.738 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.7 pp -75.55 -46.41 37.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.513 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.738 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER 179.98 173.11 0.99 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.176 0.512 . . . . 0.0 111.87 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.88 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -94.78 148.3 22.43 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.677 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.735 HD12 ' O ' ' A' ' 22' ' ' THR . 2.0 mp -101.8 -70.04 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.681 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.65 42.14 1.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.318 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.456 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 83.68 -54.32 4.94 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.547 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -96.8 -49.37 5.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.751 0.31 . . . . 0.0 110.296 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.735 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -63.84 106.68 1.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.23 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.651 ' HB ' HD11 ' A' ' 14' ' ' LEU . 30.2 m -122.59 142.43 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.485 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -87.99 124.71 34.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.673 HD21 ' CB ' ' A' ' 12' ' ' ALA . 1.3 tt -141.52 121.89 14.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.77 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.601 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 15.0 ptp -72.48 102.46 3.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.326 0.584 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.471 ' CE2' ' HG2' ' A' ' 10' ' ' GLU . 10.5 t80 -88.72 109.65 20.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.285 -178.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.91 46.52 18.85 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.602 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.9 -6.61 65.74 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.687 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.453 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -124.59 98.47 37.45 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 26' ' ' MET . 17.3 Cg_exo -68.87 143.71 56.26 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.985 2.457 . . . . 0.0 114.245 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.475 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 2.3 mtt -145.36 148.54 33.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.028 -1.442 . . . . 0.0 108.255 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.552 ' CG2' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -87.48 157.29 19.23 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.587 ' CD2' ' HB2' ' A' ' 88' ' ' TRP . 5.0 m-85 -140.8 149.39 41.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.075 0.464 . . . . 0.0 111.712 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 88' ' ' TRP . 0.3 OUTLIER -117.65 97.87 6.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.886 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.759 ' C ' HD13 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -56.77 159.54 3.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.314 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.847 HD11 ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -133.66 -178.56 5.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.797 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 63.46 38.66 9.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.038 HG11 HG12 ' A' ' 51' ' ' VAL . 13.2 t -104.38 160.3 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.478 ' N ' HG12 ' A' ' 39' ' ' VAL . 0.6 OUTLIER -66.59 179.49 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.974 0.416 . . . . 0.0 111.361 -179.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 5.9 t -105.97 143.16 26.35 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.906 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.45 ' CD ' ' HB3' ' A' ' 49' ' ' LYS . 4.6 Cg_exo -76.38 112.34 3.45 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.397 2.065 . . . . 0.0 111.808 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 76.63 -41.6 0.41 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.437 ' HB ' HG21 ' A' ' 41' ' ' THR . 0.2 OUTLIER -68.55 -178.94 1.23 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.76 0.314 . . . . 0.0 111.351 -179.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.405 ' H ' HG22 ' A' ' 44' ' ' THR . 3.0 mmmt -108.11 -41.01 5.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.032 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.425 ' O ' ' HB ' ' A' ' 41' ' ' THR . 0.4 OUTLIER -70.54 125.62 92.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.97 45.14 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.646 2.231 . . . . 0.0 114.016 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.95 95.81 4.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.572 0.225 . . . . 0.0 110.834 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.45 ' HB3' ' CD ' ' A' ' 42' ' ' PRO . 0.0 OUTLIER 171.15 42.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.95 0.405 . . . . 0.0 110.727 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 61.75 -123.78 32.61 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.619 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.038 HG12 HG11 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -117.87 148.19 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 111.376 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.46 ' O ' ' CE1' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -66.86 152.29 45.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.151 179.404 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.58 90.63 6.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.719 0.295 . . . . 0.0 110.84 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.661 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 1.1 p90 -119.88 -35.75 3.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.899 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.19 -86.5 0.78 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.624 -0.798 . . . . 0.0 115.059 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.766 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 90.7 Cg_exo -49.37 -54.52 5.33 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.431 2.754 . . . . 0.0 115.711 -177.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.661 ' HB3' ' CE2' ' A' ' 54' ' ' TYR . 13.9 tm-20 -60.23 -23.51 64.11 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.783 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.456 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -91.06 -57.17 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.609 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 28.5 m -82.73 -31.34 28.5 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . -86.63 -53.22 5.08 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.541 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -61.54 -27.87 68.92 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.001 0.429 . . . . 0.0 110.958 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.88 HG21 ' HB2' ' A' ' 17' ' ' ALA . 1.1 m -63.73 -57.48 9.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.033 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.462 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -82.95 -36.14 25.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.591 -179.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 60' ' ' ALA . 28.6 ttpt -63.2 -49.44 74.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.426 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.505 ' CB ' HG12 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -58.25 -31.49 67.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 0.0 111.055 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.487 HG12 HG12 ' A' ' 72' ' ' ILE . 25.0 m -89.81 -29.3 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.178 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -53.28 -25.48 14.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.343 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -106.02 -28.17 10.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 111.404 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.918 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -92.43 130.93 37.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.08 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -96.51 28.17 3.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.62 98.93 3.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.114 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.487 HG12 HG12 ' A' ' 66' ' ' VAL . 3.0 mt -120.97 95.26 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.392 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 1.9 mt-10 -94.61 160.35 14.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.77 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.713 HG12 ' HB3' ' A' ' 76' ' ' PHE . 56.0 t -132.08 114.99 25.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.084 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.425 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 2.3 tm-20 -79.96 53.73 1.74 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.407 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.713 ' HB3' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -97.48 164.63 12.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.112 0.482 . . . . 0.0 112.026 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -104.26 162.51 13.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.087 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.636 ' HB2' HD11 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -96.58 31.76 2.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.681 179.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.5 32.16 0.31 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.956 ' HG3' HD12 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -78.5 127.97 32.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.6 0.714 . . . . 0.0 111.062 -179.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -67.63 84.29 0.19 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.919 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.574 HG21 ' NE1' ' A' ' 88' ' ' TRP . 10.2 t -106.23 163.14 13.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.87 -69.35 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -129.58 -66.41 0.8 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.807 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -162.04 24.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.806 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.547 ' C ' ' HD3' ' A' ' 87' ' ' ARG . . . -136.34 -5.22 2.09 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 119.802 -1.19 . . . . 0.0 114.143 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.547 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -114.68 42.88 2.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.487 0.661 . . . . 0.0 111.453 -178.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.587 ' HB2' ' CD2' ' A' ' 34' ' ' PHE . 66.4 m95 -80.8 150.67 29.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.089 178.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.958 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -76.7 155.68 33.12 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.994 -0.683 . . . . 0.0 109.999 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.685 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 172.86 160.33 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.252 0.549 . . . . 0.0 111.794 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -112.31 -37.52 4.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.063 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.566 HG21 HD13 ' A' ' 14' ' ' LEU . 2.6 mp 60.12 127.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.738 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.45 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 8.9 p90 -149.07 141.46 24.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 111.321 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.918 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -111.31 119.08 37.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.491 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 76.38 20.11 1.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.071 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.93 -19.88 53.02 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.147 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.471 ' HG3' ' HE1' ' A' ' 65' ' ' MET . 0.0 OUTLIER -104.21 128.71 51.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.893 0.378 . . . . 0.0 111.426 -179.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.423 ' HB2' ' CB ' ' A' ' 101' ' ' GLU . 16.0 mtt -68.41 150.21 48.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.505 HG12 ' CB ' ' A' ' 65' ' ' MET . 33.2 m -77.78 -45.4 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.599 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.619 ' O ' HG13 ' A' ' 104' ' ' VAL . 1.0 OUTLIER -80.5 -33.96 36.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.238 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.423 ' CB ' ' HB2' ' A' ' 98' ' ' MET . 0.6 OUTLIER -71.47 -8.78 56.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.649 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -90.17 -67.88 0.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.77 ' HB3' HD23 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -55.86 -26.63 47.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.892 -179.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 100' ' ' ASN . 17.1 m -66.53 -5.71 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.96 -44.05 4.44 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 103' ' ' LEU . 0.7 OUTLIER -121.09 10.89 10.83 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.89 26.78 4.28 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.653 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.77 HD23 ' HB3' ' A' ' 103' ' ' LEU . 11.6 mt 62.57 106.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.059 0.456 . . . . 0.0 111.368 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.437 ' H ' HD12 ' A' ' 103' ' ' LEU . . . -62.59 113.19 2.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.088 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.7 pttt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.832 179.949 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.722 0.296 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.8 m -134.11 89.47 2.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.858 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.87 141.71 58.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 4' ' ' THR . 4.7 t -107.73 106.34 16.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -102.03 139.11 38.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.931 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -104.51 108.98 20.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.85 139.6 33.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.83 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.68 175.09 5.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.95 119.49 39.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.926 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -134.36 113.96 12.35 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.799 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 92.6 Cg_endo -85.67 147.49 9.63 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.713 2.275 . . . . 0.0 112.467 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.699 ' CB ' HD13 ' A' ' 25' ' ' LEU . . . -166.02 162.13 17.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.759 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.458 HG23 HD13 ' A' ' 72' ' ' ILE . 1.4 m -104.46 108.58 20.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.926 0.393 . . . . 0.0 111.258 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.856 HD11 ' HA ' ' A' ' 63' ' ' LYS . 2.4 pp -65.18 133.33 51.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.47 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.883 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.7 pp -74.67 -42.32 47.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.42 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.883 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER 179.47 170.66 1.02 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.597 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.466 ' HA ' HG12 ' A' ' 23' ' ' VAL . . . -92.92 148.17 22.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.753 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.2 mt -106.36 -74.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.391 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -118.02 42.15 2.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.824 0.345 . . . . 0.0 111.312 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.3 -56.81 5.04 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.373 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.8 -32.29 12.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.352 . . . . 0.0 110.377 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -77.21 109.86 11.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.556 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 34' ' ' PHE . 33.6 m -131.82 155.78 41.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 3.2 ttpp -119.29 135.3 54.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.803 0.335 . . . . 0.0 111.335 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.893 ' HG ' ' CE1' ' A' ' 34' ' ' PHE . 2.8 pp -141.89 146.32 35.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.303 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.553 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 6.0 ttm -72.2 101.67 2.87 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.839 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.451 ' CE1' ' CZ ' ' A' ' 76' ' ' PHE . 76.8 t80 -88.81 109.24 20.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.667 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.446 ' O ' ' OE1' ' A' ' 30' ' ' GLN . 0.1 OUTLIER 49.03 27.52 1.72 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.716 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.72 -14.55 53.28 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.608 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -116.82 98.36 51.77 Favored Pre-proline 0 C--N 1.332 -0.174 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 31.7 Cg_exo -59.44 145.9 96.59 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.377 2.052 . . . . 0.0 112.814 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.466 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 41.5 mtt -145.08 162.03 37.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.006 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -90.31 156.2 18.44 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.893 ' CE1' ' HG ' ' A' ' 25' ' ' LEU . 29.0 m-85 -142.63 121.87 13.03 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.768 0.318 . . . . 0.0 111.218 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.729 ' HB3' ' HD3' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -125.82 97.81 5.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.098 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.703 HD13 ' HB2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -178.67 161.92 1.33 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.665 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 36' ' ' LEU . 1.3 tp 164.97 -34.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.51 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mp 63.87 50.16 2.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.498 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 39' ' ' VAL . 28.0 m -130.93 112.61 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.45 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -127.86 -47.3 1.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.428 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.439 HG22 ' HD2' ' A' ' 42' ' ' PRO . 3.2 m -104.58 142.85 25.5 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.166 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.439 ' HD2' HG22 ' A' ' 41' ' ' THR . 45.1 Cg_endo -86.62 112.46 1.03 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.562 2.174 . . . . 0.0 113.144 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 72.95 -13.88 0.64 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.37 156.25 21.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.911 0.386 . . . . 0.0 111.455 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -92.75 -29.62 15.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.524 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.582 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 4.0 m170 -70.64 171.47 8.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.813 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 46' ' ' HIS . 99.7 Cg_exo -44.64 163.34 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.282 1.988 . . . . 0.0 112.695 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.438 ' HA ' HG23 ' A' ' 41' ' ' THR . 0.1 OUTLIER -37.96 142.02 0.18 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.834 -179.39 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -99.07 -50.03 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.931 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 172.15 -35.19 0.14 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.058 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.402 ' O ' ' HG3' ' A' ' 42' ' ' PRO . 2.5 m -121.57 79.14 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.873 0.368 . . . . 0.0 111.289 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.05 -178.09 3.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.522 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.75 94.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.779 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.41 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 0.3 OUTLIER -71.8 -33.99 69.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.879 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 143.08 -57.47 0.55 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.036 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.606 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 48.0 Cg_exo -56.15 -21.99 37.89 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.57 2.18 . . . . 0.0 112.299 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.523 ' HG3' HD22 ' A' ' 108' ' ' LEU . 62.9 mm-40 -94.53 -33.23 13.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.617 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.15 -48.53 6.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.781 0.324 . . . . 0.0 111.72 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.403 ' HA ' ' CB ' ' A' ' 17' ' ' ALA . 13.2 m -87.45 -61.48 1.71 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.777 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 56' ' ' PRO . . . -59.22 -37.27 77.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.614 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.452 ' CD2' ' HG2' ' A' ' 65' ' ' MET . 0.5 OUTLIER -77.37 -25.63 51.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.957 0.408 . . . . 0.0 110.644 179.647 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.696 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.8 OUTLIER -58.05 -66.32 0.5 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.947 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.856 ' HA ' HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -67.45 -32.35 73.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.646 0.26 . . . . 0.0 111.589 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -64.89 -52.89 54.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.735 0.303 . . . . 0.0 111.323 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.586 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 26.0 mmt -54.85 -27.99 46.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.228 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.84 HG13 HG12 ' A' ' 72' ' ' ILE . 18.5 t -79.05 -39.58 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.152 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -60.79 -21.66 63.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.341 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -104.6 -28.06 11.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.288 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.027 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . . . -108.06 115.52 30.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 0.0 111.172 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.488 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -70.59 -23.67 62.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.884 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.87 111.34 20.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 111.214 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.84 HG12 HG13 ' A' ' 66' ' ' VAL . 2.9 mp -136.6 93.32 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.389 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.563 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 3.9 mt-10 -105.26 128.8 53.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.74 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.797 HG21 ' CD2' ' A' ' 25' ' ' LEU . 22.0 t -103.16 123.28 56.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.448 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.74 50.74 2.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.251 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.575 ' HB3' HG12 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -92.77 148.89 21.67 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.212 -179.289 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.627 ' H ' HD11 ' A' ' 89' ' ' LEU . 7.3 t70 -73.85 156.4 37.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.225 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.48 32.52 2.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.171 0.51 . . . . 0.0 110.374 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.64 36.19 0.47 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.602 ' CB ' HD12 ' A' ' 89' ' ' LEU . 0.6 OUTLIER -78.17 128.24 33.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.622 0.725 . . . . 0.0 110.657 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -65.38 77.39 0.06 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.72 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.622 HG21 ' NE1' ' A' ' 88' ' ' TRP . 12.7 t -83.8 160.26 21.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.154 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -91.93 49.42 1.54 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.678 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.444 ' O ' ' CB ' ' A' ' 85' ' ' TYR . 7.5 tttm 77.97 32.94 0.36 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.462 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.444 ' CB ' ' O ' ' A' ' 84' ' ' LYS . 36.5 m-85 88.73 -9.39 0.47 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.601 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.31 -16.26 41.73 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.4 -0.905 . . . . 0.0 111.654 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.729 ' HD3' ' HB3' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -177.31 131.25 0.17 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.085 0.469 . . . . 0.0 111.197 179.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.71 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 19.2 m95 -127.64 171.35 11.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.391 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.835 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -90.94 157.49 17.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.694 ' N ' HD22 ' A' ' 89' ' ' LEU . . . 170.91 164.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.264 0.555 . . . . 0.0 112.077 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.577 ' C ' HD12 ' A' ' 92' ' ' ILE . 4.2 m-85 -114.24 -48.13 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.088 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.577 HD12 ' C ' ' A' ' 91' ' ' TYR . 3.2 mp 61.85 129.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.301 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.563 ' CE1' ' HB2' ' A' ' 73' ' ' GLU . 9.4 p90 -151.19 140.62 21.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.105 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.027 ' HB1' ' HB3' ' A' ' 69' ' ' ALA . . . -113.03 122.43 47.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.524 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.9 t70 78.8 33.48 0.26 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.629 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.86 20.55 62.27 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.826 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.458 ' HD3' ' HB2' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -137.13 109.97 7.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.9 0.381 . . . . 0.0 111.096 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.413 ' HA ' ' HB3' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -59.64 147.26 38.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.848 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -52.41 -33.2 17.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.974 0.416 . . . . 0.0 110.542 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.48 ' HA ' HG23 ' A' ' 104' ' ' VAL . 3.0 m-80 -80.57 -36.79 32.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.873 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -24.81 62.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.711 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.458 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . . . -91.35 -22.51 20.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.501 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.62 ' HB3' HD23 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -117.95 -66.32 1.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.806 0.336 . . . . 0.0 111.21 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.48 HG23 ' HA ' ' A' ' 100' ' ' ASN . 40.7 t -54.85 -13.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.062 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -30.82 -44.48 0.06 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 103' ' ' LEU . 0.4 OUTLIER -121.25 -4.26 9.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.513 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.81 30.28 0.97 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.193 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.62 HD23 ' HB3' ' A' ' 103' ' ' LEU . 14.0 mt 63.27 107.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.183 0.516 . . . . 0.0 111.264 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.12 136.55 37.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.196 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.789 0.328 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.6 p -108.03 137.41 46.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -90.05 124.76 35.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 m -81.32 138.07 35.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.83 120.14 29.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 112.11 8.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.698 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.477 HD22 ' HG3' ' A' ' 75' ' ' GLU . 1.3 pp -119.92 157.1 29.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -110.63 6.26 21.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.362 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.445 ' HA ' ' CE ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER 62.52 146.2 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.794 0.33 . . . . 0.0 111.185 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.895 ' O ' HG12 ' A' ' 74' ' ' VAL . 22.5 mm-40 -155.04 113.99 2.34 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.295 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -88.44 104.77 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.718 2.279 . . . . 0.0 112.003 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.64 155.58 27.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.01 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 26' ' ' MET . 87.6 m -89.01 108.26 19.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.133 0.492 . . . . 0.0 111.151 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.817 HD22 ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -79.49 111.58 15.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.024 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.818 HD12 ' N ' ' A' ' 16' ' ' LYS . 2.8 pp -75.1 -46.18 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.248 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.818 ' N ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -177.29 173.14 1.79 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.006 0.432 . . . . 0.0 111.594 179.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.817 ' HB2' HG21 ' A' ' 62' ' ' THR . . . -102.7 148.31 25.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.876 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mt -97.53 -72.91 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.639 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -118.09 41.91 2.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.713 0.292 . . . . 0.0 111.646 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.748 ' HA2' ' HB1' ' A' ' 58' ' ' ALA . . . 84.21 -52.41 4.71 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.736 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.53 -55.23 2.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 110.331 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.573 HG22 HG21 ' A' ' 33' ' ' THR . 4.0 m -68.55 106.87 2.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.148 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 17' ' ' ALA . 33.0 m -126.08 160.2 33.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.248 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.492 ' O ' HD13 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -95.73 142.4 28.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.662 179.644 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.817 ' HG ' HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -141.42 118.0 10.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.958 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.53 ' HB2' ' HB ' ' A' ' 13' ' ' THR . 3.8 mtt -72.22 99.29 2.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.572 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 5.3 t80 -96.47 104.74 16.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.192 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 38.67 52.72 1.87 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.34 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.34 -14.57 60.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.931 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.572 ' O ' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -120.75 97.08 48.63 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 6.7 Cg_exo -75.52 101.87 1.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.677 2.251 . . . . 0.0 113.101 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.436 ' O ' ' CE1' ' A' ' 34' ' ' PHE . 2.5 mtt -98.49 149.2 22.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.863 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.632 ' HB ' ' HA ' ' A' ' 87' ' ' ARG . 5.8 m -77.95 158.9 29.15 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.551 ' HA ' ' H ' ' A' ' 88' ' ' TRP . 72.4 m-85 -143.11 132.08 22.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.862 0.363 . . . . 0.0 110.833 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.467 ' HB3' ' HD3' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -133.68 114.47 13.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.376 -178.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER 170.37 -76.21 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.469 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.53 HD22 ' CG2' ' A' ' 99' ' ' VAL . 4.5 mt 53.32 -86.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.237 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -133.12 98.39 4.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.779 0.323 . . . . 0.0 110.672 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 39' ' ' VAL . 9.6 p -61.77 109.93 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.867 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.77 ' HB2' HG13 ' A' ' 51' ' ' VAL . 2.6 m-20 -136.01 -172.74 3.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 48' ' ' LYS . 1.2 t -124.53 114.88 27.08 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.153 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.546 ' HB3' ' HB3' ' A' ' 52' ' ' GLU . 22.5 Cg_exo -65.19 112.37 2.05 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.465 2.11 . . . . 0.0 112.228 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 68.71 -49.97 0.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.02 169.05 18.78 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.957 0.408 . . . . 0.0 111.384 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.404 ' HA ' HG21 ' A' ' 41' ' ' THR . 0.9 OUTLIER -119.68 -18.41 8.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.035 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.82 171.15 8.87 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.886 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -45.35 91.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.778 2.319 . . . . 0.0 112.855 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.429 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 0.8 OUTLIER -127.96 167.34 16.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.318 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.546 ' HG3' HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -133.87 148.24 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.973 0.416 . . . . 0.0 111.608 -179.394 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 42' ' ' PRO . . . 61.35 125.3 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.805 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.77 HG13 ' HB2' ' A' ' 40' ' ' ASP . 0.6 OUTLIER -70.66 162.16 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.965 0.412 . . . . 0.0 111.142 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -57.83 169.81 0.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.18 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.35 96.78 10.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.555 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.582 ' CD2' HD22 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -94.21 -35.97 12.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.527 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.06 -75.78 0.45 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.45 -0.881 . . . . 0.0 114.132 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.755 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 82.5 Cg_exo -49.69 -53.31 7.26 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.992 2.462 . . . . 0.0 114.111 -178.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.831 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 2.7 tm-20 -82.62 -13.98 55.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.748 ' HB1' ' HA2' ' A' ' 20' ' ' GLY . . . -90.6 -65.24 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.517 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 32.5 t -93.18 -42.79 9.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.581 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.755 ' HB3' ' HA ' ' A' ' 56' ' ' PRO . . . -68.76 -29.53 67.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.874 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.831 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . 4.9 t80 -90.05 -52.51 4.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.939 0.4 . . . . 0.0 111.295 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.817 HG21 ' HB2' ' A' ' 17' ' ' ALA . 16.8 m -51.79 -66.34 0.4 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.622 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -56.6 -33.31 66.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.745 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HD3' ' ND2' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -73.46 -54.46 8.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.762 0.315 . . . . 0.0 111.644 -179.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.592 ' SD ' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -51.49 -27.0 9.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.8 -179.424 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.639 HG12 HG12 ' A' ' 72' ' ' ILE . 33.6 m -99.01 -9.9 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -26.83 25.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.667 0.27 . . . . 0.0 111.305 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.4 ' ND2' ' HD3' ' A' ' 64' ' ' LYS . 25.3 p30 -103.63 -28.04 11.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.349 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -94.26 134.34 36.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.293 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -96.38 28.73 3.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.825 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.67 99.29 3.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.886 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.639 HG12 HG12 ' A' ' 66' ' ' VAL . 2.2 mp -130.16 91.29 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.071 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.427 ' HB3' ' OH ' ' A' ' 93' ' ' TYR . 0.7 OUTLIER -99.87 145.52 27.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.282 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.895 HG12 ' O ' ' A' ' 10' ' ' GLU . 14.8 p -119.9 128.69 75.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.257 0.551 . . . . 0.0 111.96 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.477 ' HG3' HD22 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -90.41 46.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.132 179.115 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.607 ' HB3' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -92.74 148.1 22.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.696 -178.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.511 ' H ' HD11 ' A' ' 89' ' ' LEU . 21.2 t0 -76.92 159.15 30.22 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.803 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.25 35.26 2.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.974 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.23 39.77 0.31 Allowed Glycine 0 CA--C 1.496 -1.152 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.773 ' CG ' HD12 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -78.28 138.94 38.86 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.296 1.046 . . . . 0.0 111.896 -178.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -66.19 69.62 0.06 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.156 -1.838 . . . . 0.0 110.615 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.887 HG21 ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -91.12 164.91 13.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.919 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.36 -43.13 11.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.644 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.502 ' O ' ' CG ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -172.03 -58.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.477 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.502 ' CG ' ' O ' ' A' ' 84' ' ' LYS . 33.4 m-85 -163.14 -10.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.04 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' A' ' 33' ' ' THR . . . -38.94 -34.54 0.29 Allowed Glycine 0 C--N 1.345 1.033 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.682 ' O ' HG22 ' A' ' 82' ' ' THR . 0.0 OUTLIER 162.88 161.24 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.493 0.663 . . . . 0.0 111.292 177.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.887 ' CD1' HG21 ' A' ' 82' ' ' THR . 12.8 m95 -126.76 172.62 10.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.162 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.828 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -76.9 161.92 28.01 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.764 ' N ' HD22 ' A' ' 89' ' ' LEU . . . -179.68 179.74 0.56 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 90' ' ' ALA . 54.3 m-85 -154.7 39.29 0.43 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.746 -1.116 . . . . 0.0 109.572 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.533 HG12 HD11 ' A' ' 25' ' ' LEU . 2.8 mp -37.99 143.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.05 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.504 ' HB3' ' HG3' ' A' ' 98' ' ' MET . 5.2 p90 -151.31 142.43 23.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.094 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.592 ' HB3' ' SD ' ' A' ' 65' ' ' MET . . . -108.81 108.82 19.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.363 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER 82.0 23.96 0.23 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.89 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.77 -38.84 2.98 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.423 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.14 133.56 34.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 111.416 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.504 ' HG3' ' HB3' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -68.96 139.43 55.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.535 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.595 HG11 ' HA ' ' A' ' 62' ' ' THR . 15.6 m -49.14 -28.57 2.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.829 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -87.68 -29.45 21.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.379 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 98' ' ' MET . 0.4 OUTLIER -58.22 -26.82 63.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.409 ' CB ' ' CE2' ' A' ' 61' ' ' PHE . . . -60.67 -67.7 0.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.352 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.842 HD11 ' HB2' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -147.75 94.71 2.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.898 0.38 . . . . 0.0 111.433 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.59 HG13 ' N ' ' A' ' 105' ' ' ARG . 8.9 p -108.93 -59.08 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.256 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.59 ' N ' HG13 ' A' ' 104' ' ' VAL . 47.1 mmm-85 -106.61 -27.85 10.6 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.488 ' OE1' ' HA ' ' A' ' 103' ' ' LEU . 0.2 OUTLIER -71.07 15.18 0.12 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.12 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 130.72 -2.61 5.67 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.1 -1.047 . . . . 0.0 114.255 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.582 HD22 ' CD2' ' A' ' 54' ' ' TYR . 5.5 mt 48.87 179.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.287 0.543 . . . . 0.0 111.81 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.842 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -102.7 137.09 41.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.069 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.869 179.917 . . . . . . . . 0 0 . 1 stop_ save_